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Abstract 
 Selectivity in both organic and medicinal chemistries represents the pinnacle of 
these scientific fields. The ability to do exactly as one intends in the most efficient manner 
facilitates a limited negative impact technology may impart in the environments in which 
it acts. As such, during these dissertation studies, I have endeavored to design new selective 
reactions to enable the most streamlined synthesis of organic molecules that may impart a 
variety of functions while simultaneously working to rationally create new drug substances 
that limit side effects in the patient, while also protecting the molecule from the harsh 
environment of an organism.  
 To briefly summarize the material contained herein, the first chapter comprises of 
the technologies I have developed for better enabled organic synthesis. These reactions can 
improve green chemistry initiatives to limit the negative impact on the environment, only 
possible because of the highly selective nature of these reactions. I expect these 
technologies should enable chemists who design molecules with many intended purposes, 
although they were designed with the intent of empowering medicinal chemists.  
 The second chapter of this work covers highly collaborative efforts to design 
improved chemotherapeutics in an effort to eradicate Tuberculosis, the leading cause of 
infectious disease mortality worldwide. These molecules range from selective pro-drugs 
that are released at the site of action by utilizing a selective targeting pro-moiety to 
rationally designed agents to take advantage of biological mechanism knowledge. These 
molecules can potentially be drugs in themselves while they certainly inform future 
endeavors to make new drug materials to combat Tuberculosis.   
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Preface 
 This document contains the majority of the technologies I have explored during the 
course of my PhD studies at the University of Minnesota. As such, the topics addressed 
herein vary greatly in their nature as the purpose of this dissertation is to report a breadth 
of new technologies relevant to modern medicinal chemists, especially those with a vested 
interest in the discovery of antibacterial chemotherapeutic agents. While a diverse array of 
medicinal chemistry-related topics is presented within these pages, the central focus of this 
work is of the importance of selectivity. 
 Selectivity, in both organic synthesis and drug development, represents the pinnacle 
of efficiency. Ideally, all technologies are developed to accomplish specific tasks with no 
“off-cycle” or “off-target” activities, other than those specifically sought by developers. In 
organic chemistry, this often manifests itself in the forms of side-product generation and 
reduced yields; while medicinal chemists and drug developers frequently struggle with 
removal of undesirable side-effects a new therapeutic may impart. During the course of 
these studies, I have pursued new technologies that hone in on optimal reactivity, using 
selectivity as a guiding principle. As such, I have been able to improve the nature of organic 
reactions as well as determine the effectiveness for the targeted delivery of 
chemotherapeutics. 
 Briefly, chapter 1 is the culmination of my efforts to impart selectivity into organic 
chemistry. I have done so by investigating the reduction of phosphine oxides by silane 
reductants. This reaction is important in its isolated form, enabling synthesis of di-and 
trivalent phosphines which have applications from medicinal chemistry to materials 
science. The full understanding of the mechanism of this reaction led to the creation of the 
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most active silane reductant recorded for this particular functional group conversion, while 
also having exquisite functional group tolerance. Additionally, this reagent can be also used 
to facilitate organocatalysis in reactions that can mediate the formation of a large variety 
of bonds. In particular, phosphine-redox mediated reactions represent an easy target for 
using our silane reductant. While these reactions are powerful, mild, and versatile, they 
frequently suffer from the generation of side-products that muddle purification and require 
the generation of a lot of waste in order to remove them. Phosphorus redox organocatalysis, 
powered by silane reduction for catalyst regeneration, alleviates these concerns by resulting 
in the regeneration of a simple-to-remove catalyst while minimizing byproduct formation. 
My efforts in studying phosphine oxide reductions has furthered this redox recycling 
research, allowing for unprecedented reactivity at ambient temperatures and efficient 
recycling. Our new reductant can also be used for other reductive processes, and the full 
scope of this reagent’s utility still needs exploration.  
 The other major part of my thesis work has focused on trying to improve human 
health by designing new chemotherapeutic and chemical-biology tool compounds to 
understand and improve treatments for the number one pathogenic bacteria, 
Mycobacterium tuberculosis. My approaches to tackling this pathogen have been quite 
diverse. One approach has focused on a target-directed pro-drug approach using a 
cephalosporin as the pro-moiety. This pro-moiety facilitates the direct delivery of toxic 
warheads while taking advantage of what is typically a resistance mechanism. In fact, 
removal of this now “activating” enzyme results in susceptibility to the -lactam targeting 
moiety as these molecules have the ability to act as dual warheads. In addition to imparting 
selectivity through a pro-drug strategy, I have had the opportunity to improve upon already 
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known drugs with natural selectivity for M. tuberculosis. These new molecules take 
advantage of the mechanism of action, which had been previously undetermined, to create 
a drug which circumvents the clinically-relevant resistance mechanism. Additionally, I 
have had the opportunity to design a molecule that is purposefully unselective. This 
particular strategy utilizes a warhead with ubiquitous activity across an important enzyme 
family, with the intended application to understand the selectivity of other drug substances 
that target this class of enzymes. Understanding the nature of a drug’s selectivity can help 
rational drug design campaigns, while predetermining off-target effects for a particular 
molecule. This probe will be particularly useful in the design of therapies for a multitude 
of pathologies in addition to informing discovery/optimization of antitubercular 
chemotherapeutics.  
 All in all, this document recounts successes and failures in these endeavors. There 
will be more to each of these studies and I am proud that others in our lab are interested in 
carrying out more experiments for these stories. As such, for some of these projects, I am 
reporting what we have initially discovered with the hope of informing future campaigns. 
Within this text is also described the logic that facilitated rapid developments in 
reagent/drug optimization, much of which has to be excluded from peer-reviewed 
manuscripts due to space constraints.  
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I. The development of chemoselective reactions through rational reagent design 
The material reproducing data, figures, and text from previously published manuscrpts 
have been done so with permission from Georg Verlag Thieme and John Wiley and Sons-
VCH.  
1.1 Introduction 
Organic compounds containing a silicon atom come in a variety of shapes, sizes, and 
substitution patterns, permitting the use of such compounds in a wide array of applications. To 
the synthetic organic chemist, silicon-containing compounds are frequently used to reap the 
benefits that silicon confers with regards to chemoselectivity, ease of use, and predictable 
behavior. In this discipline, silicon is often encountered as silyl-hydride (R3Si-H), siloxanes (R2HSi-
OSiR3), silyl chlorides (R3Si-Cl), and silyl ethers (R3Si-OCR3), although all of these compounds are 
referred to as silanes (Figure 1.1). Probably the most widely-utilized application of silanes comes 
in the form of the silyl protecting group for the alcohol.1 Silyl chlorides are utilized in a predictive 
manner as deprotonated alcohols can hydrolyze the Si-Cl bond, forming a much stronger silicon 
oxygen bond. The silyl ether is much less reactive in the majority of organic transformations 
compared to the bare alcohol as the liability from the hydrogen atom with a low pKa2 is removed. 
However, the remarkable thing about this functional group is that its incorporation within a 
molecule is reversible as treatment with highly acidic conditions or fluoride cleaves the Si-O 
bond.1 This example of silane usage highlights the predictable nature of the silyl chloride’s 
reactivity, the selectivity for modifying a hydroxyl group, which can be utilized almost ubiquitously 
through complex total syntheses, even being utilized in the synthesis of Palau’amine,3 one of the 
most complex natural products ever fully synthesized by chemists.  
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Figure 1.1. The diversity of silane functional groups and their use as materials in organic 
chemistry. 
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However, silanes containing the silyl-hydride functionality are also frequently used in 
synthetic organic chemistry, often finding themselves as reductants for a variety of functional 
groups used in many applications. Silane-mediated reductions usually occur through metal-
mediated reactions4 or act as direct hydrogen atom transfer (HAT) reagents.4 These reagents have 
been known for their high chemoselctivity, and are capable of performing certain transformations 
under significantly milder conditions than other organic reducing agents (i.e. boranes), or metal 
hydrides (i.e. LiAlH4). One such reaction is the reduction of phosphorus(V) oxides to phosphines, 
a surprisingly difficult reaction due to the strong phosphorus oxygen double bond (~110 
kcal/mol5), however, this transformation provides a simple route to phosphorus(III) compound, 
called phosphines. 
Phosphines are valuable reagents in synthetic organic chemistry and ubiquitous ligands in 
homogenous catalysis.6 Phosphine redox reactions including the Wittig,7 Staudinger,8 Appel,9 and 
Mitsunobu10 reactions foster a diverse array of synthetic chemistry utilizing the conversion of 
phosphines to phosphine oxides (PIII PV=O) as the principle thermodynamic driving force for 
reactivity. Despite their prominence, stoichiometric phosphine redox chemical processes lack 
atom economy and generate difficult-to-separate phosphine oxide waste streams.  Driven by the 
guiding principles of sustainable chemistry, there have been significant efforts to develop catalytic 
redox processes to recycle phosphines or, alternatively, to design entirely new redox neutral 
reactions operating at either the PIII or PV=O oxidation state.11 For the purposes of framing the 
work contained herein, I will skip over the majority of the redox neutral research, as these 
reactions frequently lack the ease-of-use desired by today’s medicinal chemists. While these 
processes are inherently interesting, the redox recycling approach has seemingly garnered more 
interest from the chemical community. 
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The large energy required to reduce PV=O to PIII presents unique challenges because typical 
reductants employed for this transformation (LiAlH4,12 trichlorosilane,13 Borohydride,14 
diisobutylaluminum hydride15) are incompatible with many common functional groups.16 A key 
advance in the field has been the exploration of silanes exhibiting greater chemoselectivity such 
as phenylsilane (PhSiH3)17 and diphenylsilane (Ph2SiH2) in conjunction with reactive, strained 
phosphorus heterocycles (Figure 1.2). Up until the beginnings of this work, the redox recycling 
approach utilizing these types of reagents had been successfully utilized in the Wittig,18 
Stuadinger,19 and Appel reactions,20 as well as in some new synthetic applications.21 The catalytic 
Wittig reaction (CWR), the first such reaction, was pioneered by Prof. Dr. Christopher J. O’Brien 
utilizing the power of the selective reduction of phosphine oxides by the silane reducing agent 
Ph2SiH2.18a In his initial report, O’Brien paired the strained phosphorus heterocycle, 3-methyl-1-
phenyl-phospholane-1-oxide (M1PPO), with diphenylsilane and heat. Both of these additions are 
unnecessary for typical stoichiometric Wittig reactions, with stabilized ylides, yet do not disrupt 
the reaction. These design criteria, were then applied more broadly with other phosphorus 
heterocycles to afford other redox recycling processes (Figure 1.3). However, elevated 
temperatures (~80–110 °C) or Brønsted acid additives are needed to achieve acceptable 
conversions that restrict substrate scope and have precluded widespread adoption of phosphine 
redox catalysis. Optimization of silane-mediated phosphine oxide reduction through 
semiempirical phosphine tuning and silane screening appears to have reached a plateau. We 
believe this is due to a dearth of advancement in terms of understanding/improving the rate-
determining step, the reduction of the phosphine oxide. 
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Figure 1.2. The classical Wittig Olefination and its catalytic counterpart using strained 
phosphorus heterocycles.  
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Figure 1.3. Examples of catalytic redox recycling reactions.  
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To briefly summarize what is believed concerning this reaction’s mechanism, one scientist 
seems to be the driving force behind all predictions, calculations, and design behind the silane-
mediated reduction of phosphine oxides. Dr. Kenneth Marsi postulated, more than forty years 
ago, the biomolecular reaction between phenylsilane and phosphine oxides proceeds through a 
4-membered transition state (TS-1) to produce the H-phosphonium and siloxane tight ion pair 
(Scheme 1.1).17 Subsequent intermolecular proton transfer affords the observed phosphine and 
silanol products. Contemporary Density Functional Theory (DFT) calculations support TS-1 as the 
rate-limiting step, yet diverge thereafter via a nonpolar mechanism.22,23 However, experimental 
validation is surprisingly limited and even fundamental parameters such as the reaction order and 
elementary rate constants have never been reported.  
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Scheme 1.1. Phenylsilane-mediated reductions of phosphine oxides via Marsi’s [2+2] 
transition state. 
 
  
ǂ 
TS-1 
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Strained phosphorus heterocycle P-oxides lower the activation barrier for silane reduction 
through their higher torsional strain in the pseudotetrahedral ground state that is relieved in the 
trigonal bipyramidal phosphorane of TS-1.  The influence of ring strain on reaction rates was nicely 
illustrated by van Delft, who showed 5-membered phospholane P-oxides were reduced 
quantitatively by diphenylsilane within 150 minutes under non-pseudo first order conditions (e.g. 
slight excess of silane) at 100 °C while the corresponding 6-membered phosphinane showed only 
10% conversion and the 7-membered phosphepane was unreactive under identical reaction 
conditions.20 Radosevich recently introduced the highly strained 4-membered phosphetanes for 
phosphine redox catalysis and demonstrated their superiority over phospholanes in a novel 
deoxygenative condensation of -keto esters and carboxylic acids.21a The stereoelectronic effects 
of the phosphorus heterocycle P-oxides on reactivity have been less explored, especially in the 
context of saturated heterocycles, but results with unsaturated dibenzophospholes suggest 
electron-donating substituents may increase the rate of reduction by silanes, as bis-(2,8-
trifluoromethyl)dibenzophosphole P-oxide was reduced approximately 3-fold slower than bis-
(2,8-methoxy)dibenzophosphole P-oxide or the parent dibenzophosphole P-oxide.20 While this 
may seem counterintuitive, the oxygen atom of the phosphine oxide is predicted to first interact 
with phenylsilane to form a hypervalent phenylsilicate anion prior to the predicted rate-
determining hydride transfer, thus, enhanced Lewis basicity of the phosphine oxide may be 
preferred.22 Concordant with these data, O’Brien and co-workers also experimentally showed that 
electron-poor 4-(trifluoromethyl)phenylsilane was a much more active reductant improving the 
reduction rate of TPPO with a Brønsted acid additive, although the opposing electron-rich silane 
was not shown to be a less competent reductant.24 We posit further advances to realize the 
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ultimate goal of robust, chemoselective, additive-free, room temperature reduction of phosphine 
oxides has been impeded by a fundamental misunderstanding of the reaction mechanism.  
Although the exact nature of the reduction is not necessarily understood, empirical studies 
have led to massive improvements. Improving upon the initial CWR, O’Brien further the method 
by lowering the temperature of the catalytic process to ambient temperatures.24 To achieve this, 
a catalytic benzoic acid, p-nitrobenzoic acid (PNBA), was added to facilitate faster reduction of the 
phosphine oxide. The reason behind this was never truly established, but it is notable that the 
addition of this acidic additive to a reaction that requires basic conditions rapidly leads to 
phosphine oxide reduction. Additionally, this additive could be used in tandem with an acyclic 
phosphine oxide to facilitate the first ring-strain free catalytic redox recycling protocol.24 While 
this additive could be used in the Wittig reaction with no measurable ill-effect, this strategy 
cannot necessarily be employed ubiquitously as these types of additives would interfere with 
Mitsunobu, Appel halogenation processes, and Staudinger reductions. However, other Brønsted 
acids have since found use in phosphine oxide recycling, as the phosphine oxide reduction-
promoting reagent Bis-(p-nitrophenyl)-phosphoric acid (BNPA),25 first discovered by Prof. Dr. 
Matthias Beller, has also found use in catalytic processes, generally derived from the group of 
Prof. Dr. Mecinovic.26  Additionally, trifluoromethanesulfonic acid has also found limited use in 
these sorts of reactions.27 
In addition to the aforementioned Brønsted acid additives, several Lewis acids including 
transition metal complexes (Ti(OiPr)4,28, 29, 30 Cu(OTf)231) as well as main group complexes 
(B(C6F5)3,32 borinic acids,33 fluorophosphonium salts,34 In(III)35) have been described for silane-
mediated reduction of acyclic phosphine oxides at elevated temperatures; although there are few 
examples that have been investigated in phosphine redox catalysis employing phosphorus 
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heterocycles.18-20, 36 These additives, again, seem to have been discovered through “brute-force” 
means, with limited knowledge pushing their development beyond empirical screening for 
reactivity. These additives seem to also lack broad utility over the entire reaction suite of 
phosphorus redox catalysis.  
Our initial goal was to extend this concept to its use in Mitsunobu reactions, a phosphorus-
mediated substitution of an alcohol synthon. This reaction has seen heavy use in the Aldrich lab 
specifically,37 although it is frequently avoided in industrial settings due to its heavy waste stream 
and lack of atom economy.38 The pharmaceutical round table at the green chemistry institute has 
placed special emphasis that a “greener” version of this reaction is in great need, as the reaction 
itself provides a very powerful transformation and a better version would enable many modes of 
discovery chemistry in industrial settings.38 We elected to start with the knowledge that had been 
gained by others, but hoped that our present investigations would reveal the mechanism of 
silane-mediated phosphine oxide reduction in the context of phosphine redox catalysis. Thus we 
selected phenylsilane because it has emerged as a preferred reagent due to its balance of 
reactivity and chemoselectivity; although the related reductant diphenylsilane possesses similar 
attributes. Other silane reagents such as trichlorosilane13 and hexachlorodisilane39 have been 
used as “chemoselective” reducing agents, but it is quite clear these reagents would be 
incompatible with functional groups present in Mitsunobu reactions. Moreover, phenylsilane 
contains three hydrides and it is generally assumed that all three can participate in phosphine 
oxide reduction,17 implying phenylsilanol and/or phenylsilanediol are also competent reducing 
agents. The simple alkoxysiloxanes (EtO)2SiMeH and (EtO)3SiH have also found limited use in 
phosphine redox catalysis while the inexpensive siloxanes polymethylhydrosiloxane (PHMS) and 
1,1,3,3-tetramethyldisiloxane (TMDSO)40 have primarily been used for phosphine oxide 
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reduction41 We also hoped to understand more about the Brønsted acid additives, and to get a 
better understanding of how to rationally design improvements to these processes in a manner 
that is amenable to ubiquitous application within redox recycling catalysis. Seeing that phosphine 
oxide reduction is the only unifying feature of these reductions, we rationalized that 
characterization of this reaction component should foster the most rapid improvement, hopefully 
leading to better Mitsunobu, Wittig, and Staudinger reactions. 
1.2 Development of a Catalytic Mitsunobu Reaction 
The Mitsunobu reaction is the displacement of an alcohol with a pronucleophile (Nu-H) 
mediated by phosphine and azocarboxylate reagents, which work in concert to activate the 
pronucleophile through deprotonation and convert the alcohol to a reactive alkoxyphosphonium 
species.10 Renowned for its mild reaction conditions and broad substrate tolerance, the 
Mitsunobu reaction is capable of forming C-O, C-N, C-S, C-X, and C-C bonds.42  However, the 
Mitsunobu reaction is highly under-utilized in process chemistry and manufacturing due to 
arduous purification from by-products and poor atom economy.43  Although several innovative 
reagents have been developed to facillitate purification that can be removed by liquid-liquid or 
solid-liquid extractions,44  the ideal Mitsunobu reaction would be catalytic in phosphine and 
azocarboxylate, and use innocuous reagents to recycle these catalysts.38 Toward this goal, Toy 
and co-workers  rendered the Mitsunobu catalytic in the azocarboxylate using PhI(OAc)2 to oxidize 
the hydrazine byproduct45 while Taniguchi and co-workers developed an iron-phthalocyanine 
catalytic system employing oxygen as the terminal oxidant.46 To date, a only one example of a 
Mitsunobu reaction catalytic in phosphine is presented in patent literature,47 and optimization of 
this reaction is heavily desired.44, 48 Herein we report the development and optimization of the 
first Mitsunobu reaction catalytic in phosphorus utilizing dibenzophosphole and phospholane 
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precatalysts 5PDBP and 1PPO (Scheme 1.2B), inspired by the work in the development of the 
catalytic Appel19, Staudinger20, and Wittig18 reactions. 
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Scheme 1.2. The Proposed Catalytic Mitsunobu Reaction.   
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Chemoselective reduction of the phosphine oxide product back to the phosphine in the presence 
of a reactive azo compound is required in order to complete the phosphine catalytic cycle. We 
initially investigated dibenzophosphole oxide 5PDBPO as a precatalyst due to its facile reduction 
by silanes and ability to tune the catalyst through modification of the aryl rings.19 The coupling of 
4-nitrobenzoic acid and benzyl alcohol or p-trifluoromethylbenzyl alcohol was studied as a model 
system employing stoichiometric DIAD, 10 mol% 5PDBPO and various silanes (Table 1.1). To 
benchmark these results, the yield obtained using stoichiometric triphenylphosphine (TPP) was 
determined as 84% (Table 1.1, entry 1). Polymethylhydrosiloxane and triphenylsilane did not 
provide catalytic turnover (Table 1.1, entries 3-4). Diphenylsilane (Table 1.1, entry 5) provided the 
first encouraging yield of 42%, while phenylsilane (Table 1.1, entry 6) furnished an improved 63% 
yield. We next explored the impact of PhSiH3 stoichiometry (Table 1.1, entries 8-11) on the 
outcome of the reaction. We observed that excess silane was detrimental, although it led to faster 
conversion. Conversely, lower equivalents of silane led to substantially slower conversion, but did 
result in slightly improved yields. As a control, we also measured the background reaction in the 
absence of PhSiH3 confirming its vital role (Table 1.1, entry 8). The reaction of PhSiH3 with alcohols 
in the presence of Lewis acids (i.e. p-nitrobenzoic acid) at elevated temperatures is previously 
known49 and contributed to the lower yields (Figure 1.4). Thus, even the stoichiometric TPP 
reaction was lowered from 84% to 77% when PhSiH3 was included in the reaction (Table 1.1, 
entries 1 and 2). Based on these considerations, we settled on 1.1 equivalents of PhSiH3 as 
optimal, to minimize both reaction time and undesired reactivity. Finally, we evaluated 
phospholane precatalyst 1PPO using our optimized conditions and were elated to obtain a 77% 
yield (Table 1.1, entry 12), identical to the stoichiometric TPP version under the same conditions. 
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The catalyst loading could be lowered to 5 mol% without affecting the yield, while 1 mol% still 
provided a respectable 54% yield (Table 1.1, entries 12-15).  
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Table 1.1. Development of conditions for the catalytic Mitsunobu in phosphine.[a] 
Entry R = [P] X = Silane Y = Product Yield[b] 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
H 
H 
H 
H 
H 
H 
H 
CF3 
CF3 
CF3 
CF3 
H 
H 
H 
H 
TPP 
TPP 
1 
1 
1 
1 
1 
1 
1 
1 
1 
2 
2 
2 
2 
110 
110 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
5 
2 
1 
None 
PhSiH3 
PHMS 
Ph3SiH 
Ph2SiH2 
PhSiH3 
None 
PhSiH3 
PhSiH3 
PhSiH3 
PhSiH3 
PhSiH3 
PhSiH3 
PhSiH3 
PhSiH3 
- 
1.1 
1.5 
2.0 
1.1 
1.1 
- 
0.5 
1.5 
3.0 
6.0 
1.1 
1.1 
1.1 
1.1 
1a 
1a 
1a 
1a 
1a 
1a 
1a 
1b 
1b 
1b 
1b 
1a 
1a 
1a 
1a 
84 
77 
0 
0 
42 
63 
0[c] 
66[d] 
63 
52 
43 
77 
77[e] 
58[f] 
54[g] 
[a] Reactions performed on 1 mmol scale at 0.25 M [b] Isolated 
average of two reactions [c] Reactions with the reduced form of 
5PDBPO without silane added produced 7% of product [d] 46 h [e] 
Reaction at 10 mmol scale was performed with 78% yield [f] 38 h [g] 
69 h 
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Figure 1.4. NMR spectra of selective silane reactivity; A) The spectrum of 4-
(trifluoromethyl)benzyl alcohol heated in d8-THF; B) the reaction of 4-(trifluoromethyl)benzyl 
alcohol with PNBA; C) the reaction of 4-(trifluoromethyl)benzyl alcohol with phenylsilane; and D) 
the reaction of 4-(trifluoromethyl)benzyl alcohol with PNBA and phenylsilane. All spectra were 
collected after 46 h.  
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We speculated that the greater reactivity of catalyst 1PPO was due to its more facile reduction 
by PhSiH3, which is the rate-limiting step in the phosphine catalytic cycle. van Delft and co-workers 
had indicated that 5PDBPO and 1PPO were nearly equivalent in reactivity as measured by 
reduction with Ph2SiH2 at 100 °C in 1,4-dioxane.19 To more rigorously study the relative reactivity 
of 5PDBPO and 1PPO, we measured their rates of reduction by 31P NMR under pseudo first-order 
conditions (30, 15, 7.5 equiv PhSiH3) at various temperatures ranging from 25 to 80 °C. The 
activation energies (Ea) were then calculated from the temperature dependence of the second-
order rate constants using Arrhenius and Eyring plots. Reduction of 1PPO was facile, even at 25 °C, 
as evident of its low Ea of 14.1 ± 0.4 kcal mol-1. Whereas 5PDBPO was significantly less reactive 
with a Ea of 21.3 ± 3.6 kcal mol-1 and was not reduced at 25 °C even after 120 hours. These data 
would indicate the catalytic Mitsunobu reaction should readily occur at room temperature with 
1PPO. Unfortunately, this is not realized in practice and the catalytic Mitsunobu reaction requires 
elevated temperatures to achieve complete conversion. The activation energies were determined 
in the absence of other reagents (pronucleophile, alcohol, and DIAD), which we have shown 
attenuate the rate of phosphine reduction (Table 1.2). 
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Table 1.2. The effect of p-nitrobenzoic acid on the reduction of the phosphine precatalyst 1PPO.[a] 
Entry Phosphine X = T = kobs (s-1) Half-life (min) Slowing of Rate[b] 
1 
2 
3 
4 
1PPO 
1PPO 
1PPO 
1PPO 
7.5 
15 
30 
30 
80 
80 
80 
25 
0.0028 
0.0044 
0.0085 
0.0002 
247.5 
157.5 
81.5 
3465 
6.9 
5.4 
4.3 
5.0 
[a] Reactions performed in triplicate using the procedure outlined in section 7.1.1. with 
25 mg of p-nitrobenzoic acid (PNBA) added with the catalyst. [b] Calculated by dividing 
the average kobs values for reductions without PNBA over average kobs values for 
reductions with PNBA. 
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With optimized catalytic conditions established, we then investigated the substrate scope 
with a range of alcohols and pronucleophiles (Table 1.3). For comparison purposes, the yields of 
the stoichiometric reaction conducted at room temperature are also presented. Primary benzylic, 
allylic, and alkyl alcohols (Table 1.3, entries 1-6) were reacted with p-nitrobenzoic acid to afford 
the corresponding esters in moderate to good yields. The lower yield of the benzylic substrates, 
relative to the stoichiometric reaction, is due to competitive silane reactivity of the alcohols 
(Figure 1.4). Notably, the 82% yield obtained with the simple alkyl alcohol, 3-(4-flurophenyl)-
propanol (Table 1.3, entry 5) was identical to the stoichiometric50 version. Propargyl alcohol was 
also esterified with 84% yield (Table 1.3, entry 6), similar to its stoichiometric counterpart. 
Secondary alcohols were also competent substrates (Table 1.3, entries 7-8) providing respectable 
yields with high enantiomeric purities (er >94:6). We next examined the coupling of 2-
phenylethanol with benzoic acid, aminoacid, phenol, and sulfamide pronucleophiles (Table 1.3, 
entries 9-12). These substrates all afforded the corresponding products in good to excellent yields 
compared to the stoichiometric reaction. Intramolecular reaction of Boc-protected homoserine 
furnished the -lactone in an impressive 87% yield (Table 1.3, entry 13). The background reaction 
lacking the phosphine catalyst was less than 2%. Reaction of 2,3-O-isopropylideneinosine with 
Boc-protected sulfamide provided the coupled product in 70% yield (Table 1.3, entry 14) 
highlighting the utility of the catalytic Mitsunobu reaction with more challenging substrates.  
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Table 1.3: The substrate scope of the catalytic Mitsunobu reaction.[a] 
 
Entry Product Catalytic Yield[%][b] Stoichiometric Yield[%][b,c] 
1 
 
77 94 
2 
 
76 92 
3 
 
61 80 
4 
 
50 50 
5 
 
82 82 
6  84 90 
7 
 
69[d] 77[d] 
8 
 
68[e] 78[e] 
9 
 
76 96 
10  63 83 
11  51[f] 85[f] 
12  72 90 
13   
87[g,h] 
 
98[g] 
14 
 
70[e] 93[i] 
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[a] Reactions performed on 0.5-1.0 mmol scale at 0.25 M employing 1.5 equiv of 
pronucleophile, 10 mol% loadings of catalyst 2, and 1.1 equivalents of both DIAD and PhSiH3. 
Reactions were all run at 80 °C. [b] Isolated average of two reactions. [c] Reactions 
performed at 23 °C with 1.5 equiv of pronucleophile, TPP, and DIAD without phenylsilane 
for 18 h. [d] ER 94:6 [e] ER > 99.5:0.5 [f] 48 h. [g] Concentration was 0.04 M. [h] Background 
reaction with only Boc-Hse-OH, DIAD, and PhSiH3 had trace yield. [i] 3 equiv N-boc 
sulphamide was used as the pronucleophile. 
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In order to improve this reaction for broader utility it would be necessary to improve the 
reduction of the phosphine oxide to recycle the catalyst, the rate-limiting step in the catalytic 
cycle. This would help improve the effective on-target percentage of the silane reducing agent. 
Unfortunately, in the presence of a strong pronucleophile (i.e. carboxylic acid) and elevated 
temperature promotes significant side reactivity. As mentioned, silanes can react with alcohols, 
so much so, that selectivity for product in the catalytic Mitsunobu reaction to silyl byproducts is 
rapidly shifted when silane is added to reactions (Table 1.4).  
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Table 1.4. The initial optimization of silane concentration in the catalytic Mitsunobu reaction.[a] 
 
 
Entry X = Y = Product : Silyl By-Products[b] Yield[c] 
1 
2 
3 
4 
5 
6 
7 
10 
10 
10 
10 
5 
5 
5 
0.5 
1.5 
3.0 
6.0 
1.5 
3.0 
6.0 
1.2 : 1 
1.15 : 1 
1 : 1 
1 : 1.18 
1 : 1 
1 : 1.65 
1 : 2 
66[d] 
63 
52 
43 
55 
36 
29 
[a] Reactions performed on 1.0 mmol scale in a 15 mL pressure tube at 0.25M using the general 
procedure for a catalytic Mitsunobu reaction. [b] Relative product distribution determined by 
integration of crude 19F NMR with C6F6 as internal standard. [c] Isolated average of two reactions 
after 18 h. [d] 46 h. 
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1.3 Mechanistic insight provides a means to rational reagent design 
Knowing that the rate-determining step needed improvement, I moved to even further 
characterize the requirements for silane-mediated reductions of phosphine oxides. To simplify 
this investigation, 31P NMR was used to monitor the isolated reduction reaction, and kinetics 
would be used assay the reactivity of new phosphines and/or silane pairs which should then 
translate to improved redox recycling reactions.  
To begin our mechanistic investigation, I synthesized a small series of strained phosphorus 
heterocycles to probe the impact of ring strain and electronics on reduction by phenylsilane. I 
started with the prototypical phospholane,1-phenylphospholane-1-oxide (1PPO)51, and 
generated the isoelectronic 4-membered 2,2,3-trimethyl-1-phenylphosphetane-1-oxide 
(TMPPO)52, 53 via previously-described means. Based on the hypothesis that electron-donating 
substituents may enhance the rate of reduction, we synthesized 2,2,3-trimethyl-1-
butylphosphetane-1-oxide (TMBPO) and 2,2,3-trimethyl-1-pyrrolidinylphosphetane-1-oxide 
(TMPyrPO) containing a hyperconjugatively54 donating n-butyl and resonance donating 
pyrrolidinyl substituent, respectively (Scheme 1.3). 
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Scheme 1.3. Synthesis and identification of cyclic phosphine oxide precatalysts. 
 
  
53 
 
The reactivity of phenylsilane with each phosphine oxide was monitored with 31P NMR at 80 
°C employing phosphine oxide concentrations ([PO] = 0.04 M) relevant in phosphine redox 
catalysis under pseudo-first order conditions ([phenylsilane] = 0.40 M) as described in the 
methods section (Chapter 1.8). Data were gathered every 2-5 minutes and an unbiased 
automated integration platform, developed by Dr. Carter Eiden, was used to analyze the data in 
a quick and efficient manner.55 When I first ran the reduction of TMPPO with this rate of sampling, 
I ended up with reduction profile that looked quite peculiar. Noticing that the curvature did not 
appear to be reminiscent of reactions governed by first-order kinetics. I approached Dr. Carter 
Eiden, a kineticist, with my intriguing data and asked for help evaluating this reaction with such a 
complex order.  He agreed, and even agreed to help gather more data to interpret as the 
reaction’s behavior was very abnormal and had so much information in even one curve. The 
reaction progress curves, gathered by Dr. Carter Eiden, shown in Figure 1.5 demonstrate the 
complexity of this reduction as the 4-membered phosphetane oxide TMPPO and the 5-membered 
phospholane oxide 1PPO were reduced at equal rates indicating that additional ring strain in the 
phosphetane does not translate into improved reactivity. On the other hand, as predicted, 
increasing the Lewis basicity of the phosphetane oxide by incorporation of electron-donating 
substituents in TMBPO and TMPyrPO led to a two- and four-fold enhancement in rate, 
respectively (Table 1.5). As a crude measure of Lewis basicity, I directed my undergraduate 
mentee, Kathleen Wang, to calculate the Mulliken charges56 for the oxygen atom of each 
phosphine oxide using DFT and the M06-2X/6-31+G(d,p) basis set57 to provide an estimate of the 
partial charge on the oxygen atom for this series of compounds. As summarized in Table 1.6, the 
calculated Mulliken charges for each of the phosphine oxides correlate nicely with the observed 
reactivity. While TPPO was calculated to be more Lewis basic than the other phosphine oxides, its 
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lack of ring-strain renders this compound inert under these reaction conditions, owing to the 
necessity of ring strain first hypothesized by O’Brien and Chass.18 Although TMPyrPO was the 
most reactive phosphine oxide examined; its incompatibility in polar polar solvents (THF, MeCN, 
DMF) and tendency to over-reduce to a secondary phosphetane17 suggests it may not be an ideal 
precatalyst in phosphine redox reactions. 
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Figure 1.5. The reduction of strained phosphorus heterocycles by PhSiH3 at 80 °C; A) 
The average reaction progress curves  of reduction as determined with 31P NMR; B) The 
derivative curve of the reduction of TMPPO.  Data collected by Dr. Carter Eiden.
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  Table 1.5. Comparison of precatalyst reductions by phenylsilane at 80 °C. 
 
Entry PO kobs (min-1)a t50% (min) t90% (min) 
1 TPPO n.d.c n.d.c n.d.c 
2 1PPO 0.028 37.3 91 
3 TMPPO 0.027 36.5 92 
4 TMBPO 0.054 16.4 48 
5 TMPyrPO 0.103 8.4 21 
aSee chapter 1.8; bCould not be determined. 
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Table 1.6. Calculated Mulliken charges of phosphine oxide 
precatalysts.a 
Entry PO Charge (P)b Charge (O)b 
1 TPPO 0.824959 -0.711251 
2 1PPO 0.165482 -0.577962 
3 TMPPO 0.904052 -0.583227 
4 TMBPO 1.162698 -0.675419 
5 TMPyrPO 1.497421 -0.769144 
aDFT calculations performed with Gaussian using the M06-
2X/6-31+G(d,p) basis set; bAtomic units. 
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Intriguingly, all four reduction progress curves (Figure 1.5A) display an initial “lag phase” 
where the rate of reduction of the phosphine oxide increases following initiation. Such behavior 
is indicative of a multi-step kinetic mechanism. For added evidence against a single-step kinetic 
mechanism, the curves in Figure 1.5A were fit to both a single exponential and the sum of two 
exponentials. Upon visual inspection, it is clear the double-exponential fitting is far superior 
(Figure 1.6, Table 1.7), an assessment confirmed quantitatively as the variance per data point is 5 
to 13-fold lower. The double exponential fitting was then used to generate derivative curves 
similar to the one shown in Figure 1.5B (Figure 1.7), which shows a pronounced rate increase 
during the early time points. 
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Figure 1.6. The single and double exponential fittings for reduction progress curves 
observed for the reduction of phosphine oxide precatalysts with PhSiH3. Data fitting by Dr. 
Carter Eiden. 
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Table 1.7. Numerical comparison between single- and double-exponential fitting of reduction curves. 
Entry Variance (%PO Reduced)2 # Data Points Variance Per Data Point 
1PPO-Single 612.79 26 23.57 
1PPO-Double 60.93 26 2.34 
TMPPO-Single 468.99 28 16.74 
TMPPO-Double 37.93 28 1.35 
TMBPO-Single 215.23 16 13.45 
TMBPO-Double 35.14 16 2.20 
TMPyrPO-Single 133.23 14 9.52 
TMPyrPO-Double 37.09 14 2.65 
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Figure 1.7. The fitting (A) and derivative (B) curves of 1PPO (left, purple), TMPPO 
(center, green), and TMBPO (right, blue).  
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This information was quite notable because it conflicts with the proposed single-step kinetic 
mechanism for reduction of phosphine oxides by phenylsilane (Figure 1.8, Mechanism I).17 We 
then explored whether an intermediate phosphine oxide-silane complex could explain the 
observed “lag” phase (Figure 1.8, Mechanism II).  In order for this mechanism to be operative, the 
intermediate should accumulate to detectable levels given that both reaction steps are kinetically 
distinguishable. However, a new time-dependent resonance in 31P NMR besides the phosphine 
product was never observed during the reaction. For a sequential kinetic mechanism such as 
Mechanism II containing one intermediate, the normalized rate (expressed as the percent 
substrate remaining per unit time) should be independent of the initial variable substrate 
concentration leading to diagnostic superimposable reaction progress curves at different fixed 
substrate concentrations. However, we showed increasing the concentration of phosphine oxide, 
still under pseudo first-order conditions, changed the kinetic profile providing further evidence 
against Mechanism II (Figure 1.9).  
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Figure 1.8. The propoesed kinetic mechanisms for the reduction of phosphine oxides by 
PhSiH3.   
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Figure 1.9. The A) Observed reduction of TMPPO under pseudo first order conditions 
with PhSiH3; B, C, D) Fitting of raw data; E) Observed reduction times to 50% and 90% 
completion. Data collected by Dr. Carter Eiden.  
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Our next hypothesis to explain the biphasic kinetic profile in Figure 1.5 was the realization 
the silanol byproducts may reduce phosphine oxides more rapidly than phenylsilane and thus may 
be kinetically distinguishable leading to the proposal of Mechanism III (Figure 1.8). Recently, 
Fianchini, has proposed, using computational methods, that silanol byproducts are competent 
reducing agents with the potential to accelerate the rate of phosphine oxide reduction.58  As the 
concentration of phenylsilane does not change over the course of the reaction, a dependence of 
the reduction rate on the concentration of phosphine oxide strongly suggests it is present at a 
greater or similar concentration than a rapid reductant. Seeing that silanol byproducts are the 
only likely culprit to act as this rapid reductant we chose to attempt to isolate this species. Silanols 
exist in equilibrium with the corresponding disiloxanes through self-condensation and that 
equilibrium favors the disiloxane species (association constants of ~104 M-1) except for substrates 
containing multiple bulky substituents, while silanediols equilibrate into complex polymeric 
structures.59 Consequently, we prepared, 1,3-diphenyldisiloxane (DPDS) that equilibrates to 
phenylsilanol, the initial byproduct from one turnover of phenylsilane (Scheme 1.4). 18a, 60 DPDS 
was evaluated against each of the cyclic phosphine P-oxides resulting in rapid reduction at 
ambient temperature (Figure 1.10). Illustrating the remarkable enhanced reactivity of DPDS, the 
electron-rich phosphetane oxides TMBPO and TMPyrPO were completely reduced within 30 
minutes while TMPPO and 1PPO required 75 and 150 minutes, respectively (Table 1.7) at ambient 
temperature. Most significantly, DPDS displayed single step kinetics as evidenced by the reaction 
progress and derivative curves in Figure 1.7 that follow single-exponential decay. These results 
support Mechanism III wherein the fast step corresponds to reduction by phenylsilanol and the 
slow step to reduction by phenylsilane. By this mechanism, DPDS itself would also be a viable 
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reductant, but would follow the Curtain-Hammett principle, likely only reacting through its silanol 
form.  
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Scheme 1.4. Synthesis and equilibrium of DPDS.  
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Figure 1.10. The reduction of phosphine oxide precatalysts with DPDS at 25 °C. A) 
Reaction progress curves using 31P NMR; B) The dervicative curve of the the reduction of TMPPO 
with DPDS. Data collected by Dr. Carter Eiden.  
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Table 1.8. Comparison of phosphacycle P-oxides reductions by DPDS at 25 °C. 
 
Entry PO kobs (min-1)a t50% (min) t90% (min) 
1 TPPO n.d.c n.d.c n.d.c 
2 1PPO 0.010 69.1 233 
3 TMPPO 0.018 37.9 129 
4 TMBPO 0.114 5.7 20 
5 TMPyrPO 0.093 9 23 
aSee Chapter 1.8; bCould not be determined. 
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To rigorously define the kinetic mechanism of DPDS-mediated phosphine oxide 
reduction, we monitored the reduction of TMBPO by DPDS. The rate exhibited a linear 
dependence on both DPDS and TMBPO concentration confirming the reaction is first order with 
respect to each substrate and second order overall furnishing a second order rate constant of 
(Figure 1.11). We then monitored the reaction kinetics at temperatures ranging from 0 to 25 °C 
to measure the energy barrier for the reaction. The activation parameters were determined by an 
Eyring plot (Figure 1.12), which showed a straight line over this temperature range indicating a 
single rate-limiting step and providing the activation parameters H‡ = 13.7 ± 0.9 kcal/mol, S‡ = 
–0.02 ± 1.2·10-4 kcal/mol and G298K
‡ = 18.8 ± 1.9 kcal/mol.  This compares favorably against the 
activation parameters gathered for TPPO in which H‡ = 17.3 ± 1.2 kcal/mol, S‡ = –0.01 ± 1.4·10-
4 cal/mol and G298K
‡ = 21.5 ± 3.6 kcal/mol (Figure 1.13). The negative values for the entropy of 
activation could imply an associative mechanism while the small enthalpies of activation deviate 
substantially from previously calculated transition states with phenylsilane.  
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Figure 1.11. The comparison of rate of reduction vs. the concentration of DPDS employed 
in the reduction of TPPO at 110 °C. Data collected by Dr. Carter Eiden. 
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Figure 1.12. Eyring plot of the silane-mediated reduction of TMPPO with DPDS over the 
temperature range of 0 – 25 °C. Data collected by Dr. Carter Eiden. 
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Figure 1.13. The Eyring plot of the silane-mediated reduction of TPPO with DPDS over 
the temperature range of 80 – 120 °C.  
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Although Mechanism III can account for a biphasic kinetic profile, detailed numerical 
investigation of the reaction progress curves in Figure 1.5 showed it could not simulate the 
experimental reaction progress curves. In Mechanism III, one would only expect a small increase 
in the rate of reduction over the initial time points; however, Figure 1.7 indicates a substantial 
rate increase. As detailed in the rest of this section, we evaluated the rate laws governing this 
kinetic scheme and show the observed increase in reaction velocity is incongruent with 
Mechanism III. 
The rate law for Mechanism III is given by equation 1 and the initial rate of the reaction is 
simplified to equation 2 because the concentration of both phenylsilanol and phenylsilanediol are 
both zero. 
𝑑[𝑃]
𝑑𝑡
= 𝑘1[𝑃ℎ𝑆𝑖𝐻3][𝑃𝑂] + 𝑘2[𝑃ℎ𝑆𝑖𝐻2𝑂𝐻][𝑃𝑂] + 𝑘3[𝑃ℎ𝑆𝑖(𝑂𝐻)2𝐻][𝑃𝑂]                          (eq 1) 
𝑅𝑎𝑡𝑒𝑖 = 𝑘1[𝑃ℎ𝑆𝑖𝐻3]𝑖[𝑃𝑂]𝑖                                                          (eq 2) 
The theoretical maximum rate at any time point can be calculated with a few underlying 
assumptions of this sequential reaction wherein each silane species can contribute to the overall 
rate. The first assumption is that k2 and k3 >> k1, which allows implementation of the steady-state 
approximation to calculate the concentration of the intermediate phenylsilanol. Under these 
conditions the concentration of phenylsilanol will be low as it is consumed much faster than it is 
produced and importantly remain constant during most of the time course. As shown in the 
methods subchapter using mathematical simulations (Figure 1.14 and Table 1.9), this appears to 
be reasonable assumption and is supported by the experimental data from Figure 1.5 and Figure 
1.10. To apply the steady-state approximation to calculate the concentration of phenylsilandiol, 
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it is necessary that k3 > k2, otherwise phenylsilandiol can build up during the reaction and exhibit 
more pronounced time-dependent changes in concentration. However, if k2 ≤ k3, then its 
contribution to the overall rate will be diminished. Since we are attempting to calculate the 
maximum theoretical velocity, we will presume k3 > k2 to simplify analysis and provide an upper 
limit to the reaction rate.  
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Figure 1.14. Graphical comparison of reaction progress curves (Figure 1.5B) and the fit 
obtained by the indicated parameters. Data fitting by Dr. Carter Eiden. 
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Table 1.9. Rate constants obtained through simulation. 
 k3 = k2 k3 = 10k2 k3 = ∞ 
 k1 k2 k1 k2 k1 k2 
1PPO 0.049 1.83 0.051 1.14 0.058 0.87 
TMPPO 0.038 3.01 0.039 1.90 0.040 1.67 
TMBPO 0.077 8.23 0.078 5.46 0.079 5.02 
TMPyrPO 0.133 25.0 0.134 16.7 0.135 15.4 
All rate constants are in units of (M-1s-1) 
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To illustrate our analysis, we elected to determine the maximum rate of Mechanism III at 
50% conversion because the reaction should be at steady-state and the reaction velocity can be 
accurately determined at this time. Under the pseudo first-order conditions, the rate at 50% 
conversion is given by equation 3.   
𝑑[𝑃]
𝑑𝑡
=
𝑘1[𝑃ℎ𝑆𝑖𝐻3]𝑖[𝑃𝑂]𝑖
2
+
𝑘2[𝑃ℎ𝑆𝑖𝐻2𝑂𝐻][𝑃𝑂]𝑖
2
+
𝑘3[𝑃ℎ𝑆𝑖(𝑂𝐻)2𝐻][𝑃𝑂]𝑖
2
                            (eq 3) 
The first term is clearly half of the initial rate presented in equation 2. To determine the 
value of the second term, we apply the steady-state approximation and set the derivative of the 
concentration of phenylsilanol with respect to time to be zero at 50% conversion as described in 
equation 4, leading to the equality displayed in equation 5. 
𝑑[𝑃ℎ𝑆𝑖𝐻2𝑂𝐻]
𝑑𝑡
=
𝑘1[𝑃ℎ𝑆𝑖𝐻3]𝑖[𝑃𝑂]𝑖
2
−
𝑘2[𝑃ℎ𝑆𝑖𝐻2𝑂𝐻][𝑃𝑂]𝑖
2
 =  0                              (eq 4) 
𝑘1[𝑃ℎ𝑆𝑖𝐻3]𝑖[𝑃𝑂]𝑖
2
=
𝑘2[𝑃ℎ𝑆𝑖𝐻2𝑂𝐻][𝑃𝑂]𝑖
2
                                                   (eq 5) 
Equation 5 indicates that the second term of equation 3 would be, at a maximum, equal 
to the half of the initial rate. The exact same strategy can then be applied to the third term of 
equation 3, which similarly shows the third term should be equal to half of the initial rate. From 
this analysis, the maximum value of the rate of phosphine formation at 50% conversion should be 
1.5 times that of the initial rate, which also seems intuitively correct. 
To determine the observed rate fold increase at 50% completion, we fit each of the curves 
in Figure 1.5A to a sum of two exponentials (Figure 1.6). This provides a very accurate estimate of 
the rate of reduction at 50% conversion, but struggles to precisely measure the initial rate. 
Therefore, we chose to use the average rate over the first two time points as an extremely 
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conservative estimate of the initial rate. As seen in Figure 1.7, the fold increase over initial of the 
rate of reduction at 50% conversion with TMBPO, TMPPO, and 1PPO are all larger than 1.5, with 
TMPPO in particular displaying an 11.4-fold increase. Consequently, we conclude the rate law in 
Equation 1 is indeed violated and Mechanism III cannot be correct.  
Because the kinetic profile for reduction of TMBPO, TMPPO, and 1PPO by phenylsilane 
does not conform to Mechanism III and  DPDS-mediated reductions are both rapid and behave as 
expected with single-exponential character, we proposed Mechanism IV, where phenylsilanol is 
generated by the reaction of phenylsilane with water, releasing hydrogen gas.  As previously 
discussed, it is well known that reduction of phosphine oxides by phenylsilane results in the 
production of both hydrogen gas and water.16, 17, 51 In the experimental section of his account from 
1974, Marsi writes: “Initial slow evolution of hydrogen signals the onset of the reaction.” This 
finding is not accounted for in his proposed mechanism, although it is consistent with our novel 
proposal. It is also noteworthy that tri-substituted hydrido-silanes, incapable of producing 
hydrido-silanol species like phenylsilanol, require temperatures exceeding 250 °C to reduce 
phosphine oxides.13, 61 This empirical evidence supports our hypothesis that phenylsilane is not 
itself an active reductant at synthetically-practical temperatures, but requires in-situ pre-
activation to generate the active reductant phenylsilanol.  
The Role of Water, a Previously Unknown Player in the Reduction of Phosphine Oxides. 
While Mechanism IV has explained all of our observations to this point, we had yet to verify the 
first step, wherein phenylsilane reacts with water. We thus preheated phenylsilane with wet (300 
– 1000 ppm water) d8-THF at 80 °C prior to the addition of phosphine oxide, reasoning that 
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preincubation would generate phenylsilanol and thereby increase the initial reaction rate.  
However, no rate increase was observed compared to the preincubation-free control (Figure 
1.15), suggesting that phenylsilane does not spontaneously react with adventitious water, and 
implies another component of the reaction must catalyze the necessary activation step. 
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Figure 1.15. The comparision of the reduction of with 1PPO no changes to the conditions 
in Figure 1.5 (purple, circles), phosphorus preheating (green, squares), and silane 
preheating (blue, triangles).   
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This was perplexing until we further investigated O’Brien’s catalytic Wittig reaction, in 
which the addition of catalytic p-nitrobenzoic acid dramatically enhanced the rate of phenysilane-
mediated reduction of phospholane precatalysts.24 During our own studies, we found excess 
benzoic acids actually decreased the rate of reduction;51 however, the addition of 
tetrabutylammonium p-nitrobenzoate to phenylsilane and TMPPO at 80 °C promoted completion 
within 5 minutes. Benzoate activation likely proceeds via coordination to the silicon atom to form 
a hypervalent phenylsilicate anion (Scheme 1.5A), similar to a mechanism proposed by Denton 
and coworkers (Scheme 1.5B).62 We hypothesized that the phosphine oxide similarly activates 
phenylsilane through Lewis base catalysis to react with water (Scheme 1.5A) as captured in 
Mechanism V (Figure 1.8). The requirement of phosphine oxides for activation would also finally 
explain the dependence of the rate constants for the slow step of phenylsilane-mediated 
phosphine oxide reduction (Figure 1.9) on phosphine oxide concentration. Intriguingly, we found 
that Lewis bases such as amines or phosphines did not promote phenylsilanol formation.24 We 
thus surmise Lewis bases, capable of forming an oxyanion complex with phenylsilane, are 
necessary to catalyze the reaction of phenylsilane with water, as a result of the natural affinity of 
silicon for oxygen.  
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Scheme 1.5. The mechanism of phenylsilanol generation using oxyanionic additives (top) 
and the mechanism of phenylsilanol generation with carboxylate additives as proposed by 
Denton and co-workers (bottom).  
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Returning to investigating the mechanism of phosphine oxide reduction by phenylsilane, 
we added Lewis acids in an attempt to directly block our proposed Lewis base activation of 
phenylsilane to phenylsilanol. Hindering the first step in Mechanism V should decrease the rate 
of reduction. Reductions of 1PPO by phenylsilane were performed in combination with either LiCl 
or ZnCl2. Compared to the no-additive positive control, both Lewis acids attenuated reduction 
(Figure 1.16). In particular, the more Lewis acidic ZnCl2 completely abolished the phenylsilane-
mediated reduction of 1PPO. These results are consistent with our hypothesis and suggest the 
Lewis acids inhibited reduction through coordination of the phosphine oxide15 and/or 
adventitious water in solution, thus preventing phenylsilane pre-activation. 
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Figure 1.16. Reductions of 1PPO by PhSiH3 with or without Lewis acid additives.   
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Simulation of Mechanism V furnished an excellent fit to the curves from Figure 1.5A, 
providing further evidence of paradoxical phospine oxide catalysis of silane pre-activation. These 
mathematical analyses also revealed substantial differences in the rate of phenylsilanol 
formation, defined by the rate constant k1, among the phosphorus heterocycles (Table 1.9) 
wherein TMPPO and 1PPO were nearly the same while TMBPO and TMPyrPO were approximately 
two and four-fold higher, respectively. The relative reactivity of these compounds also correlates 
nearly perfectly with their oxyanionic character as measured by the Mulliken charges of the 
oxygen atom (Table 1.6). Unsurprisingly, we note that too strong of oxyanionic character, as found 
in inorganic alkoxide or hydroxide bases, is detrimental to the reaction as the silane reagent is 
completely consumed in a flurry of gas release. While phosphine oxides can catalyze oxidation of 
phenylsilane to phenylsilanol, they are much less efficient than the deprotonated forms of 4-
nitrobenzoic acid (PNBA) or bis(p-nitrophenyl)phosphoric acid (BNPA), which are capable of 
quantitatively converting phenylsilane to phenylsilanol at room temperature in minutes, 
explaining their dramatic impact on reactivity. Optimal additives for silane pre-activation seem to 
be those with a finely tuned oxyanionic character. PNBA requires a tertiary amine base to 
facilitate deprotonation to generate the carboxylate oxyanion while Beller’s strongly acidic BNPA 
can be deprotonated directly by the phosphine oxide.25-26   
The water necessary for the pre-activation of phenylsilane is regenerated when 
phenylsilanetriol condenses into silyl-oxy polymers, releasing one and a half equivalents of water 
for each molecule of phenylsilane consumed.29 This part is in accordance with the observation by 
Marsi, who observed production of water during the course of the reduction17 as well as Lemaire’s 
observation of cyclic siloxane oligomers.29 The initial pre-activation of phenylsilane does require 
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some adventitious water to initiate the reaction, thus rigorous removal of water during solvent 
and regent purification should be avoided. Also notable is that the constant addition of water to 
the reaction should greatly affect the rate of silanol formation. Seeing as there would be more 
water to react with phenylsilane, thus generating phenylsilanol, the rate of reduction should 
increase substantially during the course of the reaction, a trend that is consistent with our data. 
Although water is essential, too much water is detrimental as addition of excess water greatly 
reduced the rate of reduction.51 The full mechanism occurring in a phosphorous recycling reaction 
with phenylsilane is displayed in Figure 1.17, showing the cycle of water regeneration, 
phenylsilanol formation as catalyzed by phosphine oxides, and reduction to the corresponding 
phosphine with retention of configuration.17, 63 
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Figure 1.17. The water cycle in PhSiH3-mediated phosphine oxide reductions.   
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  The significant rate enhancement gained with DPDS prompted further exploration into 
silane reactivity. We performed a screen of commercially available silicon hydride derivatives with 
our panel of four cyclic phosphine oxides at 80 °C. Standard mono-hydrido silanes (triethylsilane, 
triphenylsilane, and tris(trimethylsilyl)silane) showed null activity along with 1,1,3,3-tetramethyl 
disiloxane (TMDSO) and its polymeric counterpart polymethylhydrosiloxane (PMHS). 
Trimethoxysilane, another well-known reductant for cyclic phosphine oxides, was a competent 
reductant, yet it was no faster than phenylsilane (Figure 1.18). In the postulated [2+2] transition 
state (Scheme 1.1), the interaction between the silane and the P=O oxygen atom should be 
enhanced by increasing the partial positive character on the silicon atom. Indeed, O’Brien has 
previously shown that removing electron density on the silicon atom of a silane increased its 
activity.24 However, to our surprise, 1,1,3,3-tetramethyldisilazane (TMDSA) resulted in adept 
reduction at 80 °C (Figure 1.18) even though TMDSA was expected to be inferior to TMDSO due 
to the lower electronegativity of nitrogen. As summarized in Table 1.10, calculated Mulliken 
charges of silanes do not correlate with known silane reactivity as exemplified with trichlorosilane, 
which is one of the most reactive silane reducing agents,13, 16 yet is calculated to be the least 
electron-deficient. Conversely, (MeO)3SiH is calculated to have the most electron-deficient silicon 
atom, but is not the most active reducing agent in our series (Figure 1.18). To further complicate 
matters, we have observed a nearly 10-20 kcal/mol difference in the calculated activation 
energies for the reduction of TPPO by phenylsilane23 or trichlorosilane22 compared to our 
experimentally-determined values with DPDS.64  Taken together, these results indicate the 
substantial gap in reactivity between silanes cannot be explained by the electron density on the 
silicon atom and suggest an alternate transition state.  
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Figure 1.18. Comparisson of the reduction of 1PPO by common silane reducing agents 
under pseudo first-order condtions at 80 °C.   
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Table 1.10. Calculated Mulliken charges of silane materials.a 
Entry Silane Charge (Si)b Charge (H)b 
1 Et3SiH 0.742627 -0.110760 
2 n-Hexylsilane 0.603273 -0.114822 
3 TMDSO 0.823776 c -0.121330 
4 TMDSA 0.886715 c -0.110102 
5 Cl3SiH 0.481423 -0.041978 
6 (MeO)3SiH 1.334744 -0.125532 
7 Ph3SiH 0.672585 -0.108150 
8 Ph2SiH2 0.799329 -0.112974 
9 PhSiH3 0.534424 -0.103606 
10 p-(CF3)-PhSiH3 0.524771 -0.109707 
11 DPDS 0.823438c -0.120892 
12 PhSiH2(OH) 0.865300 -0.115566 
aDFT calculations performed with Gaussian using the M06-2X/6-
31+G(d,p) basis set; bAtomic units; cAverage of two silicon centers.  
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We even explored the difference between terta-alkyl disiloxane and disilazane 
reductants, expecting neither substances to be effective, although this turned out to not be the 
case as the silazane (TMDSA) was much more active than its oxygenaceous analog (Figure 1.19). 
To explain the observed differences between the silazane TMDSA and siloxane TMDSO, we 
hypothesized that a key hydrogen bond between the silane and the oxygen atom of the phosphine 
oxide is required.65 The competency of the silazane TMDSA is derived from its ability to serve as 
a hydrogen bond donor whereas the disiloxane TMDSO20 cannot on its own participate in a 
hydrogen bond interaction with the phosphine oxide because it is a hydrogen bond acceptor 
(Scheme 1.6). Similarly, the far greater reactivity of phenylsilanol (in equilibrium with DPDS) as 
compared to phenysilane could also be a result of its hydrogen-bond donating capacity. Unlike 
DPDS, TMDSO does not equilibrate to a silanol in the absence of strong Lewis or Brønsted acids.59 
Our hypothesis implies formation of a six-membered transition state (TS-2), in which a hydrogen-
bond creates a bridge between the silanol/silazane and the phosphine oxide. As described in the 
next section we examined this putative transition state through NMR studies to probe silanol-
phosphine oxide H-bonding, Hammett analysis, kinetic isotope effects, as well as the synthesis 
and evaluation of siloxanes to test the requirement for hydrido-silanol formation.  
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Figure 1.19. The reduction of 1PPO by TMDSO (red) and TMDSA (blue) at 80 °C. Data 
collected by Dr. Carter Eiden.  
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Scheme 1.6. The amended trasnsition state theory to account for our and others’ 
observations.  
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The hydrogen bonding between silanols and phosphine oxides has recently been shown 
by Prof. Dr. Blumel and co-workers to be the primary interaction for adsorption of phosphine 
oxides onto silica surfaces.65 These authors also reported a crystal structure of the TPPOHOSiPh3 
adduct with a mean O···H distance of 1.8 Å. The strength of this interaction is evidenced by the 
lengthening of the P=O bond from 1.479 Å in pure TPPO to 1.503 Å in the TPPOHOSiPh3 adduct. 
These researchers also showed that the presence of hydrogen bonding could be shown using 
solid-state NMR technique as bound TPPO had a unique down-field shift (represented in ppm) 
compared to free TPPO.65 This phenomenon is also recapitulated in the solution phase as Blumel 
and co-workers also previously demonstrated that hydrogen peroxide complexes of various 
phosphine oxides presented this same trend. Using solution-phase 31P NMR to monitor potential 
H-bond interactions, we confirmed TPPO likely interacts via hydrogen-bonding with both 
diphenylsilanediol (Table 1.11) and triphenylsilanol (Table 1.12) at ambient temperature in d8-THF 
as evidenced by the same downfield shift in 31P NMR spectra (Figure 1.20). Also in accordance 
with Blümel’s data, the addition of water led to a greater downfield shift detected by 31P NMR 
(Table 1.11) indicative of the tighter hydrogen-bonding network. While water can increase the 
strength of phosphine oxide adsorption onto silica surfaces by acting as a bridge between these 
two surfaces, the placement of water between a phosphine and a silyl hydride would displace the 
crucial P=O···H-O-Si interaction, which is consistent with our observations that addition of water 
reduces the overall rate of silane-mediated reduction of phosphine oxides (Figure 1.21). 
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Table 1.11. Hydrogen-bonding between diphenylsilanediol and TPPO 
monitored by 31P NMR. 
 
Entry X Y  ppma  ppmb 
1 0.0 0.0 23.69 0.00 
2 0.5 0.0 24.40 0.71 
3 1.0 0.0 25.20 1.51 
4 2.0 0.0 26.23 2.54 
5 0.0 2.0 24.50 0.81 
6 0.5 2.0 25.34 1.65 
7 1.0 2.0 25.78 2.09 
8 2.0 2.0 26.65 2.96 
aTPP used as internal standard ( = -5.41 ppm); bCompared to 
TPPO alone. 
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Table 1.12. The effect of temperature on additive studies. 
 
Entry Temp (°C)  Shift (ppm)  (ppm) 
1 23 23.70 0.00 
2 23 26.53 +2.83 
3 80 26.55 +2.85 
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Figure 1.20. An example of observed downfield NMR shifts in 31P NMR experiments with 
additives.  
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Figure 1.21. The effect of excess water on the observed rate of phosphine oxide reduction 
by silanes. Data collected by Dr. Carter Eiden.  
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To probe charge build up in the transition state we measured the rates of DPDS-mediated 
reduction of a panel of nine triphenylphosphine oxides (Figure 1.22) containing a range of 
electron-withdrawing and electron-donating substituents on one of the aryl rings, which were 
synthesized by adding aryl Grignard reagents to diphenylphosphoryl chloride. The rates for 
reduction (k) were monitored by 31P NMR under pseudo first-order conditions (0.40 M DPDS, 0.04 
M phosphine oxide). A plot of the relative rates Log(kX/kH) versus the Hammett P substituent 
constant (Figure 1.22) gave a linear fit with a slope ( = -0.3951, R2 = 0.9685). The negative slope 
() suggests a modest build-up of positive charge at phosphorous in the rate determining step, 
indicative of either phosphine oxide equilibration to its ylide resonance form, or direct hydride 
transfer to the phosphorus center.66 To experimentally verify that hydride transfer is the rate-
limited step during phosphine oxide reductions, we also measured the primary kinetic isotope 
effect (KIE) for reduction of TPPO by DPDS. For this study we synthesized tetradeuterated d4-
DPDS wherein all Si-H bonds were replaced with Si-D.  We observed a large KIE of 5.3 at 110 °C 
consistent with hydride transfer as the rate-determining step (Figure 1.23).  
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Figure 1.22. The Hammett plot for the reduction of acyclic phosphine oxides by DPDS at 
110 °C. Data collected by Kathleen Wang.  
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Figure 1.23. The kinetic isotope effect for the reduction of phosphine oxides with proteo- 
and deutero-DPDS at 110 °C. Data collected by Kathleen Wang.  
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While the previous NMR, Hammett, and KIE studies provided valuable mechanistic 
information, these studies failed to provide unequivocal confirmation for TS-2 or against TS-1. We 
thus devised and synthesized a series of Si,Si-diphenylsilanes to probe whether hydridosilanols 
(H-SiR2OH) are absolutely required for reduction. Diphenylsilane, a commonly used reductant of 
phosphine oxides with similar kinetics as phenylsilane (Figure 1.18) was used as a benchmark for 
reactivity. 1,1,3,3-tetraphenyldisiloxane (TPDS), which equilibrates to form diphenylsilanol, 
should be a more rapid reductant than diphenylsilane, as it bypasses the proposed pre-activation 
step, much like DPDS. Methyldiphenylsilane (MDPS), on the other hand, is unable to form a 
hydridosilanol, and should thus provide evidence as to whether or not reduction can proceed 
through TS-1 at 80 °C. The reactivity of these silanes was evaluated in the reduction of TMPPO. In 
line with our expectations, TPDS was indeed faster than diphenylsilane, while MDPS was 
completely unreactive at 80 °C (Figure 1.24). As outlined in Scheme 1.7, both TPDS and 
diphenylsilane are capable of forming a hydrido-silanol, the active functional group for reduction, 
while MDPS cannot, and therefore does not lead to reduction at temperatures below 110 °C. 
Moreover, every tri-substituted silane, outside of those silanes containing alkoxy or chloro 
functionalities, which can easily hydrolyze to afford hydrido-silanols, were incompetent reducing 
agents at 110 °C. Trisubstituted silanes can reduce phosphine oxides at temperatures exceeding 
250 °C, 13, 16, 61 which is consistent with the higher energy TS-1, whereas hydrido-silanols are 
effective at 80 °C, presumably through TS-2.  
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Figure 1.24. The reduction of TMPPO with Si, Si-diphenylsilannes at 80 °C. Data 
collected by Dr. Carter Eiden.  
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Scheme 1.7. Putative reactivity and transition states of MDPS (top), diphenylsialne, and 
TPDS (bottom) with phosphine oxides.  
  
ǂ 
ǂ 
TS-2 
TS-1 
104 
 
The interactions of phenylsilane/phenylsilanol, and phosphines oxides were calculated by 
DFT employing the M06-2X/6-31+g(d,p) level of theory,56 analogous to previous studies. Also in 
conjunction with other studies, these calculations were performed under the assumption that a 
non-polar, aprotic solvent is used for these reactions. Unsurprisingly, before engaging in either 
transition state, a pre-reaction complex is formed in which atoms of both molecules come in 
proximity of each other. However, modeling only this part of the reaction led to an interesting 
theoretical find in which the pre-reaction complex (PC) formed between phenylsilanol and 
phosphine oxides is actually favorable (Figure 1.25). In fact, this is the only such case that has been 
reported. The reduction in entropy is outshined by the favorable enthalpy from the formation of 
the hydrogen bond (Table 1.13). While these calculations are not indicative of the six-membered 
transition state being ultimately lower in energy, it does reflect the rapid nature of the reaction’s 
onset. We are continuing to investigate this reaction and our proposed mechanism via 
computational means. 
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Figure 1.25. The optimized PC of TPPO with A) PhSi(OH)H2 and B) PhSiH3 at the M06-
2X level of theory. Data collected by Kathleen Wang. 
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Table 1.13. The calculated energies and geometries of PCs with TPPO at the M06-2X level of theory. 
Parameter TPPO + 
PhSi(OH)H2 
TPPO + PhSiH3 TPPO + PhSiH3 
(Freq) 
H (kcal/mol) -8.3 -0.6 -0.6 
S (cal/mol) -19.3 -39.7 -34.1 
G (kcal/mol) -2.6 +11.2 +9.6 
P=O (Å) 1.5117 1.4995 1.5117 
P=O···HO-
Si/P=O···H-Si (Å) 
1.7340 4.9163 2.8729 
Si-H···P (Å) 4.1240 4.2717 4.1240 
Si···P (Å) 4.3157 4.6469 4.3157 
P=O···H-R (°) 114.12 n.d. 108.01 
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In addition to gaining an understanding about the reactivity of phenylsilanes, we wished 
to further characterize the requirements for activating inexpensive and safe alkyl disiloxanes. 
Disiloxanes can react via TS-2 only if a metallic species, Lewis acid, or hydrogen atom bridges the 
gap between the oxygen of the disiloxane and the phosphine oxide, or if the equilibrium is shifted 
such that the silanol form is favored. For example, adding acid could shift disiloxane-silanol 
equilibrium by promoting dissociation to the silanol monomer thereby turning the silane into an 
H-bond donor, or could conversely turn the phosphine oxide into the H-bond donor through 
protonation. Consequently, addition of a borderline Lewis acid, such as ZnCl2, greatly improved 
the rate of reduction by TMDSO. ZnCl2 may operate by shifting the equilibrium in similar manner 
as a protic acid, and/or by coordinating to both the reductant and phosphine oxide. In support of 
the latter mechanism, isolated 31P NMR experiments with TPPO confirmed ZnCl2 caused the 
greatest downfield NMR shift among the Lewis acid examined while LiCl induced the smallest 
shift, consistent with its inability to promote reduction by TMDSO. Interestingly, monitoring of 
the interactions of protic acids and phosphosphine oxides using the same assay also indicated 
eventual activity (Table 1.14). As summarized in Figure 1.26, reduction rate enhancement 
correlated very well with the downfield shift observed in 31P NMR experiments. This finding can 
lead to the discovery of additives that are optimized to “activate” the phosphine oxide or 
disiloxane to improve reductive capabilities with green silane reducing agents such as PMHS.  
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Table 1.14. The 31P NMR shifts resultant upon additive addition. 
 
Entry Acid 1 Equiv Shift 
(ppm) 
 (ppm) 2 Equiv Shift 
(ppm) 
 (ppm) 
1 None 23.70 0.00 23.70 0.00 
2 CH3C(O)OH 26.12 +2.42 27.36 +3.66 
3 CHCl2C(O)OH 28.11 +4.41 30.22 +6.52 
4 CCl3C(O)OH 28.79 +5.09 31.45 +7.75 
5 CF2ClC(O)OH 31.15 +7.45 31.83 +8.13 
6 CF3C(O)OH 30.70 +7.00 32.07 +8.37 
7 PNBA 27.04 +3.34 n.d.a n.d. a 
8 CH3SO3H 31.21 +7.51 33.81 +10.11 
9 BNPA 32.55 +8.85 n.d. a n.d. a 
aSolubility limited testing this set of conditions 
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Figure 1.26. The reduction of 1PPO using TMDSO and additives at 80 °C. A) With 
Brønsted acid additives; B) With Lewis acid additives.  
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We are also able to provide insight towards a report by Lemaire and co-workers, who 
used TMDSO to reduce phosphine oxides with titanium(IV) tetra-iso-propoxide as an additive and 
proposed a phosphorous-centered radical as a key reduction intermediate.29 To test for the 
presence of this radical intermediate we synthesized a cyclopropanated phosphine radical clock; 
however, no detectable formation of ring-opened products were observed under Lemaire’s 
conditions (Chapter 1.8). While the rates of -scission for phosporanyl radicals, proposed by 
Lemaire, is rather fast, and could account for our results, we hypothesized the Lewis acid may act 
through a variation of TS-2 by activating dissociation of TMDSO into a monomeric silanoate and 
by coordinating the phosphine oxide and silanoate specied via a 6-membered transition state 
analogous to TS-2. Ti(OiPr)4 is known to disproportionate TMDSO through a complex mechanism 
(Scheme 1.8), resulting in a silicon-titanium complex and release of gaseous dimethylsilane.67 
Additional reports have pointed towards an active Ti(III) species, another borderline Lewis Acid, 
which produces silane oligomers and reduces the phosphine oxide.29, 62 These combined 
observations suggests that a silyl-oxy Ti(III) species reduces phosphine oxides through the six-
membered transition state TS-2, as the borderline Lewis acidic Ti(III) center substitutes for the 
Lewis-acidic proton (Schemes 1.6 and 1.8). Again, promoting the degradation of PMHS with 
similar, optimized, reagents might facilitate the use of this green, inexpensive, and safe silane.  
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Scheme 1.8. The amended mechanistic proposal for the reduction of phosphine oxides by 
TMDSO/Ti(IV) reduction systems.  
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 With a better understanding of the necessity for silane-mediated reductions of phosphine 
oxides, we hoped to be able to find a predictive model for the design of future phosphines for 
optimal redox catalysis. We tried to find a correlation of reaction rate to a variety of theoretical 
parameters from crude Mulliken charges to nucleophilicity parameters (Tables 1.15 and 1.16). As 
expected, we could not find any sort of correlation between silane reduction effectiveness and 
electronic parameters (Tables 1.10 and 1.15). However, we were surprised to find that there 
didn’t seem to be any correlations of phosphine oxide global electronic parameters and reactivity 
when a larger set of phosphines were compared to each other (Table 1.16). As summarized in 
Figure 1.27, when phosphines of a similar nature are compared, calculated electronic parameters 
very tightly correlate with the rate of reduction by silane reducing agents. Yet, this assumption 
cannot be made when comparing silanes across scaffolds. With the current knowledge of 
phosphine oxide reactivity, we believe that new catalysts can easily be designed that add electron 
density to the oxygen atom while maintaining ring strain. These catalysts should pair well with 
disiloxane reducing agents, and the degree of strain necessary would be dictated by the desired 
application, as 4-membered phosphines lack the nucleophilicity necessary to mediate a variety of 
these reactions, while acyclic phosphines could be utilized in reactions which are tolerant of 
heating.  
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Table 1.15. The calculated global electronic parameters for silane materials. 
Entry Silane μ (au) η (au) ω (eV) Nmax (eV) N (eV) 
1 DHDS -0.1623 0.3419 1.05 12.91 1.74 
2 TPDS -0.1507 0.2895 1.07 14.16 2.77 
3 DPDS -0.1550 0.2925 1.12 14.42 2.61 
4 PhSiH3 -0.1534 0.3125 1.02 13.35 2.38 
5 Ph2SiH2 -0.1517 0.3039 1.03 13.59 2.55 
6 (MeO)3SiH -0.1710 0.3668 1.08 12.69 1.17 
7 PhSi(OH)H2 -0.1462 0.3182 0.91 12.50 2.50 
8 Ph2Si(OH)H -0.1545 0.2980 1.09 14.10 2.55 
9 (nHexyl)Si(OH)H2 -0.1688 0.3479 1.11 13.20 1.48 
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Table 1.16. The calculated global electronic parameters for phosphine oxide materials. 
Entry PO μ (au) η (au) ω (eV) Nmax (eV) N (eV) 
1 TPPO -0.1605 0.3045 1.15 14.34 2.30 
2 S9 -0.1316 0.2459 0.96 14.56 3.88 
3 S10 -0.1619 0.2838 1.26 15.53 2.54 
4 S11 -0.1727 0.2941 1.38 15.98 2.11 
5 S12 -0.1802 0.2821 1.57 17.39 2.07 
6 S13 -0.1861 0.2688 1.75 18.84 2.09 
7 S14 -0.1813 0.2741 1.63 18.01 2.15 
8 S15 -0.1556 0.2976 1.11 14.23 2.53 
9 1PPO -0.1590 0.3071 1.12 14.09 2.32 
10 TMPPO -0.1587 0.3018 1.14 14.31 2.38 
11 TMBPO -0.1533 0.3114 1.03 13.40 2.40 
12 TMPyrPO -0.1388 0.2874 0.92 13.14 3.12 
13 S16 -0.1608 0.3049 1.15 14.34 2.30 
14 S17 -0.1475 0.2778 1.07 14.45 3.02 
15 S18 -0.1668 0.2937 1.29 15.46 2.27 
16 S19 -0.1675 0.2836 1.35 16.07 2.40 
17 S20 -0.1744 0.2704 1.53 17.54 2.38 
18 S21 -0.1566 0.2996 1.11 14.23 2.47 
19 S22 -0.1778 0.2522 1.71 19.19 2.54 
20 S23 -0.1656 0.2425 1.54 18.58 3.01 
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Figure 1.27. The comparison of the computed nucleophilicity index at the M06-2X/6-
31+G(d,p) level of theory and the reduction of phosphine oxides. A) Acyclic phosphine 
oxides (Figure 1.22); B) Current and previously reported phosphine oxides incorporating 
cyclic and acyclic phosphine oxide reagents. Data collected by Kathleen Wang.  
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 The combination of rational reagent synthesis and kinetic analysis led to the 
characterization of the entire mechanism of phosphine oxide reduction by phenylsilane, as well 
as the determination of the transition state of reduction by any hydridosilane. This directly led to 
the development of DPDS, an unparalleled reducing agent for phosphine oxides. Reductions of 
phosphine oxides by silanes, such as phenylsilane, underwent with a sigmoidal curve under 
pseudo-first-order conditions, data which suggested that the previously proposed mechanism 
was incongruous with the actual mechanism. Our results have overturned the accepted 
mechanism, while simultaneously explaining over 50 years of reported observations, thus 
enlightening our own discovery efforts. Hydrido-silanols represent supreme reducing agents 
which circumvent the slow activation step, as evident by the lack of a sigmoidal reaction progress 
curve and rapid reduction of both acyclic and cyclic phosphine oxides.64 This work also highlights 
the power of reaction progress kinetic analysis and simulation to extract subtle kinetic features, 
which can prove crucial for prioritizing among multiple possible reaction mechanisms 
1.4 Scalable preparation of hydrido-disiloxanes 
With the discovery of the reason as to why DPDS is such a powerful reductant, we decided 
to pursue the use of this reagent in the development of redox recycling reactions, a feat that 
required scaled-up synthesis of this reagent from simple, inexpensive, and widely-available 
starting materials. 
The synthesis of silanols and disiloxanes is well known as these compounds have 
applications in a broad range of chemistry, from the synthesis of therapeutics68 to liquid crystals.69  
Transition-metal catalyzed oxidation of precursor silanes is the most common strategy to prepare 
silanols and disiloxanes,70 but these methods lead to complete oxidation of the silane to either a 
117 
 
mono-, di-, or tri-silanol depending on the number of Si-H bonds.71 One report of an In(III)-
catalyzed direct oxidation suggests that the mono-oxidation product can be obtained;72 however, 
this reaction was only performed on a small scale, and the reaction was not extended to 
phenylsilane. The generation of a full equivalent of hydrogen gas is also a safety concern. Hydrido-
disiloxanes have historically been prepared through an alternative two-step sequence invoving 
preparation and isolation of a mono-halogenated silane followed by hydrolysis (Scheme 1.9).73 
Synthesis of the intermediate halosilanes is challenging, as is evident by the lack of their 
commercial availability,74 with multiple methods furnishing complex mixtures.75 Consequently, 
much effort has been put into the synthesis of mono-halogenated silanes and two complimentary 
approaches have emerged that address previous synthetic deficiencies. The first of these employs 
concentrated HBr to displace a phenyl group on a silane with a bromide76 while the second 
approach uses copper(II) chloride to directly chlorinate hydrido-silanes.77  Zhang and co-
workers77b further improved on the latter copper(II) chloride halogenation through “ball-milling”. 
Herein, we report a one-pot experimental method for the preparation of DPDS and related 
hydrido-disiloxane reagents in high purity from commercially available silanes. This scalable 
procedure furnishes hydrido-disiloxanes in improved yield,72, 77 substantially lowers the time 
required to obtain product with only a single purification step. 
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Scheme 1.9. Synthesis of hydrido-disiloxane materials from literature and this work.  
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The synthesis of DPDS begins with the complexation of CuCl2 and catalytic CuI in diethyl 
ether for 30 min in the presence of either chrome or ceramic spheres. Phenylsilane is then added 
and the reaction is ball-milled at 350 rpm at ambient temperature under air with an overhead 
stirrer for 1.5 h until 100% conversion is noted by 1H NMR to afford the intermediate 
chlorophenylsilane. The reaction mixture is filtered directly onto ice chips (chapter 1.8) and 
extracted with diethyl ether to afford DPDS in 93% percent yield and approximately 95% purity, 
which is sufficient for most applications.  Distillation under high-vacuum can be performed to 
provide DPDS in >99% purity and 88% overall yield in cases where higher purity is required (Table 
1.17, Entry 1). The reaction is scalable and does not require increased reaction times to obtain 
purified product. For example, DPDS is obtained in 88% yield on a 10 gram scale in less than three 
hours. The reaction conditions can be extended to secondary arylsilanes as well as alkylsilanes, as 
diphenylsilane and n-hexylsilane were readily converted to 1,1,3,3-tetraphenyl-disiloxane TPDS 
and 1,3-di-n-hexyl-disiloxane DHDS in 90% and 85% yield, respectively (Table 1, Entries 2-3) while 
a combination of these substitution patterns was also tolerated as 1,3-dimethyl-1,3-diphenyl-
disiloxane DMDPDS was synthesized in  85% yield (Table 1.17, Entry 4). 
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Table 1.17. The Direct Synthesis of Symmetrical Disiloxanes from Commercially-Available Silanes. 
 
Entry Product Yield (%)a 
1 
 
93b c 
2 
 
90 
3 
 
85d 
4 
 
85 
aIsolated Yield of two trials at 15 mmol scale 
bYield was 93% before distillation (>95% purity) snd 88% after distillation (99% purity) 
cYield on 90 mmol (10 gram) scale was 88% (with >95% purity) 
dThis reaction required 5 hours for step “a” before filtration onto ice 
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Our efficient approach utilizes mechano-chemistry in an effort to significantly reduce the 
reaction time from more than 8 hours (magnetic stirring) to only 1.5 hours. During the reaction 
CuCl2 is reduced to a Cu(I) species, which coat the CuCl2 particles and hinder progression of the 
reaction. The physical grinding during the comminution process ensures CuCl2 is continually 
exposed. As such, the balls utilized should be fairly large in diameter (at least ½ inch) to avoid the 
inhibition of the reaction through buildup of byproduct on the heterogeneous CuCl2.  We explored 
different materials for the ball-milling procedure and found ceramic spheres were preferred over 
chrome ones since the reaction yield was compromised when metal balls were reused multiple 
times (Chapter 1.8). This is likely due to the inert nature of ceramic, as this material is chemically 
stable to the reaction conditions. Another advantage with respect to laboratory scale reactions 
utilizing transition metal catalysis is the CuCl2 mediated mechano-chemical method does not 
produce a stoichiometric amount of hydrogen gas, and all byproducts are simply washed away 
with cold water. In addition, this protocol can be implemented in standard laboratory glassware, 
rather than requiring specialized ball-milling equipment.  
We have described an efficient one-pot mechano-chemical procedure for the synthesis 
of hydrido-disiloxanes. The high yield, simple experimental set-up, and short reaction time are all 
ideal for laboratory scale preparations of hydrido-disiloxanes, which are valuable compounds for 
the chemoselective reduction of phosphine oxides. The ability to easily prepare useful quantities 
of hydrido-disiloxanes is expected to not only make the newly characterized reducing agent DPDS 
highly accessible for both phosphorous recycling and phosphine synthesis, but also to unleash the 
full potential of this entire class of under-explored reagents through stimulating further 
investigations into their unique reactivity. 
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We expect to find broad usage of DPDS and other hydrido-silanols in both conventional 
phosphine syntheses as well as future catalytic-in-phosphine reactions due to its excellent 
chemoselectivity and superior reducing power. Additional applications of DPDS may also be 
discovered, and thus a scalable synthesis was mandatory in order to discovery the true potential 
of this novel reagent.  
1.5 Characterization of 1,3-diphenyl-disiloxane as a chemoselective reducing agent 
Trivalent phosphorus(III) compounds promote a substantial portion of synthetic organic 
chemistry, from classical transformations including the Wittig olefination7 and Mitsunobu 
condensation10 to contemporary metal-catalyzed bond formations such as Suzuki-Miyaura and 
Buchwald-Hartwig reactions.78 Reduction of stable phosphine(V) oxides remains the most 
straightforward preparation of phosphines, and is often essential for the construction of easily-
oxidized electron-rich phosphines.6, 16 Unfortunately, current methods are extremely harsh, which 
limits the substrate scope and precludes reaction telescoping.79 
Common reducing agents such as aluminum hydrides either require prolonged heating or 
the addition of strong alkylating agents (e.g. MeOTf) to furnish phosphines from their 
corresponding oxides.80 Such conditions are marred by indiscriminate functional group reduction 
and necessitate special precautions for handling on a large scale. Silanes are thus preferred due 
to their improved chemoselectivity,13, 17, 39 yet remain incompatible with many functional groups 
as they require elevated temperatures and additives such as Ti(OiPr)429 (Scheme 1.10). In a 
significant advance in the field, Beller and co-workers disclosed the silane-mediated reduction of 
phosphines employing a strong Brønsted acid along with a large excess of silane, enabling 
chemoselective reduction of acyclic phosphines at 110 °C even in the presence of sensitive 
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functional groups.25 Though impressive, optimal conditions required four equivalents of silane per 
P=O bond, a strong Brønsted acid, and refluxing conditions (toluene, 110 °C, 24 h), leaving 
considerable room for improvement in regards to atom economy and reaction rate. Other 
Brønsted acid additives have been reported to promote silane-mediated reductions, but none of 
these methods have greater functional group specificity, nor the optimal atom economy of an 
additive-free system.24, 27 Specifically, laboratory-scale syntheses of phosphines would be greatly 
enhanced with a rapid, chemoselective, and low-temperature method for reduction of phosphine 
oxides, whereas industrial-scale syntheses would benefit from a more atom-economical and 
additive-free method to reduce waste generation and improve the ease of purification.38 
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Scheme 1.10. The silane-mediated reduction of phosphine oxides from this and previous 
work.  
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     To begin our investigation into an improved method for reduction of phosphine oxides, 
we selected triphenylphosphine oxide (TPPO) as a model substrate employing refluxing toluene 
as the initial reaction conditions. To render this method easy to implement, all reactions were 
performed without the exclusion of air or water. Consistent with precedent,25, 29 common silyl 
hydrides (PhSiH3, Ph2SiH2, (MeO)3SiH, (EtO)2MeSiH, and TMDSO) were ineffective reductants as 
determined by 31P NMR (Table 1.18, entries 1–5), with only PhSiH3 producing an appreciable 
amount of triphenylphosphine (TPP). n-Hexylsilane (Table 1.18, entry 6) was also a poor reagent, 
at which point we noted that two of the most commonly used classes of reductants were aryl 
silanes (PhSiH3, Ph2SiH2) and alkyl siloxanes (TMDSO, PHMS). Since we found aryl silanes were 
much more effective than alkyl silanes, we hypothesized that the corresponding aryl siloxanes 
would be superior to alkyl siloxanes.  Surprisingly, aryl siloxanes have not been explored as 
potential reductants for phosphine oxides. As such, we wished to apply the known reactivity of 
DPDS to determine if it could reduce acyclic phosphine oxides. To our delight, 1.5 equivalents of 
DPDS afforded a 99% isolated yield of TPP in 24 h (Table 1.18, entry 7). To highlight the reducing 
power of this new reagent, only 0.75 equivalents of DPDS produced an 84% isolated yield of 
reduced phosphine (Table 1.18, entry 8). An investigation of “green” solvents (Table 1.19) 
indicated that toluene (PhMe) and tert-butyl acetate (TBAc) were optimal for this reduction. Using 
TBAc for improved solubility, we consistently obtained a 99% yield of TPP with 1.25 equivalents 
of DPDS in 24 h (Table 1.18, Entry 11). These reaction conditions also worked well on 10 mmol 
scale, as the reduction of TPPO occurred in quantitative yield. 
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Table 1.18. The Optimization of Additive-Free Phosphine Oxide Reductions with DPDS.  
 
Entry Silane X Solvent Yield (%)[a] 
1 PhSiH3 1.5 d8-PhMe 33[b] 
2 Ph2SiH2 1.5 d8-PhMe 0[b] 
3 (MeO)3SiH 1.5 d8-PhMe <5[b] 
4 (EtO)2MeSiH 1.5 d8-PhMe 0[b] 
5 TMDSO 1.5 d8-PhMe 0[b] 
6 C6H13SiH3 1.5 d8-PhMe 5[b] 
7 DPDS 1.5 PhMe 99 
8 DPDS 0.75 PhMe 84 
9 DPDS 1.0 TBAc 90 
10 DPDS 1.1 TBAc 95 
11 DPDS 1.25 TBAc 99 
[a]Average isolated percent yields for two reactions at 0.5 mmol scale after 24 hours, 
[b]Average 31P NMR yield for two reactions at 0.5 mmol scale after 24 hours. 
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Table 1.19.  Solvent Screen of Phosphine Oxide Reductions at 110 °C.  
 
Entry Solvent Boiling Point Isolated Yield[a] 
1 Toluene 110 Quant. 
2 Heptane 108 N/A[b] 
3 Cyclohexane 80 N/A[c] 
4 2-MeTHF 80 N/A[c] 
5 Methyl cyclohexane 101 94 
6 CPME 106 92 
7 TBAc 95 99 
8 Ethyl lactate 154 24 
9 [Bmim] PF6 N/A 66 
[a]Average isolated yield of at least two reactions after 24 hours, [b]Phosphine oxides 
were not at all soluble in these reaction schemes, [c]The reaction mixture completely 
over-boiled at this temperature.  
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A real-time comparison of our optimized reaction with DPDS to those reported by Beller25 
and Lemaire29 revealed that our system, under “dump-and-stir” conditions as described above, is 
the fastest of the three, concluding in about half the time as the next most rapid method (Figure 
1.28). This is despite the fact that Beller’s conditions include four equivalents of silane, which 
causes the observed single-exponential decay of the concentration of TPPO. The sluggishness of 
Lemaire’s conditions without the exclusion of air and water is also notable. Our system is additive-
free and utilizes only a slight stoichiometric excess of silane, yet it still reaches completion much 
more rapidly than the current state-of-the-art conditions. 
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Figure 1.28. Reaction progress curves of the reduction of TPPO, monitored by 31P NMR, 
comparing Lemaire’s system29 (blue), Beller’s system25 (red), and 1.25 equiv DPDS 
(green). Data collected by Dr. Carter Eiden.  
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We monitored the reaction kinetics at temperatures ranging from 80 to 120 °C to measure 
the energy barrier for the reaction.  Arrhenius analysis (Figure 1.29) indicated an activation energy 
of 18.0 ± 1.1 kcal/mol for the reduction of TPPO by DPDS. This was surprising, as our 
measurements indicate a profoundly smaller energy barrier than the >40 kcal/mol calculated by 
Demchuk and co-workers for the reduction of TPPO by phenylsilane23 as well as the 27.2 kcal/mol 
calculated by Krenske for the reduction of trimethylphosphine oxide with trichlorosilane.22 While 
decreasing the electron density of the silicon atom has been postulated to improve the rate of 
reduction, our disiloxane reagent would still not be as Lewis acidic as trichlorosilane.22 The drastic 
differences between experimental and calculated activation energies suggests that DPDS may 
reduce phosphine oxides through an alternative mechanism as previously presented. We also 
believe that silanes are not simple reducing agents, as DPDS seems to react similarly to the 
combination of phenylsilane and a Brønsted acid catalyst.81 
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Figure 1.29. Arrhenius analysis of the reduction of TPPO with DPDS over the temperature 
range of 80 – 120 °C.  
132 
 
We next investigated the chemoselectivity of DPDS with a variety of substrates containing 
reactive functional groups (Chapter 1.8). At 110 °C, DPDS did not reduce aldehyde, nitro, ester, 
olefin, and cyano functional groups (Chapter 1.8), indicating that DPDS is very selective for the 
P=O bond. However, DPDS did react with unprotected alcohols to form a transiently protected 
compound that we and others21a, 51 have been unable to isolate (Chapter 1.8). This compatibility 
profile indicates that DPDS would be suitable for exploration as a reductant in redox recycling 
reactions,18-21, 24, 51 while also indicating that our reaction conditions are on par with the state-of-
the-art reductions.25 Satisfied with the observed chemoselectivity, we examined the scope of 
DPDS reduction with a panel of acyclic phosphine oxides. Both electron-rich and electron-
deficient tertiary phosphine oxides were cleanly reduced, furnishing high yields of the 
corresponding phosphines (Table 1.20, entries 1–4). It is noteworthy that extremely electron-poor 
substrates, such as hexatrifluoromethyl phosphine oxide, take longer to reduce (Table 1.20, Entry 
5). Tricyclohexylphosphine oxide also reacted lethargically, though the success of electron-rich 
triarylphposphine oxides suggests difficulties are likely due to steric concerns rather than 
electronic effects. Bidentate phosphine oxides were successfully reduced (Table 1.20, entries 9–
12) with high fidelity in yields ranging from 75–94%. Reduction of chiral phosphine oxide derived 
from DIPAMP to the corresponding phosphine occurred with retention of configuration. 
Phosphines containing reactive functional groups such aldehyde  were also readily reduced 
without undesired reactivity (Table 1.20, entries 13-14). Lastly, we found secondary phosphine 
oxides such as diphenylphosphine oxide (DPPO) and di-tert-butylphosphine oxide (DTBPO) were 
reduced the fastest (Table 1.20, entries 14-15), with quantitative conversion to DPPO complete 
within 10 minutes. The differential reactivity between DPPO and DTBPO also points to steric 
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effects as a crucial indicator for the rapidity of reduction with DPDS. Our exploration of the scope 
of this reaction, in addition to our knowledge from stability studies, indicates that our new 
method is extremely mild while maintaining atom efficiency.  
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Table 1.20. The Substrate Scope of Additive-Free Reductions of Phosphine Oxides by DPDS. 
 
Entry Phosphine  Yield (%)[a] 
1 
 
 89 
2 
 
 87 
3 
 
 82 
4 
 
 81 
5 
 
 60[b] 
6 
 
 80[b] 
7 
 
 93 
8 
 
 87 
9[c]   88
 
10[c] 
 
 94 
11[c] 
 
 79 
12[c] 
 
 75[d],[e] 
13 
 
 97 
14 
 
 96[f] 
15   >99
[f],[g] 
135 
 
16   73
[f],[h] 
[a]Average isolated percent yields for two reactions at 0.5 mmol scale after 16-24 hours, 
[b]Reactions isolated after 48 hours, [c]Reactions utilized 2.5 equivalents of DPDS (1.25 
equiv. per P=O), [d](R,R)-DIPAMP dioxide utilized as the starting material, [e] D20 = -85.6 (c 
= 0.7), [f]Yield determined by 31P NMR, [g]Reactions complete within 10 minutes. [h]Reactions 
complete within 3 hours. 
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Having completed the development of a mild, additive-free, and atom-economical 
methodology for the reduction of phosphine oxides, we next attempted to create the first 
ambient system in order to further expand the applicable substrate scope. We observed that the 
addition of 20 mol% of bis-(p-nitrophenyl)phosphoric acid (BNPA),25 to reductions with DPDS at 
110 °C resulted in quantitative isolated yields within an hour (Table 1.21). This result, in 
combination with the success of Beller’s application of BNPA,25 indicates that with more robust 
phosphine oxides, the addition of BNPA to DPDS-promoted reductions at 110 °C would radically 
decrease the time to completion without harming the yield, and could potentially be used to 
lower the required temperature. We were delighted to find that addition of a combination of 
BNPA and DPDS to a solution of TPPO in EtOAc at room temperature temperature furnished TPP 
in quantitative yield after 48 hours (Table 1.22). Applying similar conditions to a range of acyclic 
mono- and bidentate phosphorous(V) oxides consistently afforded the product phosphines in 
both high yield and high specificity (Table 1.23). Additionally, the corresponding phosphines were 
produced in exquisite purity, frequently only requiring filtration through a plug of silica gel. Similar 
to the additive-free system, sterically encumbered phosphine oxides with multiple cycloalkyl 
substituents exhibited sluggish reactivity. At ambient temperature, we observed flawless 
functional group compatibility with DPDS and BNPA, as an unprotected alcohol-containing 
phosphine oxide was reduced to its corresponding phosphine with high fidelity. An additional 
benefit of the extremely gentle reaction conditions was a sharp increase in the yield of secondary 
phosphine DTBP when compared to the additive-free system (Table 1.23, Entry 15), as DTBPO 
degrades at elevated temperatures.  
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Table 1.21. Reductions of TPPO with DPDS and BNPA at 
110 °C.  
 
Entry Time Isolated Yield[a] 
1 35 min 88 
2 60 min 99 
[a]Average isolated yield of at least two reactions. 
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Table 1.22. Reductions of TPPO with DPDS and BNPA at 23 °C. 
 
Entry X equiv Y mol% Isolated Yield[a] 
1 1.25 10 58 
2 2.5 10 91 
3 1.25 20 97 
4 2.5 20 99 
[a]Average isolated yield of at least two reactions after 48 hours. 
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Table 1.23. DPDS-Mediated Reductions of Acyclic Phosphine Oxides at Ambient Temperature. 
 
Entry Phosphine  Yield (%)[a] 
1 
 
 99 
2 
 
 75 
3 
 
 88 
4 
 
 82 
5 
 
 73 
6 
 
 84[b] 
7 
 
 92[b] 
8 
 
 82[b] 
9 
 
 85 
10[c]   96
[d] 
11[c] 
 
 83 
12[c] 
 
 89[e],[f] 
13   >99
[g],[h],[i] 
14   >99
[g],[h] 
[a]Average isolated percent yields for two reactions at 0.25 mmol scale after 48 hours, 
[b]Reactions isolated after 70 h, [c]Reactions utilized 5.0 equivalents of DPDS (2.5 equiv. per 
P=O) and 40 mol% BNPA (20 mol% per P=O), [d]Reductions with only 20 mol% BNPA (10 mol% 
per P=O) furnished 93% yields after 70 h, [e](S,S)-DIPAMP dioxide utilized as the starting 
material, [f][]D20 = 86.2 (c = 0.7), [g]Yield determined by 31P NMR, [h]Reaction complete within 
18 h, [i]Yield (as determined by NMR) without BNPA was 80% after 24 h.  
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To further illustrate the utility of DPDS, we sought to improve Beller’s domino reductive 
arylation reaction to prepare tertiary phosphines from secondary phosphine oxides, as it required 
multiple days to furnish products31 whereas DPDS can reduce DPPO in a matter of minutes. As 
shown in Scheme 1.10, DPDS afforded phosphines with similar yields as reported by Beller, but in 
a fraction of the time. These results further highlight the enhanced reactivity of DPDS and 
compatibility with telescoped reactions.  
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.  
Scheme 1.11. The domino synthesis of trivalent phosphines from secondary phosphine 
oxide DPPO.  
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Since we had already characterized the reduction of both cyclic and acyclic phosphines 
with DPDS, while also investigating the reagent’s functional group compatibility, we wished to 
take this new silane into a redox recycling reaction. We initially chose the Wittig reaction with 
stabilized ylides as a model reaction for determining the effectiveness of our precatalysts in whole 
reaction schemes. As summarized in Table 1, our initial catalyst, 1-phenylphospholane-1-oxide 
(1PPO)51 was highly effective compared to all of our phosphetane precatalysts (Scheme 1.3 and 
Table 1.24, entries 1-4) in regards to the formation of ethyl cinnamate. We attributed this 
difference in reactivity to the lack of nucleophilicity of the phosphetane catalysts,21 as the 
phosphorus ylide would be much more difficult to generate via SN2 displacement of the alkyl 
bromide without the addition of heat. Also notable is that 2,2,3-trimethyl-1-pyrrolidyl-
phosphetane-1-oxide degrades in the polar solvents we explored including EtOAc, MeCN, and 
THF. We also noted that at least one equivalent of DPDS was needed to amply promote the 
reaction over an 18 hour time period (Table 1, entries 5-8), while an excess of DPDS didn’t seem 
to bolster the yield over this time course. As such, we selected 1 equivalent of DPDS as an optimal 
amount of reductant necessary for additive-free recycling and continued forth with EtOAc, a 
solvent often sourced from renewable resources.  
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Table 1.24. Optimization of Additive-Free Catalytic Wittig Reactions with Stabilized Ylides at Ambient 
Temperature.a 
 
Entry Precatalyst X equiv Yieldb 
1 1PPO 1.0 77 (99) 
2 TMPPO 1.0 28 (77) 
3 TMBPO 1.0 18 (63)c 
4 TMPyrPO 1.0 0c 
5 1PPO 0.5 20 (66) 
6 1PPO 0.8 44 (71) 
aCatalytic reactions performed in triplicate at 0.25 mmol scale; bAverage isolated yield, yields in 
parentheses are based on recovered starting material; cHeavy catalyst degradation noted. 
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With optimal reaction conditions in hand, we further explored the use of DPDS in an array 
of redox recycling reactions (Table 1.25). Additive-free catalytic Wittig reactions worked as 
expected, tolerating both electron-donating and electron-withdrawing substituents on 
benzaldehydes. Different stabilized ylides could also be employed to produce both di- and tri-
substituted olefins while the added steric bulk diminished the yield of the tri-substituted olefin 
under these “dump and stir” conditions. In each case, the trans olefin was highly favored, likely 
due to reversible 1,4 conjugate addition of the phosphine into the ,-unsaturated carbonyl 
compounds. Unfortunately, these reaction conditions are insufficient for the utilization of 
aliphatic aldehydes. We note, however, that no aliphatic aldehyde has been reported to be 
successfully utilized in catalytic Wittig reactions.18, 24, 82, 83 We also attempted to use preactalyst 
1PPO with semi-stablized bromides (benzyl bromide), also without any success. An alternate 
strategy may need to be employed in which an alternate catalyst/base combination afford olefins 
from semi-stable alkyl bromides, as was similarly noted by O’Brien.18 
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Table 1.25. Substrate Scope of Additive-Free Catalytic Wittig Reactions at Ambient Temperature. 
 
Entry Product  Yielda E/Z Ratiob 
1 
 
 
76 94:6 
2 
 
 
74 >95:5 
3 
 
 
76c >95:5 
4 
 
 
54c 90:10 
5 
 
 
Traced - 
aAverage isolated yield for at least two reactions at 0.25 mmol scale after 24 h; bDetermined 
with 1H NMR; c46 h; dLess than 2% yield, a new spot could be detected with KMnO4 staining in 
thin-layer chromatography (TLC) analysis.  
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In addition to reactions which afford olefins and amines, we were highly interested in 
ambient temperature catalysis to promote the substitution of alcohols. While the previously 
reported methods for the catalytic Appel20 and Mitsunobu51 reactions worked for their reported 
substrates at elevated temperatures, the power of these reactions generally lies with the fact that 
no heating is necessary, allowing for the incorporation of these reactions in the later stages of 
complex syntheses. When we first attempted a room-temperature Mitsunobu reaction, we were 
unable to isolate any product. We quickly discerned that the lack of product generation was due 
to rapid reduction of the Huisgen intermediate formed between the phosphine and diisopropyl 
azodicarboxylate (DIAD), which is resultant of the attack of the azodicarboxylate by the phosphine 
(Scheme 1.11).84 Resulting in the formation of the unreactive hydrazine byproduct, without 
leading to the formation of the desired substitution product (Figure 1.30).  
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Scheme 1.12. A) A generalized catalytic mitsunobu reactionREF; B) The desired catalytic 
Mitsunobu reaction (blue) utilizing phenylsilane and undesired premature reduction (red) 
promoted by DPDS.  
148 
 
 
Figure 1.30. The silane-mediated reduction of DIAD as conferred by the reactivity with a 
phosphine, leading to an unproductive catalytic Mitsubonu protocol.   
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This particularly reducible phosphorus(V) intermediate is, however, not present during 
the course of the halogen substitution in Appel reactions. As such, we decided to use the silane-
tolerant bromonium ion donor diethyl bromomalonate identified by van Delft and co-workers.20 
Again using 1 equivalent of DPDS, we were able to create an Appel reaction with similar 
limitations as those previously reported (Table 1.26). We noted that the use of 1PPO could 
generate higher yields of bromides, but with a wide range of yields. We believe this is due to 
reactivity between the reduced form of the catalyst and the aliphatic bromides to form an 
unreactive phosphonium bromide compound which shuts down reaction progress. Use of less 
nucleophilic TMPPO garnered a bit more consistency, but did not really improve yields overall. 
This change likely reduced the amount of nucleophilic attack of the desired bromide product, but 
it seems unlikely that redox recycling in the Appel halogenation will take hold as design criteria 
for improved recycling catalysts directly contrasts with properties that would reduce side-product 
formation.  
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Table 1.26. Substrate Scope of Additive-Free Catalytic Appel Reactions at Ambient Temperature. 
 
Entry Product  [PO] Yielda Yield Rangeb 
1 
  
1PPO 68 62-76 
2 TMPPO 71 68-74 
3 
 
 
1PPO 64 55-73 
4 TMPPO 64 62-66 
5 
 
 
1PPO 20 18-27 
6 TMPPO 35 28-42 
aAverage isolated yield for at least two reactions at 0.25 mmol scale after 24 h; bThe range of 
yields collected for isolated catalytic Appel halogenation reactions. 
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 While DPDS could easily be utilized in ambient temperature additive-free Wittig 
reactions, we continued our exploration of this reagent within the suite of phosphorus redox 
catalysis. We found a similar dependence on the amount of DPDS needed for ambient-
temperature recycling in the Staudinger reduction, as 1 equivalent of DPDS furnished the highest 
yield of the desired amine (Table 1.27). Summarized in Table 4, we were able to successfully 
employ DPDS in the reduction of azides even in the presence of other easily reducible functional 
groups which would not be tolerated using transition metal-catalyzed hydrogenation (Table 1.28, 
Entry 2). Again, electron donating and electron withdrawing substituents seem to have little effect 
on the outcome of reductions (Table 1.28, entries 1-4) as these substitutions were well tolerated, 
generating yields ranging from 85% to 92%. In addition to working with benzylic azides, the 
reaction could also be employed with aromatic azides (Table 1.28, entries 5-6) and aliphatic azides 
(Table 1.28, entries 7-8). Notably, alkyl chloride 4g was reduced without racemization of the chiral 
center and no polymerized products were identified, a feat that could not occur with reductions 
occurring at higher temperatures.  
  
152 
 
Table 1.27. Optimization of the catalytic Staudinger reduction with 1PPO. 
 
Entry X equiv  Yielda 
1 0.5  62 
2 0.75  77 
3 1.0  92 
aAverage isolated yield for at least two reactions at 0.25 mmol scale after 24 h. 
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Table 1.28. Substrate Scope of Additive-Free Catalytic Staudinger Reductions at Ambient Temperature. 
 
Entry Product  Yielda 
1 
 
 92 
2 
 
 90 
    
3 
 
 93 
4 
 
 85 
5 
 
 77 
6 
 
 88 
7 
 
 82 
aAverage isolated yield for at least two reactions at 0.25 mmol scale after 24 h. 
 
  
154 
 
Unfortunately, capture of the phosphineimine was impossible when employing DPDS as 
the reductant with 1PPO as the precatalyst. Using alternative phosphines which reduce as a 
slower rate would be necessary in order to capture this intermediate for tandem Staudinger 
reactions such as the Staudinger/aza-wittig tandem reaction.19 We do note, however, that 
“traceless” Staudinger ligations81, 85 would be unlikely to occur at room temperature as additional 
heat promotes the formation of the amide bond13 (Chapter 1.8) between the amine and the 
carboxylic acid.  However, while exploring this reaction, we were able to identify the rates in which 
DPDS reduces acyclic phosphinimines. Most notably, this investigation did lead to the 
identification of conditions in which triphenylphosphine (TPP) is recycled during the course of 
Staudinger reductions (Table 1.29). The reaction works very similarly to reductions employing 
1PPO, but takes a longer time to go to completion, but is still complete within a reasonable 48 
hours. Using triphenylphosphine oxide (TPPO) as the initial phosphorus reagent, however, did not 
yield any notable reactivity over the same time period, indicative of direct reduction of the 
phosphinimine rather than hydrolysis followed by reduction. Also, using phenylsilane and TPP 
only yielded a trace amount of product after 48 hours, and less than 20% conversion was noted 
after 120 hours in reactions run at ambient temperature. 
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Table 1.29. Substrate Scope of Additive-Free Catalytic Staudinger Reductions at Ambient Temperature 
Utilizing TPP as the Catalyst. 
 
Entry Product  Yielda 
1 
 
 95 
2 
 
 89 
3 
 
 93 
4 
 
 93 
5 
 
 88 
6 
 
 88 
aAverage isolated yield for at least two reactions at 0.25 mmol scale after 48 h. 
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To further characterize why TPP can be utilized in catalytic Staudinger reductions 
employing DPDS to recycle the catalyst, we sought to characterize the energy input needed to 
afford reduction. To this effect, we isolated the reduction of N-benzyl-1, 1, 1-triphenyl-5-
phosphanimine (BTPI) under pseudo first-order conditions using 31P NMR as we have previously 
reported.51 Comparing reductions of BTPI with DPDS and phenylsilane immediately indicated that 
phenylsilane would not be a competent reducing agent for these reactions. At 45 °C, the 
disiloxane shows a stark increase in compared to the corresponding silane (Table 1.30 and Figure 
1.31).  
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Figure 1.31. The average reduction of BTPI with PhSiH3 (blue, circles) and DPDS (red, 
squares) under pseudo first-order conditions as monitored with 31P NMR at 45 °C.  
  
158 
 
Table 1.30. Observed Rate Constants for the Silane-Mediated Reduction of XX under Pseudo First-Order 
Conditions.a 
Entry Silane Temperature (K) Kobs (min-1)b 
1 DPDS 296 0.010 
2 DPDS 313 0.358 
3 DPDS 318 0.050 
4 DPDS 323 0.059 
5 DPDS 343 0.189 
aReactions performed in triplicate directly in NMR tubes using d8-PhMe as the solvent and 
freshly prepared BTPI at [BTPI]i = 0.05 M and [Silane]i = 0.50 M; bAverage values fitting to 1st 
order decay.  
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Eyring analysis of this reduction with DPDS (Figure 1.32) yielded the thermodynamic 
parameters of the transition state, indicating H‡ = 11.7 ± 0.4 kcal/mol, S‡ = –0.03 ± 1.9·10-4 
cal/mol and G298K
‡ = 20.0 ± 1.6 kcal/mol. These numbers are lower than those calculated for the 
reduction of TPPO by DPDS,64 recapitulated here as H‡ = 17.3 ± 1.2 kcal/mol, S‡ = –0.01 ± 1.4·10-
4 cal/mol and G298K
‡ = 21.5 ± 3.6 kcal/mol, however; the free energy of activation is not actually 
significantly lower while the enthalpy of activation is significantly reduced.  
160 
 
0 .0 0 2 6 0 .0 0 2 8 0 .0 0 3 0 0 .0 0 3 2 0 .0 0 3 4 0 .0 0 3 6
-1 0 .5
-1 0 .0
-9 .5
-9 .0
-8 .5
-8 .0
-7 .5
1 /T  (K
-1
)
ln
(K
/T
)
y  =  -5 8 9 3 (1 /T ) +  9 .7 0
R
2
 =  0 .9 9 6 0
 
Figure 1.32. The Eyring plot for the reduction of BTPI with DPDS over a temperature 
range of 23 – 70 °C.  
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This small change in energy may very well explain the differences in reactivity between 
phosphinimines and phosphine oxides as only the phosphinimine is reduced at ambient 
temperature without an additive, although, there may be other factors at play which we cannot 
observe directly in these types of experiments. Additionally, we explored the reduction of BTPI in 
a 1:1 stoichiometry with DPDS and found that the reduction is nearly complete within 24 hours 
(Figure 1.33), faster than the reduction of TPPO with DPDS when BNPA is added.64 Also, the 
reduction displays nearly ideal first-order kinetics, with no detectable intermediate in our NMR 
experiments. We also note that trying to identify the resting state of the catalytic reaction was 
difficult as the state of the phosphine changes over the course of the Staudinger reduction (Figure 
SX). However, the rate limiting step is surely the reduction of the phosphinimine as the formation 
of the phosphinimine reaches a plateau around 30 minutes into the reaction, while the reduction 
under pseudo first-order conditions at the same temperature (23 °C) takes approximately 4 hours 
to reach completion (Table 1.30).  
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Figure 1.33. The average reduction of BTPI with DPDS at even stoichiometries at 23 °C 
as determined with 31P NMR.   
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While we have demonstrated that DPDS can be utilized in combination with cyclic 
phosphine oxides in additive-free Wittig recycling reactions, we hoped to utilize much a more 
readily accessible phosphines, such as TPP, with DPDS in other catalytic reactions. Since these 
reactions, unlike the Staudinger reduction, do not go through a phosphinimine intermediate, we 
knew that we required a new set of optimal conditions in order to utilize TPP in redox recycling 
Wittig reactions. Knowing that acyclic phosphines require heat to be reduced without an additive, 
we first investigated additive-free recycling in Wittig reactions by simply adding heat to the 
system. As summarized in Table 1.31, optimization of such a reaction ultimately could not surpass 
the 65% yield mark (Table 1.31, Entry X). Addition of the additive BNPA, first utilized by Beller and 
co-workers25 and later in room-temperature reductions of phosphines with DPDS,64 allowed for a 
much more tractable reaction with TPP. These reactions proceeded cleanly, producing olefins 
with predominantly trans configurations with high fidelity. Unfortunately, addition of this 
intermediate would interfere in catalytic Mitsunobu reactions, although we had already identified 
that reactions with phosphinimine intermediates can only utilize DPDS if the amine is the desired 
product, and thus recycling Mitsunobu reactions would require investigation of an entirely 
different recycling regime.  
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Table 1.31. Optimization of catalytic Wittig reactions with TPP catalysis. 
 
Entry X equiv Y equiv Solvent T °C Yield E/Z Ratio 
1 0.0 1.0 THF 65 44 92:8 
2 0.0 1.0 PhMe 65 59 92:8 
3 0.0 1.0 PhMe 80 65 94:6 
4 0.0 1.0 PhMe 110 63 93:7 
5 0.1 1.0 PhMe 80 60 93:7 
6 0.2 1.0 CH4Cl2 80 67 94:6 
7 0.2 1.5 CH4Cl2 80 69 94:6 
aAverage isolated yield for at least two reactions at 0.25 mmol scale after 48 h. 
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For this TPP-catalyzed protocol, similar functional group tolerance as the additive-free 
reaction was noted (Table 1.32). Both electron-rich and electron-poor benzaldehydes are 
tolerated, although, in this case, electron-poor substrates react substantially faster, while 
frequently affording higher yields. Also in parallel with the additive-free system aliphatic 
aldehydes are unable to produce much olefin product. However, unlike our ambient temperature 
reaction, the synthesis of olefins with semi-stabilized ylides is possible (Table 1.32, Entry 13). 
While the cis:trans ratios are not ideal, as there is little selectivity for one isomer, the use of these 
types of ylides could possibly be improved with an alternate catalyst and base system.18, 82 We 
believe this reaction could be employed easily by many labs as DPDS is a simple reagent to 
synthesize, and TPP is easily purchased. This reaction, as well as its room-temperature equivalent 
offers researchers in both academic and industrial labs the ability to utilize catalytic Wittig 
reactions as DPDS is an easily accessed reagent without the need to isolate silyl chlorides or use 
lithium aluminum hydride to synthesize this reagent.  
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Table 1.32. Substrate scope of catalytic Wittig reactions utilizing triphenylphosphine. 
 
Entry Product Yielda E/Z Ratiob 
1 
 
71 11:1 
2 
 
60 14:1 
3 
 
71 14:1 
4 
 
32 >95:5 
5 
 
15 >95:5 
6 
 
58 95:5 
7 
 
82 >95:5 
8 
 
57 13:1 
9 
 
17 >95:5 
167 
 
 
aAverage isolated yield for at least two reactions at 0.25 mmol scale; bDetermined with 1H NMR. 
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45 3:1 
11 
 
18 95:5 
12 
 
19 >95:5 
13 
 
52 67:33 
14 
 
68 63:37 
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In conclusion, the new reducing disiloxane agent DPDS can be utilized in catalytic redox 
recycling reactions. Specifically, DPDS can be deployed in additive-free catalytic Wittig, 
Staudinger, and Appel reactions at ambient temperature with the use of phospholane precatalyst 
1PPO. This enhanced reducing agent could also be utilized in recycling reactions employing the 
typical phosphine TPP in catalytic Staudinger reductions at ambient temperature, taking 
advantage of the rapid reduction of phosphinimines. TPP was also demonstrated as a competent 
catalyst in Wittig reaction when DPDS is utilized in conjunction with a Brønsted acidic additive at 
elevated temperatures. DPDS can be further examined in other redox recycling processes to 
improve tandem Staudinger reactions as well as the Mitsunobu reaction, although the disiloxane 
and/or phosphine catalysts may need to be tuned to be less reactive in order to avoid unwanted 
reactivity. We expect that these reactions should be able to provide a platform for future 
discoveries towards greener chemistries with improved atom economy and simplified purification 
schemes.  
1.6 1,3-Diphenyl-disiloxane as a multi-functional organic reducing agent 
 While DPDS is an excellent chemoselective reductant of phosphine oxides,64 we 
wished to further explore the utility of this reagent. To this effect, we sought to utilize 
DPDS in other silane-mediated organic transformations. An obvious, and potentially very 
useful, application of DPDS is in other reductive processes falling under the broad category 
of metal-catalyzed hydrosilation reactions.4 The breadth of this field has been extensively 
reviewed throughout the maturation of this chemical conversion. Briefly, all of these sorts 
of reactions involve the transfer of a hydride and results in a new silicon-containing 
compound as summarized in Scheme 1.13. These processes occur over π molecular orbitals 
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between carbon-carbon and carbon-heteroatom bond types. While these reactions can 
occur spontaneously with the addition of enough thermal energy, more tractable synthetic 
methods often exploit multi-functional transition metal catalysts in either the homogenous 
or heterogeneous phases.4 
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Scheme 1.13. The literature proposed mechanisms of hydrogen atom transfer reactions.   
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 While the act of adding a silylhydride over a π-system can be applied in many 
relevant processes for chemical industry, we noted that the metal-mediated hydrosilation 
of carboxamides86 as a particularly interesting transformation for the synthesis of new 
therapeutics, as secondary and tertiary amines are present in the vast majority of 
pharmacologically active substances. Additionally, the generation of amide starting 
materials is quite facile from a plethora of commercially-available amines and carboxylic 
acids, a starting material seeing more use in novel forms of powerful organic methods.87 
While the reduction of carboxamides using a silane and metal catalyst is well-known, and 
recently reviewed,86 the design of these systems has been purely based on empirical 
observation, and the utility of these reactions is limited in scope. Limitations sometimes 
include a lack of functional group tolerance, but more frequently the limitations of these 
methods relate to the types of carboxamides that can be reduced to the corresponding 
amines. Generally, a single metal/silane pair can be used to reduce secondary or tertiary 
carboxamides, but not both. This trend is notable, as a synthetic chemist must choose 
wisely how they prepare their retrosynthetic analysis and judge the cost-effectiveness of 
their route.  
While these limitations to these methodologies do exist, there does seem to be a 
trend that predicts the potential reactivity of carboxamide hydrosilation. After searching 
the literature, it seems apparent that oxygen-containing silane materials, such as 
diethoxyxmethylsilane (DEMS), are applied in the reduction of tertiary carboxamides,86, 88 
while phenylsilanes are employed in the reduction of secondary amides62 in tandem with 
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many transition metals with varying d-electron configurations. Recently, Matthias Beller 
and co-workers disclosed one such method utilizing the very inexpensive combination of 
ZnII(OAc)2 and (OEt)3SiH for the reduction of tertiary carboxamides which exudes high 
fidelity for the specific reduction in question (Scheme 1.12).88 In their disclosure, the new 
method is tolerant of various easily-reduced functionalities including nitro, ester, cyano, 
and ketone. We noted that in their supporting information, however, was a single example 
in which a reduction was performed with phenylsilane, indicating that both phenylsilane 
and siloxycompounds would be capable of carboxamide reduction in combination with 
zinc. Seeing as DPDS contains both of these functionalities, we were hopeful that a new 
method would be possible that included this inexpensive metal source and could be 
implemented for multiple amide types.  
Our starting point was to directly replace Beller’s conditions with DPDS as a proof-
of-concept that the silane could be used with zinc, even if the silane was in great excess. 
To our delight the reaction did work to some degree, and we could easily optimize from 
this point. I first opted to look at an optimal temperature and solvent before attempting to 
lower the amount of silane necessary for reduction.  In addition, unlike other reactions 
within these works, I also attempted to reduce secondary and primary amides, potentially 
optimizing three reactions simultaneously. The initial temperature screen looked at both 
reductions at 23, 40, 65, and 80 °C in THF, as Beller’s conditions at 40 °C had worked well 
in my hands. Any temperature that showed potential for reduction of either amide, would 
then be checked for an optimal solvent. Remarkably, the reaction seemed to reduce tertiary 
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and secondary amides at both 65 and 80 °C, but only worked for the reduction of tertiary 
amides at any other lower temperatures, similar to Beller’s reaction conditions.88 This 
intriguing result indicated that the reaction with DPDS might be temperature-tunable, in 
which the temperature of the reaction dictates the selectivity of the reaction for different 
types of carboxamide reductions.89 As such, we continued the optimization campaigns for 
both   carboxamide types separately, screening solvents at 23 °C for tertiary carboxamides 
(Table 1.33) and at 65 - 80 °C for secondary carboxamides (Table 1.34). Interestingly, the 
reaction works better in 2-methyl-tetrahydrofuran (MTHF), a greener solvent than THF 
with a higher boiling point. Being able to use this solvent allowed the latter reaction to 
function at 80 °C safely, and for faster reactions. It is notable that both reactions are nearly 
complete within 4 hours, although for the purposes of giving all potential options an equal 
chance, reactions were performed for 18 hours.  
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Table 1.33. Optimization of the reduction of tertiary carboxamides. 
 
Entry X equiv Solvent % Conversiona Isolated Yieldb 
1 3.0 MTHF 100 99 
2 2.5 MTHF 100 99 
3 2.0 MTHF 100 98 
4 1.5 MTHF 89 82 
5 2.0 THF 78 66 
6 2.0 MeCN 0 - 
7 2.0 PhMe 50 - 
8 2.0 EtOAc 62 48 
aDetermined with LC-MS; bAverage isolated yield for at least two reactions at 0.25 mmol scale. 
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Table 1.34. Optimization of the reduction of secondary carboxamides. 
 
Entry Solvent Temperature (°C) % Conversiona Isolated Yieldb 
1 MTHF 23 0 - 
2 MTHF 40 22 - 
3 MTHF 65 100 92 
4 MTHF 80 100 96 
5 THF 65 50 - 
6 MeCN 80 0 - 
7 PhMe 110 36 - 
8 PhMe 80 62 - 
aDetermined with LC-MS; bAverage isolated yield for at least two reactions at 0.25 mmol scale. 
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At this point, I was able to hand off the reactions to other scientists, including 
Kathleen Wang and Malcolm Cole, to confirm my results and to finalize the silane 
concentrations. In both cases, 2 equivalents of silane can be employed and the reduction 
works quite well. A substrate scope was then explored for both reaction types, including 
molecules that contain both amide types. As summarized in Tables 1.35 and 1.36, the 
substrate scope of this reduction is fairly broad, however, unlike Beller’s reaction, our 
method with DPDS cannot tolerate cyano functionalities, and the lack of product generated 
in acetonitrile indicates that the silane is likely used up in some reaction with the nitrile. 
The reaction works with many functional groups ranging from nitro to olefin while working 
with benzylic, vinylic, and aliphatic amides with high yield. Interestingly, the reaction 
works well on modified amino acid substrates and can even perform well with a dipeptide, 
reducing only the tertiary amide in the molecule.89 Notably, primary amides remain 
untouched at all temperatures we have explored, indicating that our system is “selective” 
for secondary and tertiary amides, depending on the temperature used to perform the 
reaction.  
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Table 1.35. Substrate scope of the reduction of tertiary carboxamides. 
 
Entry Product Isolated Yielda 
1 
 
92 
2 
 
72 
3 
 
90 
4 
 
66 
5 
 
92 
6 
 
97 
7 
 
74 
8 
 
92 
9 
 
91 
aAverage isolated yield for at least two reactions at 0.25 mmol scale. 
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Table 1.36. Substrate scope of the reduction of secondary carboxamides. 
 
Entry Product Isolated Yielda 
1 
 
92 
2 
 
83 
3 
 
79 
4 
 
48b 
5 
 
90 
6 
 
60 
aAverage isolated yield for at least two reactions at 0.25 mmol scale; b3 equiv of DPDS employed. 
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While the reduction of carboxamides is a useful transformation, a way to quickly 
improve this reaction would be to have a one-pot reductive amine alkylation protocol which 
can tolerate the synthesis of secondary and tertiary amines. While processes similar to this 
have been reported for decades,90 they frequently combine the synthons of aldehydes and 
amines. For the purposes of aiding medicinal chemistry campaigns, however, I hoped to 
generate a reductive amine alkylation that can utilize a more commercially-available and 
stable synthon, the carboxylic acid.62, 91 While this has been reported previously by multiple 
groups, we hoped that our DPDS reagent could also be used universally. The zinc system 
seemed like a good place to start as it was already competent at reducing carboxamides, 
with such an inexpensive catalyst.  
Thankfully, our starting point with zinc and three equivalents of DPDS was capable 
of facilitating amide bond formation and subsequent reduction for the reaction between a 
primary amine and a carboxyilic acid. Thankfully, being that the reaction works best in 
MTHF, we were able to get 100% conversion within 16 hours at 80 °C and form the 
corresponding secondary amine. The same could also be done for the coupling of a 
secondary amine and a carboxylic acid, but the requirement for heat was maintained, an 
unsurprising fact due to amide couplings with DPDS requiring thermal input.85 This 
particular reaction was then checked for validity and reproducibility by other members of 
the lab, as it is important that this reaction can be done by other scientists other than the 
ones whom are developing the technology. As summarized in Table 1.37, a preliminary 
substrate scope has been explored and continues to expand as this publication draws nearer. 
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 Table 1.37. Preliminary substrate scope of DPDS-mediated amine alkylation. 
 
Entry Product Isolated Yielda 
1 
 
78 
2 
 
79 
3 
 
75 
4 
 
78 
5 
 
82 
6 
 
66 
aAverage isolated yield for at least two reactions at 0.25 mmol scale. 
  
181 
 
These results indicate that DPDS is in fact a very versatile reducing agent, with the 
potential to be utilized in wide manner of reactions which require improved 
chemoselectivity, or which may benefit from a multi-functional silane reagent. Even in the 
context of alkyl amine compounds, DPDS offers multiple angles for the synthesis of these 
highly desired, and highly applicable molecules from tractable synthons. We plan to flesh 
out the limitations of this chemistry further, to better understand the use of DPDS in the 
context of carboxamide reduction and amine alkylation.  
1.7 Concluding remarks 
 All in all, the work presented in this chapter highlights the use of rational reagent 
design for improved chemical processes. While our initial efforts to create a catalytic 
Mitsunobu were fruitful, it turns out the implementation of this sort of chemistry is actually 
quite difficult.92 These efforts, driven by empirical screening, certainly need improvement; 
which was initially attributed to improving the rate-determining step of the redox catalysis 
cycle. However, upon implementation of kinetic analysis to actually vastly improve this 
step, the catalytic Mitsunobu at ambient temperature could still not be realized. While an 
optimal catalytic Mitsunobu was not realizable over this time period, other redox recycling 
protocols were developed with success with either zero added thermal energy, no additional 
chemical regents, or both. As such, we believe the results presented herein represent a large 
step forward, but not quite the end of where redox recycling needs to end up for more 
ubiquitous usage.  
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 We now understand the necessary components of silane-mediated reductions for 
phosphine oxides, and have designed DPDS based on those needs, although this 
prototypical reagent still leaves room for improvement. Thankfully, being a fully 
conjugated -system, this reagent should be highly amenable to tuning via perturbation of 
the electronic nature of the reagent with electron-donating and electron-withdrawing 
functionalities. This silane modulation can be paired with phosphorus reagent design 
which, unfortunately, cannot be fully predicted. As presented, each phosphorus scaffold 
must be screened to indicate its usefulness in a given reaction, as in some cases a lack of 
nucleophilicity may be desired, or the rate at which its reduction occurs may need to be 
attenuated (as in the case of tandem Staudinger processes19). However, we expect that 
DPDS will be able to be implemented in many redox recycling schemes, which includes 
both classical, and novel organic transformations seeing as the reagent can be used to 
reduce very difficult-to-access phosphine oxides, while also maintaining a high specificity 
for this specific reaction type without perturbing typically reactive functional groups.  
 Additionally, our initial characterization of this reagent shows that the reagent can 
be paired with other additives in order to be useful in contexts outside of phosphine oxide 
reductions. We hope that symmetrical disiloxanes can be utilized in other reductive 
processes, or other metal-catalyzed reactions, such as the Hiyama-Denmark coupling.93 We 
hope that DPDS, and reagents similar to it, can be utilized in a wide array of reactions 
utilizing either siloxane materials or silyl-hydrides for chemoselective reactivity. Since the 
synthesis of such reagents is quite facile using our mechano-chemical procedure, we expect 
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that these reagents should also be easily screened for their competence since they should 
be quite easy to access in the majority of synthetic laboratories.  
1.8 Methods and materials  
1.8.1. General Considerations 
All commercially available reagents were used without further purification. Phosphine 
oxides 1PPO, TMPPO, TBPO, and triarylphosphine oxides1 were synthesized as 
previously reported. 1-Chloro-2,2,3-trimethylphosphetane-1-oxide (S1) was prepared as 
described.  Si,Si,Si-Trideutero-phenylsilane (S8) was also prepared as described. All 
disiloxanes were synthesized as described in this supporting information or using the 
protocol we recently reported. All phosphines were stored at -20 °C wrapped in foil to 
exclude light and all silanes were stored at ambient temperature in a light-shielding 
desiccator to exclude UV light. Benzyl azides were all prepared according to the procedure 
from Feringa et. al. from the corresponding benzyl bromide or benzyl chloride. Molecular 
sieves were activated by heating at 200 °C under reduced pressure. Tetrahydrofuran (THF), 
toluene, and dichloromethane (CH2Cl2) were dispensed from an Inert® solvent dispensing 
system. Deuterated THF was purchased from Sigma-Aldrich in dry 1 gram ampules and 
used without further drying. Deuterated chloroform, CD2Cl2, and toluene were purchased 
from Cambridge Isotopes and used without further drying from 10 gram bottles stored in a 
desiccator. Lithium chloride was stored in a desiccator and dried with a Bunsen burner 
immediately before use. Anhydrous magnesium chloride was dried and stored in a 
desiccator prior to use. Zinc chloride was purified in its molten form to remove water and 
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hydrogen chloride from the salt immediately before use. Anhydrous sodium sulfate was 
purchased from Fisher Chemicals and used without further purification. Pyrollidine and 
piperidine were dried over calcium hydride and freshly distilled under reduced pressure 
immediately before use. 1H, 13C, 19F, 29Si, and 31P NMR spectra were recorded on a Varian 
400 MHz spectrometer, Bruker Avance 500 MHz spectrometer, or Varian INOVA 600 
MHz spectrometer with broadband probes. High resolution mass spectra were collected on 
a Bruker BioTOF II mass spectrometer using PEG or PPG internal standards. Sodium 
formate was sometimes added in order to facilitate ionization, frequently leading to 
characterization of the [M + Na+] masses.  Silica gel column chromatography was 
performed with silica gel (Dynamic Absorbents, 60A) or using a Teledyne-Isco RF-200 
Combi-Flash system. Kugelrohr distillations were performed with a Buchi glass oven B-
585 instrument. The experiments contained herein are not hazardous outside of the typical 
flammable/explosion hazards present with the usage of organic solvents, ethereal solvents 
such as Et2O and THF should always be assayed for the presence of peroxy by-products. 
Computational experiments were performed using the resources of the Minnesota 
Supercomputing Institute (MSI), specifically through virtual machines running on Linux 
superclusters named “Itasca” and “Mesabi”. Computational resources such as Gaussian09 
and GaussView were provided through licenses available to the MSI.  
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1.8.2. Synthesis of Phosphine Precatalysts: 
1.8.2.1. 5-Phenyldibenzophosphole-1-Oxide:94 
 
To a 3-neck 500 mL round bottom flask equipped with a stir bar and fitted with a reflux 
condenser and addition funnel was added triphenylphosphine oxide (11.2 g, 40.0 mmol, 
1.00 equiv) and THF (240 mL). The reaction apparatus was purged with argon and the 
mixture was cooled to 0 C. A 1.8 M solution of phenyllithium in di-n-butyl ether (45.0 
mL, 81.0 mmol, 2.03 equiv) was added dropwise to the stirring solution. After complete 
addition of the organolithium, the reaction was heated at reflux for 46 h. After cooling to 
room temperature, H2O (150 mL) was added to the reaction and the mixture was then 
neutralized with 3 N HCl (50 mL). The layers were separated and the aqueous layer was 
extracted with EtOAc (3  100 mL). The organic layers were combined and concentrated 
under reduced pressure. The residue was purified by silica gel chromatography (hexane) 
and then recrystallized (1:9 ethyl acetate: hexanes) to yield pure 5-
phenyldibenzophosphole (5.17 g, 50%) as a white solid. All spectra and physical data 
matched that of previous reports. The purification step is unnecessary as the subsequent 
reaction is unaffected when crude material is utilized.  
To a 25 mL round bottom flask equipped with a stir bar was added 5-
phenyldibenzophosphole (260 mg, 1.00 mmol, 1.00 equiv) and Et2O (5 mL). To the 
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reaction a 35% w/w aqueous solution of hydrogen peroxide (0.345 mL, 3.53 mmol, 3.53 
equiv) was added dropwise at 23 C. A white precipitate was noted immediately. After 30 
min, the reaction was filtered and the filter cake was washed with Et2O (20 mL). Compound 
1 (178 mg, 78%) was collected from the filter as a white solid. All spectra and physical 
data matched that of previous reports. 
1.8.2.2. 1-Phenylphospholane-1-oxide (1PPO):20  
 
Warning: Dichlorophenylphosphine is a volatile liquid that is extremely noxious. Use only 
in well-ventilated areas.  
To a 1000 mL round bottom flask equipped with a stir bar was added magnesium 
powder (50 mesh, 2.82 g, 200 mmol, 4.00 equiv) and iodine (0.350 g, 1.4 mmol, 0.28 
equiv). The flask was purged with argon, and anhydrous Et2O (250 mL) was added via 
cannula. The reaction was cooled to 10 C and 1,4-dibromobutane (5.5 mL, 50 mmol, 1.00 
equiv) was added dropwise. The reaction was warmed to 23 C. After 3 h, the reaction was 
cooled to 0 C and dichlorophenylphosphine (6.3 mL, 50 mmol, 1.00 equiv) was added 
dropwise over 40 min and a white precipitate was noted immediately upon addition of this 
reagent. The reaction was warmed to 23 C and stirred overnight. The reaction was washed 
with H2O (425 mL) and saturated aqueous NaCl (425 mL). The aqueous layers were 
combined and extracted with CH2Cl2 (3  100 mL). The organic layers were combined and 
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concentrated under reduced pressure to afford crude 1-phenylphospholane (6.71 g) as a 
yellow oil, which was carried onto the next step without further purification. Note: This 
crude mixture is also extremely noxious and should be handled in a well-ventilated area.  
To a 1000 mL round bottom flask equipped with a stir bar and charged with the crude 
reaction mixture from above was added CH2Cl2 (100 mL). The reaction was cooled to 10 
C and an aqueous solution of 35% w/w hydrogen peroxide (7.94 mL, 81.7 mmol, 1.63 
equiv) was added dropwise. The reaction was warmed to 23 C. After 3 h, the reaction was 
washed sequentially with saturated aqueous NaHCO3 (2  50 mL) and saturated aqueous 
NaCl (50 mL). The organic layer was dried with magnesium sulfate and concentrated under 
reduced pressure. The reaction was purified by silica gel chromatography (1:9 MeOH: 
CH2Cl2) and 2 was isolated as an orange oil, which solidified upon cooling at -20 C (2.14 
g, 27% over two steps). All spectra and physical data matched that of previous reports. 
1.8.2.3.-n-Butyl-2,2,3-trimethylphosphetane-1-oxide (TMBPO): 
 
To a flame-dried two-neck round bottom flask equipped with a stir bar was added dried 
magnesium(0) powder (50 mesh, 0.43 g, 18 mmol), THF (2 mL), and one crystal of iodine. 
Stirring was initiated and a solution of bromobutane (1.6 mL, 15 mmol) in THF (13 mL) 
was added dropwise. When addition of the bromide was complete, the reaction was 
refluxed for 2 h. The reaction was then cooled to 0 °C and a solution of S1 (1.992 g, 12 
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mmol) in THF (10 mL) was added dropwise to the stirring solution of S2. The reaction was 
allowed to warm to 23 °C and stirred for 16 h. After 16 h, the reaction was quenched by 
the addition of H2O (25 mL). The layers were separated and the aqueous layer was washed 
with DCM (3  25 mL). The organics were combined and dried (MgSO4). The reaction 
was concentrated in vacuo to a yellow oil and loaded onto silica gel. Purification by flash 
column chromatography on silica gel (40 g SiO2, 0–10% MeOH:DCM eluent, linear 
gradient) afforded the title compound (1.30 g, 57%) as off-white needles: Rf = 0.62 (5:95 
MeOH:DCM) stained with iodine. 1H NMR (500 MHz, CDCl3)  2.46-2.40 (m, 1H), 2.10-
2.04 (m, 1H), 1.86-1.82 (m, 1H), 1.73-1.70 (app. m, 2H), 1.68-1.65 (m, 2H), 1.49-1.45 (m, 
2H), 1.26-1.16 (app. dd, 6H), 1.03-1.02 (d, 3H), 0.97-0.94 (t, 3H); 13C NMR (125 MHz)  
49.0, 37.3, 30.2, 25.9, 24.2, 23.7, 22.5, 1, 6.1, 14.4, 13.7; 31P {1H} NMR (202 MHz, CDCl3) 
 49.68. HRMS for C10H21NaOP [M + Na+] calculated 211.122; found 211.1225.  
Additional purification: Preparatory TLC (5:95 MeOH:DCM) was used to purify small 
amounts of TMBPO for some syntheses of this molecule. In order to visualize this 
molecule with iodine, heat iodine crystals and then drop into the TLC chamber. The top 
spot (stains yellow with iodine) is the desired product.  
1.8.2.4. 1-Pyrrolidyl-2,2,3-trimethylphospetane-1-oxide (TMPyrPO): 
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To a flame-dried round bottom flask equipped with a stir bar was added S1 (2.16 g, 13 
mmol), toluene (13 mL), triethylamine (2.2 mL, 16 mmol), and pyrrolidine (1.2 mL, 14.6 
mmol) sequentially. The reaction was sealed, purged with argon, and heated to 60 °C for 
24 hours. After 24 hours, the reaction was cooled to 23 °C and filtered. The cake was 
washed with EtOAc (10 mL). The filtrate was combined with the EtOAc wash, which were 
subsequently washed with 5% aqueous sodium bicarbonate (20 mL), dried (MgSO4) and 
concentrated in vacuo to afford the title compound (1.96 g, 75%) as an orange oil and 
mixture of diastreomers: 1H NMR (500 MHz, CDCl3, Mixture of diastereomers)  3.33-
3.23 (m, 4H), 2.65-2.60 (m, 1H), 2.14-2.06 (m, 1H), 1.91-1.88 (m, 4H), 1.58-1.53 (app. M, 
1H), 1.23-1.17 (app. dd, 6H), 1.03-1.02 (d, 3H); 13C NMR (125 MHz)  52.9, 52.3, 
46.6,37.8, 37.3, 26.6, 23.2, 17.5, 14.5; 31P {1H} NMR (202 MHz, CDCl3, Mixture of 
diastereomers)  48.83, 47.73. HRMS for C10H20NNaOP [M + Na+] calculated 224.1175; 
found 224.1199.  
1.8.2.5. 1-Cyclopropyl-2,2,3-trimethylphosphetane-1-oxide (S4): 
 
To a flame-dried two-neck round bottom flask equipped with a stir bar was added dried 
magnesium(0) powder (50 mesh, 0.43 g, 18 mmol), THF (2 mL), and one crystal of iodine. 
Stirring was initiated and a solution of bromocyclopropane (1.3 mL, 15 mmol) in THF (13 
mL) was added dropwise. When addition of the bromide was complete, the reaction was 
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refluxed for 2 h. The reaction was then cooled to 0 °C and a solution of S1 (2.0 g, 12 mmol) 
in THF (10 mL) was added dropwise to the stirring solution of S3. The reaction was 
allowed to warm to room temperature and was stirred for 16 h. After 16 h, the reaction was 
quenched by the addition of deionized water (25 mL). The layers were separated and the 
aqueous layer was washed with DCM (3  25 mL). The organic layers were combined and 
dried with MgSO4, concentrated in vacuo to a yellow oil, and loaded onto silica gel. 
Purification by flash column chromatography on silica gel (40 g SiO2, 0–10% MeOH:DCM 
eluent, linear gradient) afforded the title compound (730 mg, 32%) as a yellow oil and 
mixture of diastereomers: Rf = 0.60 (5:95 MeOH:DCM) stained with iodine. 
1H NMR (500 
MHz, CDCl3, Major diastereomer)  2.4-2.38 (m, 1H), 2.12-2.04 (m, 1H), 1.96-1.92 (m, 
1H), 1.21-1.16 (app. dd, 6H), 0.99-0.98 (d, 3H), 0.87-0.74 (m, 4H); 13C NMR (125 MHz, 
CDCl3, Mixture of diasteromers)  49.0, 48.6, 46.6, 37.3, 36.9, 30.2, 25.9, 25.5, 24.3, 23.7, 
22.6, 16.6, 16.1, 14.4, 14.2, 13.7, 12.1, 11.7; 31P {1H} NMR (202 MHz, CDCl3, Mixture 
of Diastereomers)  48.08 (major), 55.97 (minor). HRMS for C9H18OP [M + H+] calculated 
173.1090; found 173.1086. 
1.8.3. Reactivity of Phenylsilane with Alcohols: 
1.8.3.1. Procedure: To a NMR tube was added p-nitrobenzoic acid (25 mg, 1.5 equiv, 0.15 
mmol), d8-THF (0.5 mL), 4-(trifluoromethyl)benzyl alcohol (13.7 L, 1.0 equiv, 0.1 
mmol), hexafluorobenzene (11.5 L, 1.0 equiv, 0.1 mmol) and phenylsilane (18.5/37 L, 
1.5/3.0 equiv, 0.15/0.3 mmol). The tube was inverted three times to ensure proper mixing 
of the reagents and the interface between the tube and the cap was sealed with multiple 
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layers of paraffin wax (parafilm®) to ensure no leaks. The reaction was heated to 80 C 
and monitored with 19F NMR. 
1.8.4. Optimization of the Catalytic Mitsunobu Reaction: 
1.8.4.1. Procedure: To a 2-dram vial equipped with a stir bar was added p-nitrobenzoic acid 
(250 mg, 1.5 equiv, 1.5 mmol) and phosphine precatalyst (0.1 equiv, 0.1 mmol). Solvent 
(4 mL) was added followed by benzyl alcohol (103 L, 1.00 equiv, 1.00 mmol), DIAD 
(216 L, 1.10 equiv, 1.10 mmol), and then silane (X equiv, X mmol). Reactions were 
sealed with a PTFE septum in the screw cap and heated to the indicated temperature. When 
the reaction was deemed complete (TLC), reactions were concentrated under reduced 
pressure and purified by silica gel chromatography 
1.8.5. Optimization of Silane Stoichiometry: 
1.8.5.1. Procedure: To a 15 mL pressure tube equipped with a stir bar was added p-
nitrobenzoic acid (250 mg, 1.5 equiv, 1.5 mmol) and phosphine precatalyst (0.1 equiv, 0.1 
mmol). THF (4 mL) was added followed by 4-(trifluoromethyl)benzyl alcohol (137 L, 
1.0 equiv, 1.0 mmol), DIAD (216 L, 1.1 equiv, 1.1 mmol), hexafluorobenzene (11.5 L, 
0.1 equiv, 0.1 mmol), and then silane (X equiv, X mmol). Reactions were sealed with a 
PTFE septum in the screw cap and heated to the appropriate temperature. When the 
reaction was deemed complete, reactions were concentrated under reduced pressure and 
isolated by silica gel chromatography. 
1.8.6. Silane Reductions of Phosphine Oxide Precatalysts for Mitsunobu Studies:  
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1.8.6.1. Reaction setup: To an NMR tube was added a solution of phosphine oxide (1.0 
equiv, 0.01 mmol) in d8-THF (0.5 mL, 0.02M). Phenylsilane (9.2/18.4/37 L, 7.5/15.0/30.0 
equiv, 0.075/0.15/0.3 mmol) was added and the tube was sealed with a cap. The tube was 
inverted three times to ensure proper mixing of the silane and the interface between the 
tube and the cap was sealed with multiple layers of paraffin wax (parafilm®) to ensure no 
leaks. The reaction vessels were heated to the indicated temperature and monitored by 31P 
NMR at multiple time points as shown in Figure 1.34. 
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Figure 1.34. Representative stacked plot of 31P NMR spectra obtained during a typical 
reduction experiment. Shown is the stacked plot of the reduction of 5PDBPO with 30 equiv 
PhSiH3 at 70 °C.  
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1.8.6.2. Time points: When using 5PDBPO as the phosphine oxide, reactions can be 
effectively paused by running cold water over NMR tubes for 15-30 seconds. When using 
1PPO as the phosphine oxide, reactions can be effectively paused by running cold water 
over NMR tubes for 15-30 seconds followed by storage for short periods of time in a salt-
water ice bath. Overnight storage (if needed) can be achieved at -20 C as no reduction is 
noted at this temperature for any catalyst studied using this method.  
1.8.6.3. NMR method: Tri-substituted phosphines have very long relaxation times as the 
31P nucleus is not coupled to any other nucleus that can promote its relaxation. Because of 
this, we utilized a 35 second delay time between pulses and monitored each reaction with 
only 4 pulses per time point. While this method has been applied previously6, we confirmed 
these parameters by comparing the integration of triphenylphosphine and 
triphenylphosphine oxide with known concentrations.  
1.8.7. Synthesis of Alcohol Substrates: 
1.8.7.1. 3-(4-Fluorophenyl)propanol:95  
 
To a 200 mL round bottom flask equipped with a stir bar was added 3-(4-
fluorophenyl)propanoic acid (4.2 g, 25 mmol, 1.0 equiv) and THF (35 mL). The flask was 
purged with argon and cooled to 0 C. A 1 M solution of borane in THF (34 mL, 34 mmol, 
1.4 equiv) was added dropwise over 15 min. The reaction was warmed to 23 C. After 3 h, 
the reaction was cooled to 0 C and methanol (5 mL) and H2O (10 mL) were added to 
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quench the reaction. The reaction was concentrated under reduced pressure and the residue 
was dissolved in H2O (20 mL). The reaction mixture was extracted with EtOAc (2  20 
mL). The organic layers were combined and washed with saturated aqueous NaHCO3 (40 
mL) and saturated aqueous NaCl (40 mL). The combined organic layer was dried with 
magnesium sulfate and concentrated to give 3-(4-fluorophenyl)propanol (3.66 g, 95%) as 
a light yellow oil: Rf = 0.20 (2:8 ethyl acetate: hexanes). Spectral and physical data matched 
previous reports.  
1.8.7.2. 2-Phenylethanol:96  
 
To a 100 mL round bottom flask equipped with a stir bar was added phenylacetic acid 
(2.45 g, 18.0 mmol, 1.00 equiv) and THF (7 mL). The flask was purged with argon, and 
cooled to 0 C. A 1 M solution of borane in THF (24 mL, 24 mmol, 1.33 equiv) was added 
dropwise over 15 min. The reaction was warmed to 23 C. After 3 h, the reaction was 
cooled to 0 C and methanol (5 mL) and H2O (10 mL) was added to quench the reaction. 
The reaction mixture was diluted with EtOAc (20 mL) and the layers were separated. The 
organic layer was washed with a saturated aqueous NaHCO3 and then dried with 
magnesium sulfate. The reaction was concentrated to give 2-phenylethanol (2.08 g, 95%) 
as a colorless oil: Rf = 0.22 (2:8 ethyl acetate: hexanes). Spectral and physical data matched 
previous reports.  
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1.8.8. General Procedure for the Catalytic in Phosphine Mitsunobu Reaction:  
To a 15 mL pressure tube equipped with a stir bar was added precatalyst 1PPO (18 mg, 
0.10 equiv, 0.10 mmol) and p-nitrobenzoic acid (250 mg, 1.5 equiv, 1.5 mmol). Then, THF 
(4 mL) was added followed by benzyl alcohol (103L, 1.0 equiv, 1.0 mmol), DIAD 
(216L, 1.1 equiv, 1.1 mmol), and phenylsilane (135 L, 1.1 equiv, 1.1 mmol). The 
reaction vessel was sealed with a #15 O-ring and heated to 80 C for 18 h. The reaction 
was cooled to 23 C and concentrated under reduced pressure. The residue was purified by 
column chromatography as indicated for each compound.  
1.8.8.1. Alternate workup: The reaction was diluted by four-fold with ethyl acetate. The 
reaction mixture was washed twice with saturated aqueous NaHCO3 (1:1 volume) and then 
saturated aqueous NaCl (1:1 volume). The organics were dried with anhydrous magnesium 
sulfate and concentrated under reduced pressure. 
1.8.9. General Procedure for the Stoichiometric Mitsunobu Reaction:  
To a 2-dram vial equipped with a stir bar were sequentially added triphenylphosphine (1.5 
equiv), solid nucleophiles (1.5 equiv), solid alcohols (1.0 equiv) and tetrahydrofuran (0.25 
M).  If the reagents were liquids, then they were added following addition of THF. Next, 
diisopropyl azodicarboxylate (DIAD, 1.5 equiv) was added in a dropwise manner to initiate 
the reaction. The reaction vessel was sealed with a PTFE septum in the screw cap and 
stirred at room temperature overnight. After 18 h, the reaction was concentrated under 
reduced pressure. The residue was purified by silica gel chromatography as indicated for 
each compound.  
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1.8.10. Purification of Products in Table 1.3: All reactions can be monitored using 
standard TLC analysis. All reactions were stained with UV, iodine, KMnO4, and/or 
ninhydrin. 
Benzyl 4-nitrobenzoate:45  
Reactions were concentrated directly onto SiO2. Purified using a Teledyne-Isco Combi-
Flash system using a gradient from 0 to 10% ethyl acetate in hexanes. Isolated as a white 
to yellow solid (all had similar purity as determined by NMR): Rf = 0.42 (2:8 ethyl 
acetate:hexanes). Spectra and physical data matched previous reports.  
4-Trifluoromethylbenzyl 4-nitrobenzoate:97  
Reactions were concentrated directly onto SiO2. Purified using a Teledyne-Isco Combi-
Flash system using a gradient from 0 to 10% ethyl acetate in hexanes. Isolated as a white 
solid: Rf = 0.43 (2:8 ethyl acetate:hexanes). Spectra and physical data matched previous 
reports.  
4-Methoxybenzyl 4-nitrobenzoate:45  
Reactions were concentrated directly onto SiO2. Purified using a Teledyne-Isco Combi-
Flash system using a gradient from 0 to 10% ethyl acetate in hexanes. Isolated as a yellow 
solid: Rf = 0.43 (2:8 ethyl acetate:hexanes). Spectra and physical data matched previous 
reports.  
Geranyl 4-nitrobenzoate:  
Reactions were concentrated directly onto SiO2. Purified using a Teledyne-Isco Combi-
Flash system using a gradient from 0 to 10% ethyl acetate in hexanes. Isolated as a colorless 
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oil: Rf = 0.50 (2:8 ethyl acetate:hexanes); 
1H NMR (400 MHz, CDCl3)  8.27 (d, 2H, J = 
8.9 Hz), 8.20 (d, 2H, J = 8.9 Hz), 5.45 (t, 1H, J = 7.1 Hz), 5.07 (t, 1H, J = 7.1 Hz), 4.87 (d, 
2H, J = 7.1 Hz), 2.06–2.13 (m, 4H), 1.76 (s, 3H), 1.66 (s, 3H), 1.59 (s, 3H); 13C NMR (100 
MHz, CDCl3) 160.36, 130.68, 123.45, 117.63, 62.71, 39.51, 26.19, 25.64, 17.65; HRMS 
for C17H21NO4Na [M+Na
+]  calculated 326.1363; found 326.1361. 
3-(4-Fluorophenyl)propyl 4-nitrobenzoate:  
Reactions were concentrated directly onto SiO2. Purified using a Teledyne-Isco Combi-
Flash system using a gradient from 0 to 10% ethyl acetate in hexanes. Isolated as a colorless 
oil: Rf = 0.50 (2:8 ethyl acetate:hexanes); 
1H NMR (400 MHz, CDCl3)  8.28 (d, 2H, J = 
8.9 Hz), 8.16 (d, 2H, J = 8.9 Hz), 7.13–7.17 (m, 2H), 6.96 (t, 2H, J = 8.7 Hz), 4.37 (t, 2H, 
J = 6.5 Hz), 2.75 (t, 2H, J = 7.4 Hz), 2.06–2.13 (m, 2H); 13C NMR (100 MHz, CDCl3) 
164.60, 130.62, 129.65, 123.51, 115.38, 115.18, 65.12, 31.47, 30.18; 19F NMR (376 
MHz, CDCl3)  -117.19 (s, 1F) HRMS for C16H14NFO4Na [M+Na+] calculated 326.0799; 
found 326.0800. 
Propargyl 4-nitrobenzoate:98  
Reactions were concentrated directly onto SiO2. Purified using a Teledyne-Isco Combi-
Flash system using a gradient from 0 to 10% ethyl acetate in hexanes. Isolated as an off-
white solid: Rf = 0.45 (1:9 ethyl acetate:hexanes). Spectra and physical data matched 
previous reports.  
(R)-1-Phenylethyl 4-nitrobenzoate:45  
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Reactions were concentrated directly onto SiO2. Purified using a Teledyne-Isco Combi-
Flash system using a gradient from 0 to 20% ethyl acetate in hexanes. Isolated as a yellow 
solid (after extensive drying): Rf =  0.43 (2:8 ethyl acetate:hexanes); ER > 94:6 (5:5 
isopropanol:hexanes). Spectra and physical data matched previous reports.  
(R)-1-Ethoxy-1-oxopropan-2-yl 4-nitrobenzoate:45  
Reactions were concentrated directly onto SiO2. Purified using a Teledyne-Isco Combi-
Flash system using a gradient from 0 to 10% ethyl acetate in hexanes. Isolated as a white 
to yellow solid (all had similar purity as determined by NMR): Rf = 0.57 (2:8 ethyl 
acetate:hexanes); ER > 99.5: 0.5 (5:5 isopropanol:hexanes). Spectra and physical data 
matched previous reports.  
Phenethyl 4-nitrobenzoate:45  
Reactions were concentrated directly onto SiO2. Purified using a Teledyne-Isco Combi-
Flash system using a gradient from 0 to 10% ethyl acetate in hexanes. Isolated as a white 
solid: Rf = 0.43 (2:8 ethyl acetate:hexanes). Spectra and physical data matched previous 
reports.  
Phenethyl N-fluorenylmethyloxycarbonylvalinate:  
Reactions were concentrated directly onto SiO2. Purified using a Teledyne-Isco Combi-
Flash system using a gradient from 0 to 40% ethyl acetate in hexanes. Isolated as a colorless 
oil: Rf = 0.31 (2:8 ethyl acetate:hexanes); 
1H NMR (400 MHz, CDCl3)  7.75 (d, 2H, J = 
7.5 Hz), 7.59 (d, 2H, J = 7.1 Hz), 7.39 (t, 2H, J = 7.1 Hz), 7.18-7.32 (m, 7H), 5.25 (t, 1H, 
J = 9.1 Hz), 4.20–4.42 (m, 6H), 2.95 (t, 2H, J = 6.9 Hz), 2.05–2.13 (m, 1H), 0.90 (d, 3H, J 
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= 6.8 Hz), 0.81 (d, 3H, J = 6.8 Hz); 13C NMR (100 MHz, CDCl3) 171.96, 156.17, 143.90, 
143.77, 141.29, 137.32, 128.81, 128.53, 127.67, 127.03, 126.66, 125.05, 119.95, 66.99, 
65.64, 58.99, 47.18, 35.00, 31.25, 18.90, 17.43; HRMS for C28H29NO4Na [M+Na
+] 
calculated 466.1989; found 466.1995. 
1-Nitro-4-phenylethoxybenzene:99  
Reactions were concentrated directly onto SiO2. Purified using a Teledyne-Isco Combi-
Flash system using a gradient from 0 to 10% ethyl acetate in hexanes. Isolated as a yellow 
solid: Rf = 0.51 (2:8 ethyl acetate:hexanes). Spectra and physical data matched previous 
reports.  
tert-Butyl phenethyl(sulfamoyl)carbamate:  
Reactions were concentrated directly onto SiO2. Purified using a Teledyne-Isco Combi-
Flash system using a gradient from 0 to 30% ethyl acetate in hexanes. Isolated as a white 
solid: Rf = 0.13 (2:8 ethyl acetate:hexanes); 
1H NMR (400 MHz, CDCl3)  7.29–7.33 (m, 
2H), 7.20–7.26 (m, 3H), 4.69 (bs, 2H), 3.96 (t, 2H, J = 7.1 Hz), 2.93 (t, 2H, J = 7.1 Hz), 
1.49 (s, 9H); 13C NMR (100 MHz, CDCl3) 138.37, 129.46, 128.55, 126.78, 84.24, 48.74, 
35.41, 28.01; HRMS for C13H20N2O4SNa
 [M+Na+] calculated 323.1036; found 323.1036. 
N-tert-Butoxycarbonylhomoserine lactone:100  
Reactions were concentrated directly onto SiO2. Purified using a Teledyne-Isco Combi-
Flash system using a gradient from 0 to 50% ethyl acetate in hexanes. Isolated as a white 
solid: Rf = 0.38 (4:6 ethyl acetate:hexanes). Spectra and physical data matched previous 
reports.  
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tert-Butyl (2’,3’-O-isopropylidene-5’-deoxyinosin-5’-yl)(sulfamoyl)]carbamate:  
Reactions were concentrated directly onto SiO2. Purified using a Teledyne-Isco Combi-
Flash system using a gradient from 0 to 100% ethyl acetate in hexanes. Isolated as a white 
solid: Rf = 0.50 (ethyl acetate); 
1H NMR (400 MHz, CDCl3)  12.38 (bs, 1H), 8.27 (s, 1H), 
8.05 (s, 1H), 6.07 (d, 1H, J = 3.1 Hz), 5.23 (dd, 1H, J = 6.2, 2.9 Hz), 5.07 (t, 2H, 4.7 Hz), 
4.89 (dd, 1H, J = 6.2, 2.5 Hz), 3.50 (t, 2H, 4.7 Hz), 1.66 (s, 9H), 1.50 (s, 3H), 1.29 (s, 3H); 
13C NMR (100 MHz, CDCl3) 156.94, 155.66, 148.21, 146.48, 139.17, 124.89, 113.53, 
90.01, 87.08, 84.24, 81.68, 61.88, 28.01, 27.46, 25.59; HRMS for C18H26N6O8SNa 
[M+Na+] calculated 509.1425; found 509.1451. 
1.8.10. Synthesis of Silane Reducing Agents: 
1.8.10.1. 1,3-Diphenyl-disiloxane (DPDS): 
  
To a separatory funnel charged with partially melted ice (10 g) was added a solution of S5 
(2.0 g, 14 mmol, 2.1 mL) in diethyl ether (8 mL). The reaction was allowed to warm to 23 
°C and was swirled by hand every 10 min for 1 h. Additional diethyl ether (15 mL) was 
then added to the reaction and the aqueous layer was drained. The ether layer was washed 
with H2O (10 mL), dried (MgSO4), and concentrated in vacuo to afford the crude product. 
Purification by Kugelrohr distillation afforded the title compound (2.6 g, 82%) as a 
colorless oil: bp = 155 °C at 0.8 mmHg; NMR spectra and other physical data matched 
previous reports.73 
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1.8.10.2. 1,1,3,3-Tetraphenyl-disiloxane (TPDS): 
 
To a separatory funnel charged with partially melted ice (10 g) was added a solution of S6 
(2.1 g, 9.6 mmol, 2.0 mL) in diethyl ether (8 mL). The reaction was allowed to warm to 23 
°C and was swirled by hand every 10 min for 1 h. Additional diethyl ether (15 mL) was 
then added to the reaction and the aqueous layer was drained. The ether layer was washed 
with H2O (10 mL), dried (MgSO4), and concentrated in vacuo to afford the crude product. 
Purification by Kugelrohr distillation afforded the title compound (1.7 g, 90%) as a 
colorless solid: bp = 290 °C at 0.6 mmHg; NMR spectra and other physical data matched 
previous reports.101 
1.8.10.3. 1,3-Dimethyl-1,3-diphenyl-disiloxane (DMDPDS): 
 
To a separatory funnel charged with partially melted ice (10 g) was added a solution of S7 
(2.2 g, 13.9 mmol, 2.1 mL) in diethyl ether (8 mL). The reaction was allowed to warm to 
23 °C and was swirled by hand every 10 min for 1 h. Additional diethyl ether (15 mL) was 
then added to the reaction and the aqueous layer was drained. The ether layer was washed 
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with H2O (10 mL), dried (MgSO4), and concentrated in vacuo to afford the crude product. 
Purification by Kugelrohr distillation afforded the title compound (1.5 g, 81%) of a 
colorless oil: bp = 102 °C at 0.8 mmHg; NMR spectra and other physical data matched that 
of previous reports.102 
1.8.10.4. Si, Si, Si, Si-Tetradeutero-1,3-diphenyl-disiloxane (d4-DPDS): JAB11P047 
 
The synthesis of d4-DPDS followed a modified version of our previously published 
synthesis.6 Briefly, a 100 mL two-neck round bottom flask was charged with CuCl2 (1.344 
g, 10 mmol), CuI (193, 1 mmol), and then 20 ¼ inch ceramic spheres. Et2O (10 mL) was 
added, and the flask was fit with an overhead stirrer. The suspension was stirred at 23 °C 
for 30 minutes, and stirring was stopped. S8 (555 mg, 5 mmol) was added dropwise and 
stirring was resumed. After 3 hours, stirring was ceased, and the reaction filtered directly 
onto ice chips of D2O (10 g). The contents of the filtration flask were transferred to a 
separatory funnel and was allowed to warm to 23 °C and was swirled by hand every 5 min 
for 30 h. Additional diethyl ether (15 mL) was then added to the reaction and the aqueous 
layer was drained. The ether layer was washed with H2O (15 mL), dried (MgSO4), and 
concentrated in vacuo to afford the crude product. Purification by Kugelrohr distillation 
afforded the title compound (384 mg, 60%) of a colorless oil: bp = 86 °C at 0.56 mmHg. 
1.8.11. Reductions of Phosphine Oxide Precatalysts: 
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1.8.11.1. General Procedure for NMR Experiments: To an NMR tube was added a 
phosphine oxide precatalyst (0.02 mmol, 0.04 M), d8-toluene, d2-DCM, or d8-THF (final 
volume of 500 L), and silane (7.5–15 equiv., 0.15–0.3 mmol, 0.3–0.6 M). The tube was 
inverted three times to ensure proper mixing of the reagents and the interface between the 
tube and the cap was sealed with multiple layers of paraffin wax (parafilm®) to ensure no 
leaks. The reaction was heated to the temperature dictated by the experiment, and 
monitored by 31P NMR. 
1.8.11..2. 31P NMR Method for Monitoring the Reduction of Phosphine Oxide Precatalysts: 
The NMR method is similar to the method previously reported.51, 64 However, a 25 second 
delay time was used to increase the sampling frequency with minimal error induced during 
integration. Spectra were also collected using a decoupled method (WALTZ 16) unless 
otherwise indicated to enhance the signal to noise ratios (S/N). All peaks monitored 
correspond to the phosphorus shifts observed for the phosphine oxide, phosphine, and any 
unisolable intermediates with peaks above a 3:1 S/N ratio (please see supporting section 2 
for novel phosphine oxide shifts).  
1.8.11.3. Data Analysis of NMR Experiments 
1.8.11.3.1 Processing of Raw 31P FIDs: Phosphorous NMR spectra were integrated through 
VNMR, ACD Labs, or, for longer time courses, with an automated processor/integrator 
written in Matlab.  A folder containing NMR spectra is submitted to the program along 
with the location of a standard peak in ppm, ppm values flanking the ranges to be 
integrated, the type and degree of apodization, and degree of zerofilling desired. The 
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program then sequentially obtains the data from each folder, acquiring, apodizing, 
zerofilling, and inverse Fourier transforming the data through modifications to the 
algorithms written in MatNMR.103 The resulting spectrum is then phased using a modified 
version of the algorithm developed by Liu and co-workers.104  Finally, the spectrum is 
shifted according to the ppm of the standard provided, and the data points within the ranges 
provided are summed, providing the integrated totals.  All spectra integrated using this 
program applied a 1.2 Hz Lorentzian apodization and doubled the apparent digital 
resolution through the addition of zeros prior to the Fourier Transform. Additionally, all 
were integrated twice with the standard being set one time as the starting material peak and 
the other time as the product peak to ensure accuracy at the tail ends of the time courses.  
1.8.11.3.2 Processing the Integrated Data: Following processing of each of the time 
courses, the triplicate integrated values were averaged to produce the phosphine oxide 
reduction curves shown in Figure 1.5B & 1.10B.  Each curve was then fit to both equation 
1 for single exponential fitting and to equation 2 for double exponential fitting using the 
Microsoft Excel® add-on Solver®.  This was accomplished through minimization of the 
sum of the variances with floating amplitude(s) and rate constant(s).  An analysis of the 
quality of curve fitting for reductions using PhSiH3 is shown in Figure 1.6. Variance per 
data point is used to measure the goodness of fit as the Pearson correlation (R2) is not 
directly applicable (Table 1.5).  The use of double-exponential fitting for the curves in 
Figure 1.6 improves the variance per data point by 3-12X. 
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1.8.11.3.3 Processing the Integrated Data: Following processing of each of the time 
courses, the triplicate integrated values were averaged to produce the phosphine oxide 
reduction curves shown in Figure 1B & 3B.  Each curve was then fit to both equation 1 for 
single exponential fitting and to equation 2 for double exponential fitting using the 
Microsoft Excel® add-on Solver®.  This was accomplished through minimization of the 
sum of the variances with floating amplitude(s) and rate constant(s).  An analysis of the 
quality of curve fitting for reductions using PhSiH3 is shown in Figure 1.6. Variance per 
data point is used to measure the goodness of fit as the Pearson correlation (R2) is not 
directly applicable (Table 1.38).  The use of double-exponential fitting for the curves in 
Figure 1.6 improves the variance per data point by 3-12X. 
𝑬𝒒𝒖𝒂𝒕𝒊𝒐𝒏 𝟏. %𝑃 = 100 − 𝐴𝑒−𝑘𝑡 
𝑬𝒒𝒖𝒂𝒕𝒊𝒐𝒏 𝟐. %𝑃 = 100 − 𝐴1𝑒
−𝑘1𝑡 + 𝐴2𝑒
−𝑘2𝑡 
  
207 
 
Table 1.38. Numerical comparison between single- and double-exponential fitting of reduction curves. 
Entry Variance (%PO Reduced)2 # Points Variance Per Data Point 
1PPO-Single 612.79 26 23.57 
1PPO-Double 60.93 26 2.34 
TMPPO-Single 468.99 28 16.74 
TMPPO-Double 37.93 28 1.35 
TMBPO-Single 215.23 16 13.45 
TMBPO-Double 35.14 16 2.20 
TMPyrPO-Single 133.23 14 9.52 
TMPyrPO-Double 37.09 14 2.65 
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The equations arising from the previously described fitting are then used to obtain 
the k, t50%, and t90% values shown in Tables 1.5 and 1.8.  The k in these figures is the rate 
constant obtained from fitting to equation 1, while t50% and t90% are obtained from setting 
%P in equation 2 to 50 and 90 with the amplitudes and rate constants determined from 
fitting. 
Derivative curves were obtained through calculation of the derivative with respect 
to time of the exponentials resulting from fitting to equation 1 for DPDS reductions and 
equation 2 for phenylsilane reductions.  Often, when fitting to equation 2, this method did 
not provide an accurate representation of the actual derivative for the first two data points.  
To overcome this problem, when necessary the slope between the first two data points 
(either raw or fitted) was used as the initial derivative and the slope between the first and 
third data points (either raw or fitted) was used as the derivative at the second time point.  
It is notable that this practice overestimates the initial rates. 
1.8.11.3.4 Processing Data for the Reduction of TMPyrPO: The presence of excess 
reducing agent facilitates two reductions of TMPyrPO. One is the reduction of the 
phosphine oxide to the corresponding phosphetane, while the other is a reduction of the P-
N bond, and it appears that these reductions can occur in either order. Reduction of the P-
N bond was also noted by Radosevich and co-workers during their reduction studies while 
developing new catalysts for their dehydrative coupling reaction.105 In the data presented 
for TMPyrPO reduction, the secondary phosphetane is quantified and used for the 
percentage of phosphine that has been reduced, as isolation of the intermediate 
209 
 
phosphetanes were impractical under pseudo first-order conditions. The amino-
phosphetane was observed in the range reported by Radosevich, however quantification 
was much more accurate with the resonances produced by the secondary phosphetane.  
1.8.11.4. Reductions of Phosphine Oxides with Phenylsilane at Ambient Temperature 
1.8.11.4.1. General Procedure: To an NMR tube was added a phosphine oxide precatalyst 
(0.02 mmol, 0.04 M), d8-toluene or d8-THF (final volume of 500 L), and phenylsilane 
(24.6 L, 10 equiv., 0.2 mmol, 0.4 M). The tube was inverted three times to ensure proper 
mixing of the reagents and the interface between the tube and the cap was sealed with 
multiple layers of paraffin wax (parafilm®) to ensure no leaks. The reaction was heated to 
25 C and monitored by 31P NMR. 
1.8.11.4.2. Results: The reductions of phosphine oxide precatalysts at 25 °C proceeded as 
expected. PhSiH3 is not a powerful enough reductant to afford reduction at catalytically-
relevant concentrations with minimal heat input into the system.  The only exception would 
be with the use of TMPyrPO, which, as shown in Figure 1.35, does reduce completely 
within 6 h. However, we observed complete reduction to the secondary phosphetane, which 
degrades rapidly, rendering this catalyst-silane combination ineffective in reactions.  
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Figure 1.35. Progress curves of phosphine oxide reductions with phenylsilane at 25 °C. 
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1.8.11.5. Reductions of TMPyrPO Proceed with Two Steps 
1.8.11.5.1. General Procedure: To an NMR tube was added d8-toluene (final volume of 500 
L), TMPyrPO (40.2 mg, 0.2 mmol, 0.4 M) and then phenylsilane (3.07, 6.15, or 12.3 L, 
0.025–0.1 mmol, 0.05–0.2 M) or DPDS (5.8, 11.5, or 23.0 mg, 0.025–0.1 mmol, 0.05–0.2 
M). The tube was inverted three times to ensure proper mixing of the reagents and the 
interface between the tube and the cap was sealed with multiple layers of paraffin wax 
(parafilm®) to ensure no leaks. The reaction was heated to 25 C and monitored by 31P 
NMR. 
1.8.11.5.2. Results: As mentioned in Section 4.3.3, adding TMPyrPO to an excess of DPDS 
or phenylsilane causes over-reduction to the secondary phosphetane. In theory, using an 
excess of TMPyrPO should inhibit reduction to the secondary phosphetane. However, 
using 0.125 equivalent of either DPDS or phenylsilane still led to the formation of the 
secondary phosphetane rather than a mono-reduced product. This suggests the initial 
reduction of the phosphine oxide is slower than the rate of reduction to form the secondary 
phosphetane. Because the initial reduction is slower than the subsequent “over-reduction”, 
we believe that the data and fitting for TMPyrPO closely match the initial, slower reduction 
of the oxide to the amino-phosphetane.  
Also noteworthy about these reductions is that fewer equivalents of silane seems to 
favor reduction to the amino-phosphetane, as a buildup of a phosphorus species is observed 
around 125 ppm, rather than around 27 ppm, which was observed in reactions with heavy 
excess of silane. We speculate that the species around 27 ppm is the secondary phosphetane 
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oxide, and are currently investigating the reactivity of phosphinic amides with silanes in 
greater detail.  
1.8.11.6. The Effect of TMPPO Concentration on its Rate of Reduction 
 
1.8.11.6.1. General Procedure: To an NMR tube was added d8-toluene (451 L), 
phenylsilane (49 L, 0.4 mmol, 0.8 M), and TMPPO (4.2, 8.4, or 12.6 mg). The tube was 
inverted three times to ensure proper mixing of the reagents and the interface between the 
tube and the cap was sealed with multiple layers of paraffin wax (parafilm®) to ensure no 
leaks. The reaction was heated to 80 C and monitored by 31P NMR. 
1.8.11.6.2. Results: As shown in Figure 1.9A, increasing the concentration of TMPPO also 
increases the rate of its reduction.  The trend is also demonstrated by fitting each curve to 
Equation 2 and then determining the number of minutes until 50% and 90% of the 
phosphine oxide is reduced, as shown in Figure 1.9. 
This experiment was used to rule out Mechanism II in Figure 1.8.  If Mechanism II 
were correct, the rate of phosphine oxide reduction when measured by percentage of total 
phosphine should stay constant regardless of the concentration of phosphine oxide as long 
as pseudo-first order conditions are maintained.   
To help with illustrating why this information rules out Mechanism II, we will first 
shorten Mechanism II to the scheme below: 
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 It is important to note that this is the kinetic mechanism being discussed. The real 
mechanism that would go through this kinetic mechanism includes phenylsilane, 
phenylsilanol, phenylsilanediol, and phenylsilanetriol. However, if phenylsilane reduced 
phosphine oxides at a similar or greater rate than phenylsilanol and phenylsilanediol, then 
through reduction monitoring only k1 and k2 for phenylsilane will be able to be extracted 
from the data. If small amounts of phenylsilanol or phenylsilanediol are formed and each 
reduce at the same speed or slower than phenylsilane, then they will have a negligible effect 
on the overall reduction progress because of the >10x amount of phenylsilane present. 
 With that established, and remembering that we are making the assumption for 
Mechanism II that phenylsilane is an equal or better reductant than phenylsilanol or 
phenylsilanediol, we can write the rate of formation of the intermediate species and 
phosphine formation: 
𝑅𝑎𝑡𝑒𝑖𝑛𝑡𝑒𝑟 = 𝑘1[𝑃𝑂][𝑆𝑖𝐻] 
𝑅𝑎𝑡𝑒𝑃 = 𝑘2[𝑃𝑂 − 𝑆𝐼] 
We are under pseudo-first order conditions, so [SiH] is constant, and we can let K1 
= k1[SiH]: 
𝑅𝑎𝑡𝑒𝑖𝑛𝑡𝑒𝑟 = 𝐾1[𝑃𝑂] 
𝑅𝑎𝑡𝑒𝑃 = 𝑘2[𝑃𝑂 − 𝑆𝐼] 
  
Using these equations, we can solve for [P] and [PO-Si] as a function of time, k1, 
k2, and the initial concentration of [PO] (written as [PO]0).
106 
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[𝑃𝑂 − 𝑆𝑖] =  [𝑃𝑂]0 ∗ (
𝐾1
𝑘2 − 𝐾1
𝑒−𝐾1𝑡 +
𝐾1
𝐾1 − 𝑘2
𝑒−𝑘2𝑡) 
[𝑃] =  [𝑃𝑂]0 − [𝑃𝑂]0 ∗ (
𝑘2
𝑘2 − 𝐾1
𝑒−𝐾1𝑡 +
𝐾1
𝐾1 − 𝑘2
𝑒−𝑘2𝑡) 
If we take [P] and divide it by the initial concentration of PO, we obtain: 
[𝑃]
[𝑃𝑂]0
=  
𝑘2
𝑘2 − 𝐾1
𝑒−𝐾1𝑡 +
𝐾1
𝐾1 − 𝑘2
𝑒−𝑘2𝑡 
Therefore, the left side of the equation is equal to an expression that does not have 
[PO]0 in it, an expression that is only dependent on the rate constants and the time. When 
we drew the graphs with %PO remaining on the y-axis, what we were basically doing is 
dividing the concentration of phosphine oxide present by [PO]0. The quantity represented 
in the reduction progress curves (Figure S3A), then, should not change regardless of the 
value of [PO]0. Since changing [PO]0 does have an effect on the rate, Mechanism II cannot 
be correct.  It is also noteworthy that this data strongly supports Mechanism V, as the fact 
that phosphine oxide catalyzes the formation of phenylsilanol provides a reason for the rate 
to increase when [PO]0 increases. 
1.8.11.7. The Effects of Solvent on Phosphine Oxide Reductions 
1.8.11.7.1. General Procedure: To an NMR tube was added a phosphine oxide precatalyst 
(0.02 mmol, 0.04 M), d8-toluene, d2-DCM, or d8-THF (475 L), and then silane (10 equiv., 
0.15 mmol, 0.3 M). The tube was inverted three times to ensure proper mixing of the 
reagents and the interface between the tube and the cap was sealed with multiple layers of 
paraffin wax (parafilm®) to ensure no leaks. The reaction was heated to 80 °C and 
monitored with 31P NMR. 
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1.8.11.7.2. Results: The reductions of phosphine oxides with silanes can substantially vary 
greatly the solvent used for the reduction. The most drastic example of solvent effect is 
noted in the difference in reactivity when THF or toluene are used with the disiloxane 
DMDPDS. In this case, the use of toluene as the solvent significantly attenuates the rate of 
reduction (Figure 1.36). Fitting this data to single-exponential curves reveals that the rate 
of reduction is almost exactly 20-fold higher in THF than it is in toluene, which we attribute 
to the concentration of water in each solvent.  The excess water present in a solution of 
THF would likely cause a shift of the equilibrium between disiloxane and silanol towards 
the silanol form, increasing the rate. This necessity for water indicated that water may be 
the primary species responsible for the production of the kinetically-relevant reductant, 
however, we have also observed that too much water is detrimental to reduction rates.  
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Figure 1.36. Progress curves of the reduction of TMPPO with DMDPDS at 80 °C in THF 
and toluene. Data collected by Dr. Carter Eiden. 
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1.8.11.8. Silane Competence Screen in Catalytic Mitsunobu Reactions 
1.8.11.8.1. General Procedure: To a 2 dram vial equipped with a stir bar was added p-
nitrobenzoic acid (125 mg, 1.5 equiv, 0.75 mmol) and 1PPO (9 mg, 0.1 equiv, 0.05 mmol). 
THF (2 mL) was then added followed by benzyl alcohol (57 L, 1.00 equiv, 0.50 mmol), 
DIAD (108 L, 1.10 equiv, 0.55 mmol), and silane (1.1 equiv, 0.55 mmol). Reactions were 
sealed with a PTFE septum in the screw cap and heated to 80 °C. After 24 h, the reaction 
was cooled and concentrated directly onto silica gel. Benzyl 4-nitrobenzoate was purified 
as previously described, with all spectra matching those of former reports.51  
1.8.11.8.2. Results: When a sample of 14 commercially available silanes were screened for 
competence in a catalytic Mitsunobu reaction, only 4 of the reagents tested afforded 
product, as shown in Table 1.39. Phenylsilane and diphenylsilane worked as expected, but 
we also observed n-hexylsilane was a competent reducing agent in whole reaction schemes. 
However, further testing of n-hexylsilane revealed it required elevated temperatures to be 
a competent reducing agent.  
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Table 1.39. Silane Competency Screen in Catalytic Mitsunobu Reactions. 
 
Entry Silane Isolated Yield 
1 PhSiH3 81 
2 Ph2SiH2 42 
3 Ph3SiH No Reaction 
4 PMHS No Reaction 
5 Et3SiH No Reaction 
6 iPr3SiH No Reaction 
7 (TMS)3SiH 28 
8 TMDSO No Reaction 
9 nHexylSiH3 67 
10 DPDS 0 
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1.8.11.9. Comparison of Reduction Rates of TMPPO by Standard Silanes 
1.8.11.9.1. General Procedure: To an NMR tube was added d8-toluene (475 L), 
trimethoxysilane (25 L, 0.2 mmol, 0.4 M), and TMPPO (4.2 mg, 0.02 mmol, 0.04 M). 
The tube was inverted three times to ensure proper mixing of the reagents and the interface 
between the tube and the cap was sealed with multiple layers of paraffin wax (parafilm®) 
to ensure no leaks. The reactions were heated to 80 C and monitored by 31P NMR. 
1.8.11.9.2. Results: Figure 1.18 compares the reduction rate of TMPPO (0.04 M) with 
phenylsilane, diphenylsilane, and trimethoxysilane (each present at 0.4 M).  The rates of 
reduction for each silane are comparable, with trimethoxysilane and phenylsilane reducing 
TMPPO slightly faster than diphenylsilane. With this phosphine oxide precatalyst, little 
rate enhancement would be gained through switching between the commonly used silane 
reductants.  
1.8.11.10. Arrhenius and Eyring Analysis of the Reduction of TMBPO by DPDS 
1.8.11.10.1. General Procedure: To an NMR tube was added a phosphine oxide precatalyst 
(0.02 mmol, 0.04 M), d8-toluene or d8-THF (465 L), and then DPDS (35 mg, 7.5 equiv., 
0.15 mmol, 0.3 M). The tube was inverted three times to ensure proper mixing of the 
reagents and the interface between the tube and the cap was sealed with multiple layers of 
paraffin wax (parafilm®) to ensure no leaks. The reaction was monitored with a variable 
temperature 31P NMR experiment over a temperature range from 0 to 25 C. 
1.8.11.10.2. Results: Shown in Figure 1.37, the reduction of TMBPO over this temperature 
range resulted in a linear trend evident in the Arrhenius plot. The slope of the line was 
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utilized to calculate the energy of activation. At 14.2 ± 0.9 kcal/mol, this energy is slightly 
lower than the observed energy of activation for the reduction of TPPO by DPDS, 
indicating that the incorporation of ring strain into phosphine oxide precatalysts certainly 
has an effect on this reaction. We also plotted the data utilizing Eyring theory (Figure 1.12), 
allowing for the calculation of H‡ = 13.7 ± 0.9 kcal/mol, S‡ = –0.02 ± 1.2·10-4 cal/mol 
and G298K
‡ = 18.8 ± 1.9 kcal/mol. The energies input of this reaction is certainly lower 
than the calculated energies for the reduction of phosphine oxides via a [2+2] mechanism. 
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Figure 1.37. The Arrhenius plot for the reduction of TMBPO by DPDS over the 
temperature range 0 – 25 °C. Data collected by Dr. Carter Eiden. 
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1.8.11.11. Reduction of Acyclic Phosphine Oxides by DPDS 
 
1.8.11.11.1. General Procedure: To an NMR tube was added d8-toluene (440 L), DPDS 
(58 mg, 0.25 mmol, 0.5 M), and phosphine oxide (0.02 mmol, 0.04 M). The tube was 
inverted three times to ensure proper mixing of the reagents and the interface between the 
tube and the cap was sealed with multiple layers of paraffin wax (parafilm®) to ensure no 
leaks. The reaction was heated to 110 C and monitored with 31P NMR. 
1.8.11.11.2. Data Fitting for Acyclic Phosphine Reductions: Under pseudo-first order 
conditions, rate constants for Hammett study and KIE reductions were determined by 
averaging the percent phosphine oxide remaining over a triplicate set of data per each time 
point. The logarithm of the percent product remaining was taken and a plot of ln[PO] vs. 
time was constructed. The slope of this line was used as a preliminary guess for k and an 
exponential decay function was fitted to the raw reaction progress data. Variance between 
the data and the exponential fit function y=100*e^(-kx) was evaluated. 
1.8.11.11.3. Results: As shown in Figure 1.38, DPDS rapidly reduces TPPO at 110 C, 
with 100% conversion at 5 h. The kinetics of reduction fit excellently to a single 
exponential, as would be expected with DPDS as the reductant (Figure 1.11).  This rate of 
reduction compares favorably to the rates of reduction of TPPO observed by Lemaire and 
coworkers (TMDSO, Ti(OiPr)4, 100 C, 5 h) and Beller and coworkers (HSiMe(OEt)2, (p-
NO2C6H4O)2PO2H, 110 C, >12 h).25, 29 Due to the lack of a titanium-based or acidic29 
additive, the use of DPDS is substantially milder than both described conditions. 
Additionally, DPDS is used at about half of the concentration of TMDSO used by Lemaire 
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and coworkers, and at the same concentration as that of HSiMe(OEt)2 used by Beller and 
coworkers. The use of DPDS is thus the most broadly effective set of selective reduction 
conditions for triphenylphosphine oxide to date.  
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Figure 1.38. The reduction of TPPO with DPDS at 110 °C.  
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We then applied this reduction to a series of acyclic phosphine oxides with 
electronic perturbations, which vary the electronic character of the oxygen atom. As 
summarized in Table 1.40, the computed Mulliken charges of our series lines up well with 
their rate of reduction by DPDS. As summarized in Figure 1.22, Figure 1.39, and Table 
1.41, the rate of reduction was dependent on the nature of the oxyanionic character, as the 
rate of reduction increased at a rate which afforded a linear Hammett plot. The negative 
slope of this plot indicates the buildup of a positive charge within the rate-determining step, 
a crucial component of understanding the reaction’s mechanism. 
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Scheme 1.14. The reduction of acyclic phosphine oxides with DPDS. 
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Table 1.40. Computed Mulliken charges of acyclic phosphine oxides. 
Substrate Mulliken charge on P Mulliken charge on O 
TPPO  0.165482 -0.577962 
X = N(Me)2 (S9) 0.195433 -0.647214 
X = OMe (S10) 0.044019 -0.624292 
X = CF3 (S11) 0.468533 -0.588180 
Y = CF3 (S12) 0.364637 -0.565905 
X = CHO (S13) 0.427478 -0.592717 
X = C(O)Me (S14) 437315 -0.582638 
X = CH3 (S15) 0.320644 -0.558752 
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Figure 1.39. The reaction progress curves of reductions used to generate the Hammett plot 
in Figure 1.22. Data collected by Kathleen Wang. 
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Table 1.41.  Rate constants for the reduction of acyclic phosphine oxides. 
Substrate Substituent Constant  Rate Constant (min-1) 
TPPO  0 0.0111 
S9 -0.83 0.0231 
S10 -0.268 0.0140 
S11 0.54 0.0064 
S12 1.08 0.0038 
S13 0.42 0.0139 
S14 0.5 0.0084 
S15 -0.179 0.0087 
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1.8.11.11.4. Determination of the Kinetic Isotope Effect with d4-DPDS  
1.8.11.11.4.1. General Procedure: To a set of two Shigemi tubes were added TPPO (1.12 
mg, 0.004 mmol) and DPDS (11.6 mg, 0.05 mmol, 12.5 eq) or d4-DPDS (11.8 mg, 0.05, 
mmol, 12.5 eq) in d8-toluene (88 µL) per tube. The reactions were heated to 110 ˚ C without 
stirring, and 31P NMR spectra were collected every 10 minutes for the first two hours, then 
every hour until the reaction had run for 5 hours. 
1.8.11.11.4.2. Results: With the results of our Hammett study, we understood that our rate-
determining step included the buildup of positive charge which we hypothesized could be 
indicative of the formation of the internal salt via resonance with the phosphine oxide or 
could be the positive charge on the phosphorous during the hydrogen atom transfer (HAT). 
To determine if the HAT step was rate-determining, we utilized a deuterated silane reagent 
such that any significant difference in reduction rate would implicate the HAT as the rate-
determining step. Performance of these reductions with hydrido- and deutero-DPDS 
indicated a primary kinetic isotope effect of 5.3 at 110 °C, as the rate of reduction was 
dropped by over 5-fold at this elevated temperature as illustrated in Figure 1.23 (kH = 
0.0197; kD = 0.0037). 
1.8.11.11.5. Eyring Analysis of the Reduction of TPPO by DPDS: Having access to the 
raw data for the reduction of TPPO over a range of temperatures, we performed Eyring 
analysis (Figure 1.13) on this reduction as well. Running that data through an alternate set 
of calculations allows for the calculation of H‡ = 17.3 ± 1.2 kcal/mol, S‡ = –0.01 ± 
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1.4·10-4 cal/mol and G298K
‡ = 21.5 ± 3.6 kcal/mol. These values are still lower than those 
previously calculated.  
1.8.11.12. Determination of Reaction Order for Reductions by DPDS 
1.8.11.12.1. General Procedure: 
To an NMR tube was added d8-toluene (475 L), DPDS (0.1 M – 0.75 M), and TPPO (5.6 
mg, 0.02 mmol, 0.04 M). The tube was inverted three times to ensure proper mixing of the 
reagents and the interface between the tube and the cap was sealed with multiple layers of 
paraffin wax (parafilm®) to ensure no leaks. The reactions were heated to 110 C and 
monitored by 31P NMR. 
1.8.11.12.2. Results: As evident in Figure 1.11, the rate of reduction scales linearly with 
the concentration of DPDS employed. As such, it is easy to say that this reaction is in fact 
first order with respect to the silane reagent, and that our reagent does not undergo a more 
complex process than we have described.  
1.8.11.13. Determination of the Effect Water has on Reductions by DPDS 
1.8.11.13.1. General Procedure: 
To an NMR tube was added d8-toluene (475 L), DPDS (35 mg, 7.5 equiv., 0.15 mmol, 
0.3 M), TMPPO (4.2 mg, 0.02 mmol, 0.04 M), and water was added to each tube (0.00 – 
13.75 equiv). The tube was inverted three times to ensure proper mixing of the reagents 
and the interface between the tube and the cap was sealed with multiple layers of paraffin 
wax (parafilm®) to ensure no leaks. The reactions were heated to 25 C and monitored by 
31P NMR. 
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1.8.11.13.2. Results: As summarized in Figure 1.21, the addition of water is detrimental to 
the overall rate of reduction. We believe this is due to the ability of water to form a stronger 
hydrogen bond to the phosphine oxide, thus out competing with the hydrogen-bond 
acceptor necessary for reduction via a 6-membered transition state.  
1.8.12. In-Situ Activation of Silanes to Silanols: 
1.8.12.1. Activation of Silanes with to Silanols with Carboxylate Additives 
1.8.12.1.1. Synthesis of Tetra-n-butyl ammonium-p-nitrobenzoate: 
 
To a round bottom flask equipped a stir bar was added p-nitrobenzoic acid (500 mg, 3.0 
mmol), tetrabutylammonium bromide (1.0 g, 3.0 mmol), and THF (10 mL). The reaction 
was fitted with a reflux condenser and heated to 80 °C for 28 h. The reaction was cooled 
to 23 °C and concentrated in vacuo. The residue was taken up in cold toluene (15 mL), 
filtered, and concentrated in vacuo to afford the title compound (1.00 g, 82%) as a yellow 
solid: NMR spectra and other physical data matched that of previous reports.108 
1.8.12.1.2. General Procedure: To an NMR tube was added TMPPO (4.3 mg, 1.0 equiv., 
0.02 mmol, 0.04 M), d8-THF (475 L), PhSiH3 (25 L, 10.0 equiv., 0.2 mmol, 0.4 M), and 
tetra-n-butyl ammonium-p-nitrobenzoate (25.3 mg, 3.0 equiv, 0.06 mmol, 0.12 M). The 
tube was inverted three times to ensure proper mixing of the reagents and the interface 
between the tube and the cap was sealed with multiple layers of paraffin wax (parafilm®) 
to ensure no leaks. The reaction was heated to 80 °C and monitored by 31P NMR. 
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1.8.12.1.3. Results: Within five minutes of heating to 80 °C, all of the phosphine oxide 
precatalyst TMPPO had been reduced. Vigorous bubbling was observed, suggesting that 
hydrogen gas is rapidly evolved. This indicates that the oxyanion p-nitrobenzoate rapidly 
converts PhSiH3 to silanol, promoting extremely rapid reduction of TMPPO.  This result 
explains the observations of O’Brien24 as he discovered the addition of a catalytic amount 
of benzoic acid to his catalytic Wittig reaction containing DIPEA lowers the necessary 
temperature for reduction to 25 °C from 80 °C.  In that reaction, DIPEA abstracts the proton 
with the lowest pKa from the benzoic acid, forming DIPEA-HCl (which actually also 
increases the rate of reduction, but significantly less than carboxylate) and benzoate, which 
we demonstrated drastically increases the rate of reduction.  
1.8.12.2. Activation of Disiloxanes with Protic Acids 
1.8.12.2.1 General Procedure: To an NMR tube was added 1PPO (3.7 mg, 1.0 equiv., 0.02 
mmol, 0.04 M), d8-THF (440 L), TMDSO (53.0 L, 15.0 equiv., 0.3 mmol, 0.6 M), and 
acid (5.0 equiv., 0.1 mmol, 0.2 M). The tube was inverted three times to ensure proper 
mixing of the reagents and the interface between the tube and the cap was sealed with 
multiple layers of paraffin wax (parafilm®) to ensure no leaks. The reaction was heated to 
80 °C and monitored by 31P NMR. 
 
1.8.12.2.2. Results: As stated previously, TMDSO was completely ineffective at reducing 
phosphine oxide precatalysts at 80 °C without additives.  However, upon the addition of a 
Brønsted acid, TMDSO successfully reduced 1PPO within the two hour period this 
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reduction was monitored (Figure 1.26). With equimolar amounts of AcOH and TFA added, 
TFA induced significantly more reduction.  As siloxanes have been shown to equilibrate 
significantly more towards silanols in acidic or basic aqueous solutions as opposed to pH 
neutral solutions,109,110 we believe that reduction is occurring because TMDSO is 
equilibrating between TMDSO and dimethylsilanol.  The presence of TFA likely shifts the 
equilibration towards silanol more so than AcOH, which results in faster 1PPO reduction. 
Alternatively, the stronger acid may be getting deprotonated by the phosphine oxide, 
facilitating a hydrogen bond to the oxygen in the disiloxane reducing agent. In general, the 
lower the pKa of the acid, the more reduced product was observed.  
1.8.12.3. Activation of Disiloxanes with Lewis Acids 
1.8.12.3.1. General Procedure: To an NMR tube was added 1PPO (3.6 mg, 0.02 mmol, 
0.04 M), d8-THF (447 L), TMDSO (53 L, 0.3 mmol, 0.6 M), and LiCl, MgCl2, ZnCl2, 
or Na2SO4 (0.1 mmol, 0.2 M). The tube was inverted three times to ensure proper mixing 
of the reagents and the interface between the tube and the cap was sealed with multiple 
layers of paraffin wax (parafilm®) to ensure no leaks. The reaction was heated to 80 °C 
and monitored by 31P NMR for 7 h. 
1.8.12.3.2. Results: As shown in Figure 1.26, MgCl2, ZnCl2, and Na2SO4 all induced some 
reduction at 7 hours, with ZnCl2 superior at promoting the reduction of 1PPO. The use of 
a divalent cation seems to facilitate the formation of the six-membered transition state 
similarly to the hydrogen-bonding capabilities of a silanol. However, the monovalent 
cations of sodium sulfate seemed capable of promoting reduction to some extent. This may 
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be due to an adjustment to the balance of the water in the reaction, as too much water would 
slow reduction and may coordinate too heavily to the monovalent (and smaller) cations 
which blocks formation of the six-membered transition state. The effect that sodium sulfate 
has on reduction may also synergize with titanium additives, thus leading to lower 
temperatures necessary for reduction, as observed by Lemaire and co-workers.29 While 
divalent cations may be acting as proton surrogate, it is also possible that the addition of 
zinc may be altering the equilibrium of TMDSO more towards the active silanol reductant. 
Because Zn2+ is neither a “hard” nor “soft” Lewis acid,111 it is difficult to determine if the 
zinc is forming a relatively covalent bond with TMDSO/phosphine oxide, or if the additive 
is acting as a coordinating species. Seeing how the “hard” Lewis acids facilitate less 
reduction, it is likely that simple coordination is not all that is at play.  
1.8.12.4 Circumventing Disiloxane-Silanol Equilibria with Disilazanes 
1.8.12.4.1. General Procedure: To an NMR tube was added 1PPO (3.7 mg, 1.0 equiv., 0.02 
mmol, 0.04 M), d2-DCM (458 L), and TMDSA (42.0 L, 15.0 equiv., 0.3 mmol, 0.6 M). 
The tube was inverted three times to ensure proper mixing of the reagents and the interface 
between the tube and the cap was sealed with multiple layers of paraffin wax (parafilm®) 
to ensure no leaks. The reaction was heated to 80 °C and monitored with 31P NMR. 
1.8.12.4.2. Results: While silanols act as sufficient hydrogen-bond donors to stabilize the 
six-membered transition state, the very fact that these molecules exist in an equilibrium 
with a non-reactive entity inherently leads to sub-optimal reductive potential. One way to 
circumvent this shortcoming would be through the use of a reagent that lacks this 
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deactivation pathway, but still maintains the hydrogen-bond donor which is critical for the 
formation of the six-membered transition state. 1,1,3,3-tetramethyl disilazane (TMDSA) 
represents a commercially-available solution, and when tested in isolated reduction studies, 
the reagent was a competent reductant without an additive, unlike its disiloxane 
counterpart. As shown in Figure 1.19 TMDSA is effective at 80 °C, with approximately 
60% of reaction completion within 30 minutes, whereas TMDSO is inert for at least 14 
hours (not shown). The presence of a permanent hydrogen-bond donor indicates that the 
reagent does not need any time to equilibrate to be active. Unfortunately, TMDSA 
represents the only commercially-available hydrido-disilazane, and lacks the stability 
needed to be used in full reaction schemes. The design of a stabilized disilazane reagent 
may afford an even further improved reductant for phosphorus recycling, beyond even 
DPDS.  
1.8.12.5. Blocking Activation of Phenylsilane to Phenylsilanol with Lewis Acids 
1.8.12.5.1. General Procedure: To three separate NMR tubes was added 1PPO (0.02 mmol, 
0.04 M), d8-THF (475 L), and then PhSiH3 (25 L, 0.2 mmol, 0.4 M). To one of the tubes 
was added LiCl (4 mg, 0.1 mmol, 0.2 M) and to another was added ZnCl2 (6.8 mg, 0.05 
mmol, 0.1 M). All three tubes were inverted three times to ensure proper mixing of the 
reagents and the interface between the tubes and their respective caps were sealed with 
multiple layers of paraffin wax (parafilm®) to ensure no leaks. The reactions were heated 
to 80 C and monitored by 31P NMR. 
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1.8.12.5.2. Results: As demonstrated in Figure 1.16, the addition of ZnCl2 completely 
abolished reduction of 1PPO and the addition of LiCl significantly slowed it. Taking into 
context the results in Figure 12, where addition of ZnCl2 enhanced reduction substantially, 
it is likely that the observed reduction stoppage with ZnCl2 and PhSiH3 is due to blocking 
the activation of PhSiH3 to phenylsilanol.  We proposed that phosphine oxide catalyzed the 
formation of phenylsilanol from phenylsilane through donation of electron density from 
the phosphine oxide into the silicon atom, causing an increased chance of a reaction with 
water.  LiCl and ZnCl2 likely form Lewis acid-base pairs with the phosphine oxide, 
dramatically decreasing the potential for electron density donation into phenylsilane. The 
difference in potency between LiCl and ZnCl2 is likely due to the greater Lewis acidity of 
ZnCl2. 
1.8.12.6. Investigation of Coordination to TPPO 
1.8.12.6.1. General Procedure: To a 1-dram vial was added TPPO (70 mg, 0.25 mmol, 1 
equiv), TPP (6.5 mg, 0.025 mmol, 0.1 equiv) as an internal standard, other solid reagents 
(0.05 – 2.5 mmol, 0.1 – 10 equiv), solvent (d8-THF or d8-PhMe, 500 mL), and then liquid 
reagents (0.05 – 2.5 mmol, 0.1 – 10 equiv). The vessel was mixed vigorously with a vortex 
mixer set to its highest setting. The reaction was heated to the desired temperature (between 
23 – 80 °C) and monitored by 31P NMR with 16 one-second delay scans. The WALTZ 16 
decoupling parameter was still used to ease deconvolution. The reactions were checked 
after 1 to 45 minutes, and 5 minutes was deemed an appropriate amount of time for 
universal reaction monitoring.  
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1.8.12.6.2. Interactions with Additives: We note that NMR shift of phosphine oxide 
coordination is not affected by different temperatures (Table 1.12), but is affected by the 
saturation of the interactions. As such, adding additional substrate pronounces the 
downfield shift of the observed phosphorus signal rather than producing two distinct NMR 
resonances corresponding to coordinated and uncoordinated oxygen atoms (Table 1.42). 
Understanding the nature of this assay, we decided to pursue characterizing interactions 
between phosphine oxides and acids in 1:1 and 1:2 stoichiometric ratios. As summarized 
in Table 1.14, various carboxylic acids can interact with phosphine oxides, characterized 
by a downfield shift in the 31P NMR spectrum. These downfield shift these acids promote 
lines up very well with their ability to promote reduction as well as their pKa. Additionally, 
other acids such as methanesulfonic acid and BNPA also cause a downfield shift. To our 
delight, the downfield shift resultant of additive addition aligns well with the rate of 
reduction for phosphine oxides with disiloxanes in the presence of these functional groups 
(Figure 1.26). Generally speaking, it would seem that lower pKa predicates potential 
effectiveness of the additive in these reductions. Yet, BNPA bucks this trend, producing 
the greatest reactivity and greatest downfield shift. The strong correlation of reactivity to 
downfield shift indicates that this assay may be very effective for the discovery of acidic 
additives for disiloxane-mediated phosphine oxides.  
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Table 1.42. Stoichiometry of additives affects downfield shift 
in 31P NMR spectra.  
 
Entry X Equiv  Shift (ppm)  (ppm) 
1 0 23.70 0.00 
2 0.2 26.13 +2.43 
3 0.4 27.77 +4.07 
4 1.0 32.55 +8.85 
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Additionally, we investigated the downfield shift of phosphine oxides with neutral 
hydrogen-bond donors. Both alcohols and silanols can effectively cause a downfield NMR 
shift, but to a much lesser extent than carboxylic acids (Table 1.14). However, much like 
the results reported by Blumel and coworkers, the addition of water seems to strengthen 
this interaction as the addition of 2 equivalents of water always generated a larger 
downfield shift indicative of a better hydrogen-bonding interaction. The addition of water 
did not cause downfield shifts of the same magnitude, and molecules such as phenysilane 
(which lacks H-bond donors) do not perturb the system in any notable fashion (Table 1.43). 
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Table 1.43. Interactions of TPPO with miscellaneous organic molecules. 
 
Entry Additive Shift (ppm)  (ppm) 
1 None 23.70 0.00 
2 TMDSO 23.76 +0.06 
3 PhSiH3 23.68 -0.02 
4 DPDS 24.05 +0.35 
5 Benzyl Alcohol 27.17 +3.47 
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Addition of Lewis acidic metals also correlates with the reactivity of disiloxanes 
towards phosphine oxides. Addition of the weak Lewis acid LiCl caused a modest 3.79 
ppm downfield shift and only mildly promoted reactivity of TMDSO (Figure 1.26), while 
borderline Lewis acid ZnCl2 caused a very significant downfield shift of 17.35 ppm while 
simultaneously being better suited to facilitate reduction with TMDSO (Figure 1.26).  
1.8.13. Mathematical Modeling of Reaction Progress Curves 
1.8.13.1. Procedure: An Excel spreadsheet was used to model the reaction progress curves 
from Figure 1 for TMPyrPO, TMBPO, TMPPO, and 1PPO to Mechanism V (shown 
below, with PO being the phosphine oxide and P the reduced phosphine). 
 
To begin, the initial values for the concentrations of each of the components were 
set to 0.4 for [PhSiH3], 0.04 for [PO], and 0 for all of the others. The only exception is the 
concentration of water, which we assume for the sake of this exercise does not change, and 
is thus not included in the equations.  We then calculated the derivatives of the 
concentrations of each of the components with respect to time, according to the equations 
below (the initial rate constants were estimated). 
𝑑[𝑃ℎ𝑆𝑖𝐻3]
𝑑𝑡
= −𝑘1[𝑃𝑂][𝑃ℎ𝑆𝑖𝐻3] 
𝑑[𝑃ℎ𝑆𝑖𝐻2𝑂𝐻]
𝑑𝑡
= 𝑘1[𝑃𝑂][𝑃ℎ𝑆𝑖𝐻3] − 𝑘2[𝑃𝑂][𝑃ℎ𝑆𝑖𝐻2𝑂𝐻] 
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𝑑[𝑃ℎ𝑆𝑖(𝑂𝐻)2𝐻]
𝑑𝑡
= 𝑘2[𝑃𝑂][𝑃ℎ𝑆𝑖𝐻2𝑂𝐻] − 𝑘3[𝑃𝑂][𝑃ℎ𝑆𝑖(𝑂𝐻)2𝐻] 
𝑑[𝑃ℎ𝑆𝑖(𝑂𝐻)3]
𝑑𝑡
= 𝑘3[𝑃𝑂][𝑃ℎ𝑆𝑖(𝑂𝐻)2𝐻] 
𝑑[𝑃𝑂]
𝑑𝑡
= −𝑘2[𝑃𝑂][𝑃ℎ𝑆𝑖𝐻2𝑂𝐻] − 𝑘3[𝑃𝑂][𝑃ℎ𝑆𝑖(𝑂𝐻)2𝐻] 
𝑑[𝑃]
𝑑𝑡
= 𝑘2[𝑃𝑂][𝑃ℎ𝑆𝑖𝐻2𝑂𝐻] + 𝑘3[𝑃𝑂][𝑃ℎ𝑆𝑖(𝑂𝐻)2𝐻] 
The calculated derivatives at 0 seconds were used to determine the concentration 
of each species that would be present at 0.1 seconds. The derivatives of the concentrations 
of each species was then calculated for t = 0.1 seconds, which was used to determine the 
concentration of each species at 0.2 seconds.  This process was continued, each time with 
0.1 second iterations of time. The calculated concentration curves of phosphine oxide were 
overlaid with the curves from Figure 1.5B, and the iterative process was continued for as 
long as the concentration of phosphine oxide in each of the Figure 1.5B curves stayed 
above 5% of the initial concentration. 
We then utilized Excel Solver to solve for the rate constants.  This was done by 
minimization of the sum of the variance between the experimental concentration of 
phosphine oxide at each data point (Figure 1.5B) and the simulated concentration of 
phosphine oxide at the closest time point calculated. The rate constants were allowed to 
float, with the exception of choosing k3 to be a fixed multiple of k2. This produced two 
solutions of k1 and k2/k3 for each phosphine oxide reduction curve, but one was ruled out 
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through knowledge of the concentration of PhSiH3 throughout the reductions. The process 
was repeated for each phosphine oxide reduction curve for k3 = k2, k3 = 10k2, and k3 = ∞. 
1.8.13.2. Results: As we had previously been able to eliminate various mechanisms with 
kinetics, we chose to confirm that the final proposed mechanism did in fact result in adept 
fitting of our experimental reduction curves (Figure 1.40).  While this could have been 
accomplished through a fitting program, the degree of control that is available through 
setting up the equations by oneself made the use of Excel and Excel Solver quite attractive. 
Unsurprisingly, when fitting the simulation to the data from Figure 1.5B while letting all 
three of k1, k2, and k3 float, we obtained an infinite number of solutions, as the data is not 
precise enough to differentiate between k2 and k3.  We were able to avoid this problem by 
setting k3 to be a fixed multiple of k2.  We wanted to limit the number of analyses as the 
relationship between k2 and k3 had to be manually defined, and thus decided to run the 
simulation with k3 = k2, k3 = 10k2, and k3 = ∞.  These were chosen because a wide range of 
ratios was desired and it seemed unlikely that k3 would be slower than k2 due to the 
decreased electron density on silicon of phenylsilanediol as opposed to phenylsilanol.  For 
each of these simulations, two solutions were obtained, one with k1 fast and k2 slow, and 
one with k2 fast and k1 slow.  We were able to eliminate all solutions that had k1 fast and k2 
slow as we have observed many times that following complete reduction of phosphine 
oxide, most of the phenylsilane remains.  If k1 is fast and k2 slow, the reduction finishes 
with almost complete conversion of phenylsilane to phenylsilanol, so this possibility was 
ruled out. We thus successfully obtained a single pair of rate constants for each ratio of k2 
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and k3/phosphine oxide combination, which are shown in Table 1.44.  A graphical 
comparison each of the simulations with the data modeled is shown in Figure 1.39. 
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 Table 1.44. Rate constants obtained through simulation. 
 k3 = k2 k3 = 10k2 k3 = ∞ 
 k1 k2 k1 k2 k1 k2 
1PPO 0.049 1.83 0.051 1.14 0.058 0.87 
TMPPO 0.038 3.01 0.039 1.90 0.040 1.67 
TMBPO 0.077 8.23 0.078 5.46 0.079 5.02 
TMPyrPO 0.133 25.0 0.134 16.7 0.135 15.4 
All rate constants are in units of (M-1s-1) 
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Figure 1.40. Graphical comparison of reaction progress curves (Figure 1.5) and the fit 
obtained by the indicated parameters.Data fitting by Dr. Carter Eiden. 
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Figure 1.40 demonstrates that fitting the mechanism was quite successful, the 
simulation curves mirror the actual data quite nicely, demonstrating that the proposed 
mechanism for phenylsilane reduction could produce the data in Figure 1.7.  This is not a 
proof, as other mechanisms could certainly also fit the data, but Mechanisms I-III were 
successfully able to be ruled out with numerical analysis, and Mechanism V successfully 
matches the data. 
We were also interested in using this data to monitor the rates of each of the steps 
separately.  This would allow for a comparison of which phosphine oxides activate 
phenylsilane to phenylsilanol the fastest as well as which are reduced the fastest by 
phenylsilanol/phenylsilanediol.  Clearly, with our method of analysis, we cannot 
differentiate between k3 and k2, nor use the absolute values of the rate constants, as they 
change based on the relationship chosen between k3 and k2.  However, the data can still be 
used quite effectively, as the relative rates of the different phosphine oxides can be 
compared since the trends stay the same regardless of the relationship between k3 and k2. 
Two key points are illustrated by Table 1.44. 
1. 1PPO activates phenylsilane to phenylsilanol faster than TMPPO but is reduced 
by the produced silanols slower than the phosphetane. 
2. The phosphetanes follow a clear trend demonstrating adding electron density to the 
phosphine oxide causes both faster activation of phenylsilanol and faster reduction 
by silanols 
The first point confirms the expected differences in reactivity between 1PPO and 
TMPPO based on the reduction curves in Figure 1.5 and Figure 1.10.  The two phosphine 
oxides are reduced at similar rates in Figure 1.5, while in Figure 1.10, TMPPO is reduced 
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nearly twice as fast as 1PPO.  The difference in Figure 1.10 suggests silanols reduce 
TMPPO faster than 1PPO (based on the Arrhenius equation, which is an 
oversimplification), indicating that the similar rates observed in Figure 1.5 would be a 
result of faster phenylsilane activation by 1PPO. This is interesting because 1PPO and 
TMPPO likely have fairly similar amounts of electron density on the phosphine oxide, 
meaning the differences in ring strain/steric hindrance are causing the differing rates of the 
steps. With further exploration, this knowledge could be used in future design of phosphine 
oxide precatalysts.   
The second point, that adding electron density to the phosphine oxide causes both 
faster activation and reduction, provides further support for our theory that oxygen-based 
Lewis basicity is necessary for phenylsilanol formation. Also, the greater the degree of 
oxyanionic character, the more facile the activation of phenylsilane.  It is important to note, 
for future phosphine design, that greater electron density on the phosphine oxide also 
causes faster reduction with silanols.  
As a final point, Figure 1.10 shows TMBPO and TMPyrPO are reduced at similar 
rates, and Table 1.44 suggests they are not.  It is important to remember that when we are 
monitoring TMPyrPO reduction, we are actually observing the presence of the secondary 
phosphetane, which requires two reductions.  This is likely why a “lag phase” exists in 
Figure 1.10 for TMPyrPO.  Analyzing the rates of reduction in Figure 1.10 when 50% of 
the phosphine oxide is already reduced reveals TMPyrPO is being reduced at a faster rate 
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at that point, suggesting TMPyrPO should have a larger rate constant of reduction than 
TMBPO.  
1.8.13.3. Mathematical Argument against Mechanism III (Figure 1.8):  
This is a mathematical proof that if one translates kinetic mechanism Mechanism III in 
Figure 1.8 to the data in Figure 1.5, Mechanism III cannot accurately describe the data 
regardless of the kinetic constants chosen. Mechanism III is shown below. 
 
In the above mechanism, PO refers to unreduced phosphine oxide, and P the reduced 
phosphine. From the above mechanism we can write the rate of reduction as the change in 
[PO] with respect to time: 
 
𝑑[𝑃]
𝑑𝑡
= 𝑘1[𝑃ℎ𝑆𝑖𝐻3][𝑃𝑂] + 𝑘2[𝑃ℎ𝑆𝑖𝐻2𝑂𝐻][𝑃𝑂] + 𝑘3[𝑃ℎ𝑆𝑖(𝑂𝐻)2𝐻][𝑃𝑂] 
Due to the fact that we are operating in pseudo-first order conditions with an excess of 
phenylsilane: 
[𝑃ℎ𝑆𝑖𝐻3] = [𝑃ℎ𝑆𝑖𝐻3]𝑖 
Now, at time t = 0, it is also known that:  
[𝑃ℎ𝑆𝑖𝐻2𝑂𝐻]𝑖 = [𝑃ℎ𝑆𝑖(𝑂𝐻)2𝐻]𝑖 = 0 
The initial rate of phosphine formation is thus: 
𝑅𝑎𝑡𝑒𝑖 = 𝑘1[𝑃ℎ𝑆𝑖𝐻3]𝑖[𝑃𝑂]𝑖 
To prove that the maximum rate at 50% PO reduced is 3/2 the initial rate of reduction, we 
first write the rate of reduction where half the PO has already been reduced. 
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𝑑[𝑃]
𝑑𝑡
=
𝑘1[𝑃ℎ𝑆𝑖𝐻3]𝑖[𝑃𝑂]𝑖
2
+
𝑘2[𝑃ℎ𝑆𝑖𝐻2𝑂𝐻][𝑃𝑂]𝑖
2
+
𝑘3[𝑃ℎ𝑆𝑖(𝑂𝐻)2𝐻][𝑃𝑂]𝑖
2
 
Evaluating the above equation term by term, it is clear that the first term is equal to half of 
the initial rate.  To evaluate the second term, we note that this term would be at a maximum 
when the concentration of phenylsilanol is at a maximum.  From the proposed mechanism, 
the concentration of phenylsilanol will reach a maximum at the time its rate of formation 
equals its rate of consumption, or where the derivative of the concentration of phenylsilanol 
is zero.  We then write the derivative of the concentration of phenylsilanol with respect to 
time at 50% PO reduced. 
𝑑[𝑃ℎ𝑆𝑖𝐻2𝑂𝐻]
𝑑𝑡
=
𝑘1[𝑃ℎ𝑆𝑖𝐻3]𝑖[𝑃𝑂]𝑖
2
−
𝑘2[𝑃ℎ𝑆𝑖𝐻2𝑂𝐻][𝑃𝑂]𝑖
2
 
Setting that derivative to 0, we obtain: 
𝑘1[𝑃ℎ𝑆𝑖𝐻3]𝑖[𝑃𝑂]𝑖
2
=
𝑘2[𝑃ℎ𝑆𝑖𝐻2𝑂𝐻][𝑃𝑂]𝑖
2
 
This means the second term can, at a maximum, be equal to half the initial rate.   
We can apply the same strategy to the third term.  The concentration of phenylsilanediol 
will also be at a maximum when its rate of formation equals its rate of consumption.  The 
derivative of phenylsilanediol at 50% PO reduced is: 
 
𝑑[𝑃ℎ𝑆𝑖(𝑂𝐻)2𝐻]
𝑑𝑡
=
𝑘2[𝑃ℎ𝑆𝑖𝐻2𝑂𝐻][𝑃𝑂]𝑖
2
−
𝑘3[𝑃ℎ𝑆𝑖(𝑂𝐻)2𝐻][𝑃𝑂]𝑖
2
 
Again setting the derivative to 0: 
𝑘2[𝑃ℎ𝑆𝑖𝐻2𝑂𝐻][𝑃𝑂]𝑖
2
=
𝑘3[𝑃ℎ𝑆𝑖(𝑂𝐻)2𝐻][𝑃𝑂]𝑖
2
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Now, we have already shown that the maximum the term on the left in the equation above 
could be is half of the initial rate.  Since they are equal, this is also the maximum that the 
term on the right could be, and we have now shown that the maximum all three terms can 
be is just half the initial rate.  Adding up all of them, we find that the maximum rate of 
phosphine oxide reduction following this mechanism at 50% PO reduced is just 3/2 the 
initial rate, providing strong evidence via Figure 5 and Table S2 that this mechanism is 
incorrect. 
 
𝑑[𝑃]
𝑑𝑡
=
𝑘1[𝑃ℎ𝑆𝑖𝐻3]𝑖[𝑃𝑂]𝑖
2
+
𝑘2[𝑃ℎ𝑆𝑖𝐻2𝑂𝐻][𝑃𝑂]𝑖
2
+
𝑘3[𝑃ℎ𝑆𝑖(𝑂𝐻)2𝐻][𝑃𝑂]𝑖
2
=  
3
2
𝑅𝑎𝑡𝑒𝑖 
It is also worth mentioning again that the derivative curves were created as described in 
Figure 1.7, which deliberately overestimates the initial rate.  This means that the values 
listed in Table 1.5 are most likely an underestimation of the actual rate increase at 50% 
reduction. 
1.8.14. Testing for a Phosphorous-Centered Radical Intermediate: 
1.8.14.1. Procedure for the Reduction of S4 with DPDS: To an NMR tube was added S4 
(3.6 mg, 0.02 mmol, 0.04 M), d8-toluene (450 L), and DPDS (53 mg, 7.5 equiv., 0.15 
mmol, 0.3 M). The tube was inverted three times to ensure proper mixing of the reagents 
and the interface between the tube and the cap was sealed with multiple layers of paraffin 
wax (parafilm®) to ensure no leaks. The reaction was heated to 25 °C and monitored by 
31P NMR and 1H NMR. After 4 h, the crude reaction mixture was poured from the NMR 
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tube into a 1 dram vial. Aqueous hydrogen peroxide (30 %, 200 L) was then added to the 
reaction mixture and the reaction was shaken on an orbital shaker for 10 minutes at 25 °C 
in which a color change to bright yellow was observed. The crude mixture was then diluted 
with DCM (3 mL) and samples were diluted another 1000-fold with acetonitrile. Samples 
were analyzed with an LC-MS using a C-18 column and an electrospray ionization source 
in positive mode. The ions corresponding to m/z = 173 and 175 were extracted from the 
total ion source to monitor the presence of the cyclopropyl and n-propyl compounds, 
respectively.  
1.8.14.2. Procedure for the Reduction of S4 with TMDSO without any Additives: To an 
NMR tube was added S4 (3.6 mg, 0.02 mmol, 0.04 M), d8-toluene (482 L), and then 
TMDSO (17.7 L, 5.0 equiv., 0.10 mmol, 0.2 M). The tube was inverted three times to 
ensure proper mixing of the reagents and the interface between the tube and the cap was 
sealed with multiple layers of paraffin wax (parafilm®) to ensure no leaks. The reaction 
was heated to 80 °C and monitored by 31P NMR and 1H NMR. After 4 h, the crude reaction 
mixture was poured from the NMR tube into a 1 dram vial. Aqueous hydrogen peroxide 
(30 %, 200 L) was then added to the reaction mixture and the reaction was shaken on an 
orbital shaker for 10 minutes at 25 °C in which a color change to bright yellow was 
observed. The crude mixture was then diluted as in section 1.8.14 and monitored by LC-
MS using a C-18 column and an electrospray ionization source in positive mode. The ions 
corresponding to m/z = 173 and 175 were extracted from the total ion source to monitor the 
presence of the cyclopropyl and n-propyl compounds, respectively. 
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1.8.14.3. Procedure for the Reduction of S4 with TMDSO with the Addition of Ti(iOPr)4: 
To an NMR tube was added S4 (3.6 mg, 0.02 mmol, 0.04 M), d8-toluene (481.7 L), 
TMDSO (17.7 L, 5.0 equiv., 0.10 mmol, 0.2 M), and then Ti(iOPr)4 (0.6 L, 0.1 equiv., 
0.002 mmol, 0.004 M). The tube was inverted three times to ensure proper mixing of the 
reagents and the interface between the tube and the cap was sealed with multiple layers of 
paraffin wax (parafilm®) to ensure no leaks. The reaction was heated to 80 °C and 
monitored by 31P NMR. After 4 h, the crude reaction mixture was poured from the NMR 
tube into a 1 dram vial. Aqueous hydrogen peroxide (30 %, 200 L) was then added to the 
reaction mixture and the reaction was shaken on an orbital shaker for 10 minutes at 25 °C 
in which a color change to bright yellow was observed. The crude mixture was then diluted 
as in section 1.8.14 and monitored by LC-MS using a C-18 column and an electrospray 
ionization source in positive mode. The ions corresponding to m/z = 173 and 175 were 
extracted from the total ion source to monitor the presence of the cyclopropyl and n-propyl 
compounds, respectively. 
1.8.14.4. LC-MS Methodology for product detection: An Agilent 1100 series HPLC stack 
was utilized with an Agilent Zorbax 300 SB-C18 column (150 x 0.5 mm, 5 m) as the 
stationary phase at 25 °C. The mobile phase consisted of 0.1% formic acid in water (A) 
and 0.1% formic acid in acetonitrile (B) with a flow rate of 15 L/min. The mass 
spectrometry was performed by an Agilent MSD SL Iontrap in positive mode with the 
acquisition parameters shown in Figure 1.41. The exact ion current for m/z = 173 ± 1 and 
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m/z = 175 ± 1 were isolated form the total ion current corresponding to the mass to charge 
ratios of S4 and 1-n-propyl-2,2,3-trimethylphosphetane-1-oxide, respectively.  
 
1.8.14.5. Results: These experiments all utilized the “radical clock” of a cyclopropyl ring 
adjacent to the potential location of a radical center. Since cyclopropyl represents the 
fastest known radical clock, we imagined that if a radical was induced during the reduction 
of our phosphine S4, we would see the presence of a new peak by either NMR methods or 
mass spectrometry. The reaction, which would only occur in the presence of a radical 
(Scheme 1.15), would produce a new peak by NMR and the presence of the unique 
cyclopropyl peaks would disappear in favor of an n-propyl1 side chain.112 Mass-
spectrometry analysis would also show a new peak at [M+2],2 corroborating the existence 
of the n-propyl compound. Unfortunately, the 1H NMR spectra were inconclusive when 
titanium was added, and so this method was unable to discern if the cyclopropyl ring did 
indeed open. However, the MS analysis was successfully able to discern the presence of 
product. Shown in Figure 1.41, both reductions with DPDS, and TMDSO with Ti(iOPr)4 
produce the phosphine with the cyclopropyl intact, in contrast to the result expected based 
                                                 
 
1 While the phosphonium ylide would be present for a brief time, the presence of water in 
the solvent would lead to an oxidation event as previously observed.106 An excess of silane 
would lead to another round of reduction, resulting in the production of 1-n-propyl-2,2,3-
trimethylphosphetane. 
2 Above the 0.01% integration of m/z = 175 due to natural isotope abundance of C13 (1%) 
for 9 carbons.  
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on the mechanism proposed by Lemaire and co-workers.29 A peak corresponding to m/z = 
175 was observed, although the intensity was approximately 0.01% of the peak 
corresponding to m/z = 173, which is approximately equal to the natural frequency of two 
carbons with a mass of 13 AMUs in a 9-carbon compound (natural isotope abundance). 
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Scheme 1.15. (A) The reduction of S4 with ring opening of the cyclopropyl side-chain 
with the phosphorus-centered radical as proposed by Lemaire and co-workers.29 (B) The 
reduction of S4 without a phosphorus-centered radical, consistent with our observations.  
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Figure 1.41. A) The LC-MS trace of the reduction of S4 with TMDSO and 10 mol% 
Ti(iPrO)4, and B) The LC-MS trace of the reduction of S4 with DPDS. 
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These results indicated the need for a new mechanism to be proposed, one in which 
a phosphorus-centered radical is avoided and that accounts for the observations we and 
others107, 113 have made with titanium additives. We propose that the reductions proceed 
with the formation of our six-membered transition state and utilizes the titanium in place 
of the proton.  
1.8.14.6 Discussion: The titanium-catalyzed reduction of phosphine oxides lacks a 
phosphorus-centered radical, prompting the need for a new mechanism to describe the 
reduction process. Previous studies utilized NMR, gas chromatography, mass 
spectrometry, X-ray crystallography, and EPR; while we utilized NMR and a novel radical 
clock reagent to track the nature of the single-electron transfer previously described. The 
updated mechanism, shown in Scheme 1.16, includes the findings of our studies in addition 
to the previously described byproducts and intermediates. 
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Scheme 1.16. The mechanism of titanium-catalyzed reductions of phosphine oxides with 
TMDSO. This scheme specifically states the reports where various intermediates have 
been observed. 
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 The work of Samuel and co-workers67 seems to accurately describe the 
disproportionation of TMDSO by bis-cyclopentadienyl titanium complexes. This study 
used a combination of X-ray crystallography, NMR, IR, and GC studies to identify 
intermediates and the nature of the metal complexes. These data indicate that siloxanes, 
specifically TMDSO, are capable of forming intermediates which include a Si-O-Ti motif, 
which we propose facilitates the reduction of phosphine oxides (Scheme 1.16). Samuel and 
co-workers also collected the gas released, identifying that the reaction of TMDSO with a 
titanium complexes produces dimethylsilane. 
 Lemaire and coworkers29 also conducted several 29Si NMR studies that revealed 
multiple species that cannot be accounted for by the mechanism proposed by Samuel. We 
presume these to be due to Lemaire using this system to reduce phosphine oxides.  The Si-
Si bond, observed by Lemaire, is easily explained as a small amount of TMDSO acts as a 
suicide reagent allowing for the activation of Ti(IV) to Ti(III), Samuel’s 
dimethyltitanocene released methane during this reduction rather than the presumed 
alcohol which is derived from the alkoxymetal complex. Since the titanium is catalytic in 
respect to the amount of TMDSO, it only makes sense that only a small amount of the silyl 
silane would ever be observed in NMR. While the presence of a titanium hydride was not 
necessarily observed in Lemaire’s EPR studies, it is notable that these studies were 
conducted at concentrations 32-fold less than the catalytically-relevant system. 
Stoichiometric studies by Samuel confirmed that multiple titanium(III) hydride species are 
possible, as these complexes could be isolated and studied by both NMR and X-ray 
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crystallography.  However, the non-stoichiometric studies by Samuel would indicate that 
the titanium hydride may be short-lived or that it may mostly exist as a dinuclear titanium 
complex with the high valency (through ethoxde briging ligands),67 corroborated by the 
observations of Lemaire’s EPR studies.29  
 The new mechanism we propose takes into account the observations in titanium-
catalyzed disproportionation, the 29Si NMR studies, and the lack of a phosphorus radical 
as noted in our radical clock experiments. In addition, this mechanism also implies that two 
equivalents of silylhydride are required for reduction. Because TMDSO contains two 
silylhydride centers, only one equivalent should be enough to reduce one equivalent of 
phosphine oxide and the reaction should never be able to go to completion with less than 
one equivalent of TMDSO (Note: a slight excess promotes faster completion). The new 
mechanism also utilizes the titanium as if it was a “large proton” in the six-membered 
transition state which leads to phosphine oxide reduction and eventually linear silanol 
oligomers. These linear chains can cyclize to form 8 to 10-membered rings as observed by 
both Samuel and Lemaire.  
1.8.15. Computational Modeling of Silane and Phosphine Oxide Materials:  
1.8.15.1. General Procedure: All density functional theory (DFT) calculations were 
performed using Gaussian09114 on a Linux supercomputer. Electronic parameters were 
calculated from structures optimized at the M06-2X/6-31+G(d,p)57 and B3LYP/6-
31+G(d,p)115 levels of theory in benzene using the default SCRF model. Vibrational mode 
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analysis was used to confirm each optimized structure represented potential energy 
minima. 
Coordinate outputs are logged at the end of this document in the appendix.  
1.8.15.2 Results of Geometry Minimizations: The computed structures of silane materials 
and phosphine oxide materials are shown in Table 1.45 and Table 1.46, respectively. Each 
entry depicts the optimal geometry as calculated at both levels of theory, and highlights the 
differences in bond angles around critical components of either material type. These 
structures were then used to calculate Mulliken charges (Tables 1.6 and 1.10) which can 
be used to compare materials of a similar type at the same level of theory, as well as global 
electronic parameters that are more robustly comparable across reagent classes and levels 
of theory.  
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Table 1.45. The computed structures of silane materials studied in this report. 
Entry Silane M06-2X optimized geometry B3LYP optimized geometry 
1 Et3SiH 
 
 
 
2 n-Hexylsilane 
  
3 TMDSO 
  
4 TMDSA 
  
5 Cl3SiH 
  
6 (MeO)3SiH 
 
 
7 Ph3SiH 
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8 Ph2SiH2 
 
 
9 PhSiH3 
  
10 
p-(CF3)-
PhSiH3 
 
 
11 DPDS 
  
12 PhSiH2(OH) 
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Table 1.46.  The computed structures of phosphine oxides studied in this report. 
Entry PO M06-2X optimized geometry B3LYP optimized geometry 
1 TPPO 
 
 
 
2 1PPO 
 
 
3 TMPPO 
 
 
4 TMBPO 
  
5 TMPyrPO 
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1.8.15.3. Global Computational Trends 
 
1.8.15.3.1. Comparison of Empirical Data: To compare computed trends between 
phosphine oxides in the Hammett series and the cyclic phosphine oxides in the literature,82 
initial rates for the Hammett series were calculated using the same fitting function and 
initial rate equation for consistency’s sake. 
Fitting function: Y = Y0 + A1*exp[-(X-X0)/t1] 
Initial rate: R = -(A1/t1)*exp(X0/t1) 
1.8.15.3.2. Computation of Reactivity Indices: All reactivity indices, including global 
electronic properties, were computed using the following equations, determined with 
values generated with relevant chemical species at the M062X/6-31+G(d,p) level of 
theory.116 
Chemical Electron Potential: 𝜇 =
𝐸𝐻𝑂𝑀𝑂+𝐸𝐿𝑈𝑀𝑂
2
 
Chemical Hardness: 𝜂 = 𝐸𝐿𝑈𝑀𝑂 − 𝐸𝐻𝑂𝑀𝑂 
Global Electrophilicity:  𝜔 =
𝜇2
2𝜂
 
Maximum amount of electronic charge accepted by electrophile: ∆𝑁𝑚𝑎𝑥 = −
𝜇
𝜂
 
Nucleophilicity index: 𝑁 = 𝐸𝐻𝑂𝑀𝑂(𝑠𝑢𝑏𝑠𝑡𝑟𝑎𝑡𝑒) −
𝐸𝐻𝑂𝑀𝑂(𝑡𝑒𝑡𝑟𝑎𝑐𝑦𝑎𝑛𝑜𝑒𝑡ℎ𝑦𝑙𝑒𝑛𝑒) 
1.8.15.3.3. Results: The calculations of both silanes (Table1.15) and phophine oxides 
(Table 1.16) are shown. These values were then used to determine if a correlation could be 
found that computationally links catalyst/reductant design to activity. Unfortunately, no 
such correlation could be found for silanes, as summarized in Figure 1.42. For phosphine 
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oxides, the computational parameter nucleophilicity index (N), correlates very well with 
purported activity within a phosphine scaffold, nearly matching the Hammett plot (Figures 
1.22 and 1.27). The same could also be said for five-membered phosphines (Figure 1.43), 
however, the trend is less apparent when a broad set of phosphine oxides is compared 
(Figure 1.27). With that said, a vanilla example of a certain catalyst scaffold is all that is 
needed to have an idea of designing new catalysts, since phosphine oxides within the same 
series are comparable.  
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Figure 1.42. The comparison of silane nucleophilicity index (N) and empirically-
determined initial rates of reduction with TMPPO. Data collected by Kathleen Wang. 
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Figure 1.43. The comparison of phosphine oxide nucleophilicity index (N) to empirically-
observed initial rates of reduction with 5-membered phosphine oxides. Data collected by 
Kathleen Wang. 
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1.8.16. Computational Modeling of Reaction Intermediates: 
1.8.16.1. Modeling the Pre-Reaction Complex 
1.8.16.1.1. General Procedure: Pre-reaction complexes (PCs) for the reduction of 
triphenylphosphine oxide with phenylsilane and the reduction of triphenylphosphine oxide 
with phenylsilanol were calculated using DFT at the M06-2X/6-31+G(d,p) and B3LYP/6-
31+G(d,p) levels of theory. Structures were preliminarily optimized at the HF/3-21G, 
B3LYP/3-21G, B3LYP/6-31G, and B3LYP/6-31+G levels of theory before the final 
optimizations at target levels of theory were performed. For these calculations, additional 
keywords were included to model solvent effects in benzene using the PCM model, and an 
additional keyword was included to specify an ultrafine grid. Vibrational analysis was used 
to confirm that optimized structures were at energetic minima. 
In addition, the silanol OH functional group in the optimized geometry of the 
TPPO + phenylsilanol PC was replaced with just an H, and a frequency calculation was 
performed for this structure. This was done to simulate the thermodynamics of TPPO + 
phenylsilane in the exact conformation and geometry of the TPPO + phenylsilanol PC. 
The basis set and functional used for the frequency calculations was consistent with the 
level of theory the original optimization was run at. 
Coordinate outputs are logged at the end of this supporting document in the 
appendix.  
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1.8.16.1.2. Thermodynamic Equations: Gaussian provides 𝐸𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑛𝑖𝑐 and 𝐸𝑍𝑃𝐸 in atomic 
units, and values for entropy in cal/mol in the output of frequency calculations. 𝐸𝑡𝑟𝑎𝑛𝑠 and 
𝐸𝑟𝑜𝑡 are 3RT/2 each and ∆(PV) is approximately -0.6 kcal/mol. 
𝑈(𝑇) = 𝐸𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑛𝑖𝑐 + 𝐸𝑍𝑃𝐸 + 𝐸𝑡𝑟𝑎𝑛𝑠 + 𝐸𝑟𝑜𝑡 
∆𝐻 = ∆𝑈 + ∆(𝑃𝑉) 
∆𝐺 = ∆𝐻 − 𝑇∆𝑆 
1.8.16.1.3. Results of Modeling the Interaction of TPPO with Phenylsilane and 
Phenylsilanol: The modeling to determine PCs proceeded by limiting interactions within a 
sphere of 5 Å. This was difficult to do for structures with phenylsilane, as repulsive forces 
made minimization difficult. As such, we elected to calculate energies de novo and by 
replacing atoms in the minimized structures with phenylsilanol, denoted by the addition of 
“Freq” in its entries in Tables 1.13 and 1.47. As summarized in Figures 1.25 and 1.44, the 
geometries show that the phenylsilane cannot make a specific interface that is favorable, 
until a covalent interaction occurs. However, the phenylsilanol reductants easily associate 
with each other, resulting in a PC that is stabilized through a hydrogen-bond culminating 
in the first computed PC that is energetically favorable. 
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Table 1.47. The calculated energies and geometries of PCs with TPPO at the B3LYP level of theory. 
Parameter TPPO + PhSi(OH)H2 TPPO + PhSiH3 TPPO + PhSiH3 
(Freq) 
H (kcal/mol) -14.3 -0.61 -0.07 
S (cal/mol) -27.8 -40.5 -47.2 
G (kcal/mol) -6.0 +11.5 +14.0 
P=O (Å) 1.5207 1.5093 1.5207 
P=O···HO-Si/P=O···H-Si (Å) 1.7064 3.7933 2.8767 
Si-H···P (Å) 5.2718 4.7807 5.2718 
Si···P (Å)  5.1368  5.2347 5.1368 
P=O···H-R (°) 128.96 n.d. 131.27 
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Figure 1.44. The optimized PC of TPPO with A) PhSi(OH)H2 and B) PhSiH3 at the 
B3LYP level of theory. Data collected by Kathleen Wang. 
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1.8.17. Stability of Phosphine Oxide Precatalysts: 
Although it has been previously established that the phosphine oxide 1PPO is 
stable for months at -20 °C,1 it is noteworthy that this is not necessarily true for all of these 
cyclic phosphines. While 1PPO seems to be stable at room temperature for a few days, the 
four-membered phosphetanes TMPPO, TMBPO, and TMPyrPO all have different 
stabilities which do not seem to follow a trend. Similarly to 1PPO, the precatalysts were 
all stored in clear vials wrapped with aluminum foil to exclude light. The purity of samples 
and presence of degradation was monitored by 1H and 31P NMR spectroscopy at 1 day, 3 
days, 7 days, 14 days, 30 days, 90 days, and 180 days (when applicable).  
TMBPO is the least stable precatalyst we have studied to date, and shows signs of 
degradation within two weeks of storage at -20 °C (storage at -80 °C was also ineffective 
at stopping degradation). S4 (only used in supporting experiments) had a similar stability 
profile, potentially indicating that trialkyl phosphetanes are unstable and incompatible for 
use in reactions (trialkyl phospholanes may be a suitable substitute). TMPyrPO seems to 
have limited stability at room temperature, with degradation noted after 3 days, but 
degrades only slightly after 6 months when stored at -20 °C. TMPPO has a similar stability 
profile as 1PPO, as it does not degrade when stored at -20 °C (monitored for 180 days), 
nor when stored at room temperature in a desiccator for 90 days. 1PPO is very stable when 
stored at -20 °C with the exclusion of light, as catalyst batches retained purity for at least 
18 months.  
1.8.18. The Balls for the Ball-Milling Strategy: 
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The balls used to enhance the reaction rate to form the chlorosilane intermediate 
were purchased from VXB.com (part numbers in parentheses) and degreased (using 
CH2Cl2) prior to use. For small scale reactions (1 mmol), 1000 ½ mm diameter tungsten-
carbide balls (0-5MMTUNGSTENBALLS) were employed in a small vial with a ¼ inch 
stir bar used to stir the reaction. The tungsten carbide balls are easily recycled. For larger 
reactions, ½ inch diameter chrome iron (KIT8597) or ceramic (KIT12927) balls were used. 
Sometimes, with the iron balls, a yellow (not pale yellow) crude material was obtained and 
distillation could be needed, although the product would often appear >95% pure by NMR. 
The iron balls could be reused, although the propensity to obtain this yellow crude material 
became greater. We found that the ceramic balls were better for recycling and could be 
used many times, similarly to the tungsten-carbide balls.  
1.8.19. Synthesis of Disiloxane Materials: 
1.8.19.1. General Procedure of Ball-Milling Process: 
To a 2-neck 500 mL round bottom flask was added 35 ½ inch metal or ceramic 
spheres. Then, CuCl2 (12.1 g, 90 mmol, 2.0 equiv), CuI (857 mg, 4.5 mmol, 0.1 equiv), 
and Et2O (60 mL). An overhead stirrer was fitted to the vessel and the reaction was stirred 
at 30% speed for 30 min. Phenylsilane (5.54 mL, 45 mmol, 1.0 equiv) was added dropwise 
and a color change was noted immediately. After about 1.5 h, the reaction was complete 
(completion is noted when the balls are caked with greyish solid). The reaction was filtered 
directly onto ice (45 g) and washed with 30 mL Et2O. The ether and ice were swirled every 
5 min for 15-45 min, until the ice was melted. The layers were separated and the organic 
278 
 
layer was washed with cold deionized water (2  30 mL) and then dried with MgSO4. The 
solvent and excess phenysilane were evaporated at 40 °C at reduced pressure (22 Torr). 
DPDS was obtained as a colorless to pale-yellow oil (4.80 g, 20.9 mmol) in 93% yield. 
Generally, disiloxanes were at least 95% pure.   
  
279 
 
 
Figure 1.45. Preparation of DPDS; A) Metal balls used in the reaction, B) Formation of 
the active copper complex, C) Addition of phenylsilane, D) Reaction complete, E) 
Filtration apparatus with ice in the receiving flask. 
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1.8.19.2. Procedure of Reactions without Balls (Magnetic Stirring): 
To a 2-dram vial, equipped with a ¼ inch magnetic stir-bar was added CuCl2 (1.21 
g, 9 mmol, 2.0 equiv), CuI (85.7 mg, 0.45 mmol, 0.1 equiv), and Et2O (6 mL). The reaction 
vessel was sealed with a screw cap and stirred at 750 rpm for 30 min. Phenylsilane (554 
L, 4.5 mmol, 1.0 equiv) was added dropwise and a color change was noted immediately. 
The reaction was monitored by 1H NMR for completeness. After 16 h, the reaction was 
filtered directly onto ice (5 g) and washed with 10 mL Et2O. The ether and ice were swirled 
every 5 min for 5-15 min, until the ice was melted. The layers were separated and the 
organic layer was washed with cold deionized water (2  15 mL) and then dried with 
MgSO4. The solvent and excess phenysilane were evaporated at 40 °C at reduced pressure 
(22 Torr). DPDS was obtained as a colorless oil (414 mg, 1.8 mmol) in 80% yield. 
1.8.19.3. Procedure of Reactions without Balls (Overhead Stirring): 
To a 2-neck 500 mL round bottom flask was added CuCl2 (12.1 g, 90 mmol, 2.0 
equiv), CuI (857 mg, 4.5 mmol, 0.1 equiv), and Et2O (60 mL). An overhead stirrer was 
fitted to the vessel and the reaction was stirred at 30% speed for 30 min. Phenylsilane (5.54 
mL, 45 mmol, 1.0 equiv) was added dropwise and a color change was noted immediately. 
The reaction was monitored by 1H NMR for completeness. After 20 h, the reaction was 
filtered directly onto ice (45 g) and washed with 10 mL Et2O. The ether and ice were 
swirled every 5 min for 15 min, until the ice was melted. The layers were separated and 
the organic layer was washed with cold deionized water (2  15 mL) and then dried with 
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MgSO4. The solvent and excess phenysilane were evaporated at 40 °C at reduced pressure 
(22 Torr). DPDS was obtained as a pale yellow oil (3.639 g, 15.8 mmol) in 70% yield. 
1.8.20. Additional Purifications of Disiloxanes in Table 1.17:  
1,3-Diphenyl-disiloxane [17962-59-3] (DPDS)73: Reactions were performed at 1, 15, 45, 
and 90 mmol scales. Additional purification (if needed) was achieved by distillation under 
reduced pressure (bp. 76°C at 580 mTorr). The title compound was obtained as a colorless 
to pale-yellow oil (9.1 g, 39.6 mmol) in 88% yield. 1H NMR (CDCl3) δ 7.53 (d, J = 7.6 Hz, 
4H), 7.37 (t, J = 7.6 Hz, 2H), 7.32 (t, J = 7.2 Hz, 4H), 5.06 (s, 4H); 13C NMR (CDCl3) δ 
134.10, 130.54, 128.13; HRMS (ESI) Calc. C12H14NaOSi2 [M + Na] 253.0475, Found 
253.0471. 
1,1,3,3-Tetraphenyl-disiloxane [15545-80-9] (TPDS)73, 101: Reactions were performed at 
15 mmol scale. The title compound was obtained as a colorless solid (2.58 g, 6.75 mmol) 
in 90% yield; mp. 48–49 °C [Lit.2 mp. 46–49 °C]. 1H NMR (CDCl3) δ 7.48 (d, J = 6.9 Hz, 
8H), 7.34 (t, J = 7.4 Hz, 4H), 7.27 (t, J = 7.7 Hz, 8H), 5.52 (s, 2H); 13C NMR (CDCl3) δ 
134.33, 130.24, 127.96; HRMS (ESI) Calc. C24H23OSi2 [M + H] 383.1282, Found 
383.1280. 
1,3-Di-n-hexyl-disiloxane [1203611-82-8]: Reactions were performed at 1 and 15 mmol 
scales. Additional purification (if needed) was achieved by distillation under reduced 
pressure (bp. 76°C at 580 mTorr). The title compound was obtained as a colorless to pale 
yellow oil (1.57 g, 6.38 mmol) in 85% yield. 1H NMR (CDCl3) δ 4.52 (t, J = 2.6 Hz, 4H), 
1.36–1.22 (m, 20H), 0.82 (t, J = 6.9 Hz, 6H); 13C NMR (CDCl3) δ 32.34, 31.55, 22.92, 
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22.54, 14.47, 14.10; HRMS (ESI) Calc. C12H30NaOSi2 [M + Na] 269.1727, Found 
269.1732. 
1,3-Dimethyl-1,3-diphenyl-disiloxane [6689-22-1] (DMDPS)102: Reactions were 
performed at 15 mmol scale. Additional purification (if needed) was achieved by 
distillation under reduced pressure (bp. 102 °C at 800 mTorr). The title compound was 
obtained as a colorless to pale yellow oil (1.64 g, 6.35 mmol) in 85% yield. 1H NMR 
(CDCl3) δ 7.40 (dt, J = 7.9, 1.4 Hz, 4H), 7.25-7.19 (m, 6H), 4.98 (dd, J = 2.9, 1.1 Hz, 2H), 
0.27 (d, J = 3.1 Hz, 6H); 13C NMR (CDCl3) δ 32.34, 31.55, 22.92, 22.54, 14.47, 14.10; 
HRMS (ESI) Calc. C14H18NaOSi2 [M + Na] 281.0788, Found 281.0799.  
1.8.21. Procedure for Cleaning Balls for Recycling: 
After the reaction is completed, the balls are removed from the filter and are 
separated from the excess copper salts also remaining on the filter paper. The balls are 
soaked in 50:50 acetone:water and are scrubbed by hand until the balls appear clean. The 
balls are then washed with water and acetone. The balls are then dried on a paper towel 
and stored in a closed container. Before reuse, the balls are washed with acetone and 
CH2Cl2 immediately prior to use. An image of the chrome-iron balls after washing is shown 
in Figure 1.46.  
283 
 
 
Figure 1.46. The condition of used Chrome-Iron balls after one use (left) and after two 
uses (right).  
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1.8.22. Comparison of Yields with Different Balls:  
The general procedure was used for each reaction and the type of balls used was varied. In 
each trial, either all-new or all-used balls were utilized for the reaction. As summarized in 
Table 1.48, the reaction yield was nearly the same for new chrome iron and new ceramic 
spheres. However, upon recycling, the yield stayed constant for the ceramic balls while a 
drop-off was noted for the recycled iron balls. This drop in yield was further exacerbated 
by an additional recycling step, and the initially purity of the crude material was also lower. 
For optimal performance, chrome iron balls should be retired after two uses. Ceramic balls, 
while more stable to the chemical conditions, did have longevity issues due to the 
mechanical force exerted on the balls during reactions as microfractures eventually resulted 
in the physical breaking of the ceramic material after repeated use, although this process 
was generally slower than the rate of “degradation” of the chrome iron balls.  
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Table 1.48. Comparison of Yields for the Synthesis of 2a when Different Balls are Employed.  
 
Entry Ball Material Previous Number of Usesa Yieldb 
1 Ceramic 0 93 
2 Ceramic 1 91 
3 Ceramic 2 90 
4 Chrome Iron 0 91 
5 Chrome Iron 1 88 
6 Chrome Iron 2 80 
aBalls recycled as indicated in section 2.4, bIsolated crude yield of two reactions at 45 mmol scale prior to 
additional purification.  
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1.8.23. Synthesis of Phosphine Oxides: 
1.8.23.1. General Procedure for Oxidation of Phosphines: To a stirring solution of 
phosphine  (2.0 mmol, 1 equiv) in 10 mL Et2O or CH2Cl2 was added H2O2 (30% aqueous 
solution, 5 mL). The reaction was stirred under Schotten-Baumann conditions for 30 
minutes to 16 hours. The reactions were filtered, and washed with Et2O to afford phosphine 
oxides in yields ranging from 69 to 99%.  
1.8.23.2. General Procedure for Grignard Reactions with Diphenylphosphinic chloride: A 
roundbottom flask equipped with a teflon-coated stirbar was charged with magnesium (-
90 mesh, 144 mg, 6.0 mmol, 1.2 equiv). The reaction flask and metal was flame-dried 
under reduced pressure, and the vessel was allowed to cool to 23 °C. After cooling, a 
solution of I2 (20 mg) and aromatic bromides (5.5 mmol, 1.1 equiv) in anhydrous THF (5.5 
mL) was added. The reaction vessel was heated to 60 °C with vigorous stirring. After 1.5 
hours, the reaction was cooled to 0 °C and diphenylphosphinic chloride (954 L, 5.0 mmol, 
1.0 equiv) was added in a dropwise manner. The reaction was stirred and allowed to warm 
to 23 °C slowly. After 18 hours, the reaction was again cooled to 0 °C and 6.0 mL of 2.0 
N NaOH was added to quench the reaction. The reaction layers were separated, and the 
aqueous layer was washed with EtOAc (3 x 10 mL). The organic layers were combined 
and concentrated directly onto silica gel for column chromatography to afford phosphine 
oxides in yields ranging from 73 to 92%.  
1.8.23.3. Purification of Phosphine oxides:  
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(4-(Dimethylamino)phenyl)diphenylphosphine oxide117: The reagent was prepared 
according to the procedure in section 2.2. The crude mixture was purified by column 
chromatography with 10% methanol in CH2Cl2 to afford the title compound as a white 
solid. All physical data and spectra matched literature reports. 
(4-methoxyphenyl)diphenylphosphine oxide118: The reagent was prepared according to the 
procedure in section 2.2. The crude mixture was purified by column chromatography with 
10% methanol in CH2Cl2 to afford the title compound as an off-white solid. All physical 
data and spectra matched literature reports. 
(4-(Trifluoromethyl)phenyl)diphenylphosphine oxide118: The reagent was prepared 
according to the procedure in section 2.2. The crude mixture was purified by column 
chromatography with 10% methanol in CH2Cl2 to afford the title compound as a white 
solid. All physical data and spectra matched literature reports. 
(3,5-Bis(trifluoromethyl)phenyl)diphenylphosphine oxide: The reagent was prepared 
according to the procedure in section 2.2. The crude mixture was purified by column 
chromatography with 10% methanol in CH2Cl2 to afford the title compound as a brown 
solid. 1H NMR (CDCl3, 500 MHz)  8.15 (d, J = 11.4 Hz, 2H), 8.04 (s, 1H), 7.69 – 7.61 
(m, 6H), 7.54 (dd, J = 7.6, 2.7 Hz, 4H); 13C (CDCl3, 126 MHz)  132.9, 132.0, 131.9, 
131.1, 130.3, 129.1, 129.0, 125.7; 31P (CDCl3, 202 MHz)  50.32; 19F (CDCl3, 470 MHz) 
 -62.89; HRMS (ESI) Calc. C20H13F6NaOP [M + Na] 437.0500, Found 437.0501.  
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Tris-(3,5-(trifluoromethyl)phenyl)phosphine oxide119: The reagent was prepared according 
to the procedure in section 2.1. and filtered directly to afford a white solid. All physical 
data and spectra matched literature reports.  
[1,1’-biphenyl]-2-yl)dicyclohexylphosphine oxide120: The reagent was prepared according 
to the procedure in section 2.1. and filtered directly to afford a white solid. All physical 
data and spectra matched literature reports.  
(2’,6’-dimethoxy-[1,1’-biphenyl]-2-yl)dicyclohexylphosphine oxide: The reagent was 
prepared according to the procedure in section 2.1. and filtered directly to afford an off-
white solid. 1H NMR (CDCl3, 500 MHz)  7.80 (dd, J = 10.4, 8.5 Hz, 1H), 7.44 (t, J = 8.7 
Hz, 1H), 7.37 (t, J = 8.7 Hz, 1H), 7.25 (t, J = 8.4 Hz, 1H), 7.08 (dd, J = 7.3, 3.5 Hz, 1H), 
6.54 (d, J = 8.4 Hz, 2H), 3.61 (s, 6H), 1.67 – 1.62 (m, 8H), 1.54 – 1.49 (m, 4H), 1.27 – 1.19 
(m, 2H), 1.10 – 1.00 (m, 6H); 13C (CDCl3, 126 MHz)  137.1, 136.3, 132.8, 132.0, 131.3, 
129.0, 125.7, 123.9, 121.7; 31P (CDCl3, 202 MHz)  50.32; HRMS (ESI) Calc. 
C26H35NaO3P [M + Na] 449.2211, Found 449.2187. 
1,2-Bis(diphenylphosphino oxide)ethane121: The reagent was prepared according to the 
procedure in section 2.1. and filtered directly to afford a white solid. All physical data and 
spectra matched literature reports.  
rac-2,2’-Bis(diphenylphosphino oxide)-1,1’-binapthlene29: The reagent was prepared 
according to the procedure in section 2.1. and filtered directly to afford a white solid. All 
physical data and spectra matched literature reports.  
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(9,9-Dimethyl-9H-xanthene-4,5-diyl)-bis-diphenylphosphine oxide: The reagent was 
prepared according to the procedure in section 2.1. and filtered directly to afford a white 
solid. 1H NMR (CDCl3, 500 MHz)  7.54 (d, J = 7.1 Hz, 2H), 7.34 – 7.30 (m, 11H), 7.22 
– 7.19 (m, 9H), 6.91 (t, J = 7.2 Hz, 2H), 6.70 (dd, J = 7.5 Hz, 2H), 1.63 (s, 6H); 13C (CDCl3, 
126 MHz)  153.0, 134.2, 132.1, 131.4, 130.6, 128.1, 123.0, 34.1, 33.0; 31P (CDCl3, 202 
MHz)  30.13; HRMS (ESI) Calc. C39H32NaO3P2 [M + Na] 633.1719, Found 633.1790. 
1,2-Bis [(2-methoxyphenyl)(phenylphosphine oxide)] ethane25: The reagent was prepared 
according to the procedure in section 2.1. and filtered directly to afford a white solid. All 
physical data and spectra matched literature reports.  
[4-(Dimethoxymethyl)phenyl]diphenylphosphine oxide:  The reagent was prepared 
according to the procedure in section 2.2. The crude mixture was purified by column 
chromatography with 5% methanol in CH2Cl2 to afford the title compound as a colorless 
oil. 1H NMR (CDCl3, 500 MHz)  7.68 – 7.65 (m, 6H), 7.55 (t, J = 6.5 Hz, 4H), 7.46 (t, J 
= 6.5 Hz, 4H), 5.42 (s, 1H), 3.34 (s, 6H); 13C (CDCl3, 126 MHz)  142.1, 132.9, 132.1, 
132.0, 128.5, 126.9 (d, 12.7 Hz), 126.9 (d, 11.8 Hz), 102.5, 52.9; 31P (CDCl3, 202 MHz)  
28.91; HRMS (ESI) Calc. C21H21NaO3P [M + Na] 375.1121, Found 375.1112. 
4-(Diphenylphosphine oxide)-benzaldehyde: The reagent was prepared according to the 
procedure in section 2.2. The crude mixture was purified by column chromatography with 
5% methanol in CH2Cl2 to afford the title compound as a colorless oil. 
1H NMR (CDCl3, 
500 MHz)  10.09 (s, 1H), 7.97 (d, J = 7.4 Hz, 2H), 7.87 (t, J = 8.7 Hz, 2H), 7.68 (t, J = 
8.7 Hz, 4H), 7.59 (t, J = 7.9 Hz, 2H), 7.50 (t, J = 7.2 Hz, 4H); 13C(CDCl3, 126 MHz)  
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191.6, 132.8, 132.4, 132.1, 132.0, 129.4, 128.8, 128.7; 31P (CDCl3, 202 MHz)  28.57; 
HRMS (ESI) Calc. C19H15NaO2P [M + Na] 329.0702, Found 329.0731.  
1,1’-Bis(diphenylphino oxide)ferrocene: The reagent was prepared according to the 
procedure in section 2.1. and filtered directly to afford an orange solid. 1H NMR (CDCl3, 
500 MHz)  7.51 – 7.33 (m, 20H), 4.61 (s, 4H), 4.20 (s, 4H); 13C (CDCl3, 126 MHz)  
134.2, 133.3, 131.7, 131.4, 131.3, 128.4, 74.1, 74.0, 73.5, 73.4; 31P (CDCl3, 202 MHz)  
28.50; HRMS (ESI) Calc. C34H29FeO2P2 [M + H] 587.0987, Found 587.0998. 
1.8.24. NMR Studies of Silane Reductions: 
1.8.24.1. Real-Time Reaction Monitoring of Silane-Based Reducing Conditions: 
1.8.24.1.1. General Procedure for DPDS Reduction: To an NMR tube was added d8-toluene 
(425 L), DPDS (72 mg, 0.31 mmol, 0.63 M), and TPPO (70 mg, 0.25 mmol, 0.5 M). The 
tube was inverted three times to ensure proper mixing of the reagents and the interface 
between the tube and the cap was sealed with multiple layers of paraffin wax (parafilm®) 
to ensure no leaks. The reaction was heated to 110 C and monitored with 31P NMR. 
1.8.24.1.2. General Procedure for TMDSO/Ti(OiPr)4 Reduction
29: To an NMR tube was 
added d8-toluene (500 L), TMDSO (115 µL, 0.65 mmol, 1.06 M), Ti(OiPr)4 (15.4 µL, 
0.052 mmol, 0.084 M), and TPPO (145 mg, 0.52 mmol, 0.84 M). The tube was inverted 
three times to ensure proper mixing of the reagents and the interface between the tube and 
the cap was sealed with multiple layers of paraffin wax (parafilm®) to ensure no leaks. 
The reaction was heated to 110 C and monitored with 31P NMR. 
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1.8.24.1.3. General Procedure for HSiMe(OEt)2/BNPA Reduction
25:  To an NMR tube was 
added d8-toluene (500 L), HSiMe(OEt)2 (40 L, 0.25 mmol, 0.46 M), (p-
NO2C6H4O)2PO2H (BNPA, 1.6 mg, .0047 mmol, 0.009 M), and TPPO (17.4 mg, 0.062 
mmol, 0.116 M). The tube was inverted three times to ensure proper mixing of the reagents 
and the interface between the tube and the cap was sealed with multiple layers of paraffin 
wax (parafilm®) to ensure no leaks. The reaction was heated to 110 C and monitored with 
31P NMR. 
1.8.24.1.4. Results: These reductions were run using the exact reactant concentrations 
reported by Beller25 and Lemaire29 to provide an accurate comparison of DPDS-mediated 
reduction to dump-and-stir versions of their optimized systems. We did choose to heat the 
TMDSO/Ti(OiPr)4 system to 110 C instead of the reported 100 C to normalize the 
temperatures that the reaction mixtures were heated to (presumably this would increase the 
rate of reduction). 
As shown in Figure 1.28, reduction using DPDS solely is by far the swiftest, 
completing in 10-12 h with greater than 90% conversion at 4 h. The HSiMe(OEt)2/BNPA 
reduction system was the next quickest, proceeding via first-order kinetics to furnish 
complete reduction in 16-18 h, which is very close to the reported rate.25 The 
TMDSO/Ti(IV) trials, on the other hand, struggled to perform at the reported rates under 
our conditions which did not strictly eliminate water and air from the reaction mixture. 
Figure 1.28 only shows time points for the TMDSO/Ti(IV) system after 10 hours because 
cooling the reaction any earlier resulted in unreacted TPPO crashing out. 
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It is worth noting that reductions using HSiMe(OEt)2 and BNPA require 4 
equivalents of silane to proceed at the rate in Figure 1.28. Beller and coworkers note the 
production of H2 over the course of the reaction caused by reaction of the silyl hydride with 
a proton source, which causes low yields when less equivalents of silane are used. Our 
proposed system using DPDS requires only 1.25 equivalents of silane and eschews 
additional additives, making it far more atom-economical while still achieving complete 
reduction in around 60% of the time  
We were also quite surprised to see the TMDSO/Ti(IV) system not finish. To 
ensure that we were not misrepresenting the performance of this system, we tried multiple 
sources of Ti(OiPr)4. The data shown in Figure 1.28 is from three concurrent trials with a 
never-before opened bottle of Ti(OiPr)4 from Strem Chemicals, Inc., which we have 
observed to be the best provider of our transition metals. Individual results with different 
sources of Ti(OiPr)4 are shown in Table 1.49.  
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Table 1.49. Testing Different Sources of Ti(OiPr)4. (Values Shown are % Completion). 
Time (h) Trial A Trial B Trial C Trial D Trial E Trial F 
10 62 59 56    
12    60 55 61 
14      61 
16 69 62 60    
32 76 67 66    
48 81 70 69 79 65  
Trials A-C are the concurrent trials with fresh Ti(OiPr)4 from Strem that are used in Figure 1. Trial D is with 
an older bottle of Ti(OiPr)4 from Strem stored in a desiccator, and Trials E & F are with an older bottle of 
Ti(OiPr)4 from Sigma-Aldrich stored in a desiccator. 
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1.8.24.2. Arrhenius Analysis: 
1.8.24.2.1. General Procedure for Arrhenius Analysis of TPPO Reduction with DPDS: To 
three NMR tubes was added d8-toluene (440 L), DPDS (58 mg, 0.25 mmol, 0.50 M), and 
TPPO (5.6 mg, 0.2 mmol, 0.04 M). The tubes were inverted three times to ensure proper 
mixing of the reagents and the interface between the tube and the cap was sealed with 
multiple layers of paraffin wax (parafilm®) to ensure no leaks. The reactions were heated 
to the temperature indicated and monitored with 31P NMR. 
4.2.2 Data Analysis: 
The phosphine oxide reduction time courses were fit to equation 1 to determine the 
rate constants (k) of reduction with each catalyst at each temperature.  
𝑬𝒒𝒖𝒂𝒕𝒊𝒐𝒏 𝟏. %𝑃 = −𝐴𝑒−𝑘𝑡 
Figures 1.47 shows the time course analysis and fitting to Equation 1 for TPPO. 
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Figure 1.47. Single-exponential fitting of reductions of TPPO with DPDS. 
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The k values obtained from Figure S1 was then used to generate Arrhenius plots to 
determine the activation energy of each reaction. Equation 2 shows the linearized form of 
the Arrhenius equation. 
𝑬𝒒𝒖𝒂𝒕𝒊𝒐𝒏 𝟐.  ln(𝑘) = −
𝐸𝑎
𝑅
∗
1
𝑇
+ ln(𝐴) 
Now, for our analysis, k is actually equal to a rate constant (call it k1) times the 
concentration of DPDS, since we are running these analyses using a large excess of DPDS. 
Equation 3 describes this. 
𝑬𝒒𝒖𝒂𝒕𝒊𝒐𝒏 𝟑.  ln(𝑘1 ∗ [𝑫𝑷𝑫𝑺]) = −
𝐸𝑎
𝑅
∗
1
𝑇
+ ln(𝐴) 
The natural logarithm on the left of Equation 3 can be split to provide Equation 4. 
𝑬𝒒𝒖𝒂𝒕𝒊𝒐𝒏 𝟒.  ln(𝑘1) + ln([𝑫𝑷𝑫𝑺]) = −
𝐸𝑎
𝑅
∗
1
𝑇
+ ln(𝐴) 
The natural logarithm of the concentration of DPDS is constant. This means that if we were 
doing full Arrhenius analysis, without accounting for the ln([DPDS]) term, we would 
obtain an incorrect value for the parameter A. Since we are only interested in determining 
the energy of activation, however, this is not an issue. 
Fitting the k values obtained from Figure 1.46, we generate Arrhenius plots for 
TPPO as in Figures 1.48 This provides an estimate of the activation energy for reduction. 
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Figure 1.48. Arrhenius plot for TPPO showing the activation energy. 
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1.8.25. Optimization of Additive-Free Reductions of Acyclic Phosphines: 
1.8.25.1. Silane Equivalence Screening: 
1.8.25.1.1. General Procedure: To a 2-dram vial equipped with a ¼” teflon-coated stir bar 
was added triphenylphosphine oxide (TPPO, 140 mg, 0.5 mmol, 1.0 equiv), toluene (1 
mL, 0.5 M), and then DPDS (See tables for equivalence screen). The reaction was sealed 
with a pressure-relief cap (Chemglass: CG-4912-02) and heated to 110 °C. After 16-24 
hours, the reactions were cooled to ambient temperature and then loaded directly onto silica 
gel (using approx. 10 mL acetone to wash the reaction vessel) for chromatography to yield 
compound TPP.  
1.8.25.1.2. Results: Unsurprisingly, adding more DPDS resulted in faster reduction and 
higher yields of desired product. Quantitative yields could be achieved easily with a slight 
excess of DPDS (Table 1.50). However, high yields could still be achieved with less than 
one equivalent of DPDS, which was not surprising since DPDS contains two silicon 
centers (Tables 1.50 and 1.51). When the reaction is performed overnight (16 hours), 
quantitative yields are achieved with an equivalence of DPDS corresponding to 1.25 times 
TPPO (Table 1.50), while a 24 hour reaction gave the same yield with only 1.1 equivalence 
of DPDS (Table 1.51). Unfortunately, at either of these times, using equal stoichiometry 
or lower equivalence of DPDS did not afford higher than 95% yield. In order to achieve 
our desired goal of reductions that occur with high fidelity, we sought to use 1.25 
equivalence of DPDS as our optimized conditions in toluene. These conditions were 
carried through to the next optimization of solvent.  
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Table 1.50. Silane Equivalence Screen Isolated After 16 h. 
 
Entry Concentration (M) Equiv DPDS Isolated Yield[a] 
1 0.25 0.75 78 
2 0.25 1.0 78 
3 0.25 1.5 99 
4 0.25 2.0 Quant. 
5 0.5 0.75 82 
6 0.5 1.0 89 
7 0.5 1.1 95 
8 0.5 1.25 Quant. 
9 0.5 1.5 Quant. 
10 0.5 2.0 Quant. 
[a]Average isolated yield of at least two reactions. 
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Table 1.51. Silane Equivalence Screen Isolated After 24 h. 
 
Entry X equiv Isolated Yield[a] 
1 0.75 84 
2 1.0 93 
3 1.1 97 
4 1.25 Quant. 
[a]Average isolated yield of at least two reactions. 
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While screening silane equivalence, we also investigated the requirements for 
optimal reactivity concerning concentration of the phosphorus oxide (Table 1.50). Overall, 
yields are better with more concentrated reactions. The reaction is also much more 
consistent when reducing at higher initial concentrations. Because of this reactivity, we 
chose to continue using highly concentrated reactions. It is noteworthy, however, that most 
phosphine oxides (including TPPO) are not soluble in toluene unless the reactions are 
heated.  
1.8.25.2. Solvent Screening: 
1.8.25.2.1.1. General Procedure: To a 2-dram vial equipped with a ¼” teflon-coated stir 
bar was added triphenylphosphine oxide (TPPO, 140 mg, 0.5 mmol, 1.0 equiv), solvent 
(1 mL, 0.5 M), and then DPDS (144 mg, 0.625 mmol, 1.25 equiv) The reaction was sealed 
with a pressure-relief cap (Chemglass: CG-4912-02) and heated to 110 °C. After 18 hours, 
the reactions were cooled to ambient temperature and then loaded directly onto silica gel 
(using approx. 10 mL acetone to wash the reaction vessel) for chromatography (see SI 
section 8.1) to yield compound TPP. 
1.8.25.2.1.2. Alternative Workup Procedure for Ionic Liquid [Bmim]PF6: After the 
reaction was cooled, the ionic liquid was extracted with Et2O (3 x 7 mL) and the crude 
material was evaporated (156.4 mg). The crude material was again taken up in Et2O and 
concentrated directly onto silica gel for chromatography (see SI section 8.1) to yield 
compound TPP.  
302 
 
1.8.25.2.2. Results: We investigated a range of “green” solvents, in addition to those used 
in other phosphine oxide reductions.25, 29 Unsurprisingly, TPPO was unable to dissolve in 
heptane and cyclohexane boiled off at the high temperature, and thus neither of these 
solvents could be utilized at 110 °C. The ionic liquid [Bmim]PF6 was capable of facilitating 
reduction (Table 1.19), however a side reaction is clearly occurring which results in a white 
precipitate, a yellow solution, and a “fishy” odor  in reactions before workup. We also 
investigated ethyl lactate, which is sourced from renewable resources. Unsurprisingly, the 
yield of the reduction was quite low, likely due to DPDS consumption through side 
reactivity with the abundant (and unprotected) alcohol. Methyl cyclohexane, cylopentyl 
methyl ether (CPME), and tert-butyl acetate (TBAc) were all competent solvents, and 
TBAc solubilized TPPO without heat, while methyl cyclohexane is already known to be 
poor at solubilizing phosphine oxides.29  
Because TBAc can easily solubilize phosphine oxides and reaction yields were 
comparable to reductions in toluene, we chose this solvent as the optimal solvent for 
reductions. TBAc is also attractive as a solvent because it lacks volatile organic compound 
(VOC) regulations from the United States Environmental Protection Agency. We opted to 
revisit a brief silane equivalence screen with the newly chosen solvent (Table 1.52) with 
similar results as those achieved with toluene.  
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Table 1.52. Silane Equivalence Screen in TBAc. 
 
Entry X equiv DPDS Isolated Yield[a] 
1 0.75 67 
2 1.0 90 
3 1.1 95 
4 1.25 99 
[a]Average isolated yield of at least two reactions after 24 hours. 
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1.8.26. General Procedure of Additive-Free Phosphine Oxide Reductions: 
To a 2-dram vial equipped with a ¼” teflon-coated stir bar was added phosphine 
oxides (0.1-0.5 mmol, 1.0 equiv), tert-butyl acetate (0.5 M), and then DPDS (0.125-0.625 
mmol, 1.25 equiv). The reaction was sealed with a pressure-relief cap (Chemglass: CG-
4912-02) and heated to 110 °C. After 16-24 hours, the reactions were cooled to ambient 
temperature and then loaded directly onto silica gel (using approx. 10 mL acetone to wash 
the reaction vessel) for chromatography (see SI section 8) to yield phosphines.  
1.8.26.1. Alternate Workup: When working on a large enough scale, it may be necessary 
to destroy excess unreacted DPDS. This is easily accomplished by stirring the reaction 
with an equal volume of 2.0 M NaOH for 15 minutes (Warning: Rapid gas evolution). 
The reaction layers were separated and the organic layer was concentrated onto silica gel 
to remove soluble silanol byproducts from desired phosphines.  
1.8.26.2. Determination of yields by 31P NMR: For secondary phosphine oxides, the 
reaction was set up in an NMR tube using the procedure from section 3.1.1. The reaction 
was cooled to 23 °C by running cold water over the tubes for 30 seconds. The reaction was 
checked by 31P NMR for conversion at 10, 30, 60, 90, 120, 180, 240, and 300 minutes. 
Reactions with di-tert-butyl phosphine oxide were monitored for 24 hours, at which point 
a degradant was noted to dominate the reaction mixture as no productive change in 
conversion was noted after 180 minutes. 
1.8.27. Optimization of Room-Temperature Silane-Mediated Reductions of 
Phosphine Oxides:  
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1.8.27.1. Representative Procedure: To a 2-dram vial equipped with a ¼” teflon-coated stir 
bar was added triphenylphosphine oxide (1a, 70 mg, 0.25 mmol, 1.0 equiv), BNPA (17 
mg, 0.05 mmol, 0.2 equiv), ethyl acetate (0.5 mL, 0.5 M), and then DPDS (144 mg, 0.625 
mmol, 2.5 equiv) The reaction was sealed with a cap and stirred at 23 °C for 48 hours. The 
reaction was then diluted to 3 mL with additional ethyl acetate and 1.5 mL of 2.0 N NaOH 
was added to quench the reaction (Warning: Gas evolution possible). After stirring for 15 
minutes, the layers were separated and the organic layer was concentrated onto silica gel 
to remove soluble silanol byproducts from desired phosphines using chromatography to 
yield pure phosphine 2a.  
1.8.27.2. Results: Our initial attempt to create a room-temperature reduction protocol 
combined our novel system with the phosphoric acid additive BNPA found to be highly 
effective by Beller and co-workers. Addition of BNPA to reductions with DPDS was 
beneficial, promoting reduction at 110 °C to completion within 2 hours (Table 1.21). 
Encouraged by this result, we continued with ethyl acetate as the solvent for this ambient 
temperature reaction, as this solvent is sourced from renewable resources. Unfortunately, 
only a slight excess of DPDS and 10 mol% loading of the additive did not furnish a reaction 
with high yields. This was quickly alleviated by either A) adding more additive and/or B) 
adding excess DPDS. As summarized in Table 1.22, either of these strategies resulted in a 
drastic increase in yield. In fact, adding more BNPA was the most effective way to increase 
the yield, as this additive likely only interacts with the silane to activate this reducing agent. 
Increasing both DPDS and BNPA resulted in a reaction that was done in a reasonable 
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amount of time which was general for a variety of phosphines. As such, reductions 
employing 2.5 equivalents of DPDS and 20 mol% of BNPA were selected as the optimal 
conditions with highly consistent results.  
1.8.28. Silane Compatibility Studies: 
1.8.28.1. Reactivity of DPDS with carboxylic acids 
1.8.28.1.1. General Procedure: To an NMR tube was added 3-(trifluoromethyl)-benzoic 
acid (19 mg, 0.1 mmol), d8-THF or d8-Toluene (0.5 mL), and then DPDS (53 mg, 0.22 
mmol). The tube was sealed with a cap and inverted three times to ensure proper mixing 
of the reagents and the interface between the tube and the cap was sealed with multiple 
layers of paraffin wax (parafilm®) to ensure no leaks. The reaction was heated to 80 C 
and monitored by 19F NMR.  
1.8.28.1.2. Results: Minor reactivity of DPDS and carboxylic acid was observed (Figure 
1.49) after 40 hours. With phenylsilane, no change was not observed in 19F NMR spectra 
or 1H NMR spectra when compared to the initial spectra after 40 hours of heating. Due to 
the lack of substantial reactivity at 80 °C within 18 hours, we believe DPDS can easily be 
employed in reactions that contain carboxylic acids.  
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Figure 1.49. A) No reactivity of 3-(trifluoromethyl)-benzoic acid and phenylsilane is noted 
at 1.5 h, 17.5 h, or 40.5 h; B) Reactivity of 3-(trifluoromethyl)-benzoic acid and DPDS is 
not noted at 1.5 h or 17.5 h, however, reactivity is noted at 40.5 h.  
  
308 
 
1.8.28.2. Reactivity of DPDS with alcohols  
1.8.28.2.1.1. General Procedure of Alcohol Compatibility: To an NMR tube was added d8-
THF (0.5 mL), 4-(trifluoromethyl)-benzyl alcohol (13.7 L, 1.0 equiv, 0.10 mmol), 
hexafluorobenzene (11.5 L, 1.0 equiv, 0.1 mmol) and DPDS (53 mg, 2.2 equiv, 0.22 
mmol). The tube was inverted three times to ensure proper mixing of the reagents and the 
interface between the tube and the cap was sealed with multiple layers of paraffin wax 
(parafilm®) to ensure no leaks. The reactions were either left at room temperature or heated 
to 80 C and monitored by 19F NMR.  
1.8.28.2.1.2 General Procedure of Alcohol Compatibility with Benzoic Acids: To an NMR 
tube was added 3-(trifluoromethyl)-benzoic acid (19 mg, 1.0 equiv, 0.10 mmol) or p-
nitrobenzoic acid (16 mg, 1.0 equiv, 0.10 mmol), d8-THF (0.5 mL), 4-(trifluoromethyl)-
benzyl alcohol (13.7 L, 1.0 equiv, 0.10 mmol), hexafluorobenzene (11.5 L, 1.0 equiv, 
0.1 mmol) and DPDS (53 mg, 2.2 equiv, 0.22 mmol). The tube was inverted three times to 
ensure proper mixing of the reagents and the interface between the tube and the cap was 
sealed with multiple layers of paraffin wax (parafilm®) to ensure no leaks. The reactions 
were either left at room temperature or heated to 80 C and monitored with 19F NMR.  
1.8.28.2.2. Results: Previously, we reported that phenylsilane was unreactive with benzyl 
alcohols at elevated temperature unless a carboxylic acid such as PNBA was added to the 
reaction mixture. Due to the increased reductive potential of DPDS at least in terms of 
phosphine oxide reduction, we wanted to test whether DPDS reacted with alcohols and 
whether PNBA could affect the rate of that reaction. No reactivity was observed between 
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DPDS and the benzyl alcohol at ambient temperature for 42 hours, even in the presence of 
benzoic acid (Figure 1.50 and Table 1.53, entries 1–4). However, significant reactivity was 
observed at 80 °C (Figure 1.51), as no alcohol is observed within 40.5 hours (Table 1.53, 
entries 9–12). This reaction also proceeds, albeit more slowly, at 80 °C without the 
presence of benzoic acid (Table 1.53, entries 9–10).  
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Table 1.53. The reaction of 4-(trifluoromethyl)benzyl alcohol and DPDS or phenylsilane with 
or without benzoic acid additives. 
 
Entry Benzoic Acid Silane T (°C) Time 
(Min) 
% Alcohol 
Remaining 
1 None DPDS 23 1080 >95 
2 None DPDS 23 2520 >95 
3 p-Nitrobenzoic acid DPDS 23 1080 >95 
4 p-Nitrobenzoic acid DPDS 23 2520 >95 
5 None PhSiH3 80 1050 >95 
6 None PhSiH3 80 2430 >90 
7 3-(Trifluoromethyl)-benzoic acid PhSiH3 80 1050 79 
8 3-(Trifluoromethyl)-benzoic acid PhSiH3 80 2430 25 
9 None  DPDS 80 1050 57 
10 None DPDS 80 2430 16 
11 3-(Trifluoromethyl)-benzoic acid DPDS 80 1050 25 
12 3-(Trifluoromethyl)-benzoic acid DPDS 80 2430 0 
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Figure 1.50. The reaction of 4-(trifuoromethyl)-benzyl alcohol and DPDS at 23 °C 
monitored until 42 h; B) The reaction of 4-(trifluoromethyl)-benzyl alcohol, p-nitrobenzoic 
acid, and DPDS at 23 °C monitored until 42 h. 
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Figure 1.51. A) The reaction of 4-(trifuoromethyl)-benzyl alcohol and phenylsilane at 80 
°C monitored until 40.5 h; B) The reaction of 4-(trifluoromethyl)-benzyl alcohol, 3-
(trifluoromethyl)-benzoic acid, and phenylsilane at 80 °C monitored until 40.5 h; C) The 
reaction of 4-(trifluoromethyl)-benzyl alcohol and DPDS at 80 °C monitored until 40.5 h; 
D) The reaction of 4-(trifluoromethyl)-benzyl alcohol, 3-(trifluoromethyl)-benzoic acid, 
and DPDS at 80 °C monitored until 40.5 h. Large black numbers indicate the integrations 
of the peaks. 
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1.8.28.2.3 Recovery of alcohols which have reacted with DPDS 
1.8.28.2.3.1. General Procedure: To an NMR tube was d8-PhMe (0.25 mL), 4-
(trifluoromethyl)-benzyl alcohol (17 L, 1.0 equiv, 0.125 mmol), hexafluorobenzene (11.5 
L, 1.0 equiv, 0.8 mmol) and DPDS (43 mg, 1.5 equiv, 0.1875 mmol). The tube was 
inverted three times to ensure proper mixing of the reagents and the interface between the 
tube and the cap was sealed with multiple layers of paraffin wax (parafilm®) to ensure no 
leaks. The reactions were either left at room temperature or heated to 110 C. After 18 
hours, the reaction was diluted by two-fold and the reaction was monitored by 19F NMR. 
The mixture was then either concentrated onto silica gel directly, or treated with 2.0 N 
NaOH for 15 minutes before column chromatography.  
1.8.28.2.3.2. Results: Unsurprisingly, the 19F NMR spectrum produced from the crude 
reaction mixtures were complex, as about 55% of the starting alcohol remained. The 
reaction loadeds directly onto silica gel did not result in the isolation of the silyl ether 
compound. However, 82% of the starting alcohol was recovered unchanged. Reactions that 
were treated with base also did not allow for isolation of the proposed silyl ether compound; 
however, these reactions resulted in 100% recovery of the starting alcohol, indicating that 
this transient silyl ether formation is easily reversed during the course of our normal 
workups for reductions of phosphine oxides.  
1.8.28.3. Reactivity of DPDS with aldehyde and cyano functional groups 
1.8.28.3.1. General Procedure: To an NMR tube was added 4-cyanobenzaldehyde (13.1 
mg, 1.0 equiv, 0.10 mmol), d8-PhMe (0.5 mL), and DPDS (53 mg, 2.2 equiv, 0.22 mmol). 
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The tube was inverted three times to ensure proper mixing of the reagents and the interface 
between the tube and the cap was sealed with multiple layers of paraffin wax (parafilm®) 
to ensure no leaks. The reaction was heated to 110 C and monitored with 1H NMR. 
8.3.2. Results: Much like our results obtained when DPDS was reacted with carboxylic 
acids, no reduction of the benzaldehyde was observed. As shown in Figure 1.52, the 
reduction of the aldehyde or cyano group is not observed after 16.5 hours at 110 °C. 
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Figure 1.52. The reaction of 4-cyanobenzaldehyde and DPDS does not yield any new 
materials after 16.5 hours. 
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1.8.28.4. Reactivity of DPDS with ester and nitro functional groups 
1.8.28.4.1. General Procedure: To an NMR tube was added methyl 4-nitrobenzoate (18.1 
mg, 1.0 equiv, 0.10 mmol), d8-PhMe (0.5 mL), and DPDS (53 mg, 2.2 equiv, 0.22 mmol). 
The tube was inverted three times to ensure proper mixing of the reagents and the interface 
between the tube and the cap was sealed with multiple layers of paraffin wax (parafilm®) 
to ensure no leaks. The reaction was heated to 110 C and monitored with 1H NMR. 
1.8.28.4.2. Results: Much like our results obtained when DPDS was reacted with 
carboxylic acids, no reduction of the benzaldehyde was observed. As shown in Figure 1.53, 
the reduction of the ester or nitro group is not observed after 18 hours at 110 °C. 
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Figure 1.53. The reaction of methyl 4-nitrobenzoate and DPDS does not yield any new 
materials after 18 hours. 
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1.8.28.5. Reactivity of DPDS with ,-unsaturated esters 
1.8.28.5.1. General Procedure: To an NMR tube was added ethyl cinnamate (17.6 mg, 1.0 
equiv, 0.10 mmol, 25:1 E:Z ratio), d8-PhMe (0.5 mL), and DPDS (53 mg, 2.2 equiv, 0.22 
mmol). The tube was inverted three times to ensure proper mixing of the reagents and the 
interface between the tube and the cap was sealed with multiple layers of paraffin wax 
(parafilm®) to ensure no leaks. After 16.5 h, the reaction mixture was cooled to ambient 
temperature and evaporated directly onto silica gel. The reaction was purified with a 
Teledyne-Isco Combi-Flash RF-200 system with 0.02:0.98 EtOAc: hexanes. Ethyl 
cinnamate was isolated as a colorless oil.  
1.8.28.5.2. Results: Much like our results obtained when DPDS was allowed to react with 
other functional groups, no reactivity was noted. As shown in Figure 1.54, the reduction of 
the ester or olefin is not observed after 16.5 hours at 110 °C. In addition, isomerization of 
the olefin was not noted as the final product retained the initial 25:1 E:Z ratio. 
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Figure 1.54. The reaction of ethyl cinnamate and DPDS does not yield any new materials 
or isomerized materials after 16.5 hours. 
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1.8.28.6. Reactivity of DPDS with azides 
1.8.28.6.1. General Procedure: To an NMR tube was added 4-nitrobenzoic acid (16.7 mg, 
0.1 mmol, 1.0 equiv), d8-toluene (500 L), 4-(trifluoromethyl)-benzyl azide (20.1 mg, 0.1 
mmol, 1.0 equiv), and then phenylsilane (12.3 L, 0.1 mmol, 1.0 equiv) or DPDS (17.7 
mg, 0.073 mmol, 0.73 equiv). The tube was inverted three times to ensure proper mixing 
of the reagents and the interface between the tube and its cap was sealed with multiple 
layers of paraffin wax (parafilm®) to ensure no leaks. The reaction was heated to 110 °C. 
After 21 hours, the reaction cooled to room temperature and monitored by 19F NMR.  
1.8.28.6.2. Results: The reduction of an azide with phenylsilane was possible, although the 
reaction proceeded very slowly. While only less than 15% of the azide reacted within 21 
hours (Figure 1.55), this indicates that silanes in general react with azides, a feature that 
would not be detrimental to Staudinger reduction or ligation reactions. DPDS is also not a 
more active reductant than phenylsilane (Figure 1.55). 
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Figure 1.55. A) The reaction of 4-(trifuoromethyl)-benzyl azide and phenylsilane at 110 
°C monitored until 21 h; B) The reaction of 4-(trifluoromethyl)-benzyl azide and DPDS at 
110 °C monitored until 21 h. 
  
322 
 
1.8.28.7. Reactivity of DPDS with DIAD 
1.8.28.7.1. General Procedure: To an NMR tube was added DIAD (4.9 µL, 1.0 equiv, 0.025 
mmol), d8-THF (0.5 mL), 3-(trifluoromethyl)-benzoic acid (4.7 mg, 1.0 equiv, 0.025 
mmol), and DPDS (13 mg, 2.3 equiv, 0.056 mmol). The tube was inverted three times to 
ensure proper mixing of the reagents and the interface between the tube and the cap was 
sealed with multiple layers of paraffin wax (parafilm®) to ensure no leaks. The reaction 
was heated to 80 C and monitored by 1H NMR through observation of a shift in ppm of 
the methine and methyl protons.  
1.8.28.7.2. Results: No reduction of DIAD by DPDS was observed after 17 hours (Figure 
1.56A). The addition of benzoic acid was performed to more closely mimic the conditions 
of a Mitsunobu reaction.  The methine protons and methyl protons show no shift to the 
hydrazine product, which is shown in Figure 1.56B for direct comparison between these 
reagents.  
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Figure 1.55. A) The reaction of DPDS with DIAD in the presence of 3-(trifluoromethyl)-
benzoic acid  at 80 °C after 17 hours; B) The mixture of DPDS and diisopropyl hydrazine 
dicarboxylate in d8-THF.  
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1.8.29. Purification of Phosphines in Tables 1.20 and 1.23: 
Triphenylphosphine122: Purified with a Teledyne-Isco Combi-Flash RF-200 system with 
100% hexanes. Isolated as a white solid: m.p. = 79-80 °C; all other physical data and 
spectra matched literature reports.  
(4-(Dimethylamino)phenyl)diphenylphosphine7: Purified with a Teledyne-Isco Combi-
Flash RF-200 system with 10:90 EtOAc: hexanes. Isolated as a white solid: all physical 
data and spectra matched literature reports.  
(4-(Methoxy)phenyl)diphenylphosphine123: Purified with a Teledyne-Isco Combi-Flash 
RF-200 system with 1:9 EtOAc: hexanes. Isolated as a white solid: all physical data and 
spectra matched literature reports. 
(4-(Trifluoromethyl)phenyl)diphenylphosphine124: Purified with a Teledyne-Isco Combi-
Flash RF-200 system with 100% hexanes. Isolated as a white solid: all physical data and 
spectra matched literature reports. 
(3,5-Bis(trifluoromethyl)phenyl)diphenylphosphine125: Purified with a Teledyne-Isco 
Combi-Flash RF-200 system with 100% hexanes. Isolated as a white solid: all physical 
data and spectra matched literature reports. 
Tris-(3,5-(trifluoromethyl)phenyl)phosphine126: Purified with a Teledyne-Isco Combi-
Flash RF-200 system with 100% hexanes. Isolated as a white solid: all physical data and 
spectra matched literature reports. 
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Tricyclohexylphosphine127: Purified with a Teledyne-Isco Combi-Flash RF-200 system 
with 100% hexanes. Isolated as a white solid: all physical data and spectra matched 
literature reports. 
[1,1’-biphenyl]-2-yl)dicyclohexylphosphine128: Purified with a Teledyne-Isco Combi-
Flash RF-200 system with 1:9 EtOAc: hexanes. Isolated as a white solid: all physical data 
and spectra matched literature reports. 
(2’,6’-dimethoxy-[1,1’-biphenyl]-2-yl)dicyclohexylphosphine129: Purified with a 
Teledyne-Isco Combi-Flash RF-200 system with 1:9 EtOAc: hexanes. Isolated as a white 
solid: all physical data and spectra matched literature reports. 
1,2-Bis(diphenylphosphino)ethane25: Purified with a Teledyne-Isco Combi-Flash RF-200 
system with 1:9 EtOAc: hexanes. Isolated as a white solid: all physical data and spectra 
matched literature reports. 
rac-2,2’-Bis(diphenylphosphino)-1,1’-binapthlene29: Purified with a Teledyne-Isco 
Combi-Flash RF-200 system with 1:9 EtOAc: hexanes. Isolated as a white solid: all 
physical data and spectra matched literature reports. 
(9,9-Dimethyl-9H-xanthene-4,5-diyl)-bis-diphenylphosphine130: Purified with a Teledyne-
Isco Combi-Flash RF-200 system with 1:9 EtOAc: hexanes. Isolated as a white solid: all 
physical data and spectra matched literature reports. 
1,2-Bis [(2-methoxyphenyl)(phenylphosphino)] ethane25: Purified with a Teledyne-Isco 
Combi-Flash RF-200 system with 1:9 EtOAc: hexanes. Isolated as a white solid. All 
physical data and spectra matched literature reports. For reductions at elevated temperature 
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employing R,R 1m as the substrate: the product had optical rotation []D20 = -85.6 (c = 0.7, 
CHCl3). For reductions at room temperature employing S,S 1m as the substrate: the product 
had optical rotation []D20 = 86.2 (c = 0.7, CHCl3).  
[4-(Dimethoxymethyl)phenyl]diphenylphosphine: Purified with a Teledyne-Isco Combi-
Flash RF-200 system with 1:9 EtOAc: hexanes. Isolated as a white solid. 1H NMR (CDCl3, 
500 MHz)  7.33 (d, J = 7.6 Hz, 2H), 7.23 (s, 12H), 5.29 (s, 1H), 3.24 (s, 6H); 13C (CDCl3, 
126 MHz)  138.7, 137.6, 137.1, 137.0, 133.9, 133.7, 133.5, 128.8, 128.6, 128.5, 126.9, 
126.8, 103.0, 52.9; 31P (CDCl3, 202 MHz)  -5.81; HRMS (ESI) Calc. C21H22O2P [M + H] 
337.1352, Found 337.1368. 
4-(Diphenylphosphino)benzaldehyde: Purification was not performed for this compound. 
The product was assessed for conversion and purity by 31P NMR only. 31P NMR (d8-PhMe, 
202 MHz)  -4.48. 
(2,5-Dihydroxyphenyl)diphenylphosphine: Purified with a Teledyne-Isco Combi-Flash 
RF-200 system with 2:8 EtOAc: hexanes. Isolated as a white solid. 1H NMR (d8-THF, 500 
MHz)  10.38 (s, 1H), 7.82 (s, 1H), 7.61 – 7.56 (m, 4H), 7.46 (td, J = 7.8, 3.1 Hz, 2H) 7.39 
– 7.36 (m, 4H), 6.72 (dd, J = 8.9, 2.7 Hz, 1H), 6.59 (dd, J = 8.8, 5.5 Hz, 1H), 6.38 (dd, J = 
13.9, 2.9 Hz, 1H); 13C (d8-THF, 126 MHz)  156.9, 149.8, 149.7, 133.3, 131.9, 131.8, 
130.4, 128.3, 121.9, 118.8, 118.7, 116.7, 112.0, 111.2; 31P (d8-THF, 202 MHz)  -16.52; 
HRMS (ESI) Calc. C18H16O2P [M + H] 295.0882, Found 295.0880. 
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1,1’-Bis(diphenylphino)ferrocene131: Purified with a Teledyne-Isco Combi-Flash RF-200 
system with 1:9 EtOAc: hexanes. Isolated as an orange solid: all physical data and spectra 
matched literature reports. 
1.8.30. Domino Reactions of Secondary Phosphine Oxides: 
1.8.30.1. General Procedure: To a 2-dram vial equipped with a ¼” teflon-coated stir bar 
was added diphenylphosphine oxide (1p, 101 mg, 0.5 mmol, 1.0 equiv), toluene (1.0 mL), 
and DPDS (144 mg, 0.625 mmol, 1.25 equiv) The reaction was sealed with a cap, purged 
with argon, and heated at 110 °C for 30 minutes. The reaction was then cooled to 23 °C 
and a stream of argon was maintained over the reaction mixture. Then, Cu(OTf)2 (27 mg, 
0.075 mmol, 0.15 equiv), N, N-dimethylethylenediamine (DMEDA, 11 L, 0.1 mmol, 0.2 
equiv), CsCO3 ( 320 mg, 1.0 mmol, 2.0 equiv), and aryl iodides (0.5 mmol, 1 equiv) were 
added as a solution in 0.5 mL PhMe. The reaction was resealed while maintaining an 
atmosphere of argon, and was again heated to 110 °C. After 18 hours, the reaction was 
cooled to 23 °C and diluted to 3 mL with EtOAc. While stirring, 1.5 mL of 2.0 N NaOH 
was added, and the mixture was stirred for 15 minutes. The layers were separated and the 
organic layer was further diluted to 15 mL with EtOAc. The organic layer was then washed 
with 1.0 N HCl (15 mL), saturated aqueous NaHCO3 (15 mL), and then a brine solution 
(15 mL). The organic layer was then dried with MgSO4, filtered, and concentrated. The 
residue was purified by column chromatography to afford phosphines 2a, 2t, and 2u.  
1.8.30.2. Results: Unsurprisingly, this reaction is sensitive to air and/or water.31 As such it 
is necessary to maintain an inert atmosphere during the course of these reactions. Yields 
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for the synthesis of 2a from 1p and iodobenzene varied heavily depending on the reaction’s 
atmosphere as reactions under air afforded only 36% of desired product, while reactions 
maintaining an inert atmosphere produced TPP in 78% yield.  
1.8.30.3. Purification of Products in Scheme 1.11:  
Triphenylphoshine122: Purified with a Teledyne-Isco Combi-Flash RF-200 system with 
100% hexanes. Isolated as a white solid; m.p. = 79-80 °C; all other physical data and 
spectra matched literature reports. 
Methyl-2-(diphenylphosphino)benzoate132: Purified with a Teledyne-Isco Combi-Flash 
RF-200 system with 1:9 EtOAc: hexanes. Isolated as a white solid: all physical data and 
spectra matched literature reports. 
(4-(Benzyloxy)phenyl)diphenylphosphine133: Purified with a Teledyne-Isco Combi-Flash 
RF-200 system with 1:9 EtOAc: hexanes. Isolated as a white solid: all physical data and 
spectra matched literature reports. 
1.8.31. Optimization of Disiloxane Stoichiometry in Redox Recycling Reactions 
1.8.31.1. General Procedure: To a 2-dram vial equipped with a stir bar was added 1PPO 
(4.5 mg, 0.025 mmol, 0.1 equiv), toluene (1 mL), benzaldehyde (25.5 L, 0.25 mmol, 1.0 
equiv), ethyl bromoacetate (30.4 L, 0.275 mmol, 1.1 equiv), Hünig’s base (47.5 μL, 0.275 
mmol, 1.1 equiv), and DPDS (60 mg, 0.25 mmol, 1.0 equiv). The reaction was sealed and 
stirred at 23 °C for 24 h. The reaction was then diluted with CH2Cl2 or acetone (5 mL) and 
loaded directly onto silica gel (200 mg). Individual purifications proceeded as specified. 
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1.8.31.2 Optimization of Silane Concentration:  As DPDS had been previously determined 
to be compatible with aldehydes, the only optimization we deemed required was the 
number of equivalents of DPDS. When less than one equivalent of DPDS was added, the 
yields diminished. Table 1.24 shows the dependence of yield based on the amount of silane 
added. Unsurprisingly, increased silane concentration improved the yield due to faster 
reduction kinetics for increased turnover within the 18 hour time span. It is noteworthy that 
only 0.8 equivalents of DPDS did furnish a 46% yield in the synthesis of the trisubstituted 
olefin  after 48 hours. Because the BRSM yield was high for our reactions, we chose the 
1.0 equivalent of DPDS as optimal conditions for our experiments and would opt to wait 
24 hours before workup.  
 The same trend was noted for the catalytic Stuadinger reduction and catalytic Appel 
using the cyclic precatalyst 1PPO. Adding excess DPDS did not have any real positive 
effect on the reaction, and only wasted more material than was necessary.  
1.8.32. Reductions of Phosphinimines 
1.8.32.1. Reductions of Acyclic Phosphinimines 
5.1.1 31P NMR Method: The NMR method is similar to the method previously reported.1 
However, a 25 second delay time was used to increase the sampling frequency with 
minimal error induced during integration. Spectra were also collected using a decoupled 
method (WALTZ 16) unless otherwise indicated to enhance the signal to noise ratios (S/N).  
1.8.32.1.2. Synthesis of Phosphinimines: To a 1-dram vail was added triphenylphosphine 
(32.75 mg, 0.125 mmol, 0.25 M), d8-toluene (500 L), and then benzylazide (15.6 L, 0.25 
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mmol, 0.25 M). The vial was mixed using a vortex to ensure proper mixing of the reagents 
and the interface between the tube and the cap was sealed with multiple layers of paraffin 
wax (parafilm®) to ensure no leaks. The reaction was heated to 60 C and monitored with 
31P NMR, although reactions are complete at approximately 90 minutes.  
1.8.32.1.3. Reductions of Phosphinimines with DPDS: To an NMR tube was added 
phosphinimine soltuiton as defined in section 5.2 (100 L, 0.025 mmol, 0.05 M), d8-
toluene (342 L, final volume is 500 L), and then DPDS (57.5 mg, 0.25 mmol, 0.5 M). 
The tube was inverted three times to ensure proper mixing of the reagents and the interface 
between the tube and the cap was sealed with multiple layers of paraffin wax (parafilm®) 
to ensure no leaks. The reaction was heated to the desired temperature and monitored with 
31P NMR. To ensure accuracy during time points, reactions were chilled to -10 C to stall 
the reaction for data collection.  
1.8.32.1.4. Reductions of Phosphinimines with Phenylsilane: To an NMR tube was added 
phosphinimine soltuiton as defined in section 5.2 (100 L, 0.025 mmol, 0.05 M), d8-
toluene (363 L, final volume is 500 L), and then phenylsilane (37 L, 0.25 mmol, 0.5 
M). The tube was inverted three times to ensure proper mixing of the reagents and the 
interface between the tube and the cap was sealed with multiple layers of paraffin wax 
(parafilm®) to ensure no leaks. The reaction was heated to the desired temperature and 
monitored with 31P NMR. To ensure accuracy during time points, reactions were chilled to 
-10 C to stall the reaction for data collection.  
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1.8.32.1.5. Results: We started by monitoring the reduction of an acyclic phosphinimine 
with DPDS at five temperatures (± 0.5 C) over a range of 23 – 70 C. Reductions were 
performed under pseudo first-order conditions and were carried out in triplicate. The rate 
of reduction for individual reactions were calculated as pseudo first-order rate constants by 
creating linear plots of raw data (Equation 1). The observed rate constants (kobs) of 
individual trials were then averaged and a second-order rate constant (k) was obtained by 
calculating the slope of the line generated by the plot of kobs vs. the concentration of 
reducing agent (Equation 2). These second-order rate constants at each temperature were 
then utilized in an Arrhenius plot and a line was fit (Equation 3) to determine the coefficient 
(A) and energy of activation (Ea) for reduction. This Arrhenius analysis determined the 
energy of activation to be 12.4 ± 0.4 kcal/mol while Eyring analysis (Equation 4) shown in 
Figure 1.32 also agreed with this finding as ΔHǂ= 21.9 ± 3.6 kcal/mol, ΔSǂ= 21.9 ± 3.6 
kcal/mol, and ΔGǂ= 21.9 ± 3.6 kcal/mol.  
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While the Arrhenius and Eyring analyses of the reduction with DPDS indicate that 
the reduction can readily occur at room temperature, these energies are not overly different 
from our results with phosphine oxides. However, unlike our studies with phosphine 
oxides, the reduction of a phosphinimine with phenylsilane can readily occur with the 
addition of heat. At room temperature, the reduction is very sluggish (Table 1.30), so much 
so that phenylsilane would not be applicable for the design of a catalytic Staudinger 
reduction without an additive.  
1.8.32.2. Reactivity of DPDS with DIAD 
1.8.32.2.1. General Procedure: To an NMR tube was added DIAD (4.9 µL, 1.0 equiv, 0.025 
mmol), d8-THF (0.5 mL), 3-(trifluoromethyl)-benzoic acid (4.7 mg, 1.0 equiv, 0.025 
mmol), and DPDS (13 mg, 2.3 equiv, 0.056 mmol). The tube was inverted three times to 
ensure proper mixing of the reagents and the interface between the tube and the cap was 
sealed with multiple layers of paraffin wax (parafilm®) to ensure no leaks. The reaction 
was heated to 80 C and monitored by 1H NMR through observation of a shift in ppm of 
the methine protons and terminal methyl protons. After 2.5 h, the NMR tube was cooled to 
23 C, opened, and TMPPO (1 mg, 0.2 equiv, 0.005 mmol) was added.  The tube was 
resealed, mixed, heated to a desired temperature, and monitored by 1H NMR. 
1.8.32.2.2. Results: No reduction of DIAD by DPDS was observed prior to TMPPO 
addition.64 The addition of benzoic acid was attempting to model the conditions of the 
Mitsunobu reaction.  However, 90 min following addition of TMPPO, significant 
reduction of DIAD was observed when heated to 80 °C, and, 20 hours following the 
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addition of TMPPO, no DIAD remained (Figure 1.30) at room temperature (23 °C).  
TMPPO, following addition, would be quickly reduced to a phosphine, where it could 
attack DIAD, forming a P-N bond. However, due to the lack of an alcohol, this species is 
unproductive, and does not lead to any further reactivity.134 The addition of only 0.2 
equivalents of TMPPO confirms that the 1H shift observed is not just due to P-N bond 
formation, but rather must be a phosphine-mediated reduction of DIAD by DPDS. We 
speculate that DPDS reduces the P-N bond, similarly to the reactivity observed with other 
phosphinimines.  
1.8.33. Investigation of the Catalytic Staudinger Ligation with Triphenylphosphine 
1.8.33.1 Limited Activation Occurs with Additives Reported by Ashfeld & Coworkers85 
1.8.33.1.1. General Procedure: To an NMR tube was added TPPO (4.2 mg, 0.015 mmol, 
0.03 M), d8-toluene (500 mL), PNBA (30 mg, 0.18 mmol, 0.36 M), and PhSiH3 (19 mL, 
0.15 mmol, 0.3 M) followed by N-benzylmethylamine (19 µL, 0.15 mmol, 0.3 M). The 
tube was inverted three times to ensure proper mixing of the reagents and the interface 
between the tube and its cap was sealed with multiple layers of paraffin wax (parafilm®) 
to ensure no leaks. The reaction was heated to 60 °C and monitored by 31P NMR. 
1.8.33.1.2. Results: Phosphorous NMR was taken after 16 hours, after which 49% 
reduction of the TPPO was observed. This NMR tube is meant to provide a “best-case” 
scenario for the reaction reported by Ashfeld, as in it all of the azide would have been 
reduced to amine, producing carboxylate in combination with PNBA. The carboxylate 
formed would obviously produce substantially more reduction, as demonstrated 
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previously. However, even though reduction was observed, obtaining only 49% of 
triphenylphosphine after 16 hours means that a full equivalent of TPPO would not be 
reduced over this time period even if the all phosphine-imine formed instantly performed 
the aza-Wittig, and was thus converted to TPPO. With the mechanism reported by Ashfeld, 
and assuming the conditions reported are realistic (they are not, again this is a best-case 
scenario for reduction), the maximum possible amount of turnover that could be obtained 
would be twice the catalyst loading. Since Ashfeld and coworkers report substantially 
higher amounts of turnover, this experiment provides strong evidence that the reaction does 
not go through their proposed mechanism. 
1.833.2. Investigation of Ashfeld’s Conditions85 
1.8.33.2.1. General Procedure of Catalytic Staudinger Ligations: To a 2-dram vial equipped 
with a stir bar was added 4-nitrobenzoic acid (50a mg 0.3 mmol, 1.0 equiv.), TPP (13 mg, 
0.05 mmol, 0.17 equiv.) or TPPO (13.8 mg, 0.05 mmol, 0.17 equiv.), toluene (1 mL), 
benzyl azide (45 L, 0.36 mmol, 1.2 equiv.) followed by phenylsilane (36 L, 0.3 mmol, 
1.0 equiv.). The reaction was sealed and stirred at various temperatures. After 18 h, the 
reaction was diluted with acetone (5 mL) and loaded directly onto silica gel (200 mg). 
Purification by flash column chromatography (0–50% EtOAc:hexanes eluent, step-wise 
gradient, 10% EtOAc incremental increase every 6 column volumes) afforded the product. 
1.8.33.2.2. General Procedure of Stoichiometric Staudinger Ligations: To a 2-dram vial 
equipped with a stir bar was added 4-nitrobenzoic acid (50.1 mg, 0.3 mmol, 1.0 equiv.), 
TPP (88mg, 0.33 mmol, 1.1 equiv.) toluene (1 mL), and then benzyl azide (45 L, 0.36 
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mmol, 1.2 equiv.). The reaction was sealed and stirred at various temperatures. After 18 h, 
the reaction was diluted with acetone (5 mL) and loaded directly onto silica gel (200 mg). 
Purification by flash column chromatography (0–50% EtOAc:hexanes eluent, step-wise 
gradient, 10% EtOAc incremental increase every 6 column volumes) afforded the product. 
1.8.33.2.3. Results: The reaction as reported by Ashfeld works well enough, though we 
were unable to reproduce the yields reported in their communication (Table 1.54). Since 
substantially greater than 34% turnover is being observed, it is not likely that TPPO is the 
main species being reduced by the silanes. Using TPPO as the precatalyst significantly 
lowered the yield of the reaction, even with increasing the reaction time from 18 to 24 
hours.  
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Table 1.54. Catalytic and Stoichiometric Staudinger Ligation Reactions. 
 
Entry Phosphine X = Silane Temp. (°C) Isolated Yield 
1 TPP 17 mol% Yes 60 62 
2 TPPO 17 mol% Yes 60 233 
3 TPP 17 mol% Yes 110 65 
4 TPP 17 mol% No 60 04 
5 TPP 110 mol% No 23 05 
6 TPP 110 mol% No 60 0 
7 TPP 110 mol% No 110 0 
 
  
  
                                                 
 
3 Reaction for 24 hours 
4 Obtained 16% yield of primary amine 
5 Obtained quantitative yield of primary amine 
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In addition to the previous results, we desired to test whether the reaction would 
succeed with a stoichiometric amount of phosphine, but removing the silane. Regardless 
of the temperature used, using a slight excess of TPP lead to none of the desired ligated 
product. If the mechanism proposed by Ashfeld were at play, the reaction should proceed 
smoothly once the phosphine imine is formed. However, at 60 °C the ligated product 
cannot be isolated when no silane is added. It is likely that the Staudinger ligation only 
occurs when the carboxylate is attached to the phosphine imine generated, as in the case of 
the reagents utilized by Bertozzi and co-workers in bioorthognal reactions.135  
1.8.33.3. Silane-Mediated Amide Couplings 
1.8.33.3.1. General Procedure of Silane-Mediated Amide Bond Formation: To a 2-dram 
vial equipped with a stir bar was added 4-fluorobenzoic acid (35 mg 0.25 mmol), toluene 
(1 mL), piperidine (0.3 mmol) and phenylsilane (See table S6 for equivalence). The 
reaction was sealed and stirred at various temperatures. Aliquots (50 L) of each reaction 
were pulled for analysis by 19F NMR before workup. After 20 h, the reaction was diluted 
with acetone (5 mL) and loaded directly onto silica gel (200 mg). Purification by flash 
column chromatography (0–20% EtOAc:hexanes eluent, step-wise gradient, 5% EtOAc 
incremental increase every 6 column volumes) afforded the product. 
1.8.33.3.2. Results: The reactions of amines and carboxylic acids proceeds to the amide 
when a silane and heat are added to the reaction mixture. The reaction to form the amide 
results in quantitative yields when an excess of phenylsilane is added to reactions heated 
to 80 °C or above (Table 1.55). 
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Table 1.55. Silane dependent amide bond formation. 
 
Entry X = T = Isolated Yield 
1 1.0 110 87 
2 1.5 110 Quant. 
3 2.0 110 Quant. 
4 1.5 80 Quant. 
5 1.5 37 Trace 
6 1.5 23 Trace 
7 0.0 80 0 
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1.8.33.3.3. Silane Screen in Amide Coupling Reactions 
1.8.33.3.3.1. General Procedure of Silane Screen in Amide Couplings: To a 2-dram vial 
equipped with a stir bar was added 4-nitrobenzoic acid (50.1 mg, 0.3 mmol, 1.0 equiv.), 
toluene (1 mL), 4-methoxybenzyl amine (46.6 L, 0.36 mmol, 1.2 equiv.), and then silane 
(0.3 mmol, 1.0 equiv.). The reaction was sealed and stirred at 60 °C. After 18 h, the reaction 
was diluted with acetone (5 mL) and loaded directly onto silica gel (200 mg). Purification 
by flash column chromatography (0–50% EtOAc:hexanes eluent, step-wise gradient, 10% 
EtOAc incremental increase every 6 column volumes) afforded the product. NMR Spectra 
and other physical data matched previous reports.136 
1.8.33.3.3.2. Results: Similar to the results obtained previously,137 the amide couplings 
with phenylsilane proceeded smoothly and formed product in similar amounts as Ashfeld’s 
ligation reaction. The reaction with 1.0 equivalent phenylsilane alone at 60 °C (comparable 
to Ashfeld’s report) produced the benzyl benzoyl amine in approximately 50% yield, while 
the reactions with trimethoxysilane and diethoxymethylsilane did not produce any amide 
product. It seems that the phenyl substituent on the silane is necessary for the formation of 
the “activated” ester which is necessary to form the amide. Unfortunately, we were unable 
to isolate the acyloxysilane intermediate that we and others propose is necessary for the 
amide coupling reaction. 
1.8.33.4. Remarks on the Catalytic Staudinger Ligation: While the reaction observed by 
Ashfeld and co-workers is feasible, however, the likelihood that the reaction occurs via the 
mechanism proposed in the original communication is low. Since the reaction works 
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significantly better employing the phosphine at beginning, it is likely that the phosphine 
imine actually what is being reduced by the silane, giving the amine and 
triphenylphosphine. The carboxylic acid can react with the silane to become activated for 
coupling with the nucleophilic amine, kicking out a silanol and the amide product. Having 
the amine intermediate, carboxylic acid, and the silanol certainly indicate that the TPP 
could be recycled under these conditions, while the stoichiometric reactions indicate that 
the TPP is only involved in the reduction of the azide rather than the amide bond formation. 
Ashfeld’s reaction was likely serendipitous and likely proceeds via the mechanism 
proposed by Denton and co-workers.81 
1.8.34. General Procedures 
1.8.34.1. Catalytic Wittig Reactions with 1-PPO and DPDS: To a 2-dram vial equipped 
with a tir bar was added all solid reagents (Aldehyde: 0.25 mmol, 1 equiv; Bromide:  0.275 
mmol, 1.1 equiv), followed by 1PPO (4.5 mg, 0.025 mmol, 0.1 equiv), toluene (1 mL), all 
liquid reagents (Aldehyde: 0.25 mmol, 1 equiv; Bromide:  0.275 mmol, 1.1 equiv), Hünig’s 
base (47.5 μL, 0.275 mmol, 1.1 equiv), and DPDS (60 mg, 0.25 mmol, 1.0 equiv). The 
reaction was sealed and stirred at 23 °C for 24-48 h. The reaction was then diluted with 
CH2Cl2 or acetone (5 mL) and loaded directly onto silica gel (200 mg). Individual 
purifications proceeded as specified.  
1.8.34.2. Catalytic Wittig Reactions with TPP and DPDS: To a 2-dram vial equipped with 
a stir bar was added all solid reagents (Aldehyde: 0.25 mmol, 1 equiv; Bromide:  0.275 
mmol, 1.1 equiv), followed by TPP (6.6 mg, 0.025 mmol, 0.1 equiv), C2H4Cl2 (1 mL), 
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Hünig’s base (47.5 μL, 0.275 mmol, 1.1 equiv), and DPDS (60 mg, 0.25 mmol, 1.0 equiv). 
The reaction was sealed and stirred at 80 °C for 24-48 h. The reaction was then diluted 
with DCM or acetone (5 mL) and loaded directly onto silica gel (200 mg). Individual 
purifications proceeded as specified.  
1.8.34.3. Catalytic Staudinger Reductions with 1-PPO and DPDS: To a 2-dram vial 
equipped with a stir bar was added all solid reagents (Azide:  0.25 mmol, 1.0 equiv), 1PPO 
(4.5 mg, 0.025 mmol, 0.1 equiv), toluene (1 mL), all liquid reagents (Azide:  0.25 mmol, 
1.0 equiv), and then DPDS (57.5 mg, 0.25 mmol, 1.0 equiv). The reaction was sealed and 
stirred at ambient temperature (23 °C) for 24 h. The reaction was diluted with acetone, and 
the vessel was washed with acetone (7.5 mL) and loaded directly onto silica gel (200 mg). 
Purification by flash column chromatography (0–50% EtOAc:hexanes eluent, step-wise 
gradient, 10% EtOAc incremental increase every 6 column volumes) afforded the product. 
1.8.34.4. Catalytic Staudinger Reductions with TPP and DPDS: To a 2-dram vial equipped 
with a stir bar was added all solid reagents (Azide:  0.25 mmol, 1.0 equiv), TPP (6.6 mg, 
0.025 mmol, 0.1 equiv), toluene (1 mL), all liquid reagents (Azide:  0.25 mmol, 1.0 equiv), 
and then DPDS (57.5 mg, 0.25 mmol, 1.0 equiv). The reaction was sealed and stirred at 
ambient temperature (23 °C) for 48 h. The reaction was diluted with acetone, and the vessel 
was washed with acetone (7.5 mL) and loaded directly onto silica gel (200 mg). 
Purification by flash column chromatography (0–50% EtOAc:hexanes eluent, step-wise 
gradient, 10% EtOAc incremental increase every 6 column volumes) afforded the product. 
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1.8.34.5. Catalytic Appel Halogenation Reactions with DPDS: To a 2-dram vial equipped 
with astir bar was added 1PPO (4.5 mg, 0.025 mmol, 0.1 equiv.) or TMPPO (5.4 mg, 
0.025 mmol, 0.1 equiv.), MeCN (1 mL), alcohol (0.25 mmol, 1.0 equiv.), diethyl 
bromomalonate (64 L, 0.375 mmol, 1.5 equiv.), and then DPDS (60 mg, 0.25 mmol, 1.0 
equiv.). The reaction was sealed and stirred at ambient temperature (23 °C) for 24 h. The 
reactions were purified as specified.  
1.8.34.6. Carboxamide Reductions of Tertiary Amides with Zn2+ and DPDS: To a 2-dram 
vial equipped with astir bar was added 1PPO (4.5 mg, 0.025 mmol, 0.1 equiv.) or TMPPO 
(5.4 mg, 0.025 mmol, 0.1 equiv.), MeCN (1 mL), alcohol (0.25 mmol, 1.0 equiv.), diethyl 
bromomalonate (64 L, 0.375 mmol, 1.5 equiv.), and then DPDS (60 mg, 0.25 mmol, 1.0 
equiv.). The reaction was sealed and stirred at ambient temperature (23 °C) for 24 h. The 
reactions were purified as specified.  
1.8.34.7. Carboxamide Reducions of Secondary Amids with Zn2+ and DPDS: To a 2-dram 
vial equipped with astir bar was added 1PPO (4.5 mg, 0.025 mmol, 0.1 equiv.) or TMPPO 
(5.4 mg, 0.025 mmol, 0.1 equiv.), MeCN (1 mL), alcohol (0.25 mmol, 1.0 equiv.), diethyl 
bromomalonate (64 L, 0.375 mmol, 1.5 equiv.), and then DPDS (60 mg, 0.25 mmol, 1.0 
equiv.). The reaction was sealed and stirred at ambient temperature (23 °C) for 24 h. The 
reactions were purified as specified.  
1.8.34.8. One-Pot Reductive Amine Alkylations with DPDS: To a 2-dram vial equipped 
with astir bar was added 1PPO (4.5 mg, 0.025 mmol, 0.1 equiv.) or TMPPO (5.4 mg, 
0.025 mmol, 0.1 equiv.), MeCN (1 mL), alcohol (0.25 mmol, 1.0 equiv.), diethyl 
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bromomalonate (64 L, 0.375 mmol, 1.5 equiv.), and then DPDS (60 mg, 0.25 mmol, 1.0 
equiv.). The reaction was sealed and stirred at ambient temperature (23 °C) for 24 h. The 
reactions were purified as specified.  
1.8.35. Purification of Olefin Products:Ethyl (E)-cinnamate: NMR Spectra and other 
physical data matched previous reports.138 
Diphenyl-propen-3-one: NMR Spectra and other physical data matched previous 
reports.139 
Ethyl (E)-p-methoxycinnamate: NMR Spectra and other physical data matched previous 
reports.140 
Ethyl (E)-p-cyanocinnamate: NMR Spectra and other physical data matched previous 
reports.139  
Methyl (E)-3-(p-cyanophenyl)-2-methylpropenoate: NMR Spectra and other physical data 
matched previous reports.141 
1.8.36. Purification of Amine Products: All purification were performed using a 
Teledyne Isco Retrieve® Flash chromatography Instrument using an isocratic eluent with 
60:40 hexanes: EtOAc supplanted with 5% triethylamine.  
Benzylamine: NMR Spectra and other physical data matched previous reports.142 
3-Nitrobenzylamine: NMR Spectra and other physical data matched previous reports.142 
9.3. 4-(Trifluoromethyl)benzylamine: NMR Spectra and other physical data matched 
previous reports.142 
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9.4. 4-Methoxybenzylamine: NMR Spectra and other physical data matched previous 
reports.142 
9.5. 4-Ethynylaniline: NMR Spectra and other physical data matched previous reports.142 
9.6. 3-Methoxyaniline: NMR Spectra and other physical data matched previous reports.142 
9.7. 1-Amino-3-chloropropan-2-ol Hydrochloride: NMR Spectra and other physical data 
matched previous reports.143 
1.8.37. Purification of Bromide Products 
1-Bromobutane: Purification by fractional distillation under reduced atmosphere (22 
mmHg). Unreacted butanol and acetonitrile was removed at approximately 5–7 °C and 1-
bromobutane was obtained at approximately 14–15 °C as a colorless oil (52 mg, 76% 
yield). All spectra and physical data matched previous reports.144 
1-Bromo-2-phenylethane: Reactions were loaded directly onto silica gel (250 mg). 
Purification by flash column chromatography (0–20% EtOAc:hexanes eluent, step-wise 
gradient, 5% EtOAc incremental increase every 6 column volumes) afforded the title 
compound (70.5 mg, 73%) as a pale yellow oil. All spectra and physical data matched 
previous reports.145 
1-Bromo-1-phenylethane: Reactions were loaded directly onto silica gel (250 mg). 
Purification by flash column chromatography (0–20% EtOAc:hexanes eluent, step-wise 
gradient, 5% EtOAc incremental increase every 6 column volumes) afforded the title 
compound (25 mg, 27% yield) as a pale yellow oil: Rf  = (1:4 EtOAc:hexanes). All spectra 
and physical data matched previous reports.146  
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II. Rationally Designed Medicinal and Chemical-Biological agents with intentional 
Selectivity Profiles 
2.1 Introduction 
Tuberculosis (TB) has plagued mankind for millennia and is currently the leading cause 
of infectious disease mortality and morbidity worldwide, being responsible for over 1.8 
million deaths in 2015.147 It is primarily caused by Mycobacterium tuberculosis (Mtb), an 
extremely slow-growing bacillus that requires extended periods of treatment and is 
impervious to most conventional anti-bacterials.148 The introduction of antibiotics 
combined with public practices specifically aimed to prevent the transmission of TB led to 
a near-eradication of the disease from industrialized nations in the 20th century.149 
However, the last approved first-line drug for TB chemotherapy, Rifampin, was introduced 
in 1968. Combined with the necessary treatment time, the dearth of new antibiotics has led 
to the development of multiple drug-resistant TB strains.150 In fact, reports over the last 
half century confirm the development of resistance to all first- and second-line 
antitubercular agents. The first line agents (Figure 2.1), rifampicin (RIF), isoniazid (INH), 
ethambutol (EMB), and pyrazinamide (PZA), are all administered simultaneously for the 
first 2 months of treatment.148 Then, INH and RIF are administered simultaneously for the 
remainder of the treatment regimen, lasting up to 24 months.151 This long treatment period 
often results in non-compliance, exacerbating the development of resistance and 
facilitating continuous spread of the pathogen. 
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Figure 2.1. Chemotherapeutic agents with effectiveness against Mtb; A) Clnically-used 
first line agents; B) Clinically-used reserve agents; C) Experimental agents in pre-clinical 
development; D) Experimental agents in development in the Aldrich Laboratory (ca. 2006-
2016). 
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The antitubercular agent PZA is arguably the most important drug within the 
frontline cocktail of treatment. PZA, unlike any of the other molecules, is specifically 
active in non-replicating Mtb, especially those residing in macrophages. This unique 
activity helps shorten the course of treatment substantially, promoting as short as a 6 month 
treatment in drug susceptible strains versus the necessary 1+ years needed for treatment 
without PZA. PZA is a remarkable drug in that it is significantly more potent in vivo 
compared to in vitro. Intriguingly, in order to study the compound, lower pH is necessary 
to achieve a minimum inhibitory constant (MIC).152 While this vital molecule has been 
used extensively in combination therapies, the development of resistance to PZA is quite 
substantial, and unlike other front-line chemotherapeutics, there is no replacement for PZA.  
 Resistance to PZA happens very readily, as PZA is actually only a pro-drug of the 
active metabolite.153 This activation step is actually performed by Mtb’s encoded 
nicotinamidase, PncA (Scheme 2.1). This enzyme’s natural function is to act as the first 
step of the salvage pathway for the biosynthesis of the coenzyme NADH. However, PZA 
is also acted upon by PncA, being cleaved into ammonia and the active metabolite 
pyrazinoic acid (POA) as shown in Scheme 2.2.154 POA, unlike PZA, is not active in vivo, 
as the body of mammals clears the molecule quite rapidly.155 Inhibitors of xanthine oxidase 
can be used to increase total body drug exposure, renal excretion is also quite rapid. 
Decades ago, the pharmaceutical industry attempted to circumvent PncA-mediated 
activation by generating a pyrazinoyl ester which would be activated to the desired 
metabolite by the host or pathogen.156 Unfortunately, this simple esterifaction strategy, as 
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in 1-npropyl-pyrazinoate, did not yield a replacement for PZA as cleavage of the ester was 
too rapid, and improper exposure to POA was achieved.  
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Scheme 2.1. The de novo and salvage biosynthetic pathways for NAD+/NADH.  
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Scheme 2.2. The mechanism of PncA activation of nicotinamide/PZA to active metabolites 
nicotinic acid/POA. 
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 In our efforts to identify new drug substances for M. tuberculosis, we also 
envisioned that a replacement for PZA is absolutely essential to combating global infection. 
While many drug discovery campaigns are ongoing in the Aldrich laboratory, many of 
which involve rationally-designed inhibitors for novel drug targets, my approach to drug 
discovery has been less focused on ab initio campaigns, but rather has been directed at 
modifying POA to be more amenable for treatment. As outlined in this chapter, I’ve taken 
multiple directions in order to accomplish this goal.  First, I endeavored to make a more 
selectively activated prodrug, using a -lactam targeting pro-moiety. This molecule, 1 
(Figure 2.1), was evaluated for its effectiveness against bacterial pathogens, assayed for its 
ability to release POA, and assessed for its stability in mammalian serum.  
 In addition to improving prodrug development for POA, I’ve also had the pleasure 
of working closely with Prof. Dr. Anthony Baughn and his trainees to attempt to elucidate 
the mechanism of action for POA. While still not completely understood, we’ve 
endeavored to elucidate at least the major contributor to POA’s antimycobacterial activity, 
cell-killing unique only to Mycobacteria. During these studies, we uncovered an additional 
bioactivation step which has never been hypothesized. With the knowledge of an additional 
bioactivation step, we were able to synthesize molecules that look much like the activated 
molecules, generating new amide compounds that retain the pyrazinoyl core, but with 
entirely novel structure-activity relationship (SAR) off the amide nitrogen.  
 Both of these studies highlight the necessity of high selectivity for a desired drug 
to perform optimally. In the case of the TB treatment, this is decidedly valuable as the drug 
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treatment regimen is seemingly chronic such that side effects are highly likely to manifest 
within the patient if the drug lacks selectivity. However, not every instance of a drug 
discovery campaign calls for selective substances. Frequently, a non-selective molecule is 
desirable for use as a tool when one intends to learn more about basic biology, 
biochemistry, and the interactions of families of drug targets, rather single drug targets. 
These probe molecules can inform scientists about potential liabilities during drug 
development, assist in target identification and validation, or allow for systemic modulation 
of a family of biological factors which promote similar cellular processes. While this tool 
molecule will itself never become a viable drug, its existence is warranted in that such 
molecules help inform drug discovery to alleviate a wide variety of pathologies ranging 
from chronic pain, to cancer, to battling infectious diseases. During my studies, I’ve also 
been able to develop a molecule which is deliberately unselective, but can be proved as a 
valuable asset in the discovery and characterization of a very “druggable” enzyme class. 
These examples of compound development for biological processes, while seemingly 
unrelated, expose the gamut of desired reactivity for a given molecule. These stories 
highlight the practicality of rationally-designed chemical entities, and expose the range of 
impact well-thought medicinal and biological chemistries can have when one intends to 
improve human health.  
2.2 Targeted drug delivery with a -lactam prodrug approach 
Although already stated, treatment of TB is certainly shorter when PZA is an 
effective chemotherapeutic.151 While the exact manner in which PZA acts is unknown, it 
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is well known that PZA must be activated, via hydrolysis, to POA.153 POA, the active 
metabolite, can then exert its action. Thus, the central dogma of PZA, is that one must 
always be able to access the 2-carboxylic acid in order to make a viable antitubercular 
agent. While the host is capable of converting PZA to POA,155 the most efficacious delivery 
of POA involves on-site delivery of the active metabolite, via PncA-mediated activation. 
Unfortunately, the fact that this enzyme is non-essential for pathogen survival plays a large 
role in Mtb’s ability to evade POA’s action. Treatment of patients with POA (rather than 
PZA) is unfortunately not an alternative therapy, as POA lacks the efficacy needed to treat 
the pathology, likely due to rapid clearance of the drug.155 Thus, it is absolutely necessary 
to develop another vehicle to deliver this vital drug to its site of action, while circumventing 
the resistance garnered by loss-of-function mutations of PncA.  
While previous methods to circumvent PncA-mediated activation have centered on 
esterification, these compounds have no target-directing moieties to facilitate the on-site 
activation deemed mandatory by the host’s rapid metabolism and excretion of POA. Simple 
esters are cleaved whenever they come in contact with the body’s esterases present 
ubiquitously in serum and tissues.157 This lack of on-site delivery can be alleviated by 
appending a targeting moiety to the drug, likely through an ester linkage. This strategy has 
been applied for the treatment of a variety of pathologies, although bacterial infection has 
generally been targeted through siderophore conjugates or -lactam conjugates. 
Siderophores are FeIII-chelating molecules, created by all orders of life, which facilitate the 
uptake of iron from the environment.158 In bacteria, these secondary metabolites are 
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biosynthesized, exported, and then imported with high selectivity in order for pathogens to 
acquire iron in deficient settings. The specificity garnered by these transporters has 
facilitated selective targeting of pathogens,159 however, these moieties are generally 
difficult to make, work with, and semisynthetic strategies utilizing over-expression would 
still be a challenge. Particularly in Mtb, the siderophores produced, known as 
mycobactins,160 contain moieties that would make synthetic modifications very difficult 
while also lacking a suitable location from which to append a pyrazinoyl functional group.  
While the use of siderophores as a targeting moiety has been known for decades,160 
another promoiety that has also been well studied is the use of a -lactam to foster drug 
release only in the presence of -lactam hydrolyzing enzymes known as -lactamases.161 
These enzymes are produced by bacteria to counteract -lactam containing 
antibiotics/antibacterials which target cell-wall biosynthesis,162 thereby inhibiting their 
growth and proliferation. This resistance mechanism has helped fuel drug resistance to 
many of the drugs we use for the treatment of infection, contributing to extensively- and 
totally-drug resistant strains of certain pathogens.163 While these enzymes and compounds 
can come in multiple forms,164 the most relevant system utilized in targeting therapeutics 
involves the use of the cephalosporin-type -lactam compound with serine-based 
hydrolases.165 
As such, we hoped to apply this strategy for the delivery of POA to Mtb, utilizing 
its germ-line encoded -lactamse, encoded by the gene BlaC.166 The proteinaceous product 
of this gene, BlaC, is a serine hydrolase with a very large binding surface which grants this 
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protein the ability to cleave an extended spectrum of these -lactam compounds. BlaC is 
also the reason why -lactam antibacterials are an ineffective regimen for the treatment TB 
as removal of this gene leads to bacteria which are heavily susceptible to-lactam 
compounds.167 This enzyme could thus provide a platform that can be utilized for targeted 
delivery168 of POA, directly at the site of action, without the need for PncA, a criterion not 
met by basic esters that have been previously studied.10 Much like the literature precedent, 
we also chose the cephalosporin nucleus for our initial studies, taking advantage of 
spontaneous release of POA upon -lactam bond cleavage by BlaC, shown in scheme 2.3.  
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Scheme 2.3. The spontaneous release of POA after lactam bond cleavage by BlaC. 
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 The conjugate we have envisioned is solely a prototype, although we expect to gain 
enough information with this molecule to be able to move forward with our ultimate goal 
of developing a new, stable, and orally bioavailable POA prodrug with targeted release. 
The key design criteria of our ultimate conjugate are: 1) the -lactam promoiety should be 
devoid of intrinsic antibacterial activity to prevent disruption of commensal bacteria; 2) the 
conjugate should be stable and orally bioavailable; and 3) POA should be selectively 
released by Mtb and not by the host or other commensal microorganisms. To achieve 
selective antibacterial activity, we have chosen to start with a phenylacetyl modification 
off of the exocyclic amine, a modification that does not enhance antibacterial activity,168 
however, this may conflict with our second aim as the orally-available either contain D-
amino acyl or -oximino acyl substitution patterns off of the exocyclic amine,169 which 
can enhance antibacterial properties. Our initial studies will forego this consideration for 
the time being. The last goal seems relatively straightforward to accomplish, as our desired 
hydrolase is an extended-spectrum -lactamase (ESBL) that contains an extra cavity 
(Figure 2.2) behind the 7-position of the cephalosporin nucleus when the compound is 
bound to the enzyme.168, 170 This larger binding site can accommodate a small functional 
group (i.e. methoxy) installed at the 7 position which precludes binding to the vast 
majority of -lactamases.168 
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Figure 2.2. The extra cavity behind the 7-position of the cephalosporin bound to BlaC.171  
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 Intuitively, we began with the synthesis of conjugate 1, a feat that has been 
accomplished by myself, but optimized by Malcolm Cole, another student in the Aldrich 
laboratory. The synthetic route, shown in Scheme 2.4, utilizes previously established semi-
synthetic chemistry to install the N7-phenylacyl group and add/remove protecting groups 
necessary to complete the synthesis.172 Compound 2, isolated after the first semi-synthetic 
step, was to be used as a control molecule to gauge the effectiveness (if any) of the bare 
cephalosporin compound as an antibacterial compound. Deprotection of the C3 acetyl ester 
under heavily basic conditions followed by benzhydryl protection of the carboxylic acid 
under acidic conditions afforded an alcohol intermediate.173 Then, a Mitsunobu reaction 
that was heavily optimized connected the pyrazinoyl warhead to the pro-moiety.  While 
only a 35% yield, these reaction conditions were selective for the desired transformation, 
limiting undesired 2, 3 isomerization which yields an inert compound (Scheme 2.5).168 
Deprotection of the benzhydryl protection with highly acidic conditions (TFA/CH2Cl2) in 
the presence of a cation scavenger afforded compound 1. This synthesis can be scaled up 
to generate hundreds of milligrams at a time, enough for collaborators to characterize our 
prototypical compound. We found that the cephalosporin nucleus is very hardy and is 
seemingly amenable to modification.  
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Scheme 2.4. The semi-synthetic route of conjugate 1 from commercially-available 7-
aminocephalosporanic acid.  
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Scheme 2.5. The 2, 3 isomerization of compound 1 under basic conditions.  
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 With plenty of molecule in hand, we moved forward with testing the molecule 
against living cells. I initially tested these molecules in pathogenic bacteria frequently 
encountered in the clinic such as S. aureus, P. aeruginosa, A. baumannii, and E. coli. In 
each case, compounds 1, 2, and POA were all ineffective when tested up to 800 g/mL 
(Table 2.1). This is likely due to the presence of intrinsic -lactam resistance present with 
each strain, while POA is already known to be highly selective for Mycobacteria. It is 
notable that the activity of these compounds is frequently recovered when combined with 
a substoichiometric amount of the -lactamase inhibitor clavulanate. These compounds 
were then handed off to the Baughn group, specifically Dr. Yusuke Minato, for testing in 
Mycobacteria. Notably, our compound is active in both Mtb and the closely related 
Mycobacterium bovis (BCG), even though BCG lacks the pncA gene (Table 2.1).174 This 
demonstrates a lack of need for PncA in order to deliver POA. Even more intriguing, 
however, is that our compound is also active at neutral pH, unlike PZA which requires 
acidification in order to be efficacious.  
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Table 2.1. The minimum inhibitory concentrations (MIC90) of 
compounds against Mycobacteria.
a  
MIC90 (mM) PZAb POA 1 2 
M. tuberculosis (+ pncA) 0.4 1.6 0.4 1.0 
M. bovis (- pncA) 0.4 0.8 04 1.0 
aMIC90 determined after 10 days of drug treatment with 
cultures grown in Middlebrook 7H9, pH 6.8; bpH 5.8 
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With known activity in Mtb, we then decided to probe the molecule’s mechanism 
with some selective genetic manipulation. As such, we first desired to see if a strain with 
intrinsic POA resistance also displayed resistance to conjugate 1. This strain, while still 
unpublished, was discovered through transposon insertion screening with a loss-of-
function transposon insertion in the panD conferring resistance to POA, but only light 
resistance to PZA.175 The panD gene encodes for Mtb’s aspartate decarboxylase which 
converts aspartic acid to -alanine, a central metabolite necessary for the de novo 
biosynthesis of coenzyme A (CoA),176 as shown in Scheme 2.6. Our molecule was 
evaluated against this panD strain of M. tuberculosis and was found to be more effective 
against this strain of Mtb than either PZA or POA (Table 2.2). Furthermore, conjugate 1 
was found to be cidal towards Mtb lacking PanD with a minimum bactericidal 
concentration (MBC99) of 440 M, 2-fold greater than its MIC90. This result was quite 
perplexing as we expected to at minimum see some resistance to our molecule, if the 
targeting promoiety truly had no effect on Mtb growth. However, this result was welcomed 
as we realized that our conjugate can successfully dodge confirmed resistance to POA 
which is not derived from PncA loss-of-function, an unexpected capability of our prodrug.  
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Scheme 2.6. The de novo biosynthetic pathway of Coenzyme A.  
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Table 2.2.The MIC90 of our compounds.
a 
MIC90 (M) PZAb POA 1 2 
Mtb (WT) 400 1,600 440 1,000 
Mtb (panD) 800 >6,500 220 1,000 
Mtb (blaC) 400 2,400 55 110 
aMIC90 determined after 10 days of drug treatment 
with cultures grown in Middlebrook 7H9, pH 6.8; 
bpH 5.8.  
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In order to determine how much of an effect the-lactam pro-moiety had on cells, 
we also studied our conjugate in the context of an Mtb strain that lacks a functional BlaC 
enzyme. This strain, graciously provided by Prof. Dr. Martin Pavelka (University of 
Rochester), was utilized to evaluate our molecules, although this would not necessarily 
preclude POA release. Unsurprisingly, our molecule was highly effective against this strain 
of Mtb, as expected based on the work previously reported by Prof. Pavelka (Table 2.2).167 
This demonstrates that BlaC is not necessary for the molecule’s activity as the -lactam 
can act through its own intended mechanism of cell-wall disruption via irreversible 
inhibition of Penicillin binding proteins (Figure 2.3),161 while also releasing POA 
indicating that our molecule can act as a dual therapeutic, a trait that should potentially 
reduce the frequency of resistance; a frequency that has yet to be determined. While in 
vitro assays are suggestive that the molecule may contain activity dependent on both parts 
of the conjugate, we hoped that the POA portion of the observed activity should dominate 
as the principle driver of antimycobacterial action of compound 1. We believed that the -
lactam contribution should be abolished by the presence of BlaC. In reality, this may not 
be the case, but since the conjugate is about as effective as PZA, and the cephalosporin is 
much more active in a Mtb that lacks BlaC, we expected to be able to determine that the 
molecule’s activity was due to the payload, rather than the targeting moiety. We also 
wished to determine if the -lactam pro-moiety conferred greater cell penetration in a 
similar vein as PZA and pyrazinoyl ester compounds.  
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Figure 2.3. The potential activities of conjugate 1 in Mtb. 
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In order to determine a proper way to assess POA’s contribution to compound 1’s 
activity in Mtb, I’ve had the opportunity to collaborate extensively with Prof. Anthony 
Baughn and his group. Throughout the years in their research program, Prof. Baughn and 
co-workers have had the opportunity to establish that some of the debated mechanisms of 
action are highly unlikely, using genetics as a major tool to drive these conclusions.177 
While the exact mechanism continues to elude researchers within the field, there does seem 
to be a consensus as to what qualities the phenotype of treatment should possess. To this 
effect, we can actually utilize this knowledge to assay the effectiveness of the POA 
however, a few facts from the Baughn lab’s research, and our own efforts, all of which 
remains unpublished, indicate that the effect on CoA levels may not the most optimal way 
to assess POA’s activity after release.  
 The phenotype presented upon PZA treatment, that seems to have found a 
consensus among the many groups working towards elucidating this drug’s mechanism, 
revolves around the modulation of the de novo  biosynthetic pathway (Scheme 2.6) of CoA, 
in which global CoA levels (CoA, acetyl CoA, malonyl CoA) are depleted as well as 
pantothenate, a key intermediate in the biosynthetic pathway.178 This cellular response, 
while postulated to be attributed to by multiple factors, seems to be universally observed 
and agreed upon as an indicator of POA activity. As such, we decided to characterize these 
metabolites using liquid chromatography coupled to tandem Mass-spectrometry 
(MS/MS)179 to determine the exact quantities of these molecules within cells. This targeted 
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metabolomics approach also gives us the opportunity to quantify how much, if any, of our 
pro-drug and drug are penetrating cellular membranes.  
 While it is outside of the scope of this work to describe another student’s thesis, it 
is important to highlight that cell-wall disruption and POA treatment appear to be very 
synergistic.180 While I cannot comment on all of the data leading to this hypothesis, it 
appears that variance of Mtb’s Sigma factor E (SigE) due to cell wall damage leads to 
greater susceptibility, manifesting as synergy between POA and the disrupter.180 Since the 
lactam conjugate combines POA and a known cell-wall inhibitor,165 it would not be 
surprising to receive inconclusive results from MS/MS studies. -Lactams have been 
shown to increase cofactors, such as CoA, in response to cell wall damage. This should 
complicate our attempt to profile the effect of the conjugate on the metabolome.181 While 
this conundrum exists, we hoped that the data gathered in these experiments would be 
indicative of POA treatment, with a phenotype resembling that which has been reported.  
 Even with the daunting challenge of parsing the nature of compound 1 via targeted 
metabolomics data, it was important to be properly prepared for these experiments. As 
such, I prepared standard curves of each compound and ensured that the compounds we 
intended to study were separable, while we sought the limit of detection for each molecule. 
Our metabolites of interest included CoA, Acetyl CoA, Malonyl CoA, and our conjugate 
in positive mode using MS/MS.  We also investigated the de novo biosynthesis of CoA 
intermediate, pantothenate, and searched for POA in negative mode of MS/MS studies. For 
each polarity, an internal standard was used for quantification and quality control purposes. 
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For positive mode, a lactam, ampicillin, was chosen to most accurately quantify our 
conjugate, should it get into cells, while negative mode utilized d3-POA as an internal 
standard. The mass transitions used for quantification are summarized in Table 2.5. As an 
example of a standard curve experiment, the quantification of POA is shown in Figure 
2.26, compared to its trideuterated internal standard. In this experiment, we determined that 
the limit of quantification is about 15 nM, while our input of the conjugate is much higher, 
we hoped to detect and quantify accurately all of the POA that may enter cells.  
 Armed with an effective mass-spectrometry and chromatography method, we then 
compared cellular samples of Mycobacterium bovis (BCG) treated with our conjugate for 
4 and 24 hours at 0.2 mM and 0.8 mM, as well as samples treated with POA at 1.0 mM. 
To start, the presence of POA was quite apparent in every sample and varied based on the 
time point analyzed (Figure 2.4). POA treatment seemed to reach a maximal intracellular 
concentration quite rapidly, and surprisingly declined from the 4 hour time point to the 24 
hour time point. However, the opposite trend was true for the conjugate, reflecting the need 
for enzymatically-derived POA release. Additionally, the conjugate could not be detected 
intracellularly, indicating that POA release and stronger MIC is not due to increased 
penetration of the pro-drug, but is likely due to the synergy eluded to earlier.  
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Figure 2.4. Intracellular POA concentrations in BCG after treatment with POA and 
conjugate 1. 
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 While we were able to see that POA was released, we were unable to recapitulate 
the full effect of POA, as evidenced by the lack of CoA species drop with conjugate 
treatment (Figure 2.5). Thankfully, the phenotype we characterized for POA treatment 
alone, did mirror the results previously reported. However, our conundrum is not at all 
surprising when one weighs the notion that our molecule is not limited to the mechanism 
of the payload as the delivery vehicle is already known to be antibacterial, and is actually 
effective on its own against Mtb at high enough concentrations. Unfortunately, lactams 
have been reported to increase CoA levels in bacteria,181 causing greater conflict with our 
studies, than initially expected. 
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Figure 2.5. The intracellular acetyl CoA and malonyl CoA levels of BCG treated with 
POA (red) and conjugate 1 (blue) after 24 hours of treatment.  
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 While we were not able to completely get a grasp of conjugate 1’s complex 
mechanism of action, we did wish to continue on with this prototypical molecule to 
determine if we had met our criterion of selective warhead release. To assay this property 
of our molecule we opted to monitor the stability of 1 in aqueous media, at both acidic (pH 
1.3) and neutral (pH 7.4) conditions to assess potential liabilities in aqueous conditions.182 
Additionally, we monitored the stability of 1 in plasmas derived from female mice, rats, 
and humans to assess if non-specific esterases have the capacity to foster POA release in 
mammals relevant to preclinical animal models utilized in our and collaborators’ 
laboratories.183 As summarized in Table 2.3, our conjugate is very stable in the studied 
media out to 120 minutes, with even 50% of the parent compound remaining in simulated 
gastric fluid after 120 minutes, owing to the remarkable acid stability noted for 
cephalosporin molecules.184 
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Table 2.3. The stability of conjugate 1 in different media as detected using LC-MS. 
 
Entry Media pH % Remaining at 120 minutes 
1 50 mM HEPES 7.4 > 95% 
2 Simulated Gastric Fluid 1.3 50% 
3 Female Mouse Plasma 7.4 >95% 
4 Female Rat Plasma 7.4 >95% 
5 Female Human Plasma 7.4 >95% 
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While the conjugate seems to be stable to aqueous media, we wished to determine 
the conditions necessary for POA release, to confirm that BlaC does facilitate the desired 
degradation. As such, we determined the amount of POA released by BlaC turnover with 
or without the presence of clavulanate, a known inhibitor of BlaC.185 As shown in Figure 
2.6, the presence of BlaC leads to rapid evolution of POA, a trait that is inhibited by the 
addition of clavulanate. This indicates that BlaC release is the primary method for POA 
release, while the actual rate of release is still being determined by Malcolm Cole. In 
addition, we will also test the selectivity, or lack thereof, for cleavage using a panel of -
lactamases covering a wide range of enzymes capable of this transformation to determine 
what pro-moiety scaffold is necessary for optimal selectivity for Mtb.168 
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Figure 2.6. The BlaC-mediated release of POA from conjugate 1 without (red) and with 
(blue) clavulanate. Data collected by Malcolm Cole. 
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Taken together, these results indicate that conjugate 1 is a great prototype for a new 
drug, yet the molecule presented herein is certainly not that drug. The lactam targeting 
system does have the ability to release drug when desired, but the specific conjugate is not 
as acid stable as we would like, and its pharmacology seems to be heavily affected by the 
targeting promoiety, an aspect that will likely translate to poor pharmacokinetic properties, 
unless modifications are made using the knowledge we have gained about lactam drugs 
through the decades.186 The underlying pharmacology of conjugate 1 is also much more 
complex than expected. Yet, this complexity will likely lend itself to better properties for 
the treatment of such a complex pathogen, adding more channels necessary to confer 
resistance. The ability for conjugate 1 to act as a dual warhead, should reduce the possibility 
of spontaneous resistance, and has even already been shown to circumvent a known 
resistance mechanism compared to the warhead used in mono-therapy applications. Future 
endeavors should seek to stabilize the molecule under acidic conditions, further garner 
selectivity for BlaC, and/or attempt to utilize transport mechanisms to yield a bioavailable 
drug which adheres to the tenets of our prodrug design.
2.3 A paradigm shift for the design of analogs of antitubercular drug pyrazinamide 
While we worked on the development of MS methods for targeted meatabolomic 
studies, Prof. Baughn also asked us to follow-up on a hunch he had regarding the 
mechanism of PZA. However, before getting to the hypothesis Prof. Baughn had regarding 
PZA/POA’s mechanism of action, it is important to discuss some of the findings his and 
other groups have had while studying this molecule. While already summarized over 
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multiple review articles,153 the mechanism of PZA/POA (from here on, referred to solely 
as POA) is certainly complex, while central metabolism is frequently identified as being 
disrupted by the molecule. Other theories, such as POA targeting trans-translation, have 
been debunked,187 and will not be discussed here. Yet other potential targets of the drug, 
such as the proteasome subunit ClpC1,155 remain with unknown implications as novel 
techniques to rapidly screen genetic manipulations continue to be developed. 
Deconvolution of these data is an ongoing process. While there has been much speculation 
as to what drives POA activity, multiple groups, including the Baughn group, have isolated 
some form of inhibition within the de novo biosynthetic route of CoA as the potential 
source of POA’s antitubercular activity.  
The theories presented regarding the way POA acts on this pathway are not 
necessarily contradictory, however, the interpretation of these results has led to some 
contention as to what is truly happening upon drug treatment. What can be easily stated are 
the observations made by the groups studying the interactions of POA and Mycobacteria. 
As a notable contribution to the field, Prof. Dr. Thomas Dick and Prof. Dr. Veronique 
Dartois have jointly proposed that binding to the aspartate decarboxylase enzyme PanD 
(Schemes 2.6 and 2.7) is important for whole cell inhibition.155 Indeed, this research 
program has even gone to the lengths to characterize the kinetics of binding, and have 
worked with genetic knockouts of the enzyme, showing resistance to POA. While their 
findings point to PanD as a key piece to unraveling POA activity, some of their own data 
as well as data gathered by the Baughn group conflict with the necessity of PanD 
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binding.188 It is important to restate, however, that panD strains do display in vitro 
resistance to POA even though binding to PanD has not been demonstrated to inhibit the 
enzyme’s function.155, 180 This certainly conflicts with the notion that panD strains are 
unable to confer resistance in in vivo infection models, but does indicate the necessity of 
such experiments when conducting investigations with such a complex pathogen.  
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Scheme 2.7. The CoA biosynthetic pathway showing the de novo and salvage (starting 
with pantetheine) pathways. 
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Furthermore, the fact that PanD is considered a target of POA should indicate that 
addition of any excess of downstream intermediates in the biosynthesis pathway would 
antagonize the drug’s activity. While this is true for the majority of drugs, antagonism of 
POA with CoA biosynthetic intermediates is not as straightforward as one would 
imagine.188 Addition of exogenous pantothenate, -alanine, and pantetheine all do 
antagonize POA activity, but the antagonism noted with PZA treatment is significantly less 
pronounced, though PZA is solely a prodrug of POA. Even more perplexing is the fact that 
the addition of pantothenate and -alanine is about 4-fold more antagonistic than adding 
pantetheine, even though all of these metabolites fuel CoA biosynthesis after the PanD-
catalyzed step (Scheme 2.7). This finding is most peculiar especially when coupled with 
the fact that we have been unable to find an absolute target of POA.  
Sensing the potential for incorporation of POA into the metabolome, Prof Dick’s 
researchers attempted to characterize what they believed to be the most likely candidate 
molecule for POA integration. This molecule, pyrazinoyl CoA (Figure 2.7), was 
synthesized and cellular lysates were investigated for the abundance of such a molecule. 
However, pyrazinoyl CoA was never detected by MS in targeted metabolomics studies, 
while it did seem like a likely candidate for POA integration as the amounts of typically-
anticipated CoA species should drop, and more pantothenate would be necessary to make 
up for a loss of functional CoA acyl carriers. However, the proposal of pyrazinoyl CoA 
ignores the patterns of antagonism reported by the Baughn group,188 yet does open up the 
thought process that POA, much like other known drugs, is an antimetabolite.  
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Figure 2.7. The structure of pyrazinoyl CoA.   
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In this sense, the word “antimetabolite” does not refer to a molecule which blocks 
metabolism, but actually refers to a molecule that is incorporated by biological machinery 
and converted to an active inhibitor. Examples of this strategy have found use in many 
pathologies, however, this potential mechanism prior to Dick’s work had never been 
postulated for POA. This hypothesis also correlates with our unpublished data previously 
disclosed in this thesis as intracellular POA levels are depleted over the course of drug 
treatment. Knowing about the way central metabolites affect POA treatment, we then 
hypothesized that it is possible for POA to be acting as an antimetabolite, but that its 
incorporation would be much earlier in the biosynthesis of CoA rather than modifying the 
terminal sulfhydryl of the cofactor. Our hypothesis for POA as an antimetabolite has POA 
incorporated by the enzyme CoaBC (Scheme 2.8), being converted to either the pyrazinoyl 
cysteine or pyrazinoyl cysteamine compounds which then go on to inhibit Mycobacterial 
growth. If Mtb were to use this machinery to further activate POA, then POA would 
compete with pantothenate for binding to the protein, and excess pantothenate would block 
this activation step. However, once activated by Mtb, this new molecule could act at a 
variety of places within cells, even within the same pathway, leading to an inhibition of 
CoA synthesis and depleting global CoA levels.  
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Scheme 2.8. A) The half reactions catalyzed by CoaBC; and B) Proposed activation of 
POA by CoaBC. 
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In order to test such a hypothesis, two approaches were simultaneously surveyed. 
The first approach involved direct detection of the molecule via MS, and to test if the 
proposed metabolites even have antimycobacterial activity. This part of the project relied 
on synthetic and analytical chemistry skills, making new molecules for testing within 
whole cell assays, as analytical standards, and for characterization of a new drug-like 
substance. The alternate approach involves an ongoing investigation using genetic 
manipulation of the bacteria to confirm with both over- and under-expression strains that 
the bioactivation is both specific to one enzyme, and to identify the targets of the new 
chemical entities. These orthogonal approaches are both needed to confirm our hypothesis 
of POA acting as an antimetabolite. Unfortunately, I will only really be able to discuss the 
first such approach in detail as this has been my contribution to the project and we are still 
awaiting the generation of the necessary strains of Mtb with the desired genetic 
modulations.  
 In order to detect and determine if POA is modified within Mtb, I synthesized a few 
standards for MS experiments. At first, I tried using 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (EDC), but found the low yields unsatisfactory for the synthesis of great 
enough quantities required for many of the whole-cell studies planned as my best yield 
using this reagent was 21%. To alleviate this short-coming, I turned to chemistry developed 
by the late Prof. Dr. Alan Katritsky,189 which is specifically suited for the formation of 
amide bonds from heavily withdrawn carboxylic acids. POA, a carboxylic acid adjacent to 
the electron poor pyrazine heterocycle, certainly lacks the reactivity required of traditional 
388 
 
amide coupling reagents, such as EDC, but works just fine with Katritsky’s system 
(Scheme 2.9). This methodology was then applied to make a small series of pyrazinoyl 
compounds (Figure 2.8) to assess potential antimycobacterial activity of this scaffold while 
also serving as synthetic standards to confirm further bioactivation of POA.  
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Scheme 2.9. The synthesis of new pyrazinoyl amide compounds.  
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Figure 2.8. Compounds synthesized via the route illustrated in Scheme 2.9.  
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 With a few new compounds synthesized as in Figure 2.8 I was then able to make 
new LC and MS methods to detect potential metabolites of POA. I was able to use these 
standards for two types of MS, tandem MS, described earlier, in which we would be able 
to quantify these new chemical motifs, and high-resolution MS (HRMS), to confirm 
absolute identity of compounds detected in lysate experiments. Having been given 
prepared lysate samples from cultures of Mtb, I then prepared these samples further by 
concentrating the lysate and dissolving the samples in MS-grade solvents. This facilitated 
HRMS studies in which samples could be shot on directly to the mass-spectrometer, or in 
which a short column could be added to further filter out noisy signals. The latter was 
chosen to simplify our initial readout, although direct infusions would later turn out to be 
fine for detecting any additional metabolites. Shown in Figure 2.9, we were delighted to be 
able to detect our desired compound, 3, on an Orbitrap Velos instrument in negative mode, 
using electrospray ionization (ESI). We were able to identify the splitting pattern which 
included the parent mass, its disulfide, and the unique fragment resulting from cleave of 
the Csp
2-Csp
2 bond between the nitrogenous heterocycle and the carbonyl of compound 3.  
When a sample generated from an Mtb lysate was investigated, an identical mass signature 
was detected at the same retention time of 0.85 minutes. Additionally, adding both the 
synthetic standard and the lysate simultaneously did not affect the chromatogram, nor the 
mass signature. This confirmed the presence of 3 in samples treated with POA, while 
untreated samples lacked this specific metabolite. Additionally, we also looked for, and 
detected, the presence of additional metabolites in positive mode, which further validated 
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our hypothesis (Figure 2.10). The metabolite detected in positive mode is derived from 
compound 7, the proposed metabolite generated by CoaBC action upon POA.  
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Figure 2.9. The HRMS traces and mass signatures for synthetically-derived 3 (top) and 
cellular lysates from Mtb treated with POA (bottom) as detected using ESI in negative 
mode. 
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Figure 2.10. The detected metabolite of POA in PZA-treated Mtb cellular lysates using 
HRMS-ESI in positive mode.  
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 With the ability to detect metabolites directly using HRMS, we also wished to 
characterize if these molecules possessed antimycobacterial properties, and what the effect 
of these molecules might be. With a small sample of the molecules generated, Dr. Yusuke 
Minato, of the Baughn group, evaluated these molecules in Mtb, while I counter screened 
these molecules in other pathogenic bacteria. Intriguingly, much like our parent compound, 
POA, these molecules tend to exude the need for lower pH for activity in in vitro 
experiments, yet we were able to circumvent that need for a few of these analogs. 
Unfortunately, to date, only the six analogs presented in Table 2.4 have been evaluated for 
their antitubercular activity, while not a single compound has displayed antibacterial 
activity in E. coli-K12, A. baumannii-AB5075, P. aeruginosa-PA14, or S. aureus-
USA300, even tested out to 800 g/mL. With considerable activity in Mtb, these molecules 
display the same sort of specificity and potency for Mtb, noted with the parent drug, while 
also circumventing the necessary PncA-mediated activation step, much like pyrazinoyl 
esters. However, these molecules represent a paradigm shift in SAR for the drug scaffold 
as decades of study have been devoted to modification of the heterocyclic component of 
the molecule. This is due to the central dogma of PZA, in which a carboxylic acid must be 
present for antitubercular activity. We believe our new molecules lack this part of PZA’s 
mechanism, and thus act via a novel mechanism of action. 
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 Table 2.4. The minimum inhibitory concentrations (MICs) of compounds against M. tuberculosis.a 
Entry Compound pH MIC90 (mM) Entry Compound pH MIC90 (mM) 
1 PZA 5.8 0.4 8 5 5.8 2.0 
2 PZA 7.0b >13.0 9 5 6.8 >2.0 
3 POA 5.8 0.8 10 6 5.8 0.5 
4 3 5.8 1.2 11 6 6.8 0.5 
5 3 6.8 >1.2 12 7 5.8 1.1 
6 4 5.8 0.4 13 8 5.8 0.5 
7 4 6.8 0.4 14 9 5.8 >11.5 
aMICs measured after 10 days in Middlebrook 7H9 media using wild-type virulent strain H37Rv; bValue 
determined after 14 days as in Antimicrob. Agents Chemother. 2015, 59, 7320. 
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 In order to separate our molecules from this canon philosophy, we wished to both 
biochemically and analytically confirm that compounds such as 3 do not simply act as 
dipeptide prodrugs of POA. This reaction could not be impossible for the many peptidases 
in Mtb. At this point, I recruited Evan Alexander, a highly capable chemical biologist in 
the Aldrich lab, to assist with these studies. Before initiating this project, Evan had already 
expressed, purified, and studied some of the specificity of nicotinamidase PncA (Figure 
2.11).190 With this assay already known in the lab, I handed off molecules 3 – 8 for their 
evaluation against PncA.  
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Figure 2.11. The assay and detection method using waning signal at 340 nm for PncA 
activity (top) and Michaelis-Menten curves for heteroaromatic carboxamides (bottom). 
Data collected by Joseph Ahenkorah. 
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 While these compounds could be substrates for PncA, it would be highly unlikely 
to ever detect ammonia released from these molecules. This, in turn, required detection of 
the pyrazinoate that would be liberated from the amide compounds. Again using MS, our 
compounds were compared to PZA using purified PncA, but rather than adding another 
enzyme to detect activity spectrophotometrically, the protein was removed using an 
acetonitrile crash, and samples were loaded directly onto the instrument. Monitoring at [M-
1 = 123] (still in negative mode ESI), we were unable to detect POA release when any of 
our novel compounds were incubated with PncA, even at 750 M. This result, while 
encouraging, was unsurprising given what is known about the binding pocket of PncA. 
Figure 2.12 shows a model of the active site, generated by Evan Alexander, which 
highlights the limits of the cavity, showing that the catalytic residues really do define the 
depth to which a molecule can extend into the protein. 
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Figure 2.12. The binding pocket within the active site of PncA as modeled by Evan 
Alexander.  
  
401 
 
 While the results with purified PncA indicated hope that our compounds act in an 
entirely novel manner, we could not discount the potential that Mtb may cleave these 
dipeptides using some other means. As such, we again turned to studying the whole-cell 
lysate of Mtb treated with specifically compound 3, a molecule with favorable activity, yet 
most resembles a natural dipeptide. Again, using a similar procedure described earlier, we 
intended to detect and quantify the initial molecule, POA, and CoA biosynthetic 
intermediates using MS/MS on a triple quadrupole linear trap mass spectrometer in both 
positive and negative modes. Much to our delight, POA was undetected in cultures treated 
with 3, but readily seen in those treated with either PZA or POA (Figure 2.13). While also 
detecting POA, we opted to quantify the changes to changes to CoA, acetyl CoA, and 
pantothenate in order to better understand if these molecules match POA’s resultant 
phenotype. Again, we were pleased to see the overall reduction of both CoA and acetyl 
CoA (Figure 2.14). Thankfully, POA’s activity against these metabolites scaled quite 
nicely with the dose administered, and our compound seemed similar, if not more active, 
at similar concentrations. However, compound 3 did deviate from POA in that pantothenate 
levels did not drop. In fact, treatment with 3 caused a slight (not significant) increase in 
pantothenate when compared to controls, while POA acted exactly as expected based on 
literature precedent (Figure 2.15).155 These results certainly point to 3 acting within the 
CoA biosynthetic pathway which we are currently investigating. As eluded to earlier, we 
are seeking over- and under-expression strains of each piece of the biosynthetic machinery, 
while also working on generating mutant strains which display resistance to 3. However, 
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these experiments have yet to yield fruit, and at this time, we await these materials in order 
to more fully characterize these new chemical entities. In the meantime, I have worked on 
scale-up and can safely make over 1 gram of final compounds per batch, and we have filed 
for legal protection to ensure these new chemical entities can be further developed into 
drugs if these promising results translate to in vivo experiments.  
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Figure 2.13. The raw areas of POA detected in Mycobacterium treated with vehicle 
(control), PZA, POA, and 3 at 250 M.  
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Figure 2.14. The raw areas of CoA and acetyl CoA upon treatment of vehicle (control), 
titration of POA, and 3.  
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Figure 2.15. The raw areas of pantothenate upon treatment of vehicle (control), titration of 
POA, and 3.  
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 Currently we are continuing to characterize these molecules in order to gather the 
necessary information for in vivo experiments. As for in vitro experiments remaining on 
the docket, we are seeking determination of the frequency of mutation, characterization of 
our molecules in CoaBC over- and under-expression strains, characterization of our 
molecules in CoaD over- and under-expression strains, and evaluation of our molecules 
against purified CoA biosynthetic machinery. These pieces of data are what remains before 
publication of these molecules, although we hope to move into in vivo infection models, to 
determine efficacy. We also hope to characterize the pharmacokinetic and 
pharmacodynamics properties of these molecules to determine the best molecules with 
which to move forward into efficacy studies, and to determine what prodrug strategy, if 
any, is necessary to ensure proper animal exposure toohh these drug candidates.  
2.4 Rational design of a pan-acting nucleophilic probe for the characterization of the 
PLP-dependent proteome 
While the development of selective chemotherapeutics is always desired, 
frequently, when we develop so-called “selective” agents, we intend to focus on the ability 
of a drug to bind to an intended target compared to its ability to bind related proteins. 
Determination of the selectivity profile of a pharmacologically-active substance is key to 
understanding how a molecule achieves an observable activity. Additionally, 
understanding potential liabilities of active compounds is important to avoid unnecessary 
investment, be that time and/or money, in a molecule that can result in an unnecessary 
outcome in vivo.  
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Unfortunately, this task can be difficult when one must investigate the entire 
proteome for potential binding, however, if one breaks up the proteome into related 
families the task becomes much easier. Seemingly the poster-child of enzymes in which 
selectivity is highly important for garnering a desired phenotype is the kinase family.191 
Many inhibitors developed for a member of this class of enzymes lack selectivity for their 
intended target, however, this does not mean that these molecules automatically make for 
poor drug candidates, especially when a multi-action pharmacology is desired. It is also 
notable to mention that off-target activities of drug-like substances frequently spell doom 
for the potential of these molecules to advance to clinical testing.   
Some drug discovery campaigns begin with a screen of massive amounts of 
molecules in an attempt to cover a greater chemical diversity. In modern times such 
screening usually begins with a purified protein target, generally a validated drug target, 
although whole-cell screening is still employed and is rapidly regaining popularity.192 In 
the case of screens against a purified protein, chemical “hit” compounds, are validated with 
an orthogonal assay, and confirmed for on-target activity. Yet, to discern if a molecule is 
actually selective, another process must go on, generally involving other, related, proteins. 
Continuing to use the development of kinase inhibitors as an example, this process involves 
counter-screening against other purified enzymes, a time and resource intensive process. 
Fortunately, libraries that span the “kinome” have been generated for regular screening, 
utilizing a miniaturization process that speeds up the turnaround time for results when 
screening against literally hundreds of proteins. While more optimal than what would have 
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been used even ten years ago, this still uses much more time, effort, and material, than 
focusing solely on one protein, and is essential for drug discovery campaigns. This model 
of counter screening has been used for decades, and similar libraries/testing services have 
been developed for other families of drug targets, such as G-protein coupled receptors (i.e. 
neuro-receptors). Some pieces of data require counter screens, such as monitoring whole-
cell activity against unrelated cell types or species of bacteria, as previously encountered 
in this thesis. 
In an effort to skirt this resource-intensive process, alternate strategies to 
characterize small molecule interactions with a target protein family have been extensively 
researched. Likely the most successful approach, pioneered by Prof. Dr. Benjamin 
Cravatt193 and Prof. Dr. Matthew Bogyo,193 has focused on the characterization of 
enzymatic classes that are susceptible to mechanism-based inhibition. This technique, 
commonly referred to activity-based protein profiling (ABPP), can rapidly increase the 
understanding of a drug-like substance’s selectivity profile for a family of enzymes in a 
whole-cell system in one fell swoop.194 Though extensively reviewed in the recent 
literature, I will briefly explain this technique, the technologies that underlie its capacity to 
function, and cover an example to illustrate the power of this technique. Currently, ABPP 
has been most extensively studied using molecules that react with nucleopilic proteins such 
as serine/threonine hydrolases and proteases, cysteine proteases, and in some rare instances 
ABPP has been utilized to characterize alternate enzyme classes such as histidine kinases. 
195 
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Briefly, ABPP can be applied to a wide range of protein families with a known 
mechanism. To date, protein families that have been well characterized via these means 
contain nucleophilic residues that interact with a pan-inhibitor of sorts. In the case of serine 
proteases, originally characterized by Cravatt, an electrophilic warhead is allowed to react 
with the nucleophilic serine residue in an irreversible fashion. This irreversible warhead is 
then, somehow, linked to a chemical handle that can be utilized in bio-orthogonal chemical 
reactions such as the copper-catalyzed Huisgen cyclization (“click reaction”) developed by 
Prof. Dr. K. Barry Sharpless196 or the Bertozzi-Staudinger ligation pioneered by Prof. Dr. 
Carolyn Bertozzi.197 The electrophilic warhead utilized depends on the class of enzyme 
being studied, and may be as simple as a substituted fluorophosphonate for serine 
proteases.198 This universally-acting compound, after it is allowed to react with proteins in 
an unspecific manner, can then be modified using one of these bio-orthogonal for imaging 
or enrichment purposes. During the early characterization of this technique by Cravatt, in 
concert with Prof. Dr. Dale Boger, the selectivity of a new class of fatty-acid amide 
hydrolase (FAAH) inhibitors was easy to study in single whole cell-lysate experiments.198 
To succinctly summarize how the technique was utilized in this optimization campaign, 
when a band on the gel disappeared, that meant the protein was inhibited, and thus, when 
more than one band on a gel went missing, this indicated a lack of selectivity for FAAH. 
This approach can be used with many classes of enzymes, and frequently pan-inhibitory 
probes are designed to look like certain substrates/xenobiotics rather than bind across the 
entirety of an enzyme class. In the case of FAAH, the comparator activity-based probe 
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(ABP) closely mimicked the natural substrate arachidonic acid, while unrelated studies 
have used -lactones or -lactams, to study unrelated serine hydrolases which act upon 
penicillin-containing molecules.199, 200 
In tandem with structural-information gathered via X-ray crystallography, this 
technique can rapidly inform an SAR campaign as it hones in on a selected target, while 
not requiring isolation, purification, and assay development for the related protein(s) that 
initial hit molecules may have inhibited. ABPP rapidly allows for the acquisition of 
proteomic data without excessive effort from the scientists, yet garners the same sort of 
information gleamed from counter screening. Most importantly, this approach can identify 
proteins not necessarily postulated to be affected by the molecule in question.  
While this technique has the power to inform many types of drug discovery 
campaigns, it is hampered by the need for a pan-acting warhead which covalently labels 
proteins within a family. Additionally, to date, this technique has only been utilized with 
electrophilic probes to characterize entire protein families, although a “reverse polarity” 
technique has been recently reported utilizing a hydrazine warhead to unselectively label 
cellular electrophiles, and thus far has only been characterized with post-translationally 
modified enzymes.201 However, potential enzymatic drug targets are not only nucleophilic 
proteins, and there is currently no known way to gauge the selectivity of a molecule for 
nucleophilic mechanism-based inhibitors (MBIs), or any enzyme that contains an active-
site electrophile. 
411 
 
A key enzymatic class that is susceptible to mechanism-based inhibition via its 
active-site electrophile is the PLP-dependent enzyme class.202 PLP-dependent enzymes 
utilize the coenzyme pyridoxal phosphate, an essential dietary vitamin frequently 
consumed as vitamin B6. This family of proteins is responsible for a wide array of 
biochemical activity, however, for simplicity, the mechanism of a racemase is shown in 
Figure 2.16.203  
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Figure 2.16. The mechanism of PLP-dependent racemase Alanine racemase (Alr).  
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PLP-dependent enzymes have materialized as viable drug targets for a variety of 
pathologies ranging from neurological disorders to fighting infectious diseases. While 
multiple FDA-approved drugs target a PLP-dependent enzyme as part of their principle 
mechanism of action, the actual pharmacology exuded by these drugs is not necessarily 
explainable solely by the action of the intended enzymatic target. For instance, the 
antitubercular drug D-cycloserine (DCS) is intended to treat infection by tuberculosis, with 
a known mechanism of action due to non-covalent inhibition of D-Alanine-D-alanine ligase 
(Ddl) and mechanism-based inhibition of the PLP-dependent enzyme Alanine racemase 
(Alr).204 However, the side-effects in humans manifests itself as psychosis in otherwise 
healthy patients, limiting the use of this drug in the clinic for its FDA-approved use. This 
suite of side effects can be attributed to non-specific binding with multiple identifiable 
protein targets (i.e. metabotropic glutamate receptor 4, and the N-Methyl-D-aspartate 
receptor), yet the effect that DCS has on the brain is not fully understood, and may be due 
to activity PLP-dependent enzymes such as GABA transaminase, the putative target of the 
FDA-approved antiepileptic agent Vigabatrin (Sabril®).205 In order to better characterize 
drugs like DCS, and this overall important class of drug targets, we envisioned that the 
reverse polarity ABPP strategy may be a viable approach to studying these enzymes and 
the selectivity of molecules intended to inhibit them.  
Prior to the initiation of this work, no report of reverse polarity ABPP had been 
publically released.201 As such when the first probe was designed, I based the molecule off 
of known inhibitors of PLP-dependent enzymes. While hydrazines/hydrazides have been 
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known for decades to inhibit these sorts of enzymes,206, 207 their potency has often been 
lacking for drug targets, and many of these molecules show reversible binding kinetics.208 
Additionally, these molecules are not mechanism-based inhibitors as they strictly interact 
with the carbonyl of PLP in a non-specific manner and the enzyme does not interact with 
the hydrazone adduct in any manner. While this nucleophilic warhead may be able to serve 
as a mediator of PLP-dependent enzyme profiling, the initial hope would be to have a 
molecule that is specific for the PLP cofactor, which would force interaction with the 
protein, solidifying selectivity for the desired cofactor. To this effect, a report from 1979 
would serve as the basis for the design of my probe, as N-hydroxy amino acids serve as 
mechanism based probes of racemase-type enzymes.209  
As a proof-of-concept, I started with an N-hydroxy alanine scaffold, hoping that the 
lack of functionality on the  carbon would confer the most universal binding while still 
closely mimicking the natural substrates. This molecule, synthesized under my direction 
by another one of my undergraduate mentees Christopher (Chris) Brown, would likely 
function via the mechanism outlined in Figure 2.16, forming a stable nitrone functional 
group (Figure 2.17), labeling the cofactor irreversibly. This initial molecule, known 
internally as CDB-I-143, was synthesized using standard chemistries starting with pyruvic 
acid. The Steglich esterification210 proceeded with a low yield likely due to the heavily 
withdrawing nature of the -keto substituent. Nevertheless, once the ester bond was 
formed, reductive amination, using Borch conditions, afforded the racemic amine (Scheme 
2.10) for our initial characterization.  
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Figure 2.17. The proposed nitrone-quinoid intermediate formed between a modified N-
hydroxy amino acid and PLP.  
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Scheme 2.10. The synthesis of CDB-I-143 as performed by Christopher Brown.  
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With this molecule in hand, I opted to first characterize the molecule as an inhibitor 
of a PLP-dependent enzyme. Familiar to the Aldrich group, I chose diaminopelargonic acid 
(DAPA) synthase from M. tuberculosis called BioA.211 This enzyme, a transaminase, 
catalyzes an important amination in the de novo biosynthetic route of biotin by Mtb. 
Additionally, prior to working with the enzyme, our lab had already established enzymatic 
enzymes to assay the effectiveness of inhibitors we have developed for this enzyme.212 Our 
previous knowledge of the enzyme indicated the protein has high specificity as to what can 
bind to the cofactor, and is quite slow at catalyzing its desired reaction as well as its own 
demise when an MBI is introduced. Using the coupled assay depicted in Figure 2.18, I was 
able to discern the nature of inhibition by CDB-I-143.  
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Figure 2.18. The coupled assay used to assess the activity of CDB-I-143 against BioA. 
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Notably, the molecule displays time-dependent inhibition, and seems to be unable 
to be competed out of the enzymatic pocket after preincubation. To summarize the effect 
of CDB-I-143, its specificity constant, defined as the rate of inactivation over the rate of 
the initial binding event (kinact/ki), was determined by determining the percent of inhibition 
after preincubation times varying between 5 and 45 minutes. The secondary plot, shown in 
Figure 2.19, can then be fit to a line giving the value kinact/ki = 355 Min
-1M-1, a value that 
is actually quite similar to a molecule made by a former post-doctoral scholar in our group, 
Dr. Ce Shi, which is reportedly optimized for activity against BioA.213  
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Figure 2.19. The degree of inhibiton and secondary plots used to determine the specificity 
constant of CDB-I-143.  
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This result prompted a bit further study with CDB-I-143, but also indicated that a 
more stable amide analog should be generated. To this effect, Chris once again got to work, 
however, when he attempted to make the amide analog using the same route, the Borch 
conditions90 never yielded the a-N-hydroxy amino amide compound. As a second reducing 
condition, Chris tried to use hydrogen with a Palladium catalyst, but only ended up 
generating the amine compound, finding a great way to make racemic alanine.214 To 
alleviate this short-coming, Chris attempted multiple routes, all of which included starting 
with N-hydroxy alanine, without being able to bear the desired compound by the end of his 
tenure within the lab.  
Even without a more stable amide compound, I used CDB-I-143 in preparation of 
whole-cell lysate proteomic experiments. These experiments, while informative about the 
workflow of ABPP, did not ultimately yield publishable images, however, it was apparent 
in experiments using two unrelated purified enzymes (BioA and BlaC) that the probe only 
bound to one of these enzymes. The results of this effort, which are not shown in this text 
made a few things quite clear: 1) CDB-I-143 does not bind to serine hydrolase BlaC, 
indicating the N-hydroxy alanine warhead does not bind to proteins without specificity; 2) 
Labeling the cofactor of the protein is not necessarily sufficient for gathering proteomic 
data, instead one should attempt to label the protein; 3) Copper-catalyzed “click” 
chemistry196 will work with our alkyne probe bound to the PLP coenzyme, indicating 
appropriate linker length; and 4) A next generation probe should use the same warhead for 
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targeting our desired enzyme class, but should also contain a moiety that can be induced to 
react directly with the protein to facilitate higher yields in enrichment experiments.  
Having learned about the necessity of what is needed for a probe in these studies, I 
then designed a next generation probe that includes a photo-inducible covalent interaction 
with proteins. This technique, known as photo-affinity labeling (PAL), has been used with 
regularity when studying the interface of chemistry and biology.215 Even in the Aldrich lab, 
PAL has been used to discern the specificity of molecules studied in the lab.216 While this 
field has been extensively reviewed in the literature, the main highlight that should be 
addressed is that PAL is not simple, and that optimization of the PAL moiety is often 
needed to ensure both binding and suitable kinetics of reactivity with the protein. Luckily, 
others have done much of the heavy lifting, and it was fairly straightforward to pick a PAL 
that matched out needs, while still being synthetically feasible. As such, I chose the 
diazirine as the PAL of choice, continuing to use about the same alkyl-type linker region 
between the bio-orthogonal handle and targeting warhead. With this probe, the ABP should 
retain the targeting aspect of CDB-I-143, yet should be capable of binding directly to the 
protein with rapid kinetics when 365 nm light is shined on a sample.  
Synthesis of this molecule would be arduous from typical commercially-available 
starting materials. Shown in Scheme 2.11, the originally proposed route encompassed 11 
synthetic steps, and was assigned to both, Kathleen Wang, and a first-year graduate student 
Scott Brody.  
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Scheme 2.11. The originally proposed route towards a 2nd generation ABP for PLP-
dependent enzymes.  
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Unfortunately neither of these scientists were able to put much of a dent into the 
synthesis before we discovered that a reagent containing both an alkyne and PAL moiety 
was available for purchase. While this would shorten the synthesis considerably, this 
wouldn’t necessarily make the molecule appear out of thin air, as Chris’ experiments years 
prior had indicated that making an -N-hydroxy amino amide would be much more 
difficult than making the corresponding -amino amide. To alleviate the problems noted 
by Chris, I opted to try to install the N-hydroxy moiety before the amide coupling. To this 
effect, I tried a few routes which included silicon protecting groups for the hydroxyl group. 
Summarized in Scheme 2.12, these routes all failed, as either the reduction failed for the 
protected oxime, or the protecting groups were not robust enough to survive hydrolysis of 
the ester moiety. This was peculiar, but would later be used to my advantage.  
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Scheme 2.12. The attempted synthesis of a 2nd generation ABP for PLP-dependent 
enzymes. 
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While the reductive amination type synthetic route would ultimately not work, I 
was inspired by one of Chris’ proposed routes that he was never able to pursue. In this 
direction, the final step would be a nucleophilic substitution with hydroxylamine using 2-
bromopropionic acid as the carbon skeleton of the targeting warhead. When I attempted 
the synthesis using this route I found that the reaction with the secondary bromide would 
go, however, an O-protected hydroxylamine would be optimal for selectivity and ease of 
purification. Using the route summarized in Scheme 2.13, I was able to generate 
JAB11P118, the 2nd generation PLP-dependent enzyme pan-probe for ABPP. After nearly 
three years from conceptualization, a molecule was ready that should be usable for our 
purposes.  
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Scheme 2.13. The synthesis of JAB11P118. 
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At this point, JAB11P118 was handed off to Scott Brody for further 
characterization. Although these results are still quite preliminary, I wish to highlight the 
potential of this molecule that I fantasized about for quite a long time during my tenure in 
the Aldrich lab. Scott was able to show that this molecule is capable of inhibiting another 
PLP-dependent enzyme (Figure 2.20), IlvE, an amino acid synthetase that generates 
branched chain amino acids via transaminase activity.217 In addition to studies with purified 
enzymes, Scott has also had the time to perform other necessary control studies before 
taking JAB11P118 into unknown samples. One such study performed showed that enzyme 
labeling can be competed away by other inhibitors. In this study, a cocktail of three 
potential inhibitors were preincubated with purified IlvE before JAB11P118 was added to 
the sample.218 The inhibitors; DCS, -chlroalanine, and N-hydroxy alanine, were incubated 
in 10-fold excess for 30 minutes to irreversibly label PLP, blocking the ability for 
JAB11P118 to bind. Then, this sample and no-drug control were treated with JAB11P118 
and copper-catalyzed click chemistry was utilized to label proteins with a TAMRA 
fluorophore.219 Shown in Figure 2.21, the lack of fluorescent signal in pre-treated samples 
continued to indicate that JAB11P118 only labels with specificity. 
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Figure 2.20. Time and concentration dependent inhibition of IlvE with JAB11P118. Data 
collected by Scott Brody. 
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Figure 2.21. The selective labeling of IlvE by JAB11P118 with and without a competitive 
inhibitor. Data collected by Scott Brody. 
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As such, JAB11P118 has been taken into lysate experiments220 with a strain of E. 
coli overexpressing IlvE. Shown in Figure 2.22, our probe selectively labels proteins, 
labeling IlvE quite well as indicated by fluorescent imaging. Additionally, other bands can 
be noted in the wells that have sufficient labeling, indicating that a high concentration of 
the probe is needed in order to label proteins. These bands don’t just recapitulate the 
coomassie staining in which higher abundance proteins are labeled unselectively via 
reaction with the PAL. This finding is extremely encouraging, as we can trust the probe 
not to label proteins in high abundance that lack PLP-dependent action or other 
electrophilic residues. What has yet to be fleshed out at this point, however, is MS-based 
confirmation of proteins. The samples generated thus far have focused on adding 
fluorophores to proteomic samples, rather than an enrichment handle (i.e. biotin) to 
perform affinity purification of labeled samples. While this optimization is not necessarily 
easy, this workflow has been utilized by thousands of researchers, and its robustness for 
producing the desired enrichment results is unparalleled.220  
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Figure 2.22. The selective labeling of an IlvE overexpression strain in E. coli using varying 
concentrations of JAB11P118. Data collected by Scott Brody. 
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While JAB11P118 appears to be a promising probe towards understanding the 
PLP-dependent proteome, there are more experiments necessary to prepare this story for 
publication. Currently, we are optimizing enrichment studies using a tri-functional azide 
probe that can be used for affinity-purification and gel-electrophoresis imaging of the same 
exact lysate sample. This optimization should yield proteomic samples which can be 
analyzed with MS to identify proteins that our probe binds to, facilitating an understanding 
of the PLP-proteome. We will also use JAB11P118 to investigate a variety of known PLP-
dependent enzyme inhibitors, namely, we intend to investigate DCS both bacterial and 
mammalian tissues in order to better characterize this highly intriguing drug. At this time, 
these studies are still planned, and we hope to submit an initial report which characterizes 
this reverse polarity ABP. The bulk of this additional characterization will be performed 
by others in the pursuit of their own degrees, however, it felt necessary to cover this topic 
as the idea, design, and initial synthesis was derived from my own curiosity.  
2.5 Concluding remarks 
While the efforts presented in this chapter are still ongoing, the labor presented 
herein represents much of the proof-of-concept work necessary to begin much more 
arduous characterization of these systems. These molecules exhibit the breadth of work 
one encounters during their pursuit of new drug materials. While the emphasis of the 
Aldrich group, and much of the work that has been exhibited, has remained on the 
discovery of new drug materials for the eradication of Mtb, we’ve also branched out from 
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focusing on therapeutics to gaining new tools which can be used to identify, validate, and 
study new drug targets.  
The -lactam prodrug, 1, highlights the necessity of understanding how known 
drugs interact with the body. By building a better prodrug, it is very likely that this 
conjugate can deliver the actually toxic warhead at the site of action, limiting full-body 
exposure, reducing first-pass metabolism aimed at ejecting the drug, and in this case, 
circumvent known resistance mechanisms. Likely, this strategy can find use in alternate 
applications in the treatment of pathologies derived from infectious agents. Currently 
ongoing in our laboratories is the identification of such moieties that lack selectivity for 
Mtb, yet are effective against the microbe. Such warheads may be presently known to be 
toxic when administered chronically, but these properties should very well be alleviated by 
the addition of the -lactam promoiety. We also note that, in the case of Mtb, these 
molecules have the potential to not only act as target-directed pro-drugs, but also as dual 
warhead molecules that can even promote synergy within itself.  
My research has also highlighted the importance of understanding a molecule’s 
pharmacology. As highlighted within this text, characterization of the mechanism behind 
POA’s action yielded an unforeseen development that POA is in fact an antimetabolite-
type drug. POA is bioactivated by Mtb to an active antimycobacterial compound, one that 
we were able to identify and synthetically generate. While characterization of molecules 
that resemble these activated entities is still ongoing, we now know a rational route towards 
the design of molecules which have similar activity against Mtb which may replace PZA 
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in regions of the world with endemic resistance. For now, no resistance has been isolated 
or characterized, and the exact manner in which these molecules act is still unclear, much 
like the parent molecule. Our effort, however, does point us in the right direction for 
elucidating the mechanism of this very important drug while also yielding a new drug 
scaffold with which to develop new chemotherapeutics.  
Also discussed in this chapter was an entirely unrelated project to developing new 
antitubercular agents, in the development of a new ABP for PLP-dependent enzymes. This 
project was initiated by the desire to characterize the known TB drug DCS, but ultimately 
was a foray into a new frontier for chemical biology. The design of this nucleophilic probe 
meant to characterize a specific coenzyme was conceived when no such molecule had 
existed. This concept unfortunately took much time in order to manifest itself as a usable 
probe, since multiple generations of molecules were designed and then synthesized in order 
to find a chemical moiety that is amenable to use by both experts and trainees. With a 
molecule that targets the coenzyme that is also then capable of directly labeling the enzyme 
in place, we can now move to advance the characterization of molecules which target PLP-
dependent enzymes, many of which were approved by the FDA before such rigorous 
testing was required for an application to go into human patients.  
While these projects presented within this chapter are seemingly unrelated, each 
one hopes to address the nature and importance of selectivity in drug discovery programs. 
The first project presented really emphasizes the need for selectivity, as this prodrug 
strategy would fail if any basic serum esterase were able to cleave the promoiety from the 
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warhead. Selective release with a -lactam promoiety ensures the drug 1) gets to the site 
of action; 2) limits exposure of the drug to metabolic enzymes which deactivate the 
molecule; and 3) promotes on-target activity of the drug, should any off-target effects exist. 
The second part of this work potentially explains the reason for PZA/POA’s selectivity for 
Mtb, but also takes advantage of this selective molecule as a framework for another 
selective drug. The last part presented actually highlights a case in which a lack of 
selectivity isn’t necessarily a negative quality of a molecule. The development of this probe 
was based on the need for ubiquitous binding of the targeting moiety to an entire family of 
proteins, but only that specific family. The specificity for PLP-dependent enzymes is 
necessary to then understand how other molecules, anything from new chemical matter to 
FDA-approved entities, interact with this family of proteins. This new molecule can garner 
a new appreciation for the selectivity, or lack thereof, a molecule has to exert its 
pharmacological outcome. Taken together, this body of work has attempted to utilize 
selectivity for the rational design of new chemotherapeutics for a wide range of potential 
pathologies.  
2.6 Methods and materials 
2.6.1. General Remarks 
 All commercially available reagents were used without further purification. 
Molecular sieves were activated by heating at 200 °C under reduced pressure. 
Tetrahydrofuran (THF), toluene, and dichloromethane (CH2Cl2) were dispensed from an 
Inert® solvent dispensing system. Deuterated chloroform, CD3CN, and d6-DMSO were 
purchased from Cambridge Isotopes and used without further drying from 10 gram bottles 
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stored in a desiccator. Piperidine were dried over calcium hydride and freshly distilled 
under reduced pressure immediately before use. 1H, 13C, 19F, and 31P NMR spectra were 
recorded on a Varian 400 MHz spectrometer, Bruker Avance 500 MHz spectrometer, or 
Varian INOVA 600 MHz spectrometer with broadband probes. High resolution mass 
spectra were collected on a Bruker BioTOF II mass spectrometer using PEG or PPG 
internal standards. Sodium formate was sometimes added in order to facilitate ionization, 
frequently leading to characterization of the [M + Na+] masses.  Silica gel column 
chromatography was performed with silica gel (Dynamic Absorbents, 60A) or using a 
Teledyne-Isco RF-200 Combi-Flash system. Kugelrohr distillations were performed with 
a Buchi glass oven B-585 instrument. The experiments contained herein are not hazardous 
outside of the typical flammable/explosion hazards present with the usage of organic 
solvents, ethereal solvents such as Et2O and THF should always be assayed for the presence 
of peroxy by-products.  
 Pathogenic bacterial strains were graciously supplied by either the laboratory of 
Prof. Dr. Anthony Baugh, or Prof. Dr. Ryan Hunter. Biosafety-level 3 experiments were 
all performed by the Baughn laboratory according to their protocols. All reagents used in 
these and other biological experiments are described in each experimental section.  
2.6.2. Synthesis of -Lactam conjugate 1 
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 To a 500 mL round bottom flask equipped with a stir bar was added 7-
aminosephalosporanic acid (9.00 g, 33.2 mmol, 1 equiv), acetone (75 mL), and saturated 
NaHCO3 (225 mL). The slurry was stirred until gas evolution ceased, upon which the 
reaction was cooled to 0 °C. Phenylacetyl chloride (4.75 mL, 36.3 mmol, 1.1 equiv) was 
added in a dropwise manner over 15 minutes. The reaction was stirred and allowed to warm 
slowly to 23 °C. After 16 hours, the reaction was diluted with 100 mL of EtOAC, and the 
layers were separated. The aqueous layer was acidified with 2.0 N HCl (500 mL) and the 
reaction was with EtOAc (3 x 500 mL). The organic layer was evaporated under reduced 
pressure and the resultant gum was suspended in Et2O (200 mL). After 15 minutes of 
stirring, the suspension was filtered to yield compound 2 (11.66 g, 88%) as an off-white 
solid. Physical and spectrographic data matched previous reports.173 
 To a 100 mL round bottom flask equipped with a stir bar was added 2 (2.334 g, 6 
mmol, 1.00 equiv) and a solution of water (12 mL) and MeOH (9 mL). The suspension 
was cooled to -20 °C and a cooled solution (stored on ice) of 15% NaOH (2.4 mL) was 
added over 40 minutes and the reaction was allowed to continue stirring at -20 °C. After 
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20 minutes the reaction was neutralized to a pH of 6 with slow addition of 10% HCl (~1.0 
mL). Then, a solution of diphenyl diazomethane (1.222, 6.30 mmol, 1.05 equiv) in EtOAc 
(6 mL) was added to the reaction and an addition 1.2 mL of 10% HCl was added over 90 
minutes. The reaction was warmed to 0 °C and stirred for 2 hours, upon which the reaction 
mixture was filtered and washed with EtOAc (100 mL) to afford compound M1 (1.390 g, 
45%) as a snow-white solid. Physical and spectrographic data matched previous reports.221 
 To a 100 mL round bottom flask charged with M1 (1.000 g, 1.89 mmol, 1.0 equiv) 
was added pyrazinoic acid (259 mg, 2.09 mmol, 1.1 equiv), and anhydrous THF (38 mL). 
The flask was sealed, purged with argon, and cooled to -20 °C. Triphenylphosphine (550 
mg, 2.09 mmol, 1.1 equiv) was added, the flask was resealed, and the vessel was fitted with 
an argon balloon. After dissolution of the solid, diisopropyl azodicarboxylate (DIAD, 410 
L, 2.09 mmol, 1.1 equiv) was added in a dropwise manner over 20 minutes and the 
mixture was stirred for 2 hours. The mixture was diluted with EtOAc (40 mL), poured into 
ice water (80 mL), and the layers were separated. The aqueous layer was extracted with 
EtOAc (2 x 80 mL) and the organic layers were combine and evaporated directly onto SiO2. 
Purification using a Teledyne Isco Repi-Sep Combi-Flash Rf-200 MPLC afforded 
compound M2 (421. 8 mg, 36%) as a white solid. NMRs did show some impurity as 
triphenyl phosphine oxide readily co-elutes with M2. The product was carried forward to 
deprotection without further isolation and characterization: Rf = 0.10 (50:50 hexanes: 
EtOAc).  
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 To a 50 mL round bottom charged with M2 (270 mg, 0.435 mmol, 1 equiv) was 
added CH2Cl2 (18.9 mL) and the reaction was cooled to 0 °C. With stirring, both TFA (16.7 
mL, 217.5 mmol, 500 equiv) and triisopropylsilane (TIPS, 890 L, 4.35 mmol, 10 equiv) 
were added simultaneously and the reaction was allowed to stir at 0 °C. After 15 minutes, 
the reaction mixture was evaporated under reduced pressure, using both PhMe and Et2O as 
azeotropes to remove excess TFA. The crude mixture was evaporated onto celite and 
purified using a Teledyne Isco Repi-Sep Combi-Flash Rf-200 MPLC equipped with a 
Cyano-functionalized silica gel column using a gradient of 0 – 100% MeOH in CH2Cl2 to 
afford conjugate 1 (170.2 mg, 86%) as a tan-colored solid; 1H NMR (500 MHz, d6-DMSO) 
 13.80 (br, 1H), 9.24 (d, 1H, j = 1.5 Hz), 9.11 (d, 1H, j = 8.3 Hz), 8.92 (d, 1H, j = 2.4 Hz), 
8.84 (s, 1H), 7.30 (d, 4H, j = 8.4 Hz) 7.24 (d, 1H, j = 7.1 Hz), 5.69 (dd, 1H, j = 8.3, 4.8 
Hz), 5.24 (ABq, 2H, j = 135 Hz, j(AB) = 12.8 Hz), 5.06 (d, 1H, j = 4.8 Hz), 3.75 (d, 1H, j 
= 17.8 Hz), 3.64 (d, 1H, j = 17.7 Hz), 3.54 (ABq, 2H, j = 35 Hz, j(AB) = 13.9 Hz); 13C 
NMR (125 MHz, d6-DMSO) 171.42, 166.98, 148.66, 147.84, 146.21, 145.99, 143.31, 
143.03, 136.28, 129.48, 128.70, 126.96, 123.13, 71.84, 60.19, 59.51, 57.86, 42.05, 26.04, 
22.86; HRMS for C21H18N4NaO6S
+ [M+Na+]  calculated 477.0839; found 477.0847. 
2.6.3. General procedure for the assessment of minimum inhibitory constants 
 Susceptibility was determined by measuring the optical densities of cultures 
(OD600) for three separate experiments. The MIC was defined as the concentration of drug 
compound for which growth was inhibited by at least 90% compared to a no-drug control.  
2.6.3.1. MIC testing in Mycobacteria 
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 Susceptibility testing in Mycobacteria was carried out using M. tuberculosis strain 
H37Rv and M. bovis strain BCG. Cultures were grown in Middlebrook 7H9 medium 
(Difco) supplemented with 10% (v/v) oleic acid-albumin-dextrose-catalase (Difco), 0.2% 
(v/v) glycerol, and 0.05% tyloxapol. Each strain was first grown to mid-exponential phase 
in defined media and diluted to an OD600 of 0.01 in 5 mL of culture medium adjusted to the 
desired pH in 30 mL square Nalgene bottles (Fisher). Compounds were added to the media 
in concentrations ranging between 0.5 – 1600 g/mL as indicated. Cultures were incubated 
at 37 °C with shaking on a rotary platform at 100 rpm for 10 days (unless otherwise 
indicated). 
2.6.3.2. MIC testing in other pathogens 
 Susceptibility testing in ESKAPE pathogens included E. coli strain K12, A. 
baumannii stain AB5075, P. aeruginosa strains PAO1 and PA14, A. xylosoxidans strain 
MN-001, and S. aureus strain USA300. Cultures were grown in cation-adjusted Mueller-
Hinton broth (Sigma) without any additional components or adjustment to pH. Each strain 
was then grown to the end of mid-exponential phase (OD600 = 0.6 – 0.8) and diluted to an 
OD600 of 0.01 in 200 mL of culture medium in a clear-bottom 96-well plate (Corning). 
Compounds were added to the media in concentrations ranging between 0.5 – 1600 g/mL 
as indicated. Cultures were incubated at 37 °C without shaking for 16 – 18 hours. Control 
antibacterial compounds were added as follows: E. coli – Zosyn; A. baumannii – 
Rifampicin; P. aeruginosa – Tetracycline; A. xylosoxidans – Zosyn; and S. aureus – 
Tetracycline.  
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2.6.4. HPLC method for detection of 1, POA, and other metabolites 
2.6.4.1. HPLC Method for MS/MS studies 
Reverse-Phase HPLC was performed on a Shimadzu Nexera X2 instrument 
(Shimadzu Corporation, Kyoto, Japan) equipped with a Zorbax Eclipse XDB-C8, 5 micron, 
4.6 x 150 mm column (Agilent Technologies, Santa Clara, CA). The mobile phase 
consisted of 5 mM aqueous ammonium acetate, pH unadjusted, with 2% acetonitrile as the 
aqueous component (A) and 100% acetonitrile as the organic component (B). Solvents 
used were at least mass-spectrometry grade, and were prepared within 72 hours of use. 
Elution was performed following the gradient shown in Figure 2.21 at a flow rate of 0.5 
mL/min. Detection of mass transitions and polarities for MS experiments are described in 
section 2.6.5.  
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Figure 2.23. The HPLC method used to separate and detect analytes in purified and lysate 
samples. 
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An example of a chromatogram is shown in Figure 2.24 for POA and its tris-deuterated 
standard d3-POA to illustrate a once-difficult analyte to retain on columns within the 
Aldrich lab.  
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Figure 2.24. The zoomed-in trace chromatogram of POA and d3-POA using the Eclipse 
XDB-C8 column at 0.5 mL/min flowrate using the method defined in Figure 2.23.  
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2.6.4.2. HPLC coupled to a diode array detector (DAD) 
Reverse-Phase HPLC was performed on an Agilent 1260 instrument (Agilent 
Technologies, Santa Clara, CA) equipped with a Kinetex-C18, 2.6 micron, 4.6 x 100 mm 
column (Phenomenex, Torrence, CA). The mobile phase consisted of 0.1% (v/v) aqueous 
formic acid as the aqueous component (A) and 0.1% (v/v) formic acid solution in 
acetonitrile as the organic component (B). Solvents used were at least mass-spectrometry 
grade, and were prepared within 72 hours of use. Elution was performed following the 
gradient shown in Figure 2.25 at a flow rate of 0.4 mL/min. The DAD was set to monitor 
at wavelength 254 nm with 360 nm acting as a reference wavelength.  
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Figure 2.25. The HPLC method used to detect analytes with a DAD dection system. 
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2.6.5. MS methods for the detection of 1, POA, and other metabolites 
 MS/MS development was performed using ESI in either positive or negative mode 
using an ABSciEx QTRAP 5500 (Sciex Ltd, Framingham, MA) linear trap triple 
quadrupole mass spectrometer set to ± 4500 V monitoring the desired masses ± 0.5 Da. Dr. 
Bruce Witthuhn assisted with direct infusions used to determine the power for detecting 
unique mass transitions for each metabolite, analyte, and internal standard. Each transition 
for each analyte is summarized in Table 2.5, and these typical settings were used for all 
studies.  
  
449 
 
Table 2.5.The MS parameters used to detect and quantify analytes in MS experiments.  
Entry Compounda Retention (min)b DP (V)c CE (V)d CXP (V)e Q1 (Da) Q3 (Da) 
1 POA 2.50 -35 -20 -17 123 79 
2 d3-POA 2.51 -35 -20 -17 126 82 
3 Pantothenate 3.34 -35 -25 -17 218 88 
4 Ampicillin 1.72 +35 +20 +17 350 106 
5 CoA 0.6 +35 +30 +17 768 261 
6 Acetyl CoA 0.98 +35 +36 +17 810 303 
7 Malonyl CoA 0.66 +35 +30 +17 854 347 
8 1 2.29 +49 +10 +17 485 333 
aSynthetically-derived or purchased compounds; bRetention for purified compound; cDeclustering 
potential; dCollision energy; eExit potential.  
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2.6.6. General procedure for aqueous and serum stability assays 
2.6.6.1. HPLC method 
 The HPLC method employed in these studies is described in section 2.6.4.2. 
Conjugate 1 elutes at retention time 2.85 minutes, while POA elutes at retention time 2.50 
minutes. Single quad mass spectrometry was also added as an additional detection method 
to confirm peak identities. For compound 1, reliable masses detected in positive mode 
include m/z [M+H] = 453 and the dimeric compound at m/z [M+H] = 907. For POA, the 
compound could be reliably detected at m/z [M+H] = 125.  
2.6.6.2. Stability sssays and sample preparation182, 183 
 Both serum and aqueous stability studies were performed with known protocols 
within the laboratory. Briefly, 1 (50 M) was incubated at 37 °C in simulated gastric fluid 
(pH 1.3), 50 mM HEPES (pH 7.4), CD-1 female pooled mouse plasma, Sprague-Dawley 
female pooled rat plasma, and female pooled human plasma (BioChemed, Winchester, 
VA) in triplicate experiments. “Buffer” (980 L) was heated to 37 °C for five minutes, and 
then 20 L of a 10.0 mM DMSO solution was added, the mixtures were briefly vortexed 
(3-5 s), and incubated at 37 °C. 100 L aliquots were removed from the experiment at 0, 
10, 30, 60, 120, 240, and 360 minutes and immediately quenched with the addition of 100 
mL of pure CAN. The samples were vortexed, centrifuged (60 s at 15,000 x g) and 140 L 
of the supernatant were added to HPLC vials with a conical insert. Samples were analyzed 
using the method previously described with a 50 L injection volume.  
2.6.7. General procedure for the determination of POA release with BlaC 
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2.6.7.1 Transformation of BlaC Plasmid170 
After receipt of properly ligated blaC-pet28b plasmid, which encodes for BlaC 
without the first 40 amino acids, from the Blanchard laboratory at Einstein Medical Center, 
the plasmid was transformed into E. coli BL21-DE3 cells that are engineered to more 
effectively express protein. The standard heat shock protocol was used again for 
transformation (Biolabs, N. E, 2017). The resulting cell culture was diluted 10-fold, plated 
on LB-KAN (50 µg/mL) and grown overnight at 37o C. A single colony was picked from 
the resulting plate and used for all further expression and purification of BlaC. 
2.6.7.2. BlaC expression and purification170 
A 5mL starter culture was then used to inoculate 1 L LB media containing 50 
µg/mL kanamycin. The culture was shaken at 250 rpm and 37o C until OD600 reached 0.7 
(approximately 5 hours). The culture was induced with IPTG (0.5 mM) and incubated at 
18o C for 18 hours. The resulting cell culture was centrifuged at 5000 x g for 25 mins. The 
cell pellet obtained was resuspended in 20 mL lysis buffer (25 mM Tris-HCl, 300 mM 
NaCl, pH 7.5). The cells were lysed using sonication (40% amplitude, 2 minute on/5 
minute off, 4 cycles). The insoluble fraction was centrifuged at 42,000 x g for 45 min. The 
supernatant was collected, 2 mL Ni-NTA resin was added and the mixture was incubated 
for 15 min. at 4o C.  The mixture was then passed through a sintered glass filter and the 
resin was washed with 10 mL wash buffer (25 mM Tris-HCl, 250 mM NaCl, 20 mM 
imidazole, pH 7.5). BlaC was then eluted with 2.5 mL elution buffer (25 mM Tris-HCl, 
250 mM NaCl, 250 mM imidazole, pH 7.5). A buffer exchange was performed using an 
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Amicon centrifugation filter to store the BlaC in storage buffer (25 mM Tris-HCl, 250 mM 
NaCl, pH 7.5) and thrombin was added and incubated for 24 hours to cleave the His6 N-
terminal tag. Size exclusion chromatography was performed using a Superdex 200 Hi-Load 
26-60 column (Amersham Pharmacia Biotech) using 25 mM Tris-HCl, containing 300 mM 
NaCl, pH 7.5 as elution buffer. Protein was then stored at -80 °C in a solution containing 
buffer with 25% glycerol. The yield for expression and purification was determined by 
nanodrop to be 9 mg/L. 
2.6.7.3. LC-MS Biochemical Assay 
2.6.7.3.1. LC-MS method 
Reverse-Phase HPLC was performed on an Agilent 1260 instrument (Agilent 
Technologies, Santa Clara, CA) equipped with a Zorbax Eclipse XDB-C8, 5 micron, 4.6 x 
150 mm column (Agilent Technologies, Santa Clara, CA). The mobile phase consisted of 
0.1% (v/v) aqueous formic acid as the aqueous component (A) and 0.1% (v/v) formic acid 
solution in acetonitrile as the organic component (B). Solvents used were at least mass-
spectrometry grade, and were prepared within 72 hours of use. Elution was performed 
following the gradient shown in Figure 2.26 at a flow rate of 0.8 mL/min. The DAD was 
set to monitor at wavelength 254 nm with 360 nm acting as a reference wavelength and an 
Agilent 6120 single quadrupole mass spectrometer (Agilent Technologies, Santa Clara, 
CA) set to monitor the single ion m/z = 123 Da in negative mode.A sample chromatogram 
is shown in Figure 2.27.  
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Figure 2.26. The HPLC method used to quantify POA only in BlaC release assays.  
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Figure 2.27. A sample chromatogram for the detection of POA using the method described 
in this section.  
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2.6.7.3.2. BlaC release assay 
Assay components, including 50 mM NH4OAc, 1 (100 M), and BlaC (1 M) were 
combined to a total volume of 60 L and incubated for 30 min at 23 °C (for inhibited 
replicates, enzyme and clavulanate (100 M) were pre-incubated for 30 min at 23 °C prior 
to substrate addition). 60 L of acetonitrile was added to precipitate protein, and the 
mixture was centrifuged for 10 min at 4,000 rpm at 4 °C. Following centrifugation, 24 L 
of supernatant were removed and diluted with 108 L 8:5:5 water: MeOH: ACN. Release 
of pyrazinoic acid was analyzed by HPLC using the method described in section 2.6.7.3.1 
with confirmation by MS with a single quadrupole mass spectrometer set to single ion 
monitoring at m/z = 125. 
2.6.8. General procedure for targeted metabolomics 
2.6.8.1. Cell lysate preparation 
 A culture of Mtb is grown to its mid-exponential phase in Middlebrook 7H9 media. 
Then, 10 million colony forming units (cfus) are removed and placed on an agar plate 
embedded with the desired treatment condition. After 24 hours, the cells are harvested, 
taken up in 40:40:20 MeOH:ACN:H2O, lysed, and the crude lysate is filtered through a 3 
kDa amicon filter to remove cellular debris. The lysate is allowed to decontaminate 
according to BSL3 standards, and stored at -80 °C.  
2.6.8.2. Sample preparation 
 A 200 L sample of the cellular lysate is taken into a new vessel that can be fitted 
to a rotary evaporator. The sample is then evaporated under reduced pressure (300 mTorr) 
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at 40 °C for 2 minutes. The sample is then taken up in 5 mM aqueous ammonium acetate 
with 2% ACN containing 1 M ampicillin and 1 M d3-POA at 10-fold greater 
concentration (20 L) and transferred to a sample vial containing a conical insert for 
analysis by HPLC-MS/MS.  
2.6.8.3. Data analysis 
 The data was gathered and analyzed in Analyst software (ABSciex). Samples were 
compared to a standard curve generated for each metabolite of interest on the day of the 
experiment to account for instrument drift. Standard curves covered 15 nM to 5 mM ranges 
for each compound, and values of raw area were compared to the known internal standard. 
Figure 2.28 shows an example of a standard curve generated for POA. Areas gathered in 
lysate experiments were plotted against the standard curve generated to determine the final 
concentrations of analytes in lysate experiments.  
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Figure 2.28. The standard curve of MS/MS experiments for POA.  
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2.6.9. Synthesis of pyrazinoyl amide compounds 
2.6.9.1. Synthesis of 1-pyrazinoyl-benzotriazole189 
 To a 100 mL round bottom flask equipped with a stir bar was added pyrazinoic acid 
(POA, 620 mg, 5 mmol, 1.0 equiv), 1-(methanesulfonyl)-benzotriazole (985 mg, 5 mml, 1 
equiv), THF (25 mL), and then triethylamine (1.04 mL, 7.5 mmol, 1.5 equiv). The reaction 
was stirred and heated to reflux (~70 °C) for 18 – 24 hours. The reaction was cooled and 
then concentrated in vacuo. Then, the mixture was dissolved in CHCl3 (25 mL) and washed 
with a saturated solution of NaHCO3 (3 x 25 mL) followed by drying with MgSO4. The 
organic layer was evaporated under reduced pressure and the mixture was taken up in Et2O 
(100 mL). The solution was heated to reflux (40 °C) for 20 minutes and the precipitate was 
filtered and then dried under reduced pressure to yield 1-prazinoyl-benzotriazole (866.2 
mg, 78%) as a pink solid; physical properties and spectra matched previous reports.  
2.6.9.2. Synthesis of pyrazinoyl amides 
 To a 50 mL round bottom flask equipped with a stir bar was added 1-pyrazinoyl-
benzotriazole (225 mg, 1 mmol, 1 equiv), L-cysteine (133.1 mg, 1.1 mmol, 1.1 equiv), THF 
(10 mL), and N,N-diisopropylethylamine (Hünig’s base, 440 L, 2.5 mmol, 2.5 equiv). 
The reaction was heated to reflux (~70 °C) for 16 – 48 hours and then cooled. The reaction 
was then concentrated in vacuo and purified as specified. 
2.6.9.3. Purification of pyrazinoyl amide compounds 
2.6.9.3.1. Compounds 3, 5, 10, 11, 13, 15, 17: The reaction concentrate was taken up in 
50:50 water: MeCN with 0.1% formic acid (20 mg/mL) and purified using reverse-Phase 
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HPLC on preparatory scale. HPLC was performed on an Agilent 1260 instrument (Agilent 
Technologies, Santa Clara, CA) equipped with a Phenomenex Gemini C18, 10 micron, 
21.2 x 250 mm column (Phenomenex, Torrence, CA). The mobile phase consisted of 0.1% 
(v/v) aqueous formic acid as the aqueous component (A) and 0.1% (v/v) formic acid 
solution in acetonitrile as the organic component (B). Solvents used were at least HPLC 
grade, and were prepared within 72 hours of use. Elution was performed following the 
gradient shown in Figure 2.25 at a flow rate of 21 mL/min. The DAD was set to monitor 
at wavelength 254 nm with 360 nm acting as a reference wavelength. 
2.6.9.3.2. Compounds 4, 6, 7, 9, 12, 14, 16, 18: The reaction concentrate was dissolved in 
EtOAc and concentrated onto SiO2. The compounds were purified with a Teledyne Isco 
Combi-Flash RF 200 system using a gradient from 90:10 hexanes: EtOAc to 0:100 
hexanes: EtOAc with a 10% increase in EtOAc every six column volumes.  
2.6.9.3.3. Compound 8: The reaction concentrate was dissolved in EtOAc and filtered. The 
precipitate was dried further in vacuo to yield compound 8 as a white solid.  
2.6.9.4. Characterization of biologically-evaluated pyrazinyl amides: 
N-Pyrazinoyl-L-cysteine: 1H (500 MHz, d6-DMSO)  13.17 (br, 1H), 9.22 (s, 1H), 8.96 (s, 
1H), 8.93 (s, 1H), 8.80 (s, 1H), 4.69 (q, 1H, j = 4.5 Hz), 3.09–3.04 (m, 2H), 2.09 (s, 1H); 
13C (125 MHz, d6-DMSO)  171.67, 163.25, 148.42, 144.53, 143.96, 54.86, 25.69. 
N-Pyrazinoyl-L-cysteine-methyl ester: 1H (500 MHz, CDCl3)  9.39 (s, 1H), 8.79 (s, 1H), 
8.60 (br, 2H), 5.09 (dt, 1H, j = 7.6 Hz), 3.84 (s, 3H), 3.14 (m, 2H), 1.46 (t, 1H, j = 8.9 Hz); 
13C (125 MHz, CDCl3)  170.15, 162.88, 147.70, 144.46, 142.85, 53.72, 52.97, 26.94. 
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N-Pyrazinoyl-L-alanine: 1H (500 MHz, CDCl3)  9.40 (s, 1H), 8.78 (d, 1H, j = 1.8 Hz), 
8.57 (s, 1H), 8.21 (br, 1H), 4.83 (t, 1H, j = 7.2 Hz), 1.62 (d, 3H, j = 7.2 Hz); 13C (125 MHz, 
CDCl3)  163.13, 147.86, 144.46, 142.77, 17.96. 
N-Pyrazinoyl-L-alanine-methyl ester: 1H (500 MHz, CDCl3)  9.40 (s, 1H), 8.77 (d, 1H, j 
= 1.8 Hz), 8.56 (s, 1H), 8.27 (br, 1H), 4.82 (quin, 1H, j = 7.3 Hz), 3.80 (s, 3H), 1.56 (d, 3H, 
j = 6.7 Hz); 13C (125 MHz, CDCl3)  172.98, 162.58, 147.48, 144.44, 142.69, 52.64, 48.12, 
29.72, 18.46.  
N-Pyrazinoyl-cysteamine: 1H (500 MHz, CDCl3)  9.41 (s, 1H), 8.77 (d, 1H, j = 2.1 Hz), 
8.55 (s, 1H), 3.69 (m, 2H), 2.81 (m, 2H), 1.46 (t, 1H, j = 7.9 Hz); 13C (125 MHz, CDCl3) 
 163.12, 147.44, 144.48, 142.61, 42.35, 24.62. 
N,N-Di-pyrazinoyl-cystamine: 1H (500 MHz, d6-DMSO)  9.18 (s, 2H), 9.08 (t, 2H, j = 
5.5 Hz), 8.87 (s, 2H), 8.73 (s, 2H), 3.63 (q, 4H, j = 6.5 Hz), 2.98 (t, 4H, j = 6.9 Hz); 13C 
(125 MHz, d6-DMSO)  163.39, 148.05, 145.06, 143.90, 38.76, 37.35. 
N-Pyrazinoyl-methylamine: Purified as specified in section 2.6.9.3.2. All spectra and 
physical properties matched previous reports.221 
2.6.10. MS methods for the detection of 3, 5, 7, and 8: MS/MS development was 
performed using ESI in either positive or negative mode using an ABSciEx QTRAP 5500 
(Sciex Ltd, Framingham, MA) linear trap triple quadrupole mass spectrometer set to ± 4500 
V monitoring the desired masses ± 0.5 Da. Dr. Bruce Witthuhn assisted with direct 
infusions used to determine the settings for detecting unique mass transitions for each 
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metabolite, analyte, and internal standard. Each transition for each analyte is summarized 
in Table 2.6, and these typical settings were used for all studies.   
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Table 2.6. The MS parameters used to detect and quantify analytes in MS experiments.  
Entry Compounda Ret (min)b DP (V)c CE (V)d CXP (V)e Q1 (Da) Q3 (Da) 
1 3 4.94 -35 -22 -17 226 148 
2 5 4.30 -35 -20 -17 194 122 
3 7 5.87 -35 -21 -17 182 122 
4 8 5.21 +35 +21 +17 365 182 
aSynthetically-derived compounds; bRetention for purified compound; cDeclustering potential; dCollision 
energy; eExit potential. 
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2.6.11. Assessment of PncA activity on novel compounds 
2.6.11.1. Acquisition of genetic material 
A synthetic gene encoding for pncA was ordered from integrated DNA technologies 
(Coralville, IA). Restriction enzymes, and plasmid buffers were ordered from New 
England Biolabs (Ipswich, MA). All biological buffers and reagents were obtained from 
Sigma-Aldrich (St. Louis, MO). DNA isolation kits (Qiagen Sciences, Germantown, MD), 
E. coli DH5 alpha and BL21DE3 competent cells were prepared as described (Biolabs, N. 
E, 2017).  
2.6.11.2. Cloning of PncA into pet28b(+) 
Codon optimization was performed for gene expression in E. coli using the 
protocols from integrated DNA technologies (Integrated DNA Technologies, IA, 2017). 
PncA was ligated into a pet28b(+) plasmid using protocols portrayed by Biolabs, N. E, 
2017. The pet28b(+) plasmid was linearized using the restriction endonucleases Xhol and 
Ndel. Xhol recognized the DNA sequence CTCGAG and cleaves after C-1 (Theriault et 
al., 1985). Ndel recognizes the DNA sequence CATATG and cleaves after A-1 (Watson et 
al., 1983). The ends of pncA was also cut using the same restriction endonucleases to 
compliment the plasmid sticky ends. Using T4 DNA ligase in the presence of linear 
pet28b(+) and pncA yielded cyclized plasmids containing the gene of interest. Heat 
inactivation at 65o C of restriction endonucleases and ligase was performed after every 
step. 
2.6.11.3. Transformation of PncA plasmids 
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After conformation of properly ligated PncA-pet28b the plasmid was transformed 
into E. coli BL21-DE3 cells that are engineered to more effectively express protein. The 
standard heat shock protocol was used again for transformation (Biolabs, N. E, 2017). The 
resulting cell culture was diluted 10-fold, plated on LB-KAN (50 µg/mL) and grown 
overnight at 37o C. A single colony was picked from the resulting plate and used for all 
further expression and purification of pncA. 
2.6.11.4. PncA expression and purification190 
A 5mL starter culture with E. coli overexpressing pncA was then used to inoculate 
1 L LB media containing 50 µg/mL kanamycin. The culture was shaken at 250 rpm and 
37o C until OD600 reached 0.8 (approximately 6 hours). The culture was induced with IPTG 
(0.5 mM) and incubated at 16o C for 18 hours. The resulting cell culture was centrifuged 
at 5000xg for 20 mins. The cell pellet obtained was resuspended in 20 mL lysis buffer (50 
mM HEPES, 250 mM NaCl, 5 mM imidazole, pH 7). The cells were lysed using sonication 
(50% amplitude, 1 minute on/1 minute off, 4 cycles). The insoluble fraction was 
centrifuged at 42,000xg for 45 min. The supernatant was collected, 2 mL Ni-NTA resin 
was added and the mixture was incubated for 15 min. at 4o C.  The mixture was then passed 
through a sintered glass filter and the resin was washed with 10 mL wash buffer (50 mM 
Tris, 250 mM NaCl, 60 mM imidazole, pH 8). PncA was then eluted with 2.5 mL elution 
buffer (50 mM Tris, 250 mM NaCl, 250 mM imidazole, pH 8). A buffer exchange was 
performed using an Amicon centrifugation filter to store the PncA in storage buffer (20 
mM Tris, 250 mM NaCl, pH 7.4) at -20 oC. The yield for expression and purification was 
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determined by nanodrop to be 10 mg/L.  Relative purity of the protein was determined by 
SDS-PAGE. 
2.6.11.5. Continuous Coupled Biochemical Assay190 
Initial velocities were determined by monitoring change in absorbance at 340 nM 
from the conversion of NADH to NAD+ by glutamic dehydrogenase (GDH). GDH utilizes 
ammonia to convert alpha-ketoglutarate to glutamate. The cofactor NADH is used and 
NAD+ is generated as a byproduct. Therefore, as PncA converts pyrazinamide to 
pyrazonoic acid, the ammonia generated is used by GDH, coupling amide hydrolysis to 
NAD+ generation. The typical assay uses 5 mM alpha-ketoglutarate, 8 units of GDH, 200 
µM NADH, 35 nM PncA and varying concentrations of amide substrates. The reaction is 
run in 100 µL assay buffer (100 mM HEPES, pH 7.5) in a 96 well clear bottom plate 
(Corning) in triplicate. Enzyme activities were calculated using the molar extinction 
coefficient of NADH (ε340 = 6220 M-1cm-1) and GraphPad Prism® was used to graph 
Michaelis-Menten curves to determine KM and kcat values. 
2.6.11.6. LC-MS Biochemical Assay 
The LC-MS based assay was decided upon to test analogs that were altered off the 
pyrazine amide; thus, when hydrolyzed by PncA, would not yield the necessary ammonia 
for use in the coupled assay. The output of this assays is pyrazinoic acid which can be 
detected by the 123 m/z [M-H] anion. The typical assay uses 30 nM PncA, and varying 
substrate concentrations. The assay is performed in 100 µL buffer (20 mM Tris, pH 7.5). 
The reactions were initiated with addition of PncA then allowed to incubate at room 
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temperature for 10 minutes. After incubation the reaction is terminated with addition of 
900 µL crash solution (1:1 ACN:MeOH). The resulting mixture is then vortexed for 10 
seconds and centrifuged at 5000 rpm for 5 minutes. 100 µL of the supernatant is then 
collected, filtered and submitted for LC-MS. 
2.6.12. Synthesis of CDB-I-143 and JAB11P118 
2.6.12.1. Synthesis of CDB-I-143 
 To a 25 mL round bottom flask charged with pyruvic acid (0.75 mL, 10.65 mmol, 
1.0 equiv) and equipped with a magnetic stir bar was added CH2Cl2 (10 mL), 4-
(dimethylamino)-pyridine (0.130 g, 1.06 mmol, 0.1 equiv), and 6-heptyne-1-ol (2.74 mL, 
20.00 mmol, 1.9 equiv). Then, while stirring at 0 °C, EDC-HCl (2.416 g, 11.71 mmol, 1.1 
equiv) was added slowly in a batch-wise manner. The reaction was warmed to 23 °C and 
allowed to stir at this temperature. After 3 hours, the reaction contents were poured out and 
the reaction vessel was cleaned with 10 mL of CH2Cl2. The combined organic layers were 
washed with 0.5 M HCl (20 mL) and saturated NaHCO3 (20 mL), dried over MgSO4, and 
evaporated. The crude material was checked by NMR to be pure hept-6-yn-1-yl-2-oxo-
propionate (0.6606 g, 33% yield) as a colorless oil: Rf = 0.4 (90:10 hexanes: EtOAc); 
1H 
NMR  
 To a 100 mL round bottom flask charged with hept-6-yn-1-yl-2-oxo-propionate 
(0.2000 g, 1.09 mmol, 1.0 equiv) and equipped with a magnetic stir bar was added 
hydroxylamine monohydrate (109 mg, 1.64 mmol, 1.5 equiv), EtOH (20 mL), and then 
pyridine (4 mL). The reaction was heated to 85 °C for 2 hours and then cooled. Water (25 
467 
 
mL) was added and the reaction was extracted with CH2Cl2 (4 x 25 mL), dried over MgSO4, 
and the solvent was evaporated under reduced pressure yielding the oxime product as a 
viscous oil contaminated with a bit of pyridine: Rf = 0.6 (85:15 hexanes: EtOAc). The crude 
material was carried on without further purification or characterization to the next step.  
 To a 100 mL round bottom flask charged with oxime (207 mg, 1.01 mmol, 1.00 
equiv) and equipped with a magnetic stir bar was added AcOH (10 mL) and THF (5 mL). 
The reaction was cooled to 0 °C with stirring while Na(CN)BH3 (79 mg, 1.26 mmol, 1.25 
equiv) was added slowly. The reaction was allowed to warm to 23 °C and stirred for 24 
hours. 2 N NaOH (10 mL) was then added to the reaction slowly and the aqueous mixture 
was extracted with CH2Cl2 (4 x 25 mL), dried with MgSO4, and evaporated under reduced 
pressure. Purification on Teledyne Isco Combi-Flash RF® system afforded CDB-I-143 
(137 mg, 68%) as a white solid: Rf = 0.4 (85:15 hexanes: EtOAc); 
1H NMR (400 MHz, d6-
DMSO)  12.19 (s, 1H), 4.11 (t, 2H, j = 6.5 Hz), 2.7 (t, 1H, j = 2.6 Hz), 2.12 (td, 2H, j = 
6.7 Hz), 1.89 (s, 3H), 1.62 (quin, 2H, j = 6.9 Hz), 1.46 – 1.42 (m, 4H), 1.23 (s, 1H); 13C 
NMR (100 MHz, d6-DMSO) 164.43, 148.15, 84.78, 71.66, 65.02, 27.98, 25.09, 18.02, 
10.95; HRMS for C10H17NNaO3
+ [M+Na+]  calculated 222.1101; found 222.1109. 
2.6.12.2. Synthesis of JAB11P118 
 To a 20 mL scintillation vial equipped with a magnetic stir bar was added was added 
CH2Cl2 (4 mL),  2-bromo propionic acid (30.6 mg, 0.20 mmol, 1.0 equiv), 2--(but-3-yn-
1-yl)-3H-diazirin-3-yl-ethan-1-amine (30.1 mg, 0.22 mmol, 1.1 equiv), triethylamine (22 
L, 0.30 mmol, 1.5 equiv), and 1-hydroxybenzotriazole (HOBt, 30.6 mg, 0.20 mmol, 1.0 
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equiv). The reaction vessel was wrapped with foil to exclude light and the mixture was 
cooled to 0 °C with stirring. EDC-HCl (42 mg, 0.22 mmol, 1.1 equiv) was then added, the 
vessel was sealed, and allowed to warm to 23 °C. After 18 hours, the reaction was diluted 
to 20 mL total volume with CH2Cl2 and then washed with cold (stored at 4 °C) 1.0 N HCl 
(20 mL), saturated NaHCO3 (20 mL), and dried with anhydrous MgSO4, and evaporated 
under reduced pressure. The crude material was checked by NMR and contained some 
HOBt impurity. The crude material was not further isolated nor characterized and was 
carried onto the next synthetic step.  
 To a 2-dram vial charged with the crude material from the previous synthetic step 
(54.2 mg, 0.20 mmol, 1.0 equiv) and equipped with a stir bar was added methanol (2 mL), 
triethylamine (22 L, 0.30 mmol, 1.5 equiv), and then O-tButyldimethylsilyl-
hydroxylamine (44.1 mg, 0.30 mmol, 1.5 equiv). The reaction vessel was again covered in 
foil to exclude light and heated to 50 °C. After 71 hours, the solvent and volatile 
components were evaporated under reduced pressure. The crude reaction mixture was 
dissolved in CH2Cl2 (10 mL) and then treated 2.0 N HCl (10 mL). The mixture was stirred 
vigorously under Schotten-Baumann conditions for 15 minutes and then the organic layer 
was isolated, dried with MgSO4, and evaporated under reduced. Purification on Teledyne 
Isco Combi-Flash RF® system (with UV detection turned off) afforded JAB11P118 (32.3 
mg, 72%) as a white solid: Rf = 0.2 (90:10 hexanes: EtOAc); 
1H NMR (500 MHz, CDCl3) 
 6.47 (br, 1H), 4.41 (q, 1H, j = 7 Hz), 3.15 (q, 2H, j = 6.9 Hz), 2.03 (m, 3H), 1.90 (d, 3H, 
j = 7.1 Hz), 1.73 (t, 2H, j = 6.7 Hz), 1.67 (t, 2H, j = 6.8 Hz), 1.26 (s, 1H); 13C NMR (125 
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MHz, CDCl3) 169.32, 82.62, 69.50, 45.19, 35.06, 32.32, 26.69, 26.24, 23.17, 13.23; 
HRMS for C10H17N4O2
+ [M+H+]  calculated 225.1346; found 225.1341. 
2.6.13. Assessment of CDB-I-143 binding to BioA 
2.6.13.1. BioA and BioD acquisition212 
 Both BioA and BioD purified proteins were graciously supplied by both Dr. Feng 
Liu and Dr. Carter Eiden which were expressed and purified according to the published 
procedure.  
2.6.13.2. General continuous assay setup for BioA 
To a black 384-well plate with a clear bottom (Corning) was added 69 L total of 
LDH (20 units), Phospho-enoylppyruvate (PEP, 20 mM), PK (96 units), NADH (113 nM), 
TCEP (5 mM), S-adenosyl methionine (SAM, 50 mM), KAPA (625 M), and ATP (50 
mM). Then 1 L of preincubated solutions (varying times) of CDB-I-143 (varying 
concentration) with BioA (1 M final concentration) and BioD (15 M final concentration) 
were added to initiate the reaction and the plate was added to the plate reader. UV 
absorbance at 340 nm (340 = 6220 M-1 cm-1) was monitored to determine the use of NADH 
in this coupled assay system. 100 nM of FL-1-169 (Figure 2.1; graciously supplied by Dr. 
Feng Liu) was used as a positive control for full inhibition of BioA.  
2.6.14. Expression and purifiaction of IlvE218  
A 5mL starter culture with E. coli overexpressing IlvE was then used to inoculate 
1 L LB media containing 50 µg/mL kanamycin. The culture was shaken at 250 rpm and 
37o C until OD600 reached 0.6 (approximately 3 hours). The culture was induced with IPTG 
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(0.1 mM) and incubated at 16 o C for 18 hours. The resulting cell culture was centrifuged 
at 4000 x g for 15 mins at 4 °C. The cell pellet obtained was resuspended in 20 mL lysis 
buffer (20 mM HEPES, 200 units of DNase, Complete® protease inhibitor tablet-EDTA 
free (Roche), pH 7.5). The cells were lysed using sonication (50% amplitude, 30 seconds 
on/30 seconds off, 5 cycles). The insoluble fraction was centrifuged at 42,000xg for 60 
min. The supernatant was collected, 2 mL Ni-NTA resin was added and the mixture was 
incubated for 15 min. at 4o C.  The mixture was then passed through a sintered glass filter 
and the resin was washed with 10 mL wash buffer (20 mM HEPES, 500 mM NaCl, 1 mM 
DTT, pH 7.5). IlvE was then eluted with 2.5 mL elution buffer (20 mM HEPES, 300 mM 
imidazole, 1 mM DTT, pH 7.5). A buffer exchange was performed using an Amicon 
centrifugation filter to store the IlvE in storage buffer (20 mM HEPES, 300 mM NaCl, pH 
7.5) at -20 oC. The yield for expression and purification was determined by nanodrop to be 
10 mg/L. Size exclusion chromatography was performed using a Superdex 200 Hi-Load 
26-60 column (Amersham Pharmacia Biotech) using 20 mM HEPES, containing 300 mM 
NaCl, pH 7.5 as elution buffer. Protein was then stored at -80 °C in a solution containing 
buffer with 25% glycerol.  
2.6.15. General continuous assay setup for IlvE218 
To a clear 96-well plate with a clear, flat, bottom (Corning) was added 180 L total 
of GDH (8 units), PLP (40 nM), L-glutamate (15 mM), NADH (160 nM), NH4Cl (1 mM), 
and -ketocaproate (2 mM). Then 20 L of preincubated solutions (varying times) of CDB-
I-143 or JAB11P118 (varying concentration) with IlvE (40 nM final concentration) were 
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added to initiate the reaction and the plate was added to the plate reader. UV absorbance at 
340 nm (340 = 6220 M-1 cm-1) was monitored to determine the use of NADH in this coupled 
assay system.  
2.6.16. General procedure for labeling protein and cellular lysates with JAB11P118 
2.6.16.1. Generation of cellular lysates220 
 Following a similar procedure as described in section 2.6.14, cellular lysates were 
generated from over-expression strains with or without IPTG induction. The resulting cell 
culture was centrifuged at 4000 x g for 15 mins at 4 °C. The cell pellet obtained was 
resuspended in 20 mL lysis buffer (20 mM HEPES, 200 units of DNase, Complete® 
protease inhibitor tablet-EDTA free (Roche), pH 7.5). The cells were lysed using 
sonication (50% amplitude, 30 seconds on/30 seconds off, 5 cycles). The insoluble fraction 
was centrifuged at 42,000xg for 60 min. The supernatant was collected and buffer exchange 
was performed using amcon-type filtration with centrifugation (3 cycles), exchanging into 
phosphate-buffer saline (PBS) solution.  
2.6.16.2. Labeling samples220 
 The cellular lysate or purified protein samples were each concentrated to 6 mg/mL 
of protein content, confirmed using a nano-drop UV-spectrophotometer. Then, JAB11P118 
(200 M) is added and the solution is vortexed (power level 3) for 3 seconds to mix the 
components. The mixtures are allowed to stand at 23 °C for 1 hour. Then, each sample is 
irradiated with UV light at 365 nm (hand lamp, long wave) for 1 hour at 4 °C. Then to the 
mixtures is added TAMRA-N3 (final concentration 1 mM), TCEP (final concentration 1 
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mM), TBTA (1:4 DMSO:tBuOH, final concentration 1 mM), and CuIISO4 (final 
concentration 1 mM). The solution is vortexed (power level 9) and allowed to stand at 23 
°C for 1 hour with vortex mixing every 30 minutes. The proteins will begin to precipitate 
and the solution will appear cloudy. The samples are then diluted to 2 mg/mL protein 
content and analyzed via gel electrophoresis (SDS-PAGE). Labeling was monitored with 
a Typhoon (GE) gel imager set to excite at 532 nm and detect at 670 nm for TAMRA 
fluorophore and cross-examined with coomassie staining to confirm protein content.  
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Appendix I: NMR 
31P Spectra (5PDBPO): d8- THF 
 
 
 
 
31P Spectra (5-phenyldibenzophosphole): d8- THF 
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31P Spectra (1PPO): d8- THF 
 
 
 
 
31P Spectra (1-phenylphospholane): d8- THF 
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Benzyl 4-nitrobenzoate: 1H, 13C  
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4-Trifluoromethylbenzyl 4-nitrobenzoate: 1H, 13C, 19F 
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4-Methoxybenzyl 4-nitrobenzoate: 1H, 13C  
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Geranyl 4-nitrobenzoate: 1H, 13C 
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3-(4-Fluorophenyl)propyl 4-nitrobenzoate: 1H, 13C, 19F 
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Propargyl 4-nitrobenzoate: 1H, 13C 
 
 
 
  
  
491 
 
(R)-1-Phenylethyl 4-nitrobenzoate: 1H, 13C 
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(R)-1-Ethoxy-1-oxopropan-2-yl 4-nitrobenzoate: 1H, 13C 
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Phenethyl 4-nitrobenzoate: 1H, 13C 
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Phenylethyl N-fluorenylmethyloxycarbonylvalinate: 1H, 13C 
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1-Nitro-4-phenylethoxybenzene: 1H, 13C 
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tert-Butyl phenethyl(sulfamoyl)carbamate: 1H, 13C 
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N-tert-Butoxycarbonylhomoserine lactone: 1H, 13C 
 
 
 
 
  
498 
 
tert-Butyl (2’,3’-O-isopropylidene-5’-deoxyinosin-5’-yl)(sulfamoyl)]carbamate: 1H, 13C  
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(3,5-bis(trifluoromethyl)phenyl)diphenylphosphine oxide: 1H, 13C, 31P, 19F NMR
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(2’,6’-dimethoxy-[1,1’-biphenyl]-2-yl)dicyclohexylphosphine oxide: 1H, 13C, and 31P 
NMR
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(9,9-Dimethyl-9H-xanthene-4,5-diyl)-bis-diphenylphosphine oxide: 1H, 13C, and 31P 
NMR
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[4-(Dimethoxymethyl)phenyl]diphenylphosphine oxide: 1H, 13C, and 31P NMR 
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507 
 
4-(Diphenylphosphine oxide)benzaldehyde: 1H, 13C, and 31P NMR
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509 
 
1,1’-Bis(diphenylphino oxide)ferrocene: 1H, 13C, and 31P NMR
510 
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Triphenylphosphine: 1H and 31P NMR
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(4-(Dimethylamino)phenyl)diphenylphosphine: 1H and 31P NMR
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(4-(Methoxy)phenyl)diphenylphosphine: 1H and 31P NMR
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(4-(Trifluoromethyl)phenyl)diphenylphosphine: 1H, 31P, and 19F NMR
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(3,5-Bis(trifluoromethyl)phenyl)diphenylphosphine: 1H, 31P, and 19F NMR
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Tris-(3,5-(trifluoromethyl)phenyl)phosphine: 1H, 31P, and 19F NMR
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Tricyclohexylphosphine: 1H NMR
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([1,1’-biphenyl]-2-yl)dicyclohexylphosphine: 1H and 31P NMR
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(2’,6’-dimethoxy-[1,1’-biphenyl]-2-yl)dicyclohexylphosphine: 1H and 31P NMR
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1,2-Bis(diphenylphosphino)ethane: 1H and 31P NMR
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rac-2,2’-Bis(diphenylphosphino)-1,1’-binapthlene: 1H and 31P NMR
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(9,9-Dimethyl-9H-xanthene-4,5-diyl)-bis-diphenylphosphine: 1H and 31P NMR
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(R,R)-DIPAMP: 1H and 31P NMR
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[4-(Dimethoxymethyl)phenyl]-diphenylphosphine: 1H, 13C, and 31P NMR
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4-(Diphenylphosphino)-benzaldehyde: 31P NMR
 
(2,5-Dihydroxyphenyl)diphenylphosphine: 1H, 13C, and 31P NMR
530 
 
 
531 
 
1,1’-Bis(diphenylphino)ferrocene: 1H and 31P NMR
 
 
 
 
532 
 
Methyl-2-(diphenylphosphino)benzoate: 1H and 31P NMR
 
533 
 
(4-(Benzyloxy)phenyl)diphenylphosphine: 1H and 31P NMR
 
 
 
 
534 
 
Diphenylphosphine: 31P NMR
 
DI-tert-butylphosphine (@ 110 °C): 31P NMR
 
535 
 
Di-tert-butylphosphine (@ 23 °C): 31P NMR
 
  
536 
 
1,3-Diphenyl-disiloxane (DPDS): 1H, 13C 
 
 
  
537 
 
1,1,3,3-Tetraphenyl-disiloxane (TPDS): 1H, 13C 
 
 
  
538 
 
1,3-Di-n-hexyl-disiloxane (DHDS): 1H, 13C 
 
 
  
539 
 
1,3-Dimethyl-1,3-diphenyl-disiloxane (DMDPDS): 1H, 13C 
 
  
540 
 
Ethyl-(E)-cinnamate: 
 
(E)-1,3-Diphenyl-propen-3-one:  
 
  
541 
 
Ethyl (E)-p-methoxycinnamate:  
 
Ethyl (E)-p-cyanocinnamate:  
 
  
542 
 
Methyl (E)-3-(p-cyanophenyl)-2-methylpropenoate:  
 
Ethyl (E)-p-nitrocinnamate:  
 
  
543 
 
Ethyl (E)-m-nitrocinnamate: 
544 
 
Ethyl (E)-3-(benzo[b]thiophen-2-yl)acrylate: 
 
  
545 
 
Ethyl (E)-3-(benzo[b]furan-2-yl)acrylate:  
  
546 
 
Ethyl (E)-m-bromocinnamate: 
 
  
547 
 
Benzyl (E)-cinnamate: 
  
548 
 
Ethyl (2E, 4E)-5-phenylpenta-2, 4-dienoate:  
 
  
549 
 
(E)-Cinnamonitrile:  
 
  
550 
 
Ethyl-(E)-3-(cyclohex-3-en-1-yl)acrylate: 
 
  
551 
 
Ethyl-(E)-Dodec-2-ene: 
 
  
552 
 
Ethyl-(E)-3-(pyridine-2-yl)acrylate: 
  
553 
 
(E)-3-nitrostillbene:  
 
  
554 
 
(E)-4-Cyano-3-nitrostillbene: 
 
  
555 
 
Benzylamine:  
 
m-Nitrobenzylamine:  
 
  
556 
 
p-Methoxybenzylamine:  
 
(2S)-1-Amino-3-chloro-2-propanol: 
 
  
557 
 
N-Benzylpiperideine: 
 
1-(4-bromophenyl)-N,N-dimethylmethanamine 
 
  
558 
 
Tribenzylamine 
 
 
  
559 
 
N,N-dimethylbenzylamine 
 
  
560 
 
1-(4-nitrobenzyl)piperidine 
 
  
561 
 
1-cinnamylpiperidine 
 
  
562 
 
1-boc-4-benzylpiperazine 
 
  
563 
 
N,N-dimethyl-1-(o-tolyl)methanamine 
 
  
564 
 
1-Bromobutane: 
 
1-Bromo-2-phenylethane: 
 
  
565 
 
1-Bromo-1-phenylethane: 
 
  
566 
 
Conjugate 1: 
 
  
567 
 
 
  
568 
 
Compound 3: 
 
  
569 
 
Compound 4: 
 
  
570 
 
Compound 5: 
 
  
571 
 
Compound 6: 
 
  
572 
 
Compound 7: 
 
  
573 
 
Compound 8: 
  
574 
 
CDB-I-143: 
 
 
  
575 
 
JAB11P118: 
 
 
  
576 
 
Appendix II: Coordinate outputs 
Output information for silanes considered in the Mulliken charge study is included below. 
Silane M06-2X B3LYP 
triethylsilane 
Si -1.2425507588 0.127348167 0.0289971408 
C 0.6319930165 -0.0843367981 0.1387286696 
H 0.9230868103 -0.9373216261 -0.4872854261 
H 1.1059095841 0.7976806231 -0.3123968678 
C 1.1464584175 -0.285113758 1.5705432535 
H 0.8916951743 0.5663405178 2.2102402769 
H 0.7069178142 -1.1785621288 2.0254284479 
H 2.2344851755 -0.3995607816 1.598934147 
C -1.7847392138 0.108311216 -1.7814760531 
H -1.1580194659 0.8231080524 -2.3316191358 
H -1.5527560336 -0.8796250393 -2.1989023219 
C -3.2668490214 0.4398378267 -1.999890046 
H -3.9150229915 -0.2468984774 -1.4446307967 
H -3.498741304 1.4554194413 -1.6621364477 
H -3.5458484805 0.3750729634 -3.0562066688 
C -1.7883619178 1.7329105393 0.8740168702 
H -1.0671483197 1.9797617523 1.6633371303 
H -1.7183941451 2.5475788666 0.1402615318 
C -3.2027672997 1.6776793751 1.4698439567 
H -3.9492895606 1.4152897601 0.7135432856 
H -3.2638485583 0.9216487069 2.2586160747 
H -3.4973151597 2.6380418383 1.9046883866 
H -1.8954737621 -1.0110010371 0.742814592 
SCF E = -527.628793965  
Si 0.1561039569 -0.1896116898 
0.2385895174 
C 1.86 74708158 -0.848891195 -
0.2667238614 
H 1.9645246471 -1.8654198963 
0.139 3704164 
H 1.8840060092 -0.9639512998 -
1.360103267 
C 3.067249713 0.0044 435504 
0.1855864949 
H 3.0329546176 1.0125255671 -
0.243091433 
H 3.09165 66044 0.1135337348 
1.2759363936 
H 4.01927746 -0.4453031734 -
0.12051530 54 
C -1.1485032846 -1.5040169584 -
0.1969506857 
H -1.1014917857 -1.6801 305953 -
1.2813998663 
H -0.8203352717 -2.4445787654 
0.2680967609 
C -2.6 019036237 -1.2070172688 
0.2172296655 
577 
 
H -2.6841481956 -1.0249072324 1.2 
949272674 
H -2.9960814842 -0.3231743324 -
0.2957389499 
H -3.2661851459  -2.0452679612 -
0.0247427168 
C -0.1818078555 1.493200529 -
0.5882767195 
H 0.7717199196 2.0374247162 -
0.6296670462 
H -0.4616872778 1.3094668354  -
1.6356421494 
C -1.2415710911 2.3822694432 
0.0903070914 
H -2.22351939 38 1.8985407721 
0.1175011282 
H -0.9637153283 2.611547588 
1.1251634709 
H -1.3621802184 3.3361813182 -
0.4370872482 
H 0.1487972128 0.0141123138  
1.7231740421 
SCF E = -527.8236435 
n-Hexylsilane 
Si -1.583528264 -1.1227575522 -0.1613802168 
C 0.292863386 -1.1168763908 0.0230449061 
H 0.6995250209 -2.0156857278 -0.4582233241 
H 0.7009895447 -0.2603933232 -0.5289680527 
C 0.7476677845 -1.0582330361 1.4874480748 
Si -3.6387663243 -0.2750371044 
0.0000243571 
C -1.992 5453245 0.6604314933 -
0.0000176975 
H -1.9775149233 1.3220152128 -
578 
 
H 0.3359219958 -0.1594855539 1.9669332964 
H 0.3343401355 -1.9147184642 2.0377003488 
C 2.2682719996 -1.0532254549 1.6458729698 
H 2.6830687999 -1.9530207538 1.1703493001 
H 2.6846709692 -0.1953761856 1.0995036785 
C 2.7199750468 -0.9948892123 3.1037415083 
H 2.3027114866 -0.0954509937 3.5783434621 
H 2.3011161282 -1.85246854 3.6491392828 
C 4.2392232397 -0.9897659931 3.2653779095 
H 4.654501326 -1.8884526696 2.7913463732 
H 4.6561024173 -0.1328776858 2.7206266648 
C 4.6747634194 -0.9312458944 4.7281589624 
H 4.2920593309 -0.0267820018 5.2125471094 
H 4.2904226779 -1.7931074202 5.2837016595 
H 5.7640683381 -0.9283712053 4.824583769 
H -1.9875514533 -1.1798512136 -1.5881478914 
H -2.1537805749 0.1063311847 0.4458996734 
H -2.1557427547 -2.2981359125 0.5426705359 
SCF E = -527.6092334 
0.877 5010954 
H -1.9775082861 1.32208381 
0.8774137914 
C -0.7407614876 -0.237 7272719 
0.000012352 
H -0.7603161053 -0.8983506374 
0.8781290044 
H -0.76 03189273 -0.8984128597 -
0.8780574797 
C 0.5759231068 0.553726639 -0.000 
0179642 
H 0.5982317208 1.2139272524 -
0.8792014495 
H 0.5982361926 1.213 9862069 
0.8791211143 
C 1.8264947082 -0.3351709231 
0.0000087488 
H 1.802 4617715 -0.9959535308 
0.8789932607 
H 1.8024581931 -0.9960113482 -
0.878 9321633 
C 3.1424786665 0.4544515536 -
0.0000199893 
H 3.1671197945 1.114 4177923 -
0.8783326264 
H 3.1671238401 1.1144752851 
0.8782493056 
C 4.386 944257 -0.4410090335 
579 
 
0.0000065078 
H 4.4082044701 -1.0886641349 
0.88468 84257 
H 4.4081997105 -1.0887228891 -
0.8846324863 
H 5.3075295253 0.1529 353855 -
0.0000156884 
H -4.7855617577 0.6746962492 
0.0000305393 
H -3.75 49159197 -1.1433794225 
1.20462227 
H -3.7549589013 -1.1434147245 -
1.204 5440372 
SCF E = -527.8058139 
TMDSO 
Si -5.8461276842 2.1662623296 -0.3588760916 
O -4.2131052954 2.0042387991 -0.1044511802 
C -6.6728021718 2.7616214055 1.2158741616 
C -6.5653592792 0.5191099859 -0.8881513988 
Si -3.2035112255 1.4845182207 1.1064352145 
C -1.4632516945 1.4629215379 0.431335729 
C -3.7345676277 -0.22191876 1.6795758562 
H -6.5609182317 2.0248735503 2.0192647379 
H -7.7445775558 2.9213217434 1.0592738571 
H -6.2363456631 3.7036054277 1.5607993075 
H -6.4742978778 -0.2216363953 -0.0866899941 
H -6.0458871139 0.1302321917 -1.7688134514 
H -7.6273661926 0.6170338889 -1.1361023159 
H -3.7262452075 -0.9273667837 0.8419741669 
Si 1.60537400 -0.23308600 -
0.38034300 
 O -0.00031000 -0.23180600 -
0.00004600 
 C  2.58745700 -1.01444500  
1.02057300 
 C  2.17649300  1.52731900 -
0.72065000 
 Si  -1.60637000 -0.23052500  
0.38034100 
 C -2.58725600 -1.01912100 -
1.01715400 
 C -2.17532000  1.53079400  
0.71627700 
580 
 
H -4.744987531 -0.2102515843 2.102089591 
H -3.0584493939 -0.6048489463 2.4509859037 
H -1.3875448391 0.7633714066  -0.4068082848 
H -0.7446052993 1.1571307987 1.1981209111 
H -1.176341038  2.4544009193 0.0698912301 
H -6.0214584755 3.1655352385 -1.4392468035 
 H -3.3022380325 2.431035496 2.2500349837 
SCF E = -815.0141509 
 H  2.51298400 -0.41591400  
1.93640000 
 H  3.64813300 -1.09494900  
0.75378400 
 H  2.21975100 -2.02205200  
1.24386300 
 H  2.06598000  2.15716200  
0.16981800 
 H  1.59396600  1.98026900 -
1.53043900 
 H  3.23235100  1.54349700 -
1.01682800 
 H -2.08721100  2.15557900 -
0.18000500 
 H -1.57480000  1.98915900  
1.51014800 
 H -3.22399900  1.54531100  
1.03722200 
 H -2.48853900 -0.44051100 -
1.94285400 
 H -3.65274900 -1.07320000 -
0.76389500 
 H -2.23609700 -2.03771400 -
1.21603100 
 H  1.78142800 -1.04947700 -
1.61684600 
 H -1.78302400 -1.03944700  
1.62179000 
581 
 
SCF E = -815.234843349 
TMDSA 
Si -5.7770650358 2.3086951635 -0.37389337 14 
C -6.7059311439 0.7829137101 0.210504611 
C -6.1839006984 2.69594741 01 -2.1642847117 
Si -3.1736358699 1.398370783 1.1115271831 
C -3.225192 3215 -0.4797023023 1.1718587765 
C -3.900068614 2.0851707349 2.70228463  
H -5.6408352966 3.5791518489 -2.5148231755 
H -7.2532121998 2.89403479 03 -2.2858308419 
H -5.9199725681 1.8528620481 -2.8106964859 
H -6.47466 33588 0.5399719219 1.2529482534 
H -6.4424688512 -0.0843482907 -0.4036703174 
H -7.7877437589 0.9377497308 0.1429148626 
H -2.8275487775 -0.911 2131614 0.2484983058 
H -4.254471959 -0.8344281741 1.2906572806 
H -2.63 67297397 -0.8655705312 2.0109357086 
H -3.8432946773 3.1772676478 2.719 5838351 
H -3.3672737446 1.6973670627 3.5762103198 
H -4.9539227362 1.80 46055902 2.8090970727 
N -4.060240633 2.0369876407 -0.2487569727 
H -3.5 039582753 2.3451138911 -1.0379804055 
H -1.762128144 1.8368264701 0.954 3728203 
H -6.2067912565 3.4505658455 0.4813349025 
SCF E = -795.1144843 
Si 1.49089900 -0.02841900  
0.32527300 
 C  1.54326200  1.84317800  
0.07428600 
 C  3.01969100 -0.84448900 -
0.41920100 
 Si  -1.64073900 -0.54584900 -
0.13075200 
 C -2.42110700  0.71244500 -
1.30536000 
 C -1.94494300 -0.02874100  
1.65718700 
 H  3.02561500 -1.92435500 -
0.23373700 
 H  3.93184000 -0.42520600  
0.02051600 
 H  3.06753600 -0.68342900 -
1.50269000 
 H  0.65050600  2.32956100  
0.48377900 
 H  1.60458100  2.09716700 -
0.99028000 
 H  2.41538600  2.27594000  
0.57965600 
 H -2.27036800  0.41909800 -
2.35057000 
582 
 
 H -1.97973000  1.70689000 -
1.17044300 
 H -3.50119700  0.79480800 -
1.13187200 
 H -1.52936600 -0.75928200  
2.35892300 
 H -3.02154500  0.05085500  
1.84760900 
 H -1.49948700  0.94709600  
1.88286600 
 N  0.07697300 -0.75904900 -
0.40697400 
 H  0.29521100 -1.43357800 -
1.12091600 
 H -2.28841800 -1.86690000 -
0.38879700 
 H  1.47695600 -0.26992700  
1.80000800 
SCF E = -795.329640498 
trichlorosilane 
Si -0.7708861101 0. 9378101692 -0.1023810634 
Cl 1.2697805422 0.9372636398 -0.0970179924 
Cl  -1.4465564861 2.0923253242 1.4383660654 
Cl -1.4486198822 -0.9718560589 0.1337905344 
H -1.2583880638 1.4769269257 -1.3727675441 
SCF E = -1670.6935814 
Si -0.0006315725 0.0000762636 
0.5079767649 
Cl 0. 8396679686 1.7489044028 -
0.1788917991 
Cl 1.0941171253 -1.6018263364 -0 
.178573556 
Cl -1.9344992608 -0.1469561861 -
0.1809385046 
583 
 
H -0.001787260 6 0.0002668561 
1.9745390949 
SCF E = -1670.8340696 
(MeO)3SiH 
Si -3.7413945523  0.1666779927 -0.1508212247 
O -3.8683715305 0.8995714352 -1.6222520963  
O -4.9726354996 -0.8756258938 0.1416651927 
O -2.3699970249 -0.7568515 292 -0.1128811284 
H -3.7411494617 1.2502411817 0.8355817918 
C -4.06440 33402 0.1320953299 -2.7986807756 
C -4.9284866465 -2.2748323808 -0.0902648353 
C -1.1056702872 -0.2360474599 -0.4862206712 
H -3.9596978233 0.7 960137413 -3.6589399941 
H -5.0684565489 -0.3073819713 -2.8104118445 
H  -3.3216513455 -0.6724321831 -2.8804687961 
H -5.7962597139 -2.720052043 1 0.3999749843 
H -4.0120742852 -2.7112371037 0.3177232498 
H -4.9778552 811 -2.4931891022 -1.1634238403 
H -0.3895801596 -1.0600894003 -0.4925616177 
H -0.764996046 0.5204853501 0.2304984409 
H -1.1417504537 0.21543 40365 -1.4848168354 
SCF E = -635.4314217 
Si 0.0620036604 0.064329856 -
0.3838372878 
O - 0.4388187821 1.6341033532 -
0.4277618435 
O 1.5939946082 0.0323665787 0. 
2276536104 
O -0.8490342855 -0.9039696044 
0.6088350534 
H -0.0350285453  -0.4135346174 -
1.7770575994 
C -0.3848739424 2.5484038222 
0.6717939505 
 C 2.2978442168 -1.1399497711 
0.6419719872 
C -2.2002209299 -1.283284579 6 
0.3436037623 
H -0.8165113044 3.4944761037 
0.3363728373 
H 0.650229036 8 2.717400056 
0.9860865728 
H -0.9637506439 2.1759278765 
1.5247666172 
H  2.5104812367 -1.7934450396 -
0.212970992 
H 1.7245634486 -1.699508309 1 
584 
 
.3883035177 
H 3.2453446636 -0.8193326617 
1.0820503855 
H -2.4532473925  -2.1114250846 
1.0104376931 
H -2.3289277042 -1.6154749644 -
0.6942635606  
H -2.8847803408 -0.4495220145 
0.537022296 
SCF E = -635.6340731 
triphenylsilane 
Si 0.00955900 -0.00159400 -0.96746000 
 C -0.51752600 1.69705100 -0.35516000 
 C -1.68378600 1.88564700 0.37815400 
 H -2.31549100 1.03334200 0.61456500 
 C -2.05166300 3.14234000 0.81763000 
 H -2.96550400 3.26897700 1.38879600 
 C -1.25723200 4.23344900 0.53287700 
 H -1.54585200 5.22080600 0.87826300 
 C -0.09025900 4.06674600 -0.19121300 
 H 0.53869400 4.92216300 -0.41515800 
 C 0.27326000 2.81127400 -0.62861400 
 H 1.19690600 2.69420500 -1.19115400 
 C -1.20236800 -1.29921400 -0.35055200 
 C -2.46736200 -1.42070200 -0.94522600 
 H -2.73395200 -0.78063500 -1.78440900 
 C -3.39288800 -2.35073200 -0.48464400 
 H -4.36580500 -2.42998000 -0.96016200 
 C -3.06716000 -3.18384500 0.58656700 
Si -0.01297200 0.01074900 -
0.91070500 
 C 0.13930900 -1.78185200 -
0.32752100 
 C 1.08387500 -2.18006000 
0.63558400 
 H 1.76407800 -1.44623900 
1.05993700 
 C 1.17138600 -3.51069100 
1.05807300 
 H 1.90929500 -3.79393900 
1.80373500 
 C 0.31403600 -4.47337700 
0.51998800 
 H 0.38192700 -5.50788300 
0.84498600 
 C  -0.63056400 -4.10011600 -
0.44192100 
585 
 
 H -3.78751400 -3.91198700 0.94728900 
 C -1.81446000 -3.08171800 1.18990000 
 H -1.55630800 -3.73060200 2.02149100 
 C -0.89022600 -2.14767100 0.72286200 
 H 0.08724400 -2.08158800 1.19618500 
 C 1.74397200 -0.38187400 -0.35829900 
 C 2.21112700 0.11262000 0.86146800 
 H 1.58348400 0.77956900 1.44894500 
 C 3.47084300 -0.22575200 1.33349900 
 H 3.81776300 0.16822400 2.28375300 
 C 4.28817000 -1.06428700 0.58968500 
 H 5.27489500 -1.32753200 0.95772100 
 C 3.84480900 -1.56168500 -0.62651900 
 H 4.48350000 -2.21408400 -1.21371400 
 C 2.58389900 -1.22188600 -1.09336800 
 H 2.24754000 -1.61833500 -2.04893900 
 H 0.01966700 -0.02879300 -2.45329700 
SCF E = -984.751834463 
 H  -1.29862700 -4.84407100 -
0.86718400 
 C  -0.71408600 -2.76969000 -
0.85809000 
 H  -1.45571000 -2.50018000 -
1.60728100 
 C 1.47294000 1.02661100 -
0.33487000 
 C 2.68817200 0.96371400 -
1.04403000 
 H 2.76448900 0.34274200 -
1.93400600 
 C 3.80829400 1.68786800 -
0.62938400 
 H 4.73434900 1.62425000 -
1.19414300 
 C 3.73487300 2.49696300 
0.50859400 
 H 4.60368700 3.06335400 
0.83216700 
 C 2.53754400 2.57840300 
1.22413300 
 H 2.47160900 3.20977500 
2.10597500 
 C 1.41990000 1.85192000 
0.80332700 
 H 0.49423200 1.93726700 
1.36671700 
586 
 
 C  -1.63600100 0.76889000 -
0.31275700 
 C  -2.20712000 0.41846700 
0.91145600 
 H  -1.73368300 -0.33611300 
1.53317400 
 C  -3.37931100 1.00529100 
1.34824100 
 H  -3.80513100 0.71595500 
2.30395900 
 C  -4.01193900 1.95528700 
0.56622600 
 H  -4.93480500 2.41398400 
0.90681000 
 C  -3.46843700 2.31389300 -
0.65412700 
 H  -3.96409500 3.05383900 -
1.27478800 
 C  -2.29533700 1.72679000 -
1.08644600 
 H  -1.88563400 2.01942500 -
2.04945100 
 H  -0.02958500 0.02748100 -
2.39960300 
SCF E = -985.115497490 
diphenylsilane 
Si -4.1242383804 0. 5104949448 -0.4288232893 
C -4.356960299 1.8425072355 0.8745783515 
C -3 .9825727491 3.1707434579 0.6190272983 
Si -0.0000436548 1.5255080696 -
0.0000024599 
C 1. 5644939705 0.4774037826 -
587 
 
H -3.5274379693 3.4293602728 -0. 3351266887 
C -4.1752807896 4.1677714117 1.5729447595 
H -3.8790202609 5 .1897146432 1.3564259172 
C -4.7447582453 3.8512295036 2.8062546862 
H - 4.8928785649 4.6259725233 3.5524984836 
C -5.1179171439 2.5370593587 3. 0810398569 
H -5.5561322962 2.285040024 4.0420264761 
C -4.9231128613 1. 5437210634 2.121777021 
H -5.2127705831 0.5209173365 2.3522651264 
C -2. 4819046076 0.7525322795 -1.3071418256 
C -1.3332875016 1.1265925684 -0. 5927043545 
H -1.3982142485 1.3046448059 0.4789939638 
C -0.1070658468 1 .2840416654 -1.2351432141 
H 0.770375669 1.5738908228 -0.664969507 
C -0 .0089433134 1.0730454944 -2.6104221257 
H 0.9449558441 1.198430293 -3.1 138072105 
C -1.1393402418 0.7066480901 -3.3382468119 
H -1.0688809878 0 .5472072638 -4.4099999421 
C -2.3637216006 0.5499057448 -2.6892577687 
H  -3.2393404449 0.2703701211 -3.2709011069 
H -5.1963706016 0.5553666075  -1.4547494557 
H -4.1913819752 -0.806357532 0.2533913602 
SCF E = -753.7785699 
0.0993995564 
C 1.6927829378 -0.5640481181 -1. 
0394364524 
H 0.8690060429 -0.7933282829 -
1.7116384352 
C 2.8636916625 - 1.3209612889 -
1.1253057613 
H 2.9398505263 -2.1194938117 -
1.8582102716 
 C 3.935572776 -1.0525363204 -
0.2673806115 
H 4.8461611465 -1.6415713396  -
0.3320802455 
C 3.8290323404 -0.0259850494 
0.6743090751 
H 4.656477278 7 0.1860975481 
1.3458273529 
C 2.6542940072 0.7292848636 
0.7548509546 
H  2.588163033 1.5229303187 
1.4953534778 
C -1.564514033 0.4772949575 0.0 
993679465 
C -1.6925286058 -0.5645477402 
1.0390082197 
H -0.8685643958 - 0.7940914224 
1.7108900999 
C -2.8634000646 -1.3215197871 
588 
 
1.1248784732 
H  -2.9393439976 -2.1203622099 
1.8574675189 
C -3.9355172914 -1.052760597 7 
0.2673538608 
H -4.8460753847 -1.6418425814 
0.3320524727 
C -3.8292510 822 -0.0258161846 -
0.6739390463 
H -4.6568794916 0.1865256665 -
1.345149 2294 
C -2.6545483442 0.7295071444 -
0.7544865873 
H -2.5886291849 1.5234 555082 -
1.4946835084 
H -0.1350915476 2.3978120447 -
1.198754674 
H 0.134 9463563 2.3977908303 
1.1987723872 
SCF E = -754.042198 
phenylsilane 
Si -3.7818532169 0.2393760672  -0.117724455 
C -4.1908940767 1.6954890013 0.9938141541 
C -3.425035818 6 2.8703882775 0.95200676 
H -2.5722458548 2.9389558619 0.2794907951 
C  -3.733882626 3.9599931835 1.7628793676 
H -3.1285409412 4.860210595 1.7 161702352 
C -4.8194854669 3.8923151598 2.6358182714 
H -5.0614220828 4. 739976515 3.2696781904 
Si 2.3521979515 0.0019336421 
0.0043613274 
C 0.4689756549 - 0.000507751 -
0.0106846267 
C -0.2574485157 -1.2069525393 -
0.03068254 
H  0.268842977 -2.1586123838 -
0.0580082356 
589 
 
C -5.5904697579 2.7337579916 2.6941683964 
H -6. 4348942385 2.6753770873 3.3742792511 
C -5.2760199428 1.6461121456 1.87 94252499 
H -5.8850327287 0.7470091805 1.9386719729 
H -4.1001850397 0.5 487941445 -1.5329243441 
H -4.5820411882 -0.9314117132 0.3114820713 
H - 2.3373670202 -0.0832834976 -0.0320359165 
SCF E = -522.8001768 
C -1.6546493485 -1.2102541704  -
0.0205915872 
H -2.1939937777 -2.1532583328 -
0.0376170488 
C -2.3571264 983 -0.001296698 
0.0082685519 
H -3.443458644 -0.0019778072 
0.014309244 9 
C -1.6558398275 1.2071086747 
0.0252077712 
H -2.1951419745 2.15010814 24 
0.0437852991 
C -0.2573028823 1.2047135788 
0.0150296672 
H 0.27044292 06 2.1553813616 
0.023901576 
H 2.8840351887 -0.348752393 
1.3496257742 
H  2.8451258795 1.3561966986 -
0.357187414 
H 2.8809728963 -0.9937260228 - 
0.9650167595 
SCF = -522.9653867 
4-
trifluoromethyl-
phenylsilane 
Si  -3.7580342731 0.1459921969 -0.1884992267 
C -4.1620878165 1.608152076  0.9254636629 
C -3.3912771653 2.7771460053 0.8800977498 
H -2.539270219  2.8424817416 0.2073736744 
C -3.6900182392 3.8724519222 1.6876733919 
Si  -3.87533400 -0.01193100  
0.00724200 
 C -1.98682000  0.00372000 -
0.00612900 
590 
 
H  -3.087352385 4.7731421492 1.6455554232 
C -4.7742050028 3.8007969834 2. 5568278098 
C -5.1281745555 4.960430028 3.4452127329 
C -5.556673244 2.6 496005241 2.6255615355 
H -6.3983278532 2.6061445056 3.310632349 
C -5.2 473644385 1.563374093 1.8133180068 
H -5.8606428963 0.6682097747 1.8759 112108 
H -4.0933443264 0.4642368092 -1.5963225169 
H -4.5533510684 -1.0 211201421 0.2547085587 
H -2.3114517081 -0.1619425177 -0.1068279744 
F - 4.2988865185 6.0034579324 3.2831027451 
F -5.0875392639 4.6197098013 4. 7474971812 
F -6.3768590264 5.4054961167 3.2078236861 
SCF E  = -859.7554511 
 C -1.27175100  1.20729400 -
0.00775600 
 H -1.79892100  2.15720200 -
0.01106200 
 C  0.11454000  1.22385100 -
0.00824400 
 H  0.64913100  2.16637400 -
0.01075000 
 C  0.81390100  0.02335600 -
0.00855600 
 C  2.31553000  0.00561400  
0.00117000 
 C  0.12902800 -1.18784500 -
0.00849800 
 H  0.67579900 -2.12499600 -
0.01208100 
 C -1.25587600 -1.19150200 -
0.00784700 
 H -1.77380400 -2.14580500 -
0.01114800 
 H -4.39307900  0.51120800  
1.29858700 
 H -4.34377600 -1.40787100 -
0.17812500 
 H -4.40391500  0.84425900 -
1.08577700 
 F  2.85938800  1.23449300 -
0.09074700 
591 
 
 F  2.82619100 -0.72112200 -
1.02128300 
 F  2.81352600 -0.55117700  
1.13248800 
SCF E = -860.023668903 
DPDS 
Si -3.8481180253 1.6798234117 -0.4499884605  
O -2.3054927126 1.1779544628 -0.0899769617 
Si -1.1966659153 1.5870493 727 1.0779903228 
C -4.6708010717 2.3173613718 1.1046671395 
C -5.013200 338 3.6696747265 1.2399264821 
H -4.8488169886 4.3543918459 0.410679486 1 
C -5.537553069 4.1613852344 2.4341853094 
H -5.7872795919 5.214429574  2.5234408416 
C -5.7211286889 3.304762146 3.5180845928 
H -6.1238657584  3.6869331028 4.4514091004 
C -5.3848358639 1.9556312964 3.4041710446 
H  -5.5284689081 1.2856373126 4.2465871482 
C -4.8668717539 1.4687588073  2.2055587049 
H -4.6068451307 0.4140848583 2.1315663246 
C -1.5126121636  3.3420065442 1.643733792 
C -1.4236717939 4.40872114 0.7356428184 
H -1 .0977678916 4.2256586799 -0.2869371339 
C -1.7549752413 5.7070949007 1. 1183862902 
H -1.6822813686 6.5204058552 0.4025473271 
C -2.1774337994 5 .9596283386 2.4237100976 
H -2.4373881255 6.9702917521 2.7242740114 
C - 2.2679535076 4.9136547097 3.3402781 
H -2.6080111662 5.1050592866 4.353 6617985 
Si -4.0889650533 1.1646931178 
0.1860145053 
O -2.6790946397 2.007818202 
0.3722918579 
Si -1.1324916362 2.54811793 53 
0.1824963975 
C -5.3919820236 1.7911284316 
1.3777145948 
C -6.2304426 164 2.8705604867 
1.0373844133 
H -6.1331231758 3.3468719259 
0.064327689 5 
C -7.1957911666 3.3448977851 
1.9295718259 
H -7.8324706697 4.17878319 72 
1.6474420693 
C -7.3443118107 2.7419661359 
3.182544074 
H -8.09660707 51 3.106817888 
3.876268624 
C -6.5273208242 1.6646125138 
3.5382908123 
H  -6.6432948551 1.1901002699 
592 
 
C -1.9411938207 3.6160805005 2.949616382 
H -2.0432921522 2.804 3210868 3.6666746782 
H -4.5603734415 0.5110651932 -1.0077012117 
H -3.8 070388243 2.7814317253 -1.440200738 
H 0.1417244602 1.440009214 0.46865 25471 
H -1.3338643475 0.68832055 2.2480671664 
SCF E = -1119.7243656 
4.508704895 
C -5.5627926702 1.1952283267 2 
.6422431269 
H -4.9389980436 0.3529092002 
2.9328021714 
C -0.8603861624  4.0133909186 
1.3241762424 
C 0.377684529 4.6833608377 
1.3429146238 
H 1. 1866177207 4.3562365337 
0.6919542657 
C 0.5958768793 5.7738899585 2.188 
5334797 
H 1.558767707 6.2772047916 
2.1874631328 
C -0.4262028284 6.2162 358677 
3.0350205947 
H -0.2593345839 7.0640877439 
3.6935567364 
C -1.661 9683447 5.5639932655 
3.0302957732 
H -2.4595126914 5.9032518609 
3.68561 53351 
C -1.8754476376 4.4726912569 
2.181834603 
H -2.8403193112 3.97367 3831 
2.186740535 
H -3.8261504175 -0.271335506 
593 
 
0.4614782262 
H -4.566253 77 1.344500886 -
1.20949995 
H -0.9109477086 2.945157455 -
1.2343621571 
H  -0.18081412 1.4507818829 
0.5048885023 
SCF E = -1120.0552824 
phenylsilanol 
Si -1.01323102 -3.1154552544 0.0598401994 
H -0.0545125237  -4.1053313226 0.5944118866 
H -1.2496451719 -2.0601300126 1.0803052481 
O -2.377738015 -3.9988947894 -0.2899024856 
H -3.0925555257 -3.51607756 18 -0.7235856108 
C -0.3873863759 -2.2650550547 -1.4822822924 
C 0.17331 13231 -0.9825598989 -1.4303627319 
C -0.4679108598 -2.9048826 -2.727722249 
C 0.6532806521 -0.3618694565 -2.5809503571 
H 0.2316027117 -0.45688 46493 -0.4793426011 
C 0.0053400018 -2.2877288284 -3.8818635897 
H -0.91 15595692 -3.8961818182 -2.7938946718 
C 0.569348848 -1.0156187668 -3.8076431047 
H 1.0859679321 0.6323625159 -2.5227637044 
H -0.0647951659 -2. 7962733491 -4.8387671561 
H 0.9395127783 -0.5324711632 -4.7069657295 
SCF E = -598.0261145 
Si -1.0406073246 -3.1872188939 
0.006270775 1 
H -0.4010123896 -4.5135495863 
0.1885354871 
H -0.7283179385 -2.298610 9348 
1.163925052 
O -2.6728634262 -3.5459916922 -
0.0683640876 
H -3.2606 327479 -2.7955035833 -
0.2386542765 
C -0.3822646307 -2.3354149131 -
1.52 67538438 
C -0.0212501935 -0.975966176 -
1.492301052 
C -0.2334991247 -3. 0269111302 -
2.7448292553 
C 0.4643113618 -0.3274369579 -
2.6297441047 
H  -0.1157457052 -0.416352154 -
0.5637820117 
594 
 
C 0.2503568482 -2.3840688695  -
3.8841487885 
H -0.4954331756 -4.0814712139 -
2.804394397 
C 0.599308448 7 -1.0318289469 -
3.8273662681 
H 0.7386402743 0.7232066998 -
2.581362793  
H 0.3595602522 -2.9354825079 -
4.8144301241 
H 0.9784794913 -0.53045115  -
4.7140892617 
SCF E = -598.2103802 
 
Output information for phosphine oxides and silanes considered in Mulliken charge study 
is included below. 
Phosphine 
Oxide 
M06-2X B3LYP 
TPPO 
P -0.0008084087 -0.0068907536 0.961 8992374 
O 0.0039339112 -0.0125657455 2.4641405846 
C 0.3332730342 1.635 4861071 0.2558908502 
C 1.2364047167 2.4539375572 0.943521783 
C -0.2510 028068 2.0874623546 -0.9312252266 
C 1.5607107708 3.7111344611 0.439593 0707 
H 1.670682353 2.1048682857 1.8763609093 
C 0.0770874516 3.34631357 47 -1.4338017064 
P -0.0045399962 -0.0311476054 0.896 
0716265 
O -0.0177229474 -0.1690140861 
2.3974315251 
C 0.1758655937 1.68 93294007 
0.2881694464 
C 1.4513798852 2.2746290214 
0.2272502671 
595 
 
H -0.9675037889 1.4641604451 -1.4600018453 
C 0.983162 0825 4.1559686317 -0.7502880406 
H 2.2588975861 4.3452088664 0.97660433 86 
H -0.3803078401 3.6959956538 -2.3538750854 
H 1.2344863405 5.1370515 925 -1.1411586902 
C -1.5909303028 -0.5335483066 0.2539227779 
C -1.6919 893647 -1.2425243121 -0.9470472632 
C -2.7500480058 -0.1800279441 0.953 7962232 
C -2.9466577379 -1.5832577818 -1.4513257019 
H -0.794998657 -1. 536993457 -1.4856301466 
C -4.0016007233 -0.5230381642 0.4478776273 
H - 2.6630490539 0.3515214342 1.897472827 
C -4.0998320002 -1.2218514089 -0 .755923106 
H -3.0221667561 -2.136294643 -2.3821756036 
H -4.8988225366  -0.2502304961 0.9942214287 
H -5.0755292818 -1.4909331826 -1.148420922 
 C 1.2535585058 -1.1123911219 0.247459124 
C 1.5651853497 -2.2734261197  0.9630421514 
C 1.8866574382 -0.8544700188 -0.9724264968 
C 2.4955051777  -3.1766823339 0.4538058163 
H 1.0854825391 -2.4540121259 1.9210653279 
 C 2.8157819072 -1.7615623146 -1.4801091619 
H 1.6633861009 0.0561794721  -1.5225595046 
C 3.1180391967 -2.9221712275 -0.7686171106 
H 2.73862304 6 -4.074899663 1.0124014571 
H 3.3081018386 -1.5579580783 -2.4257115879  
H 3.844856918 -3.6252732372 -1.163378335 
SCF E = -1111.2341366 
C -0.95 03664941 2.4788899986 
0.0078096926 
C 1.5972777374 3.6192295831 -0.1177 
032797 
H 2.3324893316 1.6809825349 
0.4516543415 
C -0.8029069155 3.8242 982636 -
0.3377092664 
H -1.9446449355 2.0462898099 
0.0595526442 
C 0.470 4107246 4.3954835034 -
0.4036272673 
H 2.5890276858 4.0598741203 -
0.1622 276561 
H -1.6820339703 4.4243919382 -
0.5539733849 
H 0.5845072354 5.441 5497765 -
0.6731894178 
C -1.5521110652 -0.683026001 
0.155291863 
C -1.84 5203208 -0.6318955641 -
1.21642734 
C -2.4665844172 -1.2828866431 
1.0326 810547 
C -3.033976254 -1.1776247101 -
1.7030864731 
H -1.1543140087 -0.1 621363492 -
1.9103143853 
596 
 
C -3.6570446432 -1.8284477049 
0.5433345643 
H - 2.2325767069 -1.3112432023 
2.0926744904 
C -3.9410919492 -1.778053068 - 
0.823260537 
H -3.2530545531 -1.1334313465 -
2.7660971203 
H -4.360232006 9 -2.2909626189 
1.2299853941 
H -4.8658267187 -2.2024207912 -
1.20388648 52 
C 1.3794448263 -0.9767554583 
0.1489508529 
C 2.0470121946 -1.8841027 196 
0.9842868393 
C 1.7786322443 -0.8520184216 -
1.1908140302 
C 3.093146 6476 -2.6635870299 
0.483166595 
H 1.7426739567 -1.9608823951 
2.02384795 79 
C 2.8231053284 -1.6324560143 -
1.6897122437 
H 1.2894294125 -0.137518 4767 -
1.8464767724 
C 3.4801639878 -2.5410527433 -
0.8535547717 
597 
 
H 3.6060 454693 -3.3624969574 
1.1376305685 
H 3.1272845526 -1.5276500011 -
2.7272 494262 
H 4.2938529764 -3.1461780427 -
1.2431708664 
SCF E = -1111.604154 
1PPO 
P -0.44267 5174 0.2099066541 0.4049658289 
C 0.7604588186 -0.4633825137 -0.8209020 066 
C 1.3713537002 -1.7169931322 -0.1708361833 
C 1.4116872602 -1.46826 37663 1.3456681174 
C 0.015406045 -0.9677152817 1.7445096943 
H 1.514272 2132 0.3212234002 -0.9479235831 
H 0.2944051285 -0.6496195924 -1.791247 4368 
H 2.3638807546 -1.9351959832 -0.5750066836 
H 0.7405813197 -2.5917 79788 -0.3744419112 
H 2.1563274456 -0.694940222 1.569218088 
H 1.695263 3003 -2.3675425242 1.89963309 
H -0.0158845238 -0.4477767656 2.70451243 5 
H -0.7021728103 -1.7955317792 1.7716540679 
O -0.3108191437 1.6686390 857 0.7237572769 
C -2.1157860324 -0.2193859384 -0.1698318499 
C -2.4641 599156 -1.5146631903 -0.5673889613 
H -1.7299779297 -2.3180066445 -0.53 34791633 
C -3.7553124565 -1.7848860248 -1.011681219 
H -4.0238980041 -2 .7904403778 -1.3203569804 
C -4.7026216951 -0.7607913705 -1.0591298396 
 H -5.709681289 -0.9727891897 -1.4051469062 
P 0.84349408 -0.7238328696 
0.0513093125 
C 1.7358089776 0. 2288314588 
1.3720260456 
C 2.611916145 1.2675391424 
0.6374319772 
C 3.02 77358709 0.657420588 -
0.717949038 
C 1.7578425548 0.0603333493 -
1.35862 75245 
H 2.3527946278 -0.5079553572 
1.8983901383 
H 1.0471798265 0.66985 68678 
2.0971544201 
H 3.4829524729 1.5488873605 
1.2383162946 
H 2.036166 7564 2.1853610887 
0.4619685496 
H 3.7653752745 -0.1373660189 -
0.5524215 13 
H 3.4951887576 1.4020945088 -
598 
 
C -4.3580615667 0.530284957 3 -0.66508093 
H -5.0954963235 1.3260639096 -0.7046078885 
C -3.06423050 53 0.8031659697 -0.2213756266 
H -2.7705086464 1.8029700979 0.087318611 
SCF E = -805.2815004 
1.3703939723 
H 1.960992324 -0.69380794 05 -
2.1234372437 
H 1.139582102 0.8451686974 -
1.8085815536 
O 0.94557811 97 -2.2304083404 
0.1531457457 
C -0.8982840014 -0.1573914286 -
0.0001506 049 
C -1.2472977714 1.2022154541 -
0.0450533061 
H -0.4783099851 1.97050 86998 -
0.0576466989 
C -2.5898011564 1.5846227845 -
0.0723786691 
H -2.85 12455792 2.6383172434 -
0.1061664825 
C -3.5950509419 0.6113576358 -0.05 
647722 
H -4.639128317 0.9100511563 -
0.0785719812 
C -3.2541442763 -0.74 28656784 -
0.0119466038 
H -4.0320386576 -1.5007374077 
0.0011699104 
C -1 .9101322344 -1.1272139176 
0.0174565917 
599 
 
H -1.6339489691 -2.1764440766 0 
.0557524256 
SCF E = -805.5439601 
TMPPO 
C -0.3680 912783 -0.2537178101 -0.0954935084 
C -0.6532216827 1.2094215011 -0.540 2841819 
C 0.5716534191 1.8981823769 0.155517632 
H -0.4990107515 1.2899 181653 -1.6237188379 
C -2.0347196634 1.7552196306 -0.2054024443 
P 1.37 55604635 0.2269963183 0.2255186193 
C 1.2300020998 3.0116156023 -0.6448 245449 
C 0.2743028627 2.3474799252 1.5881894419 
H -0.8536710735 -0.486 8145545 0.8580030736 
H -0.5775865003 -1.0511813709 -0.8111747517 
O 2.1 435856338 -0.1961421487 1.4377226602 
H -2.111802461 2.8161570911 -0.46 66601056 
H -2.2531429983 1.650987875 0.8616211851 
H -2.806039763 1.213 5903876 -0.7613260822 
H 1.4962590774 2.6841833582 -1.6548808919 
H 2.14 09574162 3.3644835445 -0.1500894185 
H 0.545596331 3.8650644255 -0.7318 780558 
H -0.3786372874 3.2279791421 1.5792310883 
H 1.205326002 2.60785 58371 2.0990377014 
H -0.2104597133 1.566220538 2.1820894685 
C 2.322510 9323 -0.0303205544 -1.3105552244 
C 3.7156545735 -0.0058052203 -1.18783 96976 
H 4.1546218985 0.1160053535 -0.201164238 
C 4.5203738891 -0.16318 34057 -2.3142336172 
H 5.6010760562 -0.1436634175 -2.2130914065 
C -1.3434475314 0.5620378651 -
1.5163668594 
C -1.88011906 03 1.1218400089 -
0.1615255437 
C -1.6033083064 -0.1471584096 
0.74058977 79 
H -1.2052318961 1.9157772495 
0.1809849554 
C -3.3010939643 1.6854830 08 -
0.1831855902 
P -0.4159619255 -0.7436316067 -
0.5950049824 
C -1.0614 682459 0.1578768754 
2.1372496994 
C -2.7927638683 -1.1185592388 
0.82269 32091 
H -2.1336778379 0.0870608696 -
2.1075946761 
H -0.78869203 1.24999 36469 -
2.1583561931 
O -0.4182154391 -2.191774319 -
1.0270487761 
H -3.62 01302464 1.9964405132 
0.8181507911 
H -4.0223389935 0.9512992908 -0.555 
600 
 
C 3.938 6167018 -0.3553483383 -3.566230169 
H 4.5661772236 -0.4822529061 -4.443 0241151 
C 2.5506021047 -0.3946362838 -3.6920392768 
H 2.0958317638 -0.5 575342891 -4.6641800726 
C 1.743854038 -0.2322356573 -2.5674966877 
H 0. 6637107256 -0.2768250859 -2.6788735426 
SCF E = -883.8553284 
9466377 
H -3.351841964 2.5640318936 -
0.836017933 
H -0.1843516437 0.811 4944965 
2.1058311178 
H -0.779475233 -0.7619074599 
2.6617451932 
H -1.83 23196413 0.6574550351 
2.7384917626 
H -3.587443691 -0.688108529 1.44328 
28145 
H -2.4793615862 -2.0629836607 
1.2774787797 
H -3.2189590503 -1.35 66864879 -
0.1561828869 
C 1.2863505521 -0.1485187647 -
0.2593883786 
C 2. 2437671614 -1.1175925467 
0.0813859426 
H 1.9527625622 -2.163043184 0.11 
01887833 
C 3.5608249216 -0.7434669836 
0.3576279517 
H 4.2930544923 -1.5 021267449 
0.6182273704 
C 3.9366768431 0.6011326857 
0.2892487376 
H 4.96 18690707 0.8918808568 
601 
 
0.4994580216 
C 2.9921215191 1.5711310655 -0.0593 
146187 
H 3.2816215363 2.6159524728 -
0.1242674409 
C 1.6732135673 1.1991 327056 -
0.3319277508 
H 0.9577809283 1.9672963965 -
0.6089766403 
SCF E = -884.156142 
TMBPO 
H -0.7395 619752 -0.1858195604 1.5947978028 
O 2.250278969 -0.5267543577 1.032145 3213 
C -0.6054172617 -0.1322261176 0.5092266858 
H -1.1950542925 -0.915 5718967 0.0293694035 
P 1.1881044087 0.0045467446 0.1198226131 
H -1.699 0716332 2.1902353002 1.7449928221 
H -2.8483556216 1.7355048497 0.48035 16972 
C -1.8552106794 2.1572054199 0.6625860493 
H 0.6703016173 1.74339 6543 2.319495886 
C -0.7863717265 1.3162572088 -0.0218382089 
C 0.700296 1524 1.7936333569 0.122579204 
C 1.0082854929 2.385367789 1.5000377637 
H -1.8508514682 3.1860061831 0.2861256678 
H -1.0129578759 1.2681373629  -1.0952224482 
H 2.087778206 2.5136832145 1.6188003271 
H 0.5261302694  3.3638635961 1.6075974046 
C 1.1962799498 2.7103841148 -0.986394099 
H 0 .986949168 2.3006659854 -1.9798984909 
H -0.8246886053 1.6723023183 -
1.5088321802 
O 0.348235239 1 -1.1504883395 -
1.7403310826 
C -0.4957015623 1.3845508352 -
0.50454292 7 
H 0.2411850553 2.1077114616 -
0.1492702772 
P -0.0644482548 -0.4156892 045 -
0.4840374627 
H -3.3064929203 1.9368591934 -
0.7654399246 
H -2.7025 563542 3.0005705961 
0.5114600043 
C -2.9373452462 1.9591142197 
0.264711 0291 
H -2.573387273 -0.1853631115 -
1.9163538266 
602 
 
H 2.2748262203 2.8824863216 -0.9 056252943 
H 0.6989236152 3.6859567241 -0.9169002249 
C 1.4276419725 -0. 5121462197 -1.6229672055 
H 0.5062880011 -0.3244650794 -2.1894334734 
H  2.208382174 0.1356709648 -2.0388272893 
C 1.8520412019 -1.9825004315 -1 .7174522952 
H 2.0751699542 -2.2166880621 -2.7660073587 
H 2.7805476337  -2.1146386149 -1.1504043372 
C 0.802983114 -2.9632348878 -1.1933718483 
H 0.6412050005 -2.7856060785 -0.1225134855 
H -0.1562455946 -2.77785404 39 -1.6969316577 
C 1.2240736549 -4.4160700622 -1.4023072178 
H 1.369210 2367 -4.6325665973 -2.4659463254 
H 2.1679733391 -4.62067566 -0.8870742 937 
H 0.4736377676 -5.1113440394 -1.0166231048 
SCF E = -810.0741516 
C -1.6982886184 1.0807 14716 
0.4410958443 
C -1.8356573547 -0.4661217723 
0.1453380384 
C -2.780 639106 -0.7851010688 -
1.0251791754 
H -3.7514118326 1.6370843805 
0.9243 061301 
H -1.3546753168 1.1833242409 
1.4784908122 
H -2.6850662582 -1.83 62996065 -
1.3134954372 
H -3.8214748967 -0.6066758459 -
0.7306702334 
C - 2.1780660773 -1.3332424244 
1.3580101233 
H -1.5190312625 -1.1371057758  
2.2098093671 
H -2.1124083627 -2.399900482 
1.1154466407 
H -3.2071778959  -1.1348095327 
1.6842798738 
C 1.0712037199 -0.7413157341 
0.9367536973 
 H 0.8446555087 -0.0327093519 
1.743345558 
H 0.8104852744 -1.740579012 1 
.3059111222 
603 
 
C 2.5671865216 -0.7025758886 
0.5710538306 
H 3.1327241229 - 1.0815529254 
1.4329918227 
H 2.7487937712 -1.4013301515 -
0.2537755393 
C  3.1073533449 0.6838230603 
0.1935004261 
H 2.5933081833 1.0500113744 -0 
.7039511358 
H 2.8770955546 1.3964037545 
0.9983469061 
C 4.6184389631 0. 6753536618 -
0.0650743127 
H 5.170261588 0.3445782822 
0.8229656905 
H 4.8 724129516 -0.0037268691 -
0.8871103432 
H 4.9826863991 1.6731110017 -0.3 
322900589 
SCF E = -810.3625149 
TMPyrPO 
H -0.8017353661 0.2493270487 1.802906784 
O 1.8799429764 -1.0431977 904 1.1122689348 
C -0.7450146676 0.2292368982 0.7089584313 
H -1.607680 6696 -0.3100950565 0.315343306 
P 0.9581216419 -0.2618306069 0.23860693 62 
H -0.88573119 2.8055686033 1.916956754 
H -2.2087250558 2.7519133617  0.7436001114 
H -1.9017963558 0.2724671439 -
2.1110259081 
O -0.1748266397 -2.0503666119 -
1.18949679 
C -1.149381211 0.7190241404  -
1.4516806258 
H -0.6170898486 1.4961881644 -
604 
 
C -1.1210548384 2.8100721761 0.8483770338 
H 1.2181030789  1.6829344266 2.3662826479 
C -0.4521687904 1.6439498637 0.1331585651 
C  1.1163970737 1.5850498027 0.1754485228 
C 1.7055895947 2.1111564036 1. 4846693015 
H -0.7924142605 3.768900787 0.4324465294 
H -0.7548647051 1. 660996528 -0.9220532665 
H 2.7653581002 1.8491473758 1.5465351455 
H 1.6 109521648 3.2025994382 1.5368696996 
C 1.8111645582 2.2003284168 -1.030 5817496 
H 1.4711225176 1.7433497368 -1.9664482171 
H 2.8969176009 2.072 7047109 -0.9648161781 
H 1.6053099465 3.2772870513 -1.0821266256 
N 0.87 19335075 -0.8857748889 -1.3098096212 
C 2.0754381961 -1.5025454565 -1.9 032328452 
H 2.966216056 -0.8848185503 -1.7429388478 
H 2.2602628214 -2. 4776255397 -1.4398024593 
C 1.7177730568 -1.6281119494 -3.3888971476 
C  0.1911641428 -1.7462337192 -3.3753054863 
C -0.2023910793 -0.7393828673  -2.2927624928 
H -0.2404103402 0.2764811158 -2.7195099737 
H -1.1781196 604 -0.9569499258 -1.8484094095 
H -0.2718450288 -1.5258520973 -4.34012 28422 
H -0.1074539456 -2.7534587747 -3.0658783924 
H 2.2151520601 -2.47 64262296 -3.8644721903 
H 2.0117106832 -0.7174794627 -3.923490688 
SCF E = -864.2095266 
2.0031705633 
P -0.21757263 66 -0.6486334575 -
0.6370317983 
H -3.872974448 0.9445586779 -
0.57053986 89 
H -3.230486862 2.5904945961 -
0.6424271371 
C -3.1855181607 1.6464867 347 -
0.0878226559 
H -3.0424009592 -1.3820722046 -
0.3662098373 
C -1.753 6581111 1.1102913322 -
0.0665627074 
C -1.4804230925 -0.2471611478 0.700 
9130503 
C -2.6544827775 -1.2368531068 
0.6464532482 
H -3.5547337461 1.8 391521034 
0.9261693676 
H -1.109857295 1.8755632381 
0.3851127398 
H -2.3 372767112 -2.2177101296 
1.0131608273 
H -3.4798541514 -0.8870716463 1.2 
787857342 
C -0.9831154368 -0.078508134 
2.1370322627 
H -0.0929175211 0. 5563693424 
605 
 
2.1894674527 
H -0.7342026048 -1.047000599 
2.5852251602 
H -1 .7619055604 0.3816494523 
2.7595116464 
N 1.3169665132 -0.0777248989 -0. 
2574302562 
C 2.3647325287 -1.0120755233 
0.2279301363 
H 1.9880070314 -1 .6649224738 
1.0228385319 
H 2.7055629379 -1.6537400836 -
0.5928238872 
C  3.4839997196 -0.0822709574 
0.7234837347 
C 3.3142878387 1.1761556141 -0 
.1414609889 
C 1.7889843871 1.3196068231 -
0.241286699 
H 1.4000454006 1. 8740530091 
0.6272123332 
H 1.4816907246 1.8538358618 -
1.1450650686 
H 3. 7864783538 2.0647729236 
0.2875719136 
H 3.7380206029 1.0118319749 -1.13 
8887966 
H 4.472035917 -0.5417459546 
606 
 
0.6294279502 
H 3.3282271738 0.1670 267966 
1.7798406683 
SCF E = -864.5044091 
 
Geometries from the optimizations of compounds considered in the global parameters 
study are included below. 
Compound Geometry 
Tetracyanoethylene 
C 0.6871632876 0.8886815089 -0.0000134198 
C 2.0450027059  0.8886622932 -0.0000027056 
C 2.7902332872 2.1153687052 0.0000272506 
N  3.3968210987 3.0996761501 0.0000510067 
C 2.7901996435 -0.3380651645 -0 .0000169978 
N 3.3967567709 -1.3223915416 -0.0000296466 
C -0.0580336478  2.1154089597 0.0000059196 
N -0.6645908133 3.0997353128 0.0000196097 
C  -0.0580672917 -0.3380248964 -0.0000389695 
N -0.6646551409 -1.32233231 76 -0.0000599573 
SCF E = -447.3674581 
S9 
H -1.0057414423 -0.018098437 -1.8453069674 
C -1.8347398011 0.2332053397 -1.1880447439 
C -3.0949394391 0.473115064 1 -1.727671561 
H -3.2443876512 0.4160000771 -2.8013354985 
C -4.1653705 634 0.7850667355 -0.8868424963 
H -5.1479886193 0.9716257971 -1.3093452 653 
C -3.9741609596 0.8556420375 0.4910384972 
H -4.806677029 1.0964275 222 1.1447207023 
607 
 
C -2.7110878192 0.616685127 1.0338962873 
H -2.5366893 884 0.6639819043 2.1053873208 
C -1.6389867668 0.3060218294 0.195262313 3 
P -0.0213551488 0.0330445619 0.9908729932 
O -0.1273398623 0.15050791 75 2.4823881204 
C 1.098064346 1.2985424882 0.3050806489 
C 1.6269618255  1.2393886675 -0.9885868398 
H 1.4189593565 0.3823918209 -1.6247634509 
 C 2.4434760133 2.2661668219 -1.4561740733 
H 2.8551654609 2.2159482564  -2.4593908534 
C 2.738778566 3.3526464459 -0.6316942278 
H 3.3776374089  4.150973577 -0.9969002588 
C 2.2225002448 3.4091509936 0.6615810666 
H 2 .4604391698 4.2492918244 1.3065067069 
C 1.403744 2.3830009409 1.131394 8772 
H 1.001776962 2.3997025821 2.1408069501 
C 0.5847789359 -1.5380291 545 0.3336727454 
C -0.2838265832 -2.5506261066 -0.0870628384 
H -1.3566 831428 -2.3766380676 -0.0937378299 
C 0.1920735111 -3.7870467409 -0.499 8075971 
H -0.5203742121 -4.5395562787 -0.8133491637 
C 1.5774244442 -4. 063247194 -0.508072799 
C 2.4515248168 -3.0444253357 -0.0633650966 
H 3. 5207419437 -3.2118156281 -0.032586934 
C 1.9577048224 -1.8154936058 0.3 442433135 
H 2.6595761926 -1.0558299534 0.6803426787 
N 2.0604720005 -5. 2786741526 -0.9380677047 
C 1.1297934469 -6.3589937813 -1.1986655206 
608 
 
H  1.6878558928 -7.2376223861 -1.5213257413 
H 0.5423009493 -6.6258172256  -0.3083940762 
H 0.4360038142 -6.0911361828 -2.0024361102 
C 3.462677668 1 -5.5929922452 -0.746695361 
H 3.6586677175 -6.5910346461 -1.137882941 6 
H 4.0987795629 -4.8897321872 -1.294326354 
H 3.7534053058 -5.57021285 24 0.3133811028 
SCF E = -1245.1434902 
S10 
H 1.9163553637 0.5754355078 -1.7311228139  
C 1.9424535647 1.4753749392 -1.1243621845 
C 2.4176469835 2.661187 568 -1.6705330967 
H 2.7539361124 2.6875990514 -2.7029036451 
C 2.46 99596861 3.8201723826 -0.8897995837 
H 2.8416763055 4.7465918519 -1.3 191825799 
C 2.0544297735 3.7901453937 0.437020541 
H 2.1070146714 4 .6887036465 1.0446032577 
C 1.5737669473 2.5993346837 0.9893012089 
H  1.259676563 2.5460089949 2.029833585 
C 1.5128618303 1.447213151 0. 209515403 
P 0.7319309868 -0.01309886 0.9639068369 
O 0.8688295727 0.0009083227 2.4584382368 
C 1.4675871768 -1.4821457692 0.1907301075 
C  1.070806086 -1.9845611505 -1.0530267447 
H 0.2526452153 -1.5170677 914 -1.5984378866 
C 1.7023353243 -3.1058907454 -1.5862976366 
H 1.3 93290388 -3.4869594436 -2.5554026053 
C 2.7142924103 -3.743193518 -0. 8695912231 
H 3.2059490965 -4.6190835629 -1.2832085691 
609 
 
C 3.09376886 64 -3.2619408375 0.3830345413 
H 3.8657280563 -3.7738173495 0.9504074 186 
C 2.4734554105 -2.1335507143 0.9128592634 
H 2.7421236705 -1.75 56997742 1.8966227997 
C -0.9858556471 0.0206988441 0.3655472604 
C  -1.5288068471 1.1954370554 -0.1715920398 
H -0.9028896253 2.071310284 3 -0.3185686509 
C -2.8776567648 1.252796048 -0.5161319793 
H -3.327 9601613 2.1517114818 -0.9234369803 
C -3.6790882715 0.1284013293 -0.3 438583494 
C -3.1454976277 -1.0559135246 0.1679625704 
H -3.76780238 09 -1.9415377225 0.2633552934 
C -1.8023468984 -1.1006958977 0.526688 6977 
H -1.3837282303 -2.0219290071 0.9276523944 
O -4.9893422467 0. 2190094337 -0.7435739041 
C -5.8987730401 -0.5033542036 0.0873207405 
 H -6.8875738731 -0.3726278852 -0.354629348 
H -5.6546466841 -1.5711 071978 0.1259840919 
H -5.8806916752 -0.0874804409 1.1021920461 
SCF E = -1225.7058254 
S11 
H -0.3229103307 -2.146798953 0.0517436886 
C -1 .1672878583 -2.4944084473 0.6417680932 
C -2.4663733957 -2.3030520031 0 .1737427081 
H -2.6297633591 -1.81773502 -0.7832510649 
C -3.5525880754  -2.7233566042 0.9400233853 
H -4.563522027 -2.5694378188 0.5756297139 
C  -3.3435881207 -3.3300189386 2.1785193691 
H -4.1900842318 -3.644939261 1 2.7803401326 
610 
 
C -2.0473066629 -3.524986218 2.6489684367 
H -1.86902654 02 -3.9779698917 3.6204977809 
C -0.9554758544 -3.1151268128 1.87646928 71 
P 0.6968122725 -3.4500420678 2.5551694207 
O 0.7359491706 -3.4368377 753 4.0517275298 
C 1.8160246378 -2.2340831789 1.7984395414 
C 2.4055171 674 -2.4047198226 0.5421143874 
H 2.235552139 -3.3167097967 -0.02477700 76 
C 3.2297301278 -1.4098246023 0.0192528725 
H 3.689623784 -1.54573728 15 -0.9544080048 
C 3.471464796 -0.2485423176 0.7521893139 
H 4.11730149 32 0.5232750664 0.3451785062 
C 2.8950973859 -0.0820414816 2.0111317575  
H 3.0939597159 0.8165048079 2.586453401 
C 2.069642977 -1.0734388006 2 .5366240699 
H 1.6294478088 -0.9673211007 3.5244048144 
C 1.1894422989 - 5.0660168211 1.8651270322 
C 0.7235193334 -5.5536726815 0.6420412293 
H  0.004250498 -4.9815457123 0.0617515943 
C 1.1675699147 -6.7854043324 0. 1657186506 
H 0.8130963448 -7.1693384146 -0.7847548084 
C 2.0723175234 - 7.5246354323 0.9231010489 
C 2.5305689243 -7.0549387055 2.1536513937 
H  3.2290393887 -7.648613241 2.7347525643 
C 2.0861563046 -5.8243961985 2. 6249674113 
H 2.416666876 -5.4459592519 3.5881091662 
C 2.5261894053 -8. 8770189435 0.4457025081 
F 1.8299771108 -9.8692245816 1.0324921818 
611 
 
F 3. 8219295832 -9.0970527549 0.7275351071 
F 2.373591864 -9.024706749 -0.88 07362425 
SCF E = -1448.1822637 
S12 
H 0.2375733958 -0.3749614259 0.0655597935 
C -0.58548 50099 -0.7433103866 0.6725443356 
C -1.8972879912 -0.5945567465 0.22491 37553 
H -2.0904182875 -0.1234994577 -0.7335168129 
C -2.9575250853 -1.0 410776987 1.0122036865 
H -3.9782251679 -0.9215176609 0.6626695231 
C -2 .7108868599 -1.6311143353 2.2518790386 
H -3.5377646926 -1.9665336384 2 .8695274109 
C -1.4022034745 -1.7845609611 2.7023100624 
H -1.1954116932  -2.225413023 3.6737986733 
C -0.3360424087 -1.3483681496 1.9080962944 
 P 1.3337139564 -1.638947451 2.5577919329 
O 1.4118469623 -1.6189503274  4.0517413297 
C 2.4308880225 -0.4303912422 1.7627240507 
C 2.9408757976  -0.5830362539 0.4693183989 
H 2.7172249038 -1.4755993236 -0.1101900513 
 C 3.7548817922 0.4063429155 -0.0779981762 
H 4.1523321703 0.2852216077  -1.0805630906 
C 4.0665481828 1.5432009213 0.6672727272 
H 4.7051303119  2.3104232179 0.2407950029 
C 3.5701644755 1.6907515297 1.9617977662 
H 3 .8239881582 2.5697403487 2.5454736189 
C 2.7540351702 0.7049985224 2.51 23156127 
H 2.375027687 0.795349408 3.526614075 
C 1.8315385331 -3.26270 15613 1.8799051909 
612 
 
C 1.3428272672 -3.777458029 0.6833563496 
H 0.600060 6725 -3.2301617351 0.106494542 
C 1.798091026 -5.0157575412 0.223700619 9 
C 2.7232835913 -5.7480325766 0.9522019151 
H 3.071457674 -6.710726987  0.5917335841 
C 3.193709571 -5.230616808 2.161000606 
C 2.7562867088 -3 .9998962507 2.630542886 
H 3.1093734042 -3.6071845075 3.5800506883 
C 4. 1806860586 -6.0544048942 2.9447545401 
C 1.2556455771 -5.5344998677 -1. 080349776 
F 1.5129981137 -4.6809953615 -2.0896266256 
F -0.0795083097 - 5.6826647346 -1.0348568763 
F 1.7813296341 -6.7206581581 -1.415581112 
F  3.6445987822 -7.2271347195 3.3282477101 
F 4.6064631059 -5.426664859 4 .0472353523 
F 5.2638170745 -6.3519773683 2.2036570579 
SCF E = -1785.1345575 
S15 
H -0.2817412749 0.635207499 0.0470855945 
C -1.1363766964  0.3125679745 0.6366215312 
C -2.4287618039 0.5225452663 0.1579477516 
H  -2.5772513331 0.9988413472 -0.8060973524 
C -3.5274656069 0.1314908553  0.9220196248 
H -4.5332343817 0.2994737301 0.5493341976 
C -3.3367074303  -0.4644163162 2.1686313038 
H -4.192493512 -0.7571383038 2.7687272585 
 C -2.0467262534 -0.6773584792 2.6491210993 
H -1.8817268544 -1.12291811 73 3.6264603395 
C -0.9424482513 -0.2970114535 1.8796884445 
613 
 
P 0.7018722 621 -0.6541792527 2.5732259935 
O 0.7230768162 -0.6213889385 4.07100200 98 
C 1.8275120225 0.5630005121 1.8221288707 
C 2.45798458 0.3638051347  0.5904646945 
H 2.3161197554 -0.5684313262 0.0492542903 
C 3.2841091029  1.3548367139 0.0623592978 
H 3.7753281139 1.1967646311 -0.8926228862 
C  3.4874129123 2.5410429029 0.7661225247 
H 4.1345150082 3.3100718389 0.3 555916793 
C 2.8701113103 2.7366336854 2.0015855232 
H 3.038634599 3.655 0543405 2.5550069963 
C 2.042603711 1.7492681131 2.5312674882 
H 1.57044 90029 1.8785891382 3.5014649433 
C 1.1895424093 -2.2631238352 1.8850591 287 
C 0.6875555872 -2.7755841978 0.6874359701 
H -0.0678941716 -2.22651 63947 0.1307684608 
C 1.1444567383 -4.0017025874 0.2053455715 
H 0.74680 74495 -4.3930088927 -0.7274101863 
C 2.0991766509 -4.7398846914 0.90842 78207 
C 2.5871907987 -4.2220414379 2.1148207515 
H 3.3238147347 -4.7888 663649 2.6790330688 
C 2.1391010347 -3.0000987467 2.6025430928 
H 2.5083 824861 -2.6114616584 3.5479062513 
C 2.5825521897 -6.0743332312 0.40130 85687 
H 3.6753897219 -6.1200218588 0.3990467673 
H 2.220760503 -6.88579 93556 1.0408582944 
H 2.230214029 -6.2638900728 -0.6150859785 
SCF E = -1150.5275635 
614 
 
S13 
H 0.2113406955 0.1336154119 0.0441824405 
C -0.637558461 -0.202952073 7 0.6340948345 
C -1.9335555961 -0.0085219836 0.1589009425 
H -2.0903116 483 0.4688235251 -0.8032154504 
C -3.0254065263 -0.4156316581 0.9244668 569 
H -4.0339244516 -0.2593878422 0.5543679081 
C -2.8249057067 -1.0117 277027 2.1694457021 
H -3.6756449122 -1.3161598214 2.7707181479 
C -1.53 15970309 -1.2093064917 2.6471942581 
H -1.3595913252 -1.6536949569 3.62 38416208 
C -0.4342527538 -0.8130528644 1.8755032925 
P 1.2137283847 -1. 1488343618 2.5654587821 
O 1.2426357595 -1.1223063279 4.0619980107 
C 2. 3400635416 0.0586497048 1.8053434169 
C 2.9364570417 -0.1262879787 0.55 42856385 
H 2.7665383119 -1.0438374735 -0.003731958 
C 3.7666203771 0.86 10576652 0.0266228596 
H 4.2322504458 0.7143341659 -0.9427693986 
C 4.00 7117072 2.0289239973 0.7494135149 
H 4.6577254981 2.7947879923 0.338786 7737 
C 3.4237451969 2.2095848673 2.003238504 
H 3.6219362515 3.11317972 67 2.5708128008 
C 2.5922971231 1.2257795662 2.533469895 
H 2.1465967624  1.3426077981 3.5175996672 
C 1.7106276893 -2.7680875572 1.8851693601 
C  1.2052741954 -3.283880508 0.6890864942 
H 0.4526817857 -2.7346256124 0 .1296160968 
C 1.659125207 -4.5162852305 0.2236463415 
615 
 
H 1.2703578643 -4 .9277883746 -0.7050119669 
C 2.608243402 -5.231935603 0.9541067906 
C 3. 1049659277 -4.7233880686 2.1590235888 
H 3.8341883312 -5.3070448032 2.7 125192155 
C 2.6540836354 -3.4953741708 2.6246259188 
H 3.0107999039 -3. 0909899384 3.5679139651 
C 3.0808992966 -6.5451074209 0.4444378115 
H 2. 6250341749 -6.8721614063 -0.5128900557 
O 3.9018583366 -7.2335553101 1. 0045013495 
SCF E = -1224.5133593 
S14 
H -0.0099554158 0.0678463549 0.0401807194 
C -0.8572737694 -0.259194651 5 0.6377673074 
C -2.1551419996 -0.0539875 0.1723354602 
H -2.3151692291  0.4222842757 -0.7898003026 
C -3.2445788151 -0.4483382244 0.9479959364  
H -4.2546058573 -0.2832478609 0.5858742549 
C -3.0395183892 -1.0427793 147 2.1929774333 
H -3.8881559943 -1.3371639134 2.802204853 
C -1.744182 8569 -1.2512702887 2.6607169246 
H -1.5680171961 -1.6942826159 3.637228 2884 
C -0.64943758 -0.8676964187 1.8791885636 
P 1.0011713391 -1.215894 9543 2.5580879836 
O 1.0363434894 -1.1929570195 4.0547031891 
C 2.125461 6474 -0.0055049746 1.7986533967 
C 2.7212588854 -0.1856584492 0.5467482 585 
H 2.5531984098 -1.1027021809 -0.0127740702 
C 3.5480686166 0.805614 0668 0.0207038451 
H 4.0132884816 0.662647342 -0.9494704317 
616 
 
C 3.7858292 087 1.9724627125 0.7460865841 
H 4.4336667332 2.7412991546 0.3365478286  
C 3.2030799312 2.1482511492 2.0008839418 
H 3.3990871406 3.0511107547  2.5704505708 
C 2.3753452268 1.1605138443 2.529433482 
H 1.9302694453 1. 2735392728 3.5142754935 
C 1.4856923521 -2.8330488132 1.8689235697 
C 0. 9737047353 -3.3426992172 0.6736593048 
H 0.2245564365 -2.7860480672 0.1 166604439 
C 1.4100156085 -4.5789227342 0.2006321491 
H 1.0012486241 -4. 9653748239 -0.7276859137 
C 2.3550928572 -5.3143527587 0.9211333067 
C 2 .8564872431 -4.8058706914 2.1246269168 
H 3.5810141353 -5.397871447 2.6 74381708 
C 2.42327422 -3.5742310189 2.5988132582 
H 2.7902279811 -3.181 0185337 3.5428794514 
C 2.852856233 -6.6538021961 0.4515271791 
O 3.6877 3667 -7.2564723092 1.0950882728 
C 2.2933596228 -7.2289929243 -0.830862 6372 
H 1.2082793951 -7.3508329832 -0.7576712249 
H 2.4977599331 -6.5622 55729 -1.6743147445 
H 2.7595142306 -8.1971767935 -1.0092929708 
SCF E = -1263.8189876 
S16 
P 0.919008922 -0.5737563929 0.413586 6799 
C 1.6004317132 -1.3535856305 -1.1136455359 
O 1.1601004475 -1.3106 271847 1.696162819 
C 1.8210458185 1.0151114309 0.1948554459 
H 1.158821 0933 1.7621577725 -0.2615200784 
617 
 
H 2.1445323486 1.3878792961 1.16999916 54 
H 2.2655106505 -2.1496462454 -0.7621490645 
H 0.818050276 -1.8084241 382 -1.7256628211 
C 2.3894370568 -0.2470736678 -1.8315514047 
H 3.17046 36827 -0.6601908627 -2.4780061612 
C 2.9814113222 0.6832945902 -0.75866 69578 
H 1.7195456705 0.342051232 -2.4738138864 
H 3.7321719243 0.111826 4509 -0.1945191358 
C -0.8497035156 -0.2559199508 0.1281282073 
C -1.322 6779501 0.3692469588 -1.0305221135 
C -1.7492571879 -0.6733700524 1.110 4607501 
C -2.6880213173 0.577843005 -1.2038981294 
H -0.6280956062 0.69 43057939 -1.8031823146 
C -3.1169060823 -0.4611908294 0.9363886938 
H -1 .3600728715 -1.1625337064 1.999363038 
C -3.5850705657 0.1630422957 -0. 2178728876 
H -3.053378783 1.0621365337 -2.1040187219 
H -3.8158099109 - 0.7847058061 1.7012919633 
H -4.6496802534 0.3271506829 -0.3528502478 
C  3.6427966384 1.9242257963 -1.3468058803 
H 4.0552374853 2.5640608273 - 0.5613735463 
H 4.4574099579 1.6522143646 -2.025530822 
H 2.9125864063 2 .5135383965 -1.9136317235 
SCF E = -844.579844 
S17 
C 0.5834050177 -2.6781226672 0.60518 90628 
C 0.7308048295 -1.3021508222 0.4885669607 
C 1.8104681393 -0.7426 442378 -0.2137030315 
C 2.7483019961 -1.5803734533 -0.8142635475 
618 
 
C 2.60 10880754 -2.96300267 -0.6979243436 
C 1.5299878881 -3.512855427 0.00826 61007 
H -0.2536445433 -3.0953669809 1.1578693578 
H 3.5895568936 -1.168 9352938 -1.3640918594 
H 3.3318264612 -3.6189576052 -1.1607033519 
H 1.4 344571615 -4.5903541978 0.0937149595 
C 1.8103302795 0.7430559528 -0.21 35343982 
C 2.7480050872 1.5810961143 -0.8139101751 
C 0.7305647988 1.30 2202546 0.4888658464 
C 2.6005333402 2.9636716346 -0.6972583219 
H 3.589 3328133 1.1699382202 -1.3638367593 
C 0.582908139 2.6781206952 0.605798 2216 
C 1.5293330536 3.5131649024 0.009060537 
H 3.3311466737 3.61986750 95 -1.1598932914 
H -0.2542173071 3.0950845458 1.1585752747 
H 1.4336014 415 4.5906265912 0.0947527548 
P -0.3570169201 -0.0001492581 1.14947997 8 
O -0.6935171666 -0.0003536695 2.6060345897 
C -1.8476086341 -0.000163 6823 0.1090584725 
C -3.0849878133 -0.0004319508 0.7542532191 
C -1.7803 708656 0.0000744538 -1.288096751 
C -4.258485171 -0.0004648474 -0.00055 1805 
H -3.1095547494 -0.000606042 1.8405577586 
C -2.9527782123 0.00004 06798 -2.0368954089 
H -0.8136098389 0.0002868761 -1.7877380842 
C -4.19 17489357 -0.000229729 -1.3919032483 
H -5.2223566109 -0.0006729949 0.49 85520391 
H -2.9035855744 0.0002259358 -3.1211523524 
619 
 
H -5.1053107466 -0 .0002551285 -1.9784834033 
SCF E = -1110.0380815 
S18 
C -0.154401145 -1.4427834093 0.9 195140769 
C 0.870857369 -0.2958599296 0.9948002629 
C 0.0479139143 -0.1 964812898 -1.1386577274 
H 0.2683766175 -2.4217780876 1.1508254851 
H -0 .9992316773 -1.2399245298 1.5893727196 
C 0.2279281727 0.7458596635 0.0 63703901 
H 0.8652577422 1.6077332015 -0.1492381841 
H -0.7340691978 1.1 00040182 0.450758244 
C 1.4650281441 -0.5986632097 -1.5908997412 
H 1.93 66439911 0.1862431969 -2.1897730112 
H 1.4571671677 -1.5328860991 -2.15 60161341 
H 1.1101203487 0.0203012171 2.010621169 
H -0.5712298485 0.167 5074798 -1.9598786012 
P 2.3376444039 -0.8752902118 0.0205414409 
C 3.66 05905485 0.3596059808 0.211424438 
C 4.730686973 -0.0210659175 1.029197 4678 
C 3.6640820848 1.6258385347 -0.3838212604 
C 5.7816174412 0.862721 4313 1.2633385565 
H 4.7331846653 -1.0199681191 1.4566430798 
C 4.717156 8318 2.5074415752 -0.1487606226 
H 2.8594520181 1.932508868 -1.04614017 28 
H -6.3827073761 2.8337491272 1.0623868544 
H -5.2625668788 2.9709155 739 2.4216513406 
C 5.7735247068 2.1278798667 0.6780796481 
H 6.61025745 94 0.5602144088 1.8955926154 
H 4.7162815809 3.486246544 -0.6177620954 
620 
 
 H 6.5945248121 2.8150945318 0.857068596 
O 2.8122431143 -2.2576618309 0 .3399632551 
N -0.5699098562 -1.3887650927 -0.5074422734 
S -2.143755946 6 -1.7589904176 -0.8788091402 
O -2.2396960141 -1.7210778664 -2.3296819 145 
O -2.4679377328 -2.9392678565 -0.0956721927 
C -3.134114926 -0.4145 321569 -0.2510816958 
C -3.615628703 -0.4690518315 1.0551040683 
C -3.35 95398472 0.701994063 -1.0551517026 
C -4.3124802391 0.623762256 1.56491 32717 
H -3.4652963932 -1.3674125545 1.6457884004 
C -4.0574972942 1.784 0012817 -0.5287977708 
H -3.0120486296 0.7033589224 -2.0837239912 
C -4. 5391284802 1.7631009009 0.7859657809 
H -4.6952845624 0.5867355752 2.58 11962793 
H -4.242592048 2.6556081525 -1.1510288959 
C -5.3254430135 2.9 267126923 1.3319760952 
H -4.9625092977 3.8743641831 0.9265120808 
SCF E = -1717.4562203 
S19 
P 0.4556217174 0.6166342391 0.4337161834 
O 0.638942 8536 1.3466839956 1.7312480304 
C -1.3048543586 0.30175107 0.0876438353  
C -2.1677010918 0.3859479969 1.1860367498 
C -1.821779308 -0.025780812 2 -1.170571915 
C -3.528239206 0.1300244331 1.0295932444 
H -1.757020464 3 0.6706458914 2.1508243413 
C -3.1829417031 -0.280663874 -1.3246880418  
H -1.174925365 -0.0730997025 -2.0419183349 
621 
 
C -4.0358805904 -0.2066633 522 -0.2241761845 
H -4.1924925925 0.2001276537 1.8851893903 
H -3.57770 67442 -0.5301820017 -2.3045546955 
H -5.0964713933 -0.4030617181 -0.346 9292737 
C 1.2589700079 1.3441822671 -1.0654770063 
C 2.3299862698 0.294 6923381 -1.4336204158 
C 1.3888932854 -0.9678044248 0.2667657702 
H 1.67 87935172 2.3172546511 -0.7964856553 
H 0.5387381508 1.4889825401 -1.877 0244511 
C 1.6272871784 -1.0663041776 -1.2505236415 
H 2.2903148463 -1.9 054856806 -1.4894789087 
H 0.7144885545 -1.171238932 -1.8447540418 
C 3. 4203206034 0.2395042286 -0.3370290072 
H 4.3342146106 -0.2107418248 -0. 7345975137 
H 3.6766155444 1.2392820272 0.0252846419 
C 2.8075479277 -0. 6502117491 0.7871978546 
H 3.3700063375 -1.582504325 0.8974020651 
H 2.7 837864453 -0.1478066635 1.7565066881 
H 2.7378094268 0.463574079 -2.433 5449334 
H 0.8976275305 -1.8162881631 0.7460152253 
SCF E = -882.6669597 
S20 
P 0.5387299416 0.8431354194 -0.43311 2239 
O 0.5757667658 2.1331691746 -1.1972699633 
C -1.1678528022 0.25709 22328 -0.1934755131 
C -1.5532257578 -0.6557531795 0.7944160039 
C -2.13 07559526 0.7818433367 -1.0613910908 
C -2.8841518478 -1.052158462 0.902 0956033 
H -0.8202320413 -1.0579864188 1.4893610333 
622 
 
C -3.4617021098 0.3 826515784 -0.9535543072 
H -1.8225882392 1.5156938221 -1.8010390602 
C - 3.83800791 -0.5354525931 0.0252707856 
H -3.1774411044 -1.7585787535 1. 6722600988 
H -4.2054094924 0.794474097 -1.6283994829 
H -4.8754906763 - 0.843200344 0.1117995554 
C 1.4406660146 0.8280809877 1.1817032653 
C 2. 5824473388 -0.1883911361 0.953259066 
C 1.6078980684 -0.4878310638 -1.1 284086641 
H 0.8048649554 0.5810071999 2.0364921657 
H 1.8264317325 1.84 3199973 1.3197291879 
C 2.9623885958 -0.0402911863 -0.5345699178 
H 3.76 77076742 -0.7256697648 -0.8213909491 
H 3.2442641127 0.9794292259 -0.81 46713728 
C 2.0298632405 -1.6288240667 0.9929713269 
H 2.8445906499 -2.3 423914932 1.1458076724 
H 1.3224359817 -1.7716654462 1.8165935658 
C 1.3 799280686 -1.8319091126 -0.4089671369 
H 1.9000713048 -2.621167768 -0.9 602356852 
H 0.3264645258 -2.1187788042 -0.3604147819 
H 3.409975823 -0. 0290947727 1.6491378663 
H 1.5434921395 -0.5240476821 -2.2170100323 
SCF E = -882.6667364 
S22 
P -0.2341744663 0.0033751883 0.82433 88998 
O -0.245405796 0.0092843432 2.3237611535 
C 1.4772546407 0.000326 8537 0.1859691363 
C 2.4824729666 0.0038586507 1.1584803562 
C 1.8326380 335 -0.0049888461 -1.1687730298 
623 
 
C 3.8246865855 0.0021419429 0.78133565 23 
H 2.191185389 0.0079715969 2.2051380802 
C 3.1733949563 -0.006688619 4 -1.5435355655 
H 1.0694954171 -0.0078393432 -1.9423006102 
C 4.1708054 396 -0.0031048871 -0.5678418407 
H 4.5986358452 0.0049379409 1.54237893 98 
H 3.4398173797 -0.0108026224 -2.595783379 
H 5.2158137144 -0.0044206 079 -0.8619870129 
C -1.3039823192 -1.203013809 -0.1034266195 
C -1.7953 932227 -0.003242078 -0.9884001641 
H -1.1881304817 -0.007061436 -1.9052 608427 
C -1.3031368696 1.2031261618 -0.1129458997 
C -2.3626674882 1.78 5029169 0.8300993426 
H -1.8939845343 2.4986304261 1.5134467603 
H -3.12 67984719 2.3134453223 0.2482755204 
H -2.8573521968 1.0330801264 1.4468 963613 
C -0.6548516162 2.3391335232 -0.8971807523 
H -1.4170057732 2.85 14082623 -1.4977392388 
H -0.2114501024 3.0771428683 -0.2210141523 
H 0. 1291745758 1.9931392286 -1.5743815986 
C -3.2622300332 -0.0043324613 -1 .3987741569 
H -3.4946446124 0.8780427418 -2.0042074957 
H -3.4953400289  -0.8914220213 -1.9970018833 
H -3.9255679531 -0.0005332208 -0.52937895 49 
C -2.3639593909 -1.7766598955 0.8441565402 
H -3.1283915276 -2.30921 80386 0.2665150891 
H -1.8958087004 -2.4850649694 1.5332526873 
H -2.858 2126815 -1.0194503899 1.4548269706 
624 
 
C -0.6564624127 -2.3456099612 -0.8786517917 
H -0.2136684976 -3.0786249635 -0.1966771 
H -1.4189160247 -2.8620125159 -1.4752859711 
H 0.1278932581 -2.0054916595 -1.55844043 
SCF E = -962.4474531 
S23 
P 1.2833389962 -0.3898539923 0.6108712025 
O 1.6557526951 -1.3536806364 1.6987947776 
C -0.5169926102 -0.2712465974 0.4101326199 
C -1.18495013 0.7723293502 -0.2295435423 
C -1.271 6014757 -1.3348064421 0.9313645976 
C -2.5737746523 0.7652828261 -0.368 5597792 
H -0.636772494 1.6230193891 -0.6246668275 
C -2.6496536261 -1.356258396 0.8004420538 
H -0.7540586998 -2.1328498298 1.456509007 
C -3.3 077269944 -0.3071518594 0.1452295044 
H -3.0627897565 1.5939789628 -0.8 659070398 
H -3.2454695298 -2.1689494861 1.2020817953 
C 2.0068262683 1. 3110663537 0.7052713032 
C 2.9326941909 1.3700915824 -0.5287292409 
C 2. 0525588733 -0.7123754124 -1.0369089244 
H 2.5417569594 1.4087220378 1.6 538961051 
H 1.2293953273 2.0806947913 0.6651296434 
C 2.1279661583 0.69 36458344 -1.6578725499 
H 2.6817628212 0.6769826376 -2.6034326297 
H 1.1 536982388 1.1581661352 -1.8394901286 
C 4.1172295035 0.3907527863 -0.35 23511665 
H 4.9394763668 0.6680152079 -1.0180987426 
H 4.5028351999 0.40 68704389 0.6711553655 
625 
 
C 3.5387299107 -1.0048369886 -0.7375850424 
H 4.0 21912453 -1.3917839172 -1.6400979769 
H 3.6563522245 -1.7439562621 0.05 77075323 
H 3.2525489483 2.3918257319 -0.7492055643 
H 1.5355012997 -1.4 802466439 -1.6149056939 
O -4.6570114127 -0.4148909132 0.0658258491 
C -5.3690346002 0.6230279767 -0.5776614427 
H -5.0622191572 0.7220839812 –1.6253891434 
H -6.4195550812 0.3394761271 -0.5320111569 
H -5.225699215 1.5793222266 -0.061362765 
SCF E = -997.1509048 
DHDS 
Si -4.394258159 1.9231665752 0.1148453051 
O  -3.0879792761 2.8766785482 0.4553729558 
Si -1.4920117288 3.2393777387  0.2252284964 
H -4.0617531403 0.5046621859 0.4036354297 
H -4.730511725 5 2.0375107634 -1.3271374183 
H -1.2777949024 3.6636225784 -1.1816045698 
H -0.6662778518 2.0307938744 0.4776688465 
C -0.9957991941 4.61290518 57 1.3942083858 
C 0.4779337056 5.0144963916 1.2461150337 
H -1.1964219023 4.2875225178 2.4233018223 
H -1.6434091907 5.4804353 1.2121721726 
C  0.8931303503 6.1356768216 2.1993348511 
H 1.1217776759 4.1417656664 1.4 232584197 
H 0.6752206966 5.3352037647 0.2137719949 
C 2.3598339039 6.53 6062934 2.056492218 
H 0.2554130458 7.0128300341 2.0219022656 
H 0.6997774412 5.8181388734 3.2334209756 
626 
 
H 2.9960529595 5.6571283019 2.2325559649 
H 2.5521505025 6.8519348057 1.0213556422 
C -5.8469187295 2.4691160868 1.1593824605 
C -7.1076382755 1.6316458013 0.9055894408 
H -6.0496701 697 3.5281142588 0.953117909 
H -5.5609637036 2.4091160645 2.2175791533  
C -8.3012504477 2.0715249162 1.7540316053 
H -7.386300597 1.6893527031  -0.1558092874 
H -6.8986888038 0.5722614385 1.1094982125 
C -9.55672429 2 1.2383227691 1.5059219795 
H -8.0277245617 2.0131410326 2.8167411338 
 H -8.5176593642 3.1292091053 1.5490547031 
H -9.8282146467 1.2964230977  0.4423396463 
H -9.3378565697 0.1805559739 1.7096755448 
C 2.7747713643  7.6559874275 3.0094135335 
C 4.2436438752 8.0453165274 2.8565112664 
H  2.5818280237 7.3392842184 4.0424426552 
H 2.1393083284 8.5331770905 2.8 321635424 
H 4.5221618741 8.8468437983 3.5462967814 
H 4.8965288743 7.18 90073625 3.0555480364 
H 4.4513791434 8.3910433403 1.8384648464 
C -10.7 492711912 1.6774392444 2.3541364874 
C -11.9970669614 0.835264727 2.096599521 
H -10.9671956946 2.73347927 2.1492630609 
H -10.4765942224 1.6192528356 3.4157220355 
H -12.8391246579 1.1637202637 2.7121415744 
H -12. 302284962 0.9015582443 1.0470437073 
627 
 
H -11.8083460131 -0.2197773986 2.3210304889 
SCF E = -1129.3358608 
TPDS 
Si -3.8518455845 1.8338312784 -0.3784287913  
O -2.3082942769 1.3888815821 0.0391177244 
Si -1.2119386955 1.72006921 49 1.2402286622 
C -4.7365041459 2.6181964685 1.0743801467 
C -4.9087968 475 4.0064548323 1.1779259728 
H -4.5575015731 4.6561999571 0.379070304  
C -5.5103168227 4.5713975845 2.3006562872 
H -5.6288320998 5.648923295 2 2.3660641312 
C -5.9403869912 3.7556342698 3.3464139087 
H -6.40431743 84 4.1960354721 4.2241856732 
C -5.772417666 2.3738363229 3.2655711932 
 H -6.1051032556 1.7350239668 4.0781814724 
C -5.1808240573 1.8130969389  2.134586767 
H -5.0596005899 0.7322438271 2.0838908463 
C -1.5500299382  3.3995815941 1.9974848243 
C -1.2777029515 4.5584706278 1.2541403592 
H  -0.8211072179 4.4769067611 0.2689921228 
C -1.5894951947 5.8228143397  1.7512558186 
H -1.3765080172 6.7075226557 1.1587859359 
C -2.1701497093  5.947145777 3.0129635733 
H -2.4109608924 6.9307556522 3.405555546 
C - 2.4434918275 4.8077232246 3.7682268655 
H -2.9078322872 4.900425889 4.7 455757202 
C -2.1414821736 3.5454893283 3.2606842102 
H -2.3840469195 2. 6637553729 3.8499982127 
H -4.5647017212 0.592784653 -0.7609934875 
628 
 
H 0. 1231928738 1.7382854847 0.5997850825 
C -1.3518551017 0.3708556309 2.52 76208505 
C -0.6080082666 0.4142981013 3.716656375 
C -2.211617631 -0.71 66007224 2.3225857657 
C -0.721747284 -0.5930132286 4.6723224355 
H 0.06 57182591 1.24864463 3.9051047102 
C -2.331666613 -1.7274687848 3.276378 7536 
H -2.7887251797 -0.774455121 1.4020391671 
C -1.5869180603 -1.6653 712767 4.4525026199 
H -0.139239324 -0.5424007957 5.5871967409 
H -3.002 1791091 -2.563321807 3.1005294708 
H -1.6780294098 -2.4511475963 5.1963 06323 
C -3.7241583142 3.0380405329 -1.8029089485 
C -4.8619679471 3.664 4173524 -2.3339344976 
C -2.4767369868 3.3403698509 -2.3651571203 
C -4. 7578662016 4.5656537708 -3.3911004667 
H -5.8438207181 3.4530228131 -1. 9134412422 
C -2.3655916787 4.2434973676 -3.4225549126 
H -1.584328139 2 .8582911031 -1.9719465658 
C -3.5066620499 4.8569174463 -3.9357026157 
H  -5.6487675213 5.0418411146 -3.7891235155 
H -1.3910622519 4.465684125  -3.8469070071 
H -3.4229684808 5.5599058829 -4.7589807017 
SCF E = -1581.6893376 
Diphenylsilanol 
Si 0.0315883496 1.5976476802 0.0391800535 
C 1.5509530393 0.5236509991  -0.0813591342 
C 1.5655302792 -0.6059654446 -0.912226556 
H 0.672575159 4 -0.8779057673 -1.4725461632 
629 
 
C 2.704880318 -1.4002234113 -1.021988462 1 
H 2.6993040088 -2.2724591895 -1.6686454626 
C 3.8494940217 -1.0759556 214 -0.294540897 
H 4.7385096381 -1.6943639852 -0.3770156465 
C 3.849722 7179 0.0388124049 0.542295423 
H 4.738364415 0.2887270994 1.1142323512 
 C 2.7084141009 0.8329353189 0.6464381844 
H 2.7073822755 1.6961601063 1 .3069325277 
C -1.5169652757 0.5478531028 0.093228298 
C -1.6494276297 - 0.4705877013 1.0510949367 
H -0.8446343653 -0.6490669398 1.7618786432 
C  -2.793704558 -1.2617635737 1.1034742151 
H -2.8798890286 -2.044533935  1.8510776241 
C -3.8285997097 -1.0497629246 0.191336788 
H -4.720602544  -1.6679010167 0.2296008222 
C -3.7155983608 -0.0468133714 -0.7687818382  
H -4.518380187 0.1177663184 -1.4812726498 
C -2.5675554964 0.745337990 8 -0.8129352875 
H -2.4889337136 1.5255864122 -1.5674873722 
H -0.120038 7914 2.5164706081 -1.119306614 
O 0.2661699057 2.4670536279 1.442180134 8 
H -0.397594949 3.1131089728 1.6988052613 
SCF E = -829.0356078 
n-Hexylsilanol 
Si  -3.591718638 -0.3152944631 0.0000166511 
C -1.9987887992 0.660851197 -0 .0000274198 
H -1.9929089514 1.3184173376 -0.8787259018 
H -1.99290499 1 .3184857716 0.8786200028 
C -0.7517804096 -0.2336694988 0.000003255 
630 
 
H - 0.7658097174 -0.8935462211 0.8785626556 
H -0.7658092366 -0.8936068997  -0.8785109 
C 0.5552292969 0.5598075404 -0.0000234685 
H 0.5761662775 1. 2183611771 -0.8794410115 
H 0.5761676502 1.2184159033 0.8793531091 
C 1. 7974019316 -0.3285323952 0.0000036681 
H 1.7734372651 -0.9878383202 0.8 792864967 
H 1.7734409844 -0.9878865713 -0.8792431647 
C 3.1049891255 0. 4619097714 -0.0000148153 
H 3.1279507104 1.1195006326 -0.8785069633 
H 3 .1279469408 1.119547556 0.8784423364 
C 4.3372802876 -0.4405316699 0.00 00124857 
H 4.3463239016 -1.086936343 0.8839238981 
H 4.3463295024 -1.08 69823635 -0.8838651714 
H 5.2632777056 0.1411837651 0.0000003484 
H -3.6 667943365 -1.1915353562 1.1997293596 
H -3.6668208253 -1.1916056499 -1. 1996429624 
O -4.8420047414 0.788180053 -0.0000025212 
H -5.7493638241 0 .4735870868 0.000011693 
SCF E = -602.8618275 
 
Entry M06-2X B3LYP 
PhSiH3 
Si 2.34452900 0.00060100 0.00346200 
 H 2.86396600 -0.91552800 -1.03993100 
 H 2.82712300 1.37735800 -0.25376200 
 C 0.46700000 0.00178900 -0.00804700 
 C -0.25507700 1.20344700 -0.00605400 
 C -0.25352500 -1.20269500 -0.00599200 
Si 2.35276400 0.00027100 0.00446300 
 C 0.46954000 -0.00091000 -0.01056700 
 C -0.25787400 -1.20692000 -0.00765300 
 H 0.26763600 -2.15935900 -0.01688300 
 C -1.65507800 -1.20888200 0.00247400 
 H -2.19519600 -2.15159700 0.00335900 
631 
 
 C -1.65039400 1.20507600 0.00168400 
 H 0.27480000 2.15315900 -0.01287000 
 C -1.64688400 -1.20769600 0.00186200 
 H 0.27664400 -2.15296700 -0.01294300 
 C -2.34757100 -0.00128100 0.00633600 
 H -2.19130600 2.14659300 0.00237700 
 H -2.18619600 -2.15012900 0.00280700 
 H -3.43331500 -0.00284400 0.01132100 
 H 2.86359300 -0.45588700 1.31580100 
Sum of electronic and thermal Free Energies= -522.715793 
SCF E= -522.801231926 
 C -2.35656200 0.00098100 0.00834700 
 H -3.44289400 0.00130700 0.01438100 
 C -1.65428300 1.20891400 0.00233700 
 H -2.19281100 2.15253900 0.00298500 
 C -0.25574900 1.20517800 -0.00776900 
 H 0.27277700 2.15541000 -0.01695100 
 H 2.88431000 -0.32522900 1.35615700 
 H 2.84680400 1.34701600 -0.38274100 
 H 2.88072300 -1.01406000 -0.94581400 
Sum of electronic and thermal Free Energies = 
-522.860398 
SCF E = -522.940835531 
PhSi(OH)H2 
Si 1.92552700 0.42998700 -0.30143000 
 H 2.38058600 0.25462900 -1.69459600 
 H 2.22569600 1.80676400 0.16316900 
 O 2.77756900 -0.71970300 0.55398700 
 H 2.58748000 -0.81278400 1.49324400 
 C 0.08119600 0.16818900 -0.12367400 
 C -0.78268100 1.25077700 0.09392400 
 C -0.47683100 -1.11669900 -0.22170400 
 C -2.16047800 1.06178100 0.20328200 
 H -0.37730000 2.25635700 0.18491100 
 C -1.85185000 -1.31253500 -0.10997500 
 H 0.17036800 -1.97569700 -0.38698000 
 C -2.69547300 -0.22123400 0.10092900 
 H -2.81429000 1.91202600 0.37280000 
 H -2.26645300 -2.31298700 -0.18904500 
 H -3.76730500 -0.37217600 0.18792900 
Sum of electronic and thermal Free Energies= -597.967321 
SCF E= -598.056463464 
Si 1.93173200 0.18448100 -0.44481100 
 H 2.37341600 -0.69083900 -1.55844700 
 H 2.23832600 1.61164800 -0.75546900 
 O 2.82183100 -0.36351800 0.86131700 
 H 2.62971000 0.06286500 1.70925000 
 C 0.07823500 0.06681700 -0.20016000 
 C -0.69518400 1.22713700 -0.01281100 
 C -0.58485100 -1.17588400 -0.19603200 
 C -2.07663300 1.15273000 0.17745300 
 H -0.21374300 2.20305000 -0.02013400 
 C -1.96426600 -1.25617600 -0.00582300 
 H -0.01810200 -2.09262600 -0.34647700 
 C -2.71190100 -0.09029300 0.18206700 
 H -2.65586500 2.06147900 0.31927600 
 H -2.45783700 -2.22457100 -0.00761200 
 H -3.78721400 -0.15158900 0.32825600 
Sum of electronic and thermal Free energies= -
598.122058 
SCF E = -598.196438716 
632 
 
TPPO 
P -0.00080800 -0.00689100 0.96189900 
 O 0.00393400 -0.01256600 2.46414100 
 C 0.33327300 1.63548600 0.25589100 
 C 1.23640500 2.45393800 0.94352200 
 C -0.25100300 2.08746200 -0.93122500 
 C 1.56071100 3.71113400 0.43959300 
 H 1.67068200 2.10486800 1.87636100 
 C 0.07708700 3.34631400 -1.43380200 
 H -0.96750400 1.46416000 -1.46000200 
 C 0.98316200 4.15596900 -0.75028800 
 H 2.25889800 4.34520900 0.97660400 
 H -0.38030800 3.69599600 -2.35387500 
 H 1.23448600 5.13705200 -1.14115900 
 C -1.59093000 -0.53354800 0.25392300 
 C -1.69198900 -1.24252400 -0.94704700 
 C -2.75004800 -0.18002800 0.95379600 
 C -2.94665800 -1.58325800 -1.45132600 
 H -0.79499900 -1.53699300 -1.48563000 
 C -4.00160100 -0.52303800 0.44787800 
 H -2.66304900 0.35152100 1.89747300 
 C -4.09983200 -1.22185100 -0.75592300 
 H -3.02216700 -2.13629500 -2.38217600 
 H -4.89882300 -0.25023000 0.99422100 
 H -5.07552900 -1.49093300 -1.14842100 
 C 1.25355900 -1.11239100 0.24745900 
 C 1.56518500 -2.27342600 0.96304200 
 C 1.88665700 -0.85447000 -0.97242600 
 C 2.49550500 -3.17668200 0.45380600 
 H 1.08548300 -2.45401200 1.92106500 
 C 2.81578200 -1.76156200 -1.48010900 
 H 1.66338600 0.05617900 -1.52256000 
 C 3.11803900 -2.92217100 -0.76861700 
P -0.00454000 -0.03114800 0.89607200 
 O -0.01772300 -0.16901400 2.39743200 
 C 0.17586600 1.68932900 0.28816900 
 C 1.45138000 2.27462900 0.22725000 
 C -0.95036600 2.47889000 0.00781000 
 C 1.59727800 3.61923000 -0.11770300 
 H 2.33248900 1.68098300 0.45165400 
 C -0.80290700 3.82429800 -0.33770900 
 H -1.94464500 2.04629000 0.05955300 
 C 0.47041100 4.39548400 -0.40362700 
 H 2.58902800 4.05987400 -0.16222800 
 H -1.68203400 4.42439200 -0.55397300 
 H 0.58450700 5.44155000 -0.67318900 
 C -1.55211100 -0.68302600 0.15529200 
 C -1.84520300 -0.63189600 -1.21642700 
 C -2.46658400 -1.28288700 1.03268100 
 C -3.03397600 -1.17762500 -1.70308600 
 H -1.15431400 -0.16213600 -1.91031400 
 C -3.65704500 -1.82844800 0.54333500 
 H -2.23257700 -1.31124300 2.09267400 
 C -3.94109200 -1.77805300 -0.82326100 
 H -3.25305500 -1.13343100 -2.76609700 
 H -4.36023200 -2.29096300 1.22998500 
 H -4.86582700 -2.20242100 -1.20388600 
 C 1.37944500 -0.97675500 0.14895100 
 C 2.04701200 -1.88410300 0.98428700 
 C 1.77863200 -0.85201800 -1.19081400 
 C 3.09314700 -2.66358700 0.48316700 
 H 1.74267400 -1.96088200 2.02384800 
 C 2.82310500 -1.63245600 -1.68971200 
 H 1.28942900 -0.13751800 -1.84647700 
 C 3.48016400 -2.54105300 -0.85355500 
633 
 
 H 2.73862300 -4.07490000 1.01240100 
 H 3.30810200 -1.55795800 -2.42571200 
 H 3.84485700 -3.62527300 -1.16337800 
Sum of electronic and thermal Free Energies= -1111.001265 
SCF E = -1111.23403536 
 H 3.60604500 -3.36249700 1.13763100 
 H 3.12728500 -1.52765000 -2.72724900 
 H 4.29385300 -3.14617800 -1.24317100 
Sum of electronic and thermal Free Energies= -
1111.372496 
SCF E = -1111.59150273 
 
Basic output information for pre-reaction complexes are included below: 
Entry M06-2X B3LYP 
TPPO + 
PhSiH3 
Si -2.9372160464 1.5657275156 1.286519953 
C -3.3583586513 0.3896209332 -0.1100042512 
C -4.2216764928 -0.6982883508 0.0992294902 
H -4.7112578227 -0.8250982645 1.0630530563 
C -4.4538184701 -1.6322511878 -0.906721593 
H -5.1234905071 -2.4687012741 -0.7280836564 
C -3.8197977763 -1.4957300099 -2.144840275 
H -3.9883498173 -2.2317860301 -2.9251216422 
C -2.9658200572 -0.4201385802 -2.3726117558 
H -2.4411735106 -0.3224055848 -3.317098659 
C -2.7459146841 0.5176320901 -1.3625094876 
H -2.0582239404 1.3382269863 -1.5499943097 
H -2.2856200892 2.775907056 0.7319963516 
P 0.9113693008 -0.1654299419 -0.6591209267 
O 0.2811895058 -0.4065128847 -1.9982295702 
H -2.0217458352 0.9084360239 2.2548627288 
H -4.16943196 1.948887642 2.0204027656 
C 0.6598432874 1.5386672194 -0.0628103961 
C 0.710423955 1.9056698818 1.2854981979 
C 0.4521673942 2.5186401082 -1.0401427496 
C 0.5747248561 3.2438403211 1.65105068 
Si -2.1893786731 0.4223200076 
1.9635231995 
C -2.7292137735 -0.8779511539 
0.7159229147 
C -3.9898712024 -1.4938616845 
0.8216332931 
H -4.6597881988 -1.2211701723 
1.6338815773 
C -4.403439326 -2.4577508898 -
0.1033083386 
H -5.3813960072 -2.9210619717 -
0.0030629065 
C -3.557760776 -2.8224186595 -
1.1536230031 
H -3.8756594109 -3.5708677356 -
1.8746553769 
C -2.3009995447 -2.2208330116 -
1.2732719793 
H -1.6391430738 -2.5010710185 -
2.0884221987 
634 
 
H 0.8342491235 1.1486082122 2.0554063392 
C 0.3079230134 3.8543190597 -0.6712909753 
H 0.3977722425 2.2178994483 -2.0835432071 
C 0.3761345846 4.2176790047 0.67355869 
H 0.6092095624 3.5223577156 2.6996850525 
H 0.1402756241 4.6101963052 -1.4319984003 
H 0.2629767129 5.2584605663 0.9607736853 
C 0.2837193482 -1.2705389355 0.6406869967 
C 0.9806752433 -1.5124341204 1.830639563 
C -0.952478976 -1.8838639353 0.4197157307 
C 0.4261162672 -2.3344446561 2.8079294617 
H 1.9641398918 -1.0751546374 1.9882057006 
C -1.5024052094 -2.7086271298 1.400131853 
H -1.4712171053 -1.7171227358 -0.5206330584 
C -0.8191960188 -2.9277304752 2.5943207203 
H 0.9682711486 -2.5207253852 3.7296645924 
H -2.4656560544 -3.1775624846 1.2238096792 
H -1.2493979901 -3.5701610929 3.356600168 
C 2.7161248142 -0.411724962 -0.6814383425 
C 3.2007178556 -1.3773542903 -1.5702390597 
C 3.607304611 0.2921973736 0.1332635263 
C 4.5653099739 -1.6486038155 -1.6287564542 
H 2.501582845 -1.8962486706 -2.2204790142 
C 4.9728575533 0.0171128923 0.0731569375 
H 3.2426247292 1.0666041619 0.8032533636 
C 5.4509185568 -0.9545516542 -0.8043835575 
H 4.9385424067 -2.3963200143 -2.3213993095 
H 5.6627540251 0.5682009816 0.7045119394 
H 6.5149425818 -1.1645733951 -0.8525035713 
Sum of electronic and thermal Energies = -1633.617606 
SCF E = -1634.04145 
C -1.8871804098 -1.2579663274 -
0.3487558416 
H -0.9051798306 -0.8033896272 -
0.4591943146 
H -1.9509101113 1.7419298602 
1.3221988266 
P 2.4466094702 0.99681816 -
0.3986602994 
O 1.1407420249 0.2475795874 -
0.5056072561 
H -0.9385146707 0.0256513289 
2.665219864 
H -3.2639000305 0.5802887772 
2.9813852312 
C 2.1990765783 2.8066347864 -
0.2572302189 
C 3.0733086718 3.6554963029 
0.4376201334 
C 1.0613876252 3.3461767063 -
0.8780808371 
C 2.8210609097 5.028848132 
0.4965481457 
H 3.9413268977 3.2486814791 
0.9479069101 
C 0.812563019 4.7184539415 -
0.8178706376 
H 0.3693169035 2.6839792298 -
1.3893879307 
C 1.6931079216 5.5615969524 -
0.1332234362 
H 3.5000428057 5.6786683949 
1.0412212492 
635 
 
H -0.0723206714 5.1272017364 -
1.2969823395 
H 1.4959432069 6.6286257989 -
0.0826909162 
C 3.4242725095 0.4860954015 
1.064518058 
C 4.8262469049 0.518610822 
1.1072557924 
C 2.7098332296 0.0360841771 
2.1861957847 
C 5.5038305859 0.1216383931 
2.2632278914 
H 5.3940889093 0.8365805597 
0.237790514 
C 3.3901278248 -0.3602874434 
3.3391594324 
H 1.6261832685 -0.0158801968 
2.1436545217 
C 4.7868957519 -0.3148204036 
3.380503346 
H 6.5895915071 0.1453693488 
2.2865063749 
H 2.8298817285 -0.7101700813 
4.2013231564 
H 5.3152810659 -0.6270026713 
4.2768015203 
C 3.5209230223 0.7293015179 -
1.8591608385 
C 3.4263019671 -0.5149523036 -
2.5028357542 
C 4.4072450652 1.6962572247 -
2.3562359947 
636 
 
C 4.2199031691 -0.7921597663 -
3.617220456 
H 2.7183753361 -1.2518405592 -
2.1354544476 
C 5.2007051583 1.4156351169 -
3.4722268927 
H 4.4702115031 2.6738259469 -
1.8874543964 
C 5.110306336 0.1713205999 -
4.1012634565 
H 4.1384388595 -1.7561726526 -
4.1109708423 
H 5.8810387134 2.1717079355 -
3.8535872152 
H 5.7248272603 -0.0437668959 -
4.9707936118 
Sum of electronic and thermal Energies= -
1634.159891 
SCF E = -1634.5783935 
TPPO + 
PhSiH3  
(frequency 
only) 
P 0.195266 0.681164 0.026755 
O 0.704621 1.363926 1.286521  
C -0.260398 1.916751 -1.239665 
C 0.446427 3.129929 -1.248072 
C -1.274485 1.699462 -2.184864 
C 0.148744 4.107642 -2.199318 
H 1.214358 3.307627 -0.501714 
C -1.568442,2.680112 -3.136038 
H -1.844191 0.775076 -2.175268 
C -0.856425 3.882947 -3.145299 
H 0.696593 5.045277 -2.197682 
H -2.357284 2.506819 -3.862083 
H -1.08936 4.64587 -3.882433 
P -1.154953 0.145751 -0.439533 
O -0.334704 0.159785 -1.709285 
C -2.161386 1.645294 -0.286981 
C -2.537034 2.292664 -1.467263 
C -2.572903 2.146567 0.951703 
C -3.335359 3.432953 -1.406959 
H -2.185984 1.904467 -2.419448 
C -3.373311 3.285649 1.006757 
H -2.260229 1.655291 1.870532 
C -3.755418 3.925823 -0.172081 
H -3.624596 3.939748 -2.322152 
H -3.691916 3.677102 1.96768 
H -4.375462 4.815912-0.127691 
637 
 
C -1.294553 -0.328235 0.347294 
C -1.562896 -1.526569 -0.330723 
C -2.196338 0.134945 1.319361 
C -2.727062 -2.246695 -0.047843 
H -0.8632 -1.906599 -1.068797 
C -3.357479 -0.587108 1.599174 
H -1.980237 1.051008 1.860595 
C -3.624903 -1.777205 0.91457 
H -2.926342 -3.176043 -0.57321 
H -4.048309 -0.225242 2.354842 
H -4.526763 -2.340381 1.136168 
C 1.442124 -0.427565 -0.719975 
C 2.269226 -1.162821 0.146834 
C 1.599439 -0.563768 -2.10781 
C 3.233609 -2.027512 -0.374304 
H 2.171645 -1.051444 1.222676 
C 2.566122 -1.431553 -2.623621 
H 0.980119 0.011354 -2.789012 
C 3.382323 -2.164593 -1.758146 
H 3.871552 -2.588811 0.301822 
H 2.684323 -1.52743 -3.698954 
H 4.135967 -2.835509 -2.160193 
Si 1.531847 0.726057 4.986429 
H 0.086047 0.932134 5.291468 
H 2.049543 -0.347286 5.87541 
C 2.418943 2.351134 5.33894 
C 1.909213 3.265694 6.279017 
C 3.629865 2.672751 4.697382 
C 2.584695 4.453466 6.576256 
H 0.968109 3.055506 6.78359 
C 4.307988 3.860579 4.985917 
H 4.042414 1.991205 3.957543 
C -0.108305 0.064102 1.039757 
C -0.380432 -0.777963 2.122107 
C 1.044538 0.857281 1.04057 
C 0.501317 -0.82465 3.200082 
H -1.264444 -1.410045 2.114114 
C 1.926827 0.801554 2.115677 
H 1.266156 1.491378 0.185706 
C 1.654343 -0.039881 3.194013 
H 0.296244 -1.485799 4.036134 
H 2.834792 1.396605 2.095892 
H 2.347252 -0.09155 4.028347 
C -2.283841 -1.270866 -0.332887 
C -1.793285 -2.512779 -0.757058 
C -3.582914 -1.165124 0.171622 
C -2.605097 -3.64057 -0.668525 
H -0.784193 -2.593457 -1.156811 
C -4.388906 -2.299535 0.259061 
H -3.969711 -0.200953 0.489864 
C -3.899985 -3.535308 -0.16006 
H -2.226589 -4.601542 -1.002023 
H -5.398791 -2.214809 0.647744 
H -4.530187 -4.417178 -0.096592 
Si 2.578033 -2.013745 -0.60248 
H 2.035191 -2.167788 0.776287 
H 3.385014 -3.216224 -0.911472 
C 3.661673 -0.478662 -0.622666 
C 4.713337 -0.332221 0.292792 
C 3.419114 0.564258 -1.52542 
C 5.496698 0.819988 0.313688 
H 4.919636 -1.124307 1.01172 
C 4.195494 1.724301 -1.506941 
H 2.603773 0.477654 -2.241078 
638 
 
C 3.787434 4.752395 5.929129 
H 2.171362 5.145681 7.304966 
H 5.239609 4.090845 4.47587 
H 4.313039 5.676305 6.154628 
H 1.74438582 0.28420371 3.74182697 
Sum of electronic and thermal energies = -1634.148507 
SCF E = -1634.56580789 
C 5.234797 1.853527 -0.587025 
H 6.308044 0.914893 1.029668 
H 3.990382 2.525071 -2.211465 
H 5.841541 2.754119 -0.573364 
H 1.61640781 -1.9412594 -1.52955287 
Sum of electronic and thermal energies = -
1633.612537 
SCF E = -1634.03515765 
 TPPO + 
PhSi(OH)H2 
P 0.15701600 0.69676400 0.02924700 
 O 0.63098100 1.39920900 1.28771500 
 C -0.28052800 1.91692800 -1.26035900 
 C 0.39108800 3.14926200 -1.23252800 
 C -1.24574700 1.67663900 -2.24967500 
 C 0.11093200 4.12139500 -2.19459600 
 H 1.11459700 3.34323500 -0.44669200 
 C -1.52235300 2.65176300 -3.21132700 
 H -1.79386200 0.73911500 -2.26431500 
 C -0.84254400 3.87268800 -3.18638100 
 H 0.63130800 5.07422100 -2.16516400 
 H -2.27350100 2.46066000 -3.97222400 
 H -1.06202400 4.63135900 -3.93213600 
 C -1.33503000 -0.31728900 0.32954400 
 C -1.60706200 -1.50379100 -0.36716100 
 C -2.23337600 0.13147700 1.31080500 
 C -2.77329800 -2.22454600 -0.09599800 
 H -0.90558200 -1.87619500 -1.10780500 
 C -3.39656100 -0.59145600 1.57910100 
 H -2.00853800 1.03542000 1.86875500 
 C -3.66908800 -1.76802200 0.87428200 
 H -2.97539700 -3.14537500 -0.63538000 
 H -4.08474200 -0.24128700 2.34279400 
 H -4.57257500 -2.33214600 1.08720000 
P 0.1952661685 0.6811642502 
0.0267548931 
O 0.7046212082 1.3639259535 
1.2865212252 
C -0.2603983865 1.9167512539 -
1.2396646136 
C 0.4464272402 3.1299285705 -
1.2480715392 
C -1.2744853488 1.6994615233 -
2.1848636843 
C 0.1487440131 4.1076424533 -
2.199317752 
H 1.2143582578 3.3076272995 -
0.5017135887 
C -1.5684418076 2.6801117114 -
3.1360382103 
H -1.844190821 0.7750758923 -
2.1752677877 
C -0.8564247058 3.8829472518 -
3.1452989372 
H 0.6965932122 5.0452774378 -
2.1976818041 
H -2.3572837389 2.5068189681 -
3.8620829485 
639 
 
 C 1.42140000 -0.41673100 -0.68204900 
 C 2.24490900 -1.12538500 0.21015800 
 C 1.59470300 -0.58156100 -2.06488000 
 C 3.22035600 -1.99377600 -0.28371600 
 H 2.13973200 -0.98860900 1.28275100 
 C 2.57254300 -1.45298100 -2.55188700 
 H 0.98085000 -0.02259900 -2.76448800 
 C 3.38421100 -2.16103600 -1.66204600 
 H 3.85614100 -2.53412400 0.41137200 
 H 2.70365500 -1.57057000 -3.62370000 
 H 4.14709900 -2.83495200 -2.04135900 
 Si 1.62381700 0.68740400 4.96594700 
 H 0.18925200 0.83741300 5.34938900 
 H 2.21784600 -0.39793300 5.78902700 
 C 2.47387700 2.32974500 5.33194400 
 C 1.97994500 3.19940200 6.32104800 
 C 3.64250100 2.70976200 4.64611000 
 C 2.63030700 4.39949200 6.62323000 
 H 1.06975800 2.94363500 6.86027900 
 C 4.29545200 3.90989600 4.93978000 
 H 4.03967400 2.06371300 3.86700000 
 C 3.79154700 4.75624200 5.93206700 
 H 2.22939900 5.05654200 7.39054300 
 H 5.19491100 4.18544300 4.39540500 
 H 4.29777900 5.68998300 6.16175600 
 O 1.82793300 0.20907600 3.39364200 
 H 1.38614400 0.71665400 2.67106600 
Sum of electronic and thermal Free Energies= --
1709.525079 
SCF E = -1709.86181457 
H -1.0893599623 4.6458702242 -
3.8824329242 
C -1.2945531294 -0.3282351455 
0.3472939947 
C -1.5628964357 -1.5265691871 -
0.330723113 
C -2.1963384141 0.1349446556 
1.3193609708 
C -2.7270624754 -2.2466949351 -
0.0478427836 
H -0.8631996617 -1.9065989372 -
1.0687971067 
C -3.3574789855 -0.5871082368 
1.5991741464 
H -1.9802367245 1.0510076027 
1.8605946406 
C -3.6249034224 -1.7772054113 
0.9145697996 
H -2.9263416709 -3.1760433123 -
0.5732104854 
H -4.0483093168 -0.2252422744 
2.3548417791 
H -4.5267634339 -2.3403810911 
1.1361682813 
C 1.4421237864 -0.4275650523 -
0.7199753389 
C 2.269225929 -1.1628211085 
0.1468342182 
C 1.5994391871 -0.5637677211 -
2.1078095349 
C 3.2336087514 -2.0275119471 -
0.3743037805 
640 
 
H 2.1716448862 -1.0514435551 
1.2226761758 
C 2.5661221893 -1.4315534744 -
2.6236211412 
H 0.9801190877 0.0113537787 -
2.7890124019 
C 3.3823230493 -2.1645930652 -
1.7581455358 
H 3.8715518938 -2.5888105129 
0.3018219776 
H 2.6843225726 -1.5274303927 -
3.6989538517 
H 4.1359673432 -2.8355091638 -
2.1601926125 
Si 1.5318471098 0.7260571486 
4.9864290006 
H 0.0860466226 0.9321336835 
5.291468115 
H 2.0495434965 -0.3472861262 
5.8754100202 
C 2.418943497 2.351134345 
5.3389400542 
C 1.9092128192 3.2656941721 
6.2790172335 
C 3.6298652222 2.6727507042 
4.6973815973 
C 2.5846952772 4.453466341 
6.5762560835 
H 0.9681088737 3.0555060352 
6.7835896008 
C 4.3079875932 3.8605794557 
4.9859165525 
641 
 
H 4.0424142095 1.9912046036 
3.9575428758 
C 3.787433761 4.7523949357 
5.929128698 
H 2.1713621178 5.1456809021 
7.3049664023 
H 5.2396086716 4.0908454147 
4.4758702722 
H 4.313039209 5.6763047556 
6.1546275651 
O 1.795157332 0.1786536977 
3.4445171452 
H 1.3907988528 0.6642286287 
2.6834391572 
Sum of electronic and thermal Free 
Energies=        -1709.532694 
SCF E=-1709.8681023 
 
